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In the process of gene expression, all living cells synthesise RNA. RNA is polymerised from nucleotide 
monomers in dependence of a complementary sequence on a DNA template, a gene. This is done by 
DNA-dependent RNA Polymerase (RNAP) and is called transcription. 
Previously, it was believed that only eukaryotic RNA can be 5’-“capped”. The 5’-cap in eukaryotes is 
attached post-transcriptionally and serves several functions in RNA metabolism and in translation 
(process of protein synthesis from an RNA template). Recently, a cap was found on bacterial RNA. The 
bacterial cap is not a modified canonical nucleotide (like the methylated guanosine cap of eukaryotes), 
but consists of small metabolites or cell wall precursors which are covalently bound to 5’-RNA. This 
thesis investigates how bacterial RNAP incorporates the non-canonical initiating nucleotide (NCIN)-
cap and discusses structural determinants of NCIN-capping of both RNAP enzyme and template DNA. 
RNAP accepts the cofactor and cell wall precursor as initiating substrate due to the free 3’-hydroyl group 
of the nucleotide moiety of the molecule. Functional moieties such as nicotinamide ribose or riboflavin 
on the 5’-end of the nucleotide ribose are bound as substrate by wiltype RNAP catalytic centre and RNA 
exit channel, and do not interact with upstream promoter regions. However, larger nucleotide-containing 
molecules such as uridine diphosphate N-acetylmuramic acid pentapeptide are inefficiently incorporated 
due to sigma subunit of RNAP.  
We further show that primase, RNA-polymerase of replication, incorporates NCIN into primer RNA 
and explore potential downstream effects on replication. DNA Polymerase I which replaces primer RNA 
with DNA, is differentially affected by 5’-cofactors on primer RNA. 
In the bigger picture, NCIN-caps as extensions of RNA primary structure might have a variety of 
physiological consequences, which are as of yet uncertain, but extensively discussed in this thesis. We 
argue that RNA stability, translation, localisation, and activity of regulatory RNA might be affected. 
RNA synthesis regulation in bacteria makes a fantastic target for drug development, as the cellular 
machineries of prokaryotes and eukaryotes differ. Also bacteria-infecting viruses, or bacteriophages, are 
often reported to interfere with host transcription in order to monopolise cellular resources in favour of 
their own gene expression and replication. We propose that studying the mechanisms by which 
bacteriophages hijack host gene expression could lead to the discovery or development of new 
antimicrobials. In order to investigate novel aspects of transcription regulation, we outline a 
methodology to study how bacteriophages regulate host transcription in mycobacteria. This bacterial 
family includes today’s most deadly bacterial pathogen, Mycobacterium tuberculosis. At the example 
of mycobacteriophage D29 gene product Gp53, we show that the protocol can be used to find new 
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AMP adenosine monophosphate NAD(H)(P) nicotinamide adenine dinucleotide (oxidised or reduced form)(-phosphate) 
ATP adenosine triphosphate NCIN non-canonical initiating nucleotide 
% percent NCIS non-canonical intiating substrate 
µ micro Ni nickle 
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Co cobalt O oxygen 
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CTP cytidine triphosphate ORF open reading frame 
Cu copper p pico 
Da Dalton P1/2 promoter 1/2 
DNA desoxyribonucleic acid PAGE polyacrylamide Gel Electrophoresis 
DP-CoA dephospho-Coenzyme A PCR polymerase chain reaction 
DR drug resistant Ppi pyrophosphate 
DS drug-sensitive ppm parts per million 
dsDNA double stranded DNA Pt platin 
DTT dithiothreitol PVDF polyvinylidene difluoride 
Ec E. coli rcf relative centrifugal force 
EDTA ethylenediaminetetraacetic acid Rif-pocket Rifampicin-binding pocket 
FAD flavin adenine dinucleotide RNA ribonucleic acid 
Fe iron RNAP DNA-dependent RNA polymerase 
FMN flavin mononucleotide RPc closed promoter complex 
VI 
 
FPLC fast protein liquid chromatography RPinit initially transcripbing RNAP-promoter complex 
g gram rpm revolutions per minute 
Gp gene product RPo open promoter complex 
GTP guanosine triphosphate rRNA ribosomal RNA 
H hydrogen S sulfur (unless mention in conjunction to RNA name or size) 
h hour s second 
In iodine scaRNA small Cajal body-specific RNA 
IPTG isopropyl β-D-1-thiogalactopyranoside SDS sodium dodecylsulphate 
k kilo snoRNA small nucleolar RNA 
kb kilobase sRNA small regulatory RNA 
l litre ssDNA single stranded DNA 
LB Luria Bertani SVP snake venom phosphodiesterase 
LC liquid chromatography t time 
M Molar concentration TB tuberculosis 
m milli TL trigger loop 
MDR multi-drug resistant tRNA transfer RNA 
Mg magnesium TSS/ +1 transcription start site 
Mn manganese UDP-Glc uridine diphosphate glucose 
mRNA messenger RNA UDP-GlcNAc uridine diphosphate N-acetylglucosamine 
Ms M. smegmatis UDP-MurNAc-AA5 uridine diphosphate N-acetylmuramic acid pentapeptide 
Mtb M. tuberculosis UTP uracil triphosphate 
MWCO molecular weight cut off V Volts 
N nitrogen W Watt 
n 
nano (unless in conjunction with 
nucleobasis) WHO World Health Oganisation 
    wt wildtype 
    XDR extensively drug resistant 
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1. General Introduction 
1.1 Reasoning of this study 
The central dogma of life on earth is based on three main biomolecules: DNA, RNA, and 
protein. DNA is the blueprint of life bearing the genetic code. RNA is the messenger molecule 
or intermediate, presenting the genetic code in an accessible version. Protein is the realisation 
of the genes in form of a structural or catalytic molecule. Transcription is an essential cellular 
process that is executed by all living organisms as well as DNA viruses as part of gene 
expression. DNA is transcribed into an RNA copy which either has a function itself, or is 
further translated into protein. The central enzyme of transcription is DNA-dependent RNA 
Polymerase (RNAP), which matches ribonucleotides to complementary bases on the DNA 
template strand and polymerises them to form an RNA chain, the transcript. The process of 
transcription as well as the transcript’s fate can be regulated in a variety of ways. An organism 
needs to regulate its own transcription in order to keep up with momentary requirements of a 
cell (e.g. production of enzymes to break down a specific nutrient the cell encounters), or 
interact with the environment (e.g. heatshock or infection response). In return, the organism 
can act upon other organisms in its environment, to modulate their transcription (e.g. host 
shut-off in infection). All chapters of my thesis were born from the studies of regulation of 
gene expression. However, they are vastly different in their focus. We initially intended to 
study how mycobacteriophages manage to hijack host transcription. This is an interesting 
study objective as it not only provides insight into viral and bacterial gene expression and 
potentially novel mechanisms of regulation, but this insight might also have important 
applications, first and foremost in development of new antibacterials against tuberculosis, 
which is a globally pressing issue. As these studies were beginning, discoveries were reported 
which showed a fascinating potential to research previously unnoticed mechanisms of 
regulation of gene expression via RNA synthesis and RNA primary structure. The 
phenomenon of non-canonical RNA capping might constitute an ancient mechanism as it has 
been found in eubacteria as well as eukaryotes. While the function of non-canonical capping 
is at the present time uncertain, part of the mechanism as well as hypothetical functions are 
discussed in chapter I. Chapter II is a spin-off project that is concerned with RNA synthesis in 
replication (primer synthesis), in contrast to transcription. Primase, despite being entirely 
unrelated to transcriptases, integrates non-canonical nucleotides into primer RNA, with 
potential downstream effects on replication. Chapter III describes development of a 
methodology for our lab that will enable us to further explore mycobacteriophage regulation 
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of host transcription in the future. After establishing this protocol it has been used by two 
master students in pursuit of phage regulators, and one phage inhibitor of transcription, Gp53 
of mycobacteriophage D29, has been initially characterised. 
 
1.2 The basis of RNA function is its complex and versatile structure  
RNA has many functions in the cell, most prominently ribosomal RNA (rRNA), transfer 
RNA (tRNA), and messenger RNA (mRNA).  
The majority of cellular RNA (in bacteria 83 % of total RNA dry mass, in mammalian cells 
80%) is rRNA (Lodish et al., 2004; Feijó Delgado et al., 2013). The ribosome is a ribozyme, 
supported by a protein scaffold. It translates all cellular protein from mRNA. The ribosome 
consists of two subunits. In bacteria the 70S ribosome consists of 30S and 50S subunits which 
contain 16S and 23S rRNA, respectively, in association to ribosomal protein (Brimacombe & 
Stiege, 1985, Brodersen, Nissen, 2005). rRNA operons in E.coli are transcribed from two 
operons behind promoters rrn P1 and rrn P2 (Paul, Ross, et al., 2004). Bacteria can have up 
to 15 different copies of the rRNA genes, with sequence variantion up to 1 % (Leppek and 
Barna, 2019). In E. coli, 16S, 23S and 5S rRNA precursors are cleaved from an initial 30S 
polycistronic transcript by combined actions of RNase III, RNase E, RNase G and RNase T 
(Deutscher, 2009). The protein portion of the ribosome provides a scaffold for ribozyme 
structure, and has been proposed to be involved in mRNA and tRNA binding and interaction 
with translation factors (Brodensen, Nissen, 2005).  
tRNA constitutes 15% of cellular RNA (Lodish et al., 2004). It has a clover leaf structure 
with several conserved sequences and modified bases. An amino acid is enzymatically 
attached to the tRNA 3’-OH to give aminoacylated or activated tRNA. An anticodon loop in 
the tRNA body base pairs with the codon on mRNA. Thus, identity of amino acid and cognate 
anti-codon are vital to realise the genetic code. The ribosome polymerises outgoing and 
incoming amino acids from tRNA, releasing naked tRNA (Yarus, Caporaso and Knight, 
2005). 
mRNA is a “copy” of the genetic code which is translated into a peptide sequence. The 5’-end 
of mRNA certainly exerts the biggest effect on translation by regulating initiation via 
ribosome binding. But besides that, mRNA structure plays a role in protein folding and 
translation fidelity. The more stable secondary structure regions on mRNA, the slower 
translation will progress. This allows for correct folding of compacter protein regions (Faure 
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et al., 2016). Also, high structuring in mRNA can increase transcript stability to allow for 
more frequent translation. Faure et al. also demonstrated that “fast” (less structured) regions 
on mRNA typically encode α-helices, while “slow” (densely structured) regions on mRNA 
lead to formation of β-strands and loops on protein.  
The basis of RNA versatility is RNA folding. RNA differs from DNA only by uracil/thymine 
base and by presence of 2’-OH in pentose (Westhof and Auffinger, 2000). 2’-OH allows for 
an increased flexibility of the RNA backbone as compared to DNA. Thus, besides base 
pairing to a complementary second nucleic acid, RNA folds in on itself. Various non-covalent 
interactions create secondary and tertiary structures (Batey, Rambo and Doudna, 1999).  
Secondary structure is dependent on primary base sequence. Base pairing with interrupted 
ssRNA stretches can form to hairpins, loops, helical duplexes, internal loops, bulges, and 
junctions (Batey, Rambo and Doudna, 1999). Tertiary structure is assumed after processing 
via splicing (removing parts of the transcript) or methylation of nucleobases or 2’-OH on 
ribose (Batey, Rambo and Doudna, 1999), and includes longer-range interactions (tertiary 
interactions) between more distal regions on the molecule.  
RNA structures include but are not limited to coaxial stacking, 2’-OH-mediated interactions, 
triple helices, tetraloop motifs, ribose zipper, metal-core motifs, kissing loops, and 
pseudoknots. Coaxial stacking is an alignment of a stack of helices or hairpin loops along a 
common axis in space, which improves stability. 2’-OH-mediated interactions are achieved 
when hydrogen bonds are made between 2’-OH, 3’-O, and/or phosphate oxygens to a N or O 
of a base. For example, a kink-turn motif arises from interactions of 2’-OH of neighbouring 
helices, or backbone to backbone helical interactions. Triple helices are composed of a third 
strand fitting into the major groove of double helix. Tetraloop motifs are free four-nucleotide 
sections within an otherwise base paired strand. Ribose zipper are interactions of a bulge 
between two tetraloops, backbone to backbone, with transient interactions between 2’-OH and 
N3 of a purine base and 2’-OH and O2 of a pyrimidine base creating a “zipper” within minor 
grooves of two helices. Metal-core motifs rely on tight packing of backbones to create 
electrostatic interactions which are released by binding of divalent cations. Typically 2 Mg2+, 
3 Ca2+ or abundant monovalent cation, e.g. Na+, coordinate phosphate oxygen atoms such that 
bases face outwards, causing flanking regions of the helix to stack more tightly. Kissing loops 
arise from base pairing between bases of separate loops; and pseudoknots are hairpin loops 
which base pair with a complementary region on an ssRNA stetch. Besides non-basepair 
interactions, RNA readily forms non-canonical base pairs such as Wobble base pairs which 
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rely on at least one hydrogen bond between bases. These do not support normal Watson-Crick 
helical structure but causes bases to tilt slightly, yielding a site for hydrophilic molecule 
binding (at nitrogens and oxygens of the base) and a spacious shallow groove. Both sides 
often serve as recognition sites (Westhof and Auffinger, 2000). This variety of tertiary 
structure dictates RNA stability and function. 
The secondary structure of RNA can create domains. Domains interact with other domains via 
tertiary interactions rather than base pairing, and often require metal ions. Besides cis 
interactions (within one molecule of RNA), RNA can associate with other RNAs in trans to 
form multisubunit RNAs (e.g. ribosome), or ribozymes with RNA substrates. It becomes 
apparent that RNA folding heavily relies on the molecular environment. Presence of cations, 
hydration state and molecular crowding can affect RNA structural integrity (Butcher and Pyle, 
2011). 
Eukaryotic mRNAs differ from eubacterial mRNAs in certain ways. Most importantly, 
eukaryotic mRNAs are post-transcriptionally modified on their 5’-end (RNA capping), on 
their 3’-end (polyadenylation), and internally (splicing). Also sequence signals can differ. For 
example, in contrast to eubacterial open reading frames (ORFs), eukaryotic ORF terminator 
regions include a polyadenylation signal, a sequence which attracts a dedicated polymerase to 
attach a poly(A) stretch to the 3’-end post-transcriptionally (Zhao, Hyman and Moore, 1999). 
This poly(A) tail stabilises the transcript by protecting it from 3’-nucleases. In contrast, a 
prokaryotic poly(A) tail is attached by members of RNA maturation and degradation 
multienzyme complexes to “tag” a transcript for degradation (Sarkar, 1997). 
The 5’-end of a transcript is naturally triphosphorylated, but in eukaryotes mRNAs are 
modified over several enzymatic steps to attach an inverted methylated nucleotide, most 
commonly a guanosine, via a triphosphate link. This structure will in this thesis be referred to 
as “classical eukaryotic cap” and has no bacterial analogue (Ramanathan, Robb and Chan, 
2016). The classical eukaryotic cap has multiple roles: transport across the nuclear membrane, 
translation initiation, and RNA stability (Furuichi, 2015). For a long time, the 5’-RNA cap 
was thought to distinguish eukaryotic and prokaryotic mRNA. Chapter I of this thesis is 
concerned with an update of this conception, showing that besides the classic eukaryotic cap, 
all cells produce a different type of cap, the non-canonical initiating nucleotide (NCIN)-cap. 
The NCIN-cap is integrated into RNA primary structure during transcription of some RNAs. 
The potential effect of this newly discovered structure on the function of different RNAs 
remains to be determined. 
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1.3 RNA degradation regulates gene expression 
Regulation of mRNA stability is a means of regulation of gene expression, and adaption to 
environmental requirements (Bandyra et al., 2013).  
Bacterial RNA degradation differs in Gram positive and Gram negative bacteria (Silva et al., 
2011; Mohanty and Kushner, 2016). In E. coli, the main break down machinery is the 
degradosome (figure 1.1). This multiprotein complex comprises of main endoribonuclease 
RNase E, multifunctional exoribonuclease and polyadenylation enzyme PNPase, RNA 
helicase Rh1b, and enolase whose function is unclear (Mohanty and Kushner, 2016). 
Activities of oligoribonuclease and 3’-5’-exoribonucleases is also essential for complete RNA 
breakdown. A transmembrane domain on RNase E locates the degradosome to the inner cell 
membrane. Other RNases diffuse freely in the cytosol or are located to foci within the 
nucleoid. Thus RNA localisation determines the RNA degradation path (Mohanty and 
Kushner, 2016). Pyrophosphohydrolase RppH was for a while considered the E. coli 
“decapping” enzyme analogous to eukaryotic Dcp2 (responsible for removal of m7G cap) 
(Grudzien-Nogalska and Kiledjian, 2017). Due to the preference of RNase E to 
monophosphorylated 5´-ends, triphosphorylation is considered protective, and RppH removes 
this protective molecular structure (Vasilyev and Serganov, 2015). RppH prepares transcripts 
for degradation by removing 5’-pyrophosphate to generate 5’-monophosphate, the preferred 
substrate of RNase E (Vasilyev and Serganov, 2015). However, RppH is not a stable 
component of the degradosome.  
RNA processing modulates RNA stability. While eukaryotic pol(A) tails stabilise transcripts, 
bacterial poly(A) tails function as degradation signals, as they constitute unstructured 3’-ends 
which are susceptible to exoribonucleases (Régnier and Marujo, 2013). E. coli main poly(A)-
polymerase PAPI is not directly associated to the degradosome, but is found in another 
multiprotein complex with RNA chaperone Hfq, PNPase and RNAse E (Mohanty and 
Kushner, 2016). Hfq is a pleiotropic regulator that is involved in bacterial virulence, motility, 
biofilm formation and stress response (Fantappiè et al., 2009; Zeng, McNally and Sundin, 
2013; Schuergers et al., 2014; Lai et al., 2018). The RNA chaperone pairs trans-acting sRNAs 
with their target-mRNAs, and has a preference for binding of poly(A) tail structures (Mohanty 
and Kushner, 2006, 2016; Silva et al., 2011). Cis-acting small regulatory RNAs (sRNAs) are 
transcribed in parallel to their target mRNA from the complementary strand. E. coli 
exonuclease RNase II is inhibited by 3’-secondary structures and requires the unstructured 
poly(A)-tail as a handle to initiate degradation (Mohanty and Kushner, 2016). Also its 
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homolog RNAse R requires a 3’-ssRNA, and is likely involved in breakdown of Rho-
dependently terminated RNAs (Mohanty and Kushner, 2016).  
In eukaryotes, mature mRNA is degraded mainly via a deadenylation-dependent pathway. 
The removal of the unstructured 3’-poly(A) tail precedes other exo- and endonucleolytic steps 
including 5’-decapping. Alternatively, stability of some individual mRNAs or subclasses of 
mRNAs can be regulated independently of deadenylation (Beelman and Parker, 1995). For 
example, within RNA surveillance processes, early nonsense codons lead to 5’-3’-degradation 
which is initiated by decapping (Beelman and Parker, 1995). Additionally, stability 
modulating signal sequences can be found throughout the transcript (both in non-translated 
sand translated regions) and interact with RNases or other proteins which then recruit 
nucleases (Sachs, 1993).  
Eukaryotes have an exosome, a multi protein complex with 3’-5’-exonuclease and helicase 
activity. The exosome is involved in maturation and decay of almost all types of RNAs 
(transcripts generated by RNA polymerases I , II and III). The 9-protein core of the exosome 
 
Figure 1.1 The bacterial degradosome (in Gram negatives). A. From (Bandyra et al., 2013). mRNA degradation 
in E. coli starts when 5-triphosphorylated RNA is dephosphorylated by a pyrophosphohydrolase (RppH), which 
primes it for interaction with endoribonuclease RNase E. RNase E has a preference for 5’-monophosphorylated 
RNA, although interaction with triphosphorylated RNA is also possible. RNase E also processes polycistronic 
RNA. Larger RNA fragments are then digested by further 3’-exoribonucleases (RNase R, RNase II and PNPase) 
and finally oligoribonuclease. RNA helicases and poly(A) polymerase can play a role in making 3’-ends 
accessible to exonucleases. B. From (Van den Bossche et al., 2016). Pseudomonas aeruginosa RNase E 
interactions. RNase E has several RNA-binding sites and directly interacts with RNA helicase RhIB and PNPase. 
It further has a membrane-interaction domain which anchors the degradosome to the cell periphery. 
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forms a barrel-like structure. To both ends of the barrel, an exonuclease binds, Rrp6 and 
Rrp44. The holoenzyme associates to three protein cofactors which direct different routes of 
threading of RNA substrate through the barrel using helicase activity. The routes of threading 
lead to digestion by one of the exoribonucleases. The exosome is predominantly found in the 
nucleus (Ogami, Chen and Manley, 2018). 
The classical eukaryotic m7G cap confers resistance to most ribonucleases (Sachs, 1993). It is 
removed by Dcp2, Nudt3 and Nudt16 NUDIX hydrolases in vivo and further by Nudt2, 
Nudt12, Nudt15, Nudt17 and Nudt19 at least in vitro (Grudzien-Nogalska and Kiledjian, 
2017). Besides NUDIX hydrolases, in eukaryotes also the DXO family is known to function 
as decapping enzymes. However, phosphodiesterbond cleavage by DXO removes the 
complete cap structure (m7GpppN-RNA to m7GpppN + RNA. Dcp2, Nudt3 and Nudt16 
cleave the triphosphate linkage between cap and RNA (Kiledjian, 2018). A DXO-equivalent 
in prokaryotes has not been found to date. The NUDIX hydrolases and DXO enzymes also 
play a fundamental role in removal of NCIN-capping, as will be discussed further in chapter I. 
Another contributing factor to RNA stability was recently discovered in eukaryotes. The first 
canonical nucleotide of the transcript, so the nucleotide adjacent to the m7G-cap, is usually 
methylated, giving for example a 2’-O-methyladenosine (Am). But additional methylation 
giving a N-6,2’-O-dimethyladenosine (m6Am) causes resistance of the cap to decapping 
NUDIX hydrolase Dcp2, thus conferring increased RNA stability as opposed to single 
methylated initiating nucleotides (Mauer et al., 2017; Kiledjian, 2018). This methylation is 
reversible and is considered as epigenetic regulation process. 30% of cellular RNA carries the 
“extended mRNA cap” (Mauer et al., 2017). Other functions of the methylations in eukaryotic 
mRNA 5’-regions include translation initiation and distinction of own and viral RNA (Mauer 
et al., 2017; Kiledjian, 2018). 
 
1.4 Many abundant small-molecule metabolites contain a nucleotide-moiety 
One important group of biomolecules in the cell are small metabolites which contain a 
nucleotide part. These metabolites can act as coenzymes of metabolism (e.g. flavin adenine 
dinucleotide, FAD, nicotinamide adenine dinucleotide, NAD(H) or Coenzyme A, CoA), or as 
building blocks of macromolecules or intermediates of catabolism (e.g. Uridine diphosphate 
glucose, UDP-Glc). Some argue that the nucleotide part of these molecules is not required for 
the cofactor function and thus might be – or once might have been – a handle for interaction 
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with other, nucleotide-binding molecules (White, 1976). At the example of NAD(H), 
nicotinamide undergoes redox reactions (NAD+ gets reduced to NADH, which gets oxidised 
to NAD+), while adenosine is irrelevant for the chemical reaction.  
Adenine containing cofactors such as NAD+ have been produced in vitro by ribozymatic 
modification of 5’-ATP-RNA(Huang, Bugg and Yarus, 2000) – a finding that agrees with the 
hypothesis that they might constitute “relics from an RNA World” (White, 1976; Jeffares, 
Poole and Penny, 1998). Possibly, in an RNA World, these cofactors might have been 
covalently attached to ribozymes to catalyse electron transfer reactions. Further theories about 
the chemical structure of cofactors say that they might have been part of the ribonucleic acid 
plus protein (RNP). RNP here denotes a hypothetical ancestor molecule. Also, or they might 
have been preserved in their “dinucleotide”-structure due to co-evolutionary dependence. Co-
evolutionary dependence describes the conservation of “frozen accidents”, molecules which 
might not constitute a Darwinian “fittest” but which are conserved because other molecules 
have evolved around them and require their continued existence (Jeffares, Poole and Penny, 
1998).  
Potentially, the findings presented in chapter I and II, and associated research by other groups, 
might shed new light on the function of these nucleotide handles and explain their 
evolutionary conservation. Figure 1.2 shows metabolite molecules of interest to this thesis in 
comparison to adenosine and uridine trinucleotide. 
 
1.5 Transcription is a central cellular process 
Transcription is the synthesis of RNA based on DNA sequence performed by DNA-dependent 
RNA Polymerase RNAP in bacteria and RNAP II in eukaryotes. Transcription is a central 
step of gene expression and is thus meticulously regulated by the cell, and presents a potent 
target for bacteriophage-mediated host inhibition, and also drug development. 
1.5.1 RNA polymerase structure of bacteria and eukaryotes is similar 
If not otherwise stated, the following text refers to bacterial RNAP. RNAP of bacteria and 
eukaryotes is a multisubunit enzyme composed of several protein subunits (figures 1.3 and 
1.4). The bacterial RNAP consists of a minimal set of subunits where the core enzyme is 
composed of five subunits, α2ββ’ω. It is complemented by another factor σ and can bind to a 
variety of transcription factors. The eukaryotic RNAPs are composed of more subunits, but 
















Figure 1.2 Molecular structures of ADP-containing molecules ATP, nicotinamide adenine dinucleotide (oxidised, NAD+), nicotinamide adenine dinucleotide phosphate (NADP), 
flavine adenine dinucleotide (FAD) and dephospho-Coenzyme A (DP-CoA) (Julius and Yuzenkova, 2017). UDP-containing molecules are UTP, uridine diphosphate glucose (UDP-
Glc), uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) and uridine diphosphate N-acetylmuramic acid-pentapeptide (UDP-MurNAc-5AA). * mM concentration in 
expotential phase E. coli grown on complex medium, from (Bennett, Kimball and Gao, 2009),** mM concentration in exponential phase E. coli grown on complex medium, from 
(Mengin-Lecreulx, Flouret and van Heijenoort, 1983).
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The bacterial core RNAP and has a molecular weight of ~ 400 kDa (Zhang et al., 1999; 
Mathew and Chatterji, 2006).Two copies of α-subunit αI and αII interact with DNA via C-
terminal domain, α-CTD. One subunit β and one subunit β’together make up the “crab claw” 
structure of the core enzyme, formed their coordination towards each other and the DNA 
template. Further, the ω subunit has mainly structural function, but may also be involved in 
enzyme regulation and inhibition (Mathew and Chatterji, 2006). Association to σ factor forms 
the holoenzyme α2ββ’ωσ and is only necessary for transcription initiation (M. Paget, 2015). 
The holoenzyme can contain one of several σ for transcription of different sets of genes. E. 
coli has seven sigma factors. Among those are the housekeeping/growth σ70, and the 
stationary phase σS. M. smegmatis has 26 sigma factors, including main σA and stationary 
growth σB, but also further factors for adaption to the environment, e.g. light induced σF 
(Waagmeester, Thompson and Reyrat, 2005).  
A number of functional structural domains have been identified on RNAP (see figure 1.3 B). 
The catalytic centre is located in a cleft between β and β’ (main channel) and binds two 
divalent metal ions (Mg2+) which function in nucleotide coordination and catalysis of the 
polymerisation reaction. Mg2+I is held within a cluster of 3 aspartate residues (the triad) of β’ 
(Sosunov et al., 2003). Mg2+ II enters the enzyme bound to NTP substrate and is coordinated 
in the catalytic centre next to Mg2+ I. The main channel spans front to back of the enzyme, 
and is positioned onto DNA by main channel clamp of β’. It accommodates about 12 bp 
dsDNA (before initiation), or a transcription bubble of about 13 nt, with an 8-9 nt long RNA-
DNA-hybrid, during elongation (Nudler et al., 1997; Vassylyev et al., 2002; Bochkareva et 
al., 2012). σ is partly embedded in the main channel where it will contact DNA with regions 2 
and 4 and the catalytic centre with region 3.2 (Borukhov and Nudler, 2008). Bridge helix and 
trigger loop (TL) protrude into the catalytic site and are essential for catalysis. Folding of TL 
after binding of correct substrate shifts the active site into the correct conformation for 
catalysis (Yuzenkova and Zenkin, 2010). The secondary channel between the rear end of the 
enzyme and the catalytic centre is likely the site of entry for nucleotide substrates (Batada et 
al., 2004; Vassylyev, Vassylyeva, Zhang, et al., 2007). Lid, zipper and rudder regions serve 
for structural stabilisation during elongation, by interacting with template DNA or the RNA-
DNA hybrid (Gnatt et al., 2001; Kuznedelov et al., 2002; Vassylyev, Vassylyeva, Perederina, 
et al., 2007; Yuzenkova et al., 2011). RNA chains longer than 8-9 nt are threaded through an 
RNA exit channel which spans from the main channel through flap, zipper, lid and Zn-finger 
(Korzheva et al., 2000). 
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In E. coli, RNAP core genes are located within three separate ORFs. Subunit α (gene rpoA) is 
encoded on an operon (alpha operon) together predominantly with ribosomal protein genes, 
such as rpsM (S13) or rpsD (S4) (Meek and Hayward, 1984). All genes of the operon except 
for rpoA are regulated by S4, which can repress their translation while rpoA translation is 
unaffected (Meek and Hayward, 1984). β and β’ (genes rpoB and rpoC) are transcribed from 
a common operon in conjunction to further ribosomal proteins (50S subunit) (Dennis, 1977), 
and are also regulated independently from the ribosomal protein genes on their operon (Meek 
and Hayward, 1986). ω subunit gene (rpoZ) is transcribed from same operon of SpoT (Gentry 
and Burgess, 1989), a regulator of stringent response. RpoZ was also hypothesized to execute 
a secondary function in stringent response that goes beyond being part of transcription 
machinery (Chatterji et al., 2007). Several loci encode σ, such as rpoD, the gene for σ70 (Cho 
et al., 2014). 
 
Figure 1.3 Bacterial RNAP subunits and domains. A From (Bae et al., 2015). Structure of RNAP holoenzyme in 
complex with promoter template strand. Catalytic centre is indicated by Mg2+ ion, σ factor (orange) makes 
contact to DNA (grey with yellow and purple elements) with indicated regions. β subunit is shown in mint green, 
β’ in pink and α in grey.B. From (Nudler, 2009). Important structural regions of the holoenzyme are shown. See 






1.5.2 RNA polymerase catalysis is a two metal ion mechanism 
If not otherwise stated, the following text refers to bacterial RNAP. Without σ, RNAP core 
binds to DNA indiscriminately. E. coli σ70 domains 4 and 2 recognise consensus sequences 
around -35 and -10 nucleotides upstream of the transcription start site (TSS, or +1), called -35 
element and -10 element, respectively. α-CTD interacts with an upstream AT-rich sequence, 
the UP-element, which is not present in all promoters. Utilisation of different sigma factors is 
a form of transcriptional regulation of gene expression in bacteria. Most organisms have 
several σ factors, to facilitate adaption to different environmental conditions. Alternative σ 
recognise specialised promoters, thus they direct RNAP towards different genes in alternative 
conditions. Variations in promoters include variances in recognition site sequences as 
compared to consensus (consensus in E. coli σ70 promoters is -35: 5’- TTGACA and -10: 5’-
TATAAT), variances in spacer length between those two elements (consensus is 17 +/- 1 nt), 
absence of UP-element or -35 element, and extension of -10 element by upstream TGn 
(“extended -10-element”). σ itself can be regulated via anti-sigma factors (which bind σ 
constitutively until another signal releases σ), or other regulatory proteins. For example,  
protein Crl activates E. coli stress factor σ38 to bind to core at higher affinity than without Crl 
(Gaal et al., 2006). Another growth phase related transcription control pathway in bacteria is 
via ppGpp in stringent response. The nucleotide analogue and alarmone (p)ppGpp likely acts 
on transcription by binding protein DksA which then binds RNAP secondary channel and 
prohibits transcription activity on rRNA promoters (Paul, Barker, et al., 2004), while 
enhancing transcription on amino acid promoters (Paul, Bergmann and Gourse, 2005). 
The catalysis of polymerisation takes place within the active centre of the enzyme (see figure 
1.4). Nucleotide binding sites in RNAP are called i (initiation site) and i+1 (next to initiation 
site). For the first phosphodiester bond formation, 5’-NTP binds i site, 3’-NTP binds i+1. In 
elongation, 3’-end of RNA is positioned in i site, incoming NTPs in i+1 site. The sequence of 
the growing RNA chain is determined by complementary base pairing to the template. Only 
binding of nucleotides complementary to template facilitates folding of TL to fully close the 
active site and create the environment for catalysis (Yuzenkova and Zenkin, 2010). Here, 
NTP substrates and the two metal ions are coordinated to assist nucleophilic attack of 3’-OH 
of the 3’-NMP of RNA chain on the 5’-α-phosphate of incoming NTP. Mg2+ I brings both 
substrates into the correct position for the reaction to take place. Mg2+ II enters the enzyme 
with incoming nucleotide, bound to the phosphate groups. Mg2+ II positioning between 
pyrophosphate and nucleophilic centre of 3’-RNA facilitates release of pyrophosphate by 
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hydrolysis of the phosphodiester bond. Subsequently, an ester bond to the hydroxyl group is 
made (Steitz and Steitz, 1993; Sosunov et al., 2003; Zenkin et al., 2006).  
Despite the role of TL in assuring incorporation fidelity, misincorporation occurs at a low 
rate. This can be corrected by RNAP proofreading activity (figure 1.4 C). 
Pyrophosphohydrolysis can be reversed to remove misincorporated nucleotides. The correct 
substrate is selected at the E site of catalytic centre prior to the polymerisation reaction. On 
the molecular level, matter undergoes oscillations which allow for isomerisation between 
different stages of molecular interactions. If a mismatch occurs, the 3’-end of RNA has 
altered flexibility as compared to a correctly paired hybrid, and shifts back into the E site. If 
the 3’-end of RNA disengages from i site during pausing, this is called backtracking. 
Backtracking can be resolved if the 3’-terminal dinucleotide is cleaved to restore correct 
configuration of the active site, with 3’-terminus resdsing in i site(Zenkin, Yuzenkova and 
Severinov, 2006; Yuzenkova et al., 2010). 
Incorporation mistakes, but also specific sequence signals can stall RNAP during elongation. 
This is called pausing and can lead to termination of transcription, but can also be a means to 
regulate RNA folding (Artsimovitch and Landick, 2000; Zhang, Palangat and Landick, 2010; 
Bochkareva et al., 2012). Pausing is also controlled by transcription factors, such as NusA 
(promotes pausing) or NusG (promotes elongation) (Artsimovitch and Landick, 2000; Herbert 
et al., 2010). Further, hydrolysis of backtracked RNA can be promoted by transcription 
factors such as GreA and GreB, which protrude into the active centre to replace TL in 
positioning of  Mg2+ II for hydrolysis (Laptenko et al., 2003; Sosunov et al., 2003). 
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Figure 1.4 Bacterial RNAP catalysis. A. From (Basu et al., 2014). Close-up of the crystal 
structure of T. thermophilus RNAP active site and surrounding elements interacting with 
template DNA. Metal ions in yellow MgA (Mg2+ I ) and MgB (Mg2+ II) at the active site 
and first two nucleotides are shown in green (+1 ATP, +2 CMPCPP) B. From (Guberman 
et al., 2008). Stick modelling of the active site and residues of β and β’ subunits 
interacting with nucleotides as indicated by dotted lines. Base pairing between +1 template 
and +1 ATP is indicated. C. From (Mishanina et al., 2017). Elongation is the progressive 
polymerisation of nucleotides in the active centre and translocation of RNAP along the 
template. Backtracking is the reverse reaction of polymerisation (hydrolysis) and leads to 




1.5.3 Transcription is a series of distinct steps from initiation over elongation to 
termination 
If not otherwise stated, the following text refers to bacterial RNAP. Transcription initiation 
can be described in three steps: promoter binding, open complex formation, and abortive 
initiation. 1) E. coli RNAP (EcRNAP) holoenzyme binds to promoter DNA via σ regions 4 
and 2 and α-CTD. RNAP spans an area of about 60 nt (-40 to +20) on the template. The 
RNAP-promoter complex is closed (RPc), DNA remains double stranded at first. 2) Melting 
of DNA at the active site via isomerisation of RPc conformation of RNAP holoenzyme and 
promoter forms an RNAP-promoter open complex (RPo). DNA is unwound by about one 
helix turn (Revyakin et al., 2006). The transcription bubble extends ~15 nt around the TSS. In 
many organisms, transcription initiation requires additional factors. Mycobacterial RNAP 
requires RbpA transcription factor on many promoters (Tabib-Salazar et al., 2013; Perumal et 
al., 2018). Eukaryotic RNAP requires a plethora of transcription factors to initiate 
transcription. 3) In bacteria, initiation of transcription, or the polymerisation of first few 
NTPs, takes place frequently before transcription becomes productive. This is referred to as 
abortive initiation, as strong interaction between RNAP and and promoter DNA compete with 
forwards directed catalysis leading the nascent RNA chain to reverse back into nucleotide 
binding sites. The RNAP-promoter initial transcribing complex (RPinit) produces short 
abortive RNA products (Revyakin et al., 2006). RNA-DNA hybrids are instable and abortive 
products are released. Longer RNA products are stabilised in the active centre by base pairing 
with DNA for about 8 nucleotides (Basu et al., 2014). In contrast, the very first NTP at the i 
site remains unstabilised. Therefore transcription initiation is highly dependent on substrate 
concentration which at some promoters acts as a regulatory mechanism (Basu et al., 2014). σ 
region 3.2 (σ3.2) finger loop protrudes into the catalytic centre such that the growing hybrid 
clashes into the loop. Growing RNA displaces σ3.2 loop, and loop pushes RNA backwards 
into the catalytic centre (Bae et al., 2015).  
As soon as a longer transcript (9-11 nt) is produced, RNAP manages to escape from the 
promoter to form RNA-DNA elongation complex RDe  (also called ternary elongation 
complex TEC). This was proposed to be a product of downstream DNA stress, caused by 
scrunching of ssDNA into RNAP (RPinit scrunched) (Revyakin et al., 2006). σ factor 
dissociates. The exact order of events is not known (Basu et al., 2014). While σ is free to bind 
another core RNAP (or an anti-σ factor), core RNAP progresses to the elongation stage (Bae 




Figure 1.5 From (Lee and Borukhov, 2016). Bacterial transcription initiation and transition into elongation. The 
RNAP holoenzyme recognises promoter DNA via interactions of α-CTD and σ factor. Holoenzyme 
isomerisation from RPc to open RPo goes along with promoter melting to form the open complex. The first 
nucleotide is positioned in RNAP catalytic centre (entering through NTP entry channel). A first phosphodiester 
bond is formed between first and second incoming NTPs by RPinit. RPinit scrunched struggles forwards as, 
ssDNA inside of RNAP is scrunched when RNA chain is continued. Downstream DNA stress forces RPinit 
scrunched to escape from the promoter. Nascent RNA is passed through the RNA exit channel, σ is lost and core 
RNAP proceeds to elongation (EC).  
Simply put, elongation is the repetition of phosphodiester bond formation (reviewed in 
Imashimizu et al., 2014). It requires RNAP moving forwards on the ssDNA template, keeping 
the transcription bubble open, and NTPs to enter while RNA chain exits. RNAP forwards 
movement can be explained by two different models. The power-stroke model describes 
movement as a transition state resulting from coupling of chemical energy into mechanical 
work. According to this model, a new NTP enters the active site, PPi leaves the active site, 
and the phosphodiester bond formation is the chemical conversion, followed by RNAP 
translocation as mechanical work. The Brownian rachet model disregards any transition states 
or coupling of chemical reaction and movement. It describes movement as a forwards bias in 
protein and nucleic acid oscillations caused by cognate NTP occupying and empty active site 
and being condensed to the RNA chain, followed by another NTP entering and condensation, 
which is then continued (Imashimizu et al., 2014). 
These models can also be applied to explain transcription pausing. In the Brownian rachet 
model, fluctuations within the RNA-DNA hybrid correlate to fluctuations in RNAP active 
site, markedly bridge helix and trigger loop, which are involved in polymerisation and NTP 
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binding. Some sequences can result in RNA-DNA hybrids of altered flexibility, which 
disrupts fluctuations of the elongation complex (including RNAP, template and RNA chain), 
in contrast to smooth translocation. Pausing is overcome by forwards energy of 
phosphodiester bond formation coupled with PPi release, as described in the power-stroke 
model (Imashimizu et al., 2014). Besides disrupted RNA-DNA hybrid fluctuations, further 
structural determinants can lead to stalling of RNAP. Road blocking by other proteins, 
secondary structure formations in nascent RNA chain or transcription factor binding, unusual 
structure of downstream DNA (e.g. alternative helix shapes), DNA damage (e.g. backbone 
lesions) in the transcription bubble or mismatched 3’-RNA ends can all lead to TEC stalling 
(Imashimizu et al., 2014). Backtracking due to mismatch can be resolved by cleavage of a 3’-
RNA segment to re-establish active catalytic site conformation. TL works in conjunction with 
3’-RNA for autocatalytic cleavage of the transcript (Zenkin, Yuzenkova and Severinov, 
2006).  
Pausing is a target mechanism for many transcription regulators. For example, promoter-
proximal pausing is signalled at 10-20% of E. coli transcripts due to a -10 element-like 
sequence of altered hybrid stability, which needs to be overcome by GreA binding (Marr and 
Roberts, 2000).  
Transcription termination in bacteria can occur via two main pathways. Intrinsic termination 
(also called Rho-independent termination) is conferred by nucleic acid-RNAP interactions. 
The nascent RNA chain folds into a hairpin structure followed by a U-rich segment which 
destabilises TEC. Destabilisation can be caused by hypertranslocation of RNA relative to 
DNA (hypertranslocation model). Alternatively, the hairpin pulls the 3’-end of the i site into 
the exit channel (slippage model). Or the transcription bubble collapses due to RNAP 
conformational change triggered by the hairpin loop (allosteric model) (Gusarov and Nudler, 
1999; Yarnell and Roberts, 1999; Toulokhonov, Artsimovitch and Landick, 2001; Larson et 
al., 2008; Santangelo and Artsimovitch, 2011; Molodtsov, Anikin and McAllister, 2014; 
Roberts, 2019). The main requirement of intrinsic termination is the double stranded segment 
of the hairpin to be ~8-9 nt in relative distance to the end of the U-rich terminator. In vitro, the 
hairpin can be replaced by DNA or RNA probe binding (Yarnell and Roberts, 1999). Intrinsic 
termination is related to transcription pausing. Pausing signals are similar to downstream end 
of intrinsic termination sequences (Gusarov and Nudler, 1999; Yarnell and Roberts, 1999).  
In Rho-dependent termination, the ATP-dependent RNA translocase Rho binds to an 
unstructured C-rich segment on nascent RNA and a conserved region on RNAP and moves in 
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5’-3’-direction along RNA via ATP-hydrolysis. As it approaches the elongation complex, it 
pushes RNAP off the transcript (Richardson, 1982; Wu and Platt, 1993; Thomsen et al., 
2016). This type of termination was shown to be essential (in organisms who have Rho). Rho 
activity prevents production of as antisense transcripts, which can lead to DNA damage as 
they can insert themselves into negatively coiled DNA (Peters et al., 2012; Raghunathan et 
al., 2018).  
A further type of termination is specific to transcription-coupled DNA repair. ATP-dependent 
DNA translocase MfD “patrols” DNA via ATP hydrolysis energy until it encounters a 
transcription elongation complex that was stalled on damaged DNA. It then binds RNAP and 
removes it from template and also recruits DNA repair enzyme UvrA (Selby and Sancar, 
1993; Roberts and Park, 2004; J. Fan et al., 2016; Adebali et al., 2017; Le et al., 2018). 
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2. Materials and Methods 
2.1.1 Supplier lists 
Reagents, enzymes and services were purchased from suppliers listed in tables 2.1 and 2.2. 
Also reusable consumables are listed, but not one-off use items such as petri dishes. 
Manufacturers of devices are given in the text. 
Table 2.1 Supplier of chemicals, consumables, kits and commercial media 
Supplier Chemicals, kits, constructs, services 
BioRad Micro Bio-Spin 6 
Eurofins DNA sequencing services 
Expedeon SDS-PAGE precast gels 
  SDS-PAGE run buffer 20x 
  InstantBlue  
Fingerprints Proteomics Protein Mass Spectrometry 
Fischer Scientific TEMED 
Formedium Glucose 
  Kanamycin sulfate 
  Carbenicillin 
  Amino Acids and Casamino Acids 
GE Healthcare His-Trap FF Ni-column 5 ml 
  Resource Q ion exchange column 1 ml 
  NTPs 
  Gel elution kit 
  Streptavidin sepharose 
Hartman Analytics Radiochemicals 
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Invitrogen SDS-PAGe NuPAGE precast gels 
  NuPAGE Run Buffer 
Integrated DNA Technologies (IDT) DNA oligos, gBlocks 
Melford Proteinase K 
Merck-Millipore 0.45 µM PVDF-filter 
  0.22 µm Whatman filter 
Qiagen all other kits 
Remel M. smegmatis growth media 7H9, 7H10 
Santa Cruz Bovine Serum Albumin 
Sigma-Aldrich all unless mentioned in this list 
Spectrum Laboratories Spectra-Pore 6 Dialysis Membrane 















Table 2.2 Supplier of enzymes 
Supplier enzyme 
Agilent Technologies QuikChange kit Ultra 
Epibio Terminator enzyme 
New England biolabs 
all restriction endonucleases 
RNase H + buffer 
DNA Polymerase I + buffer 
T4 DNA Ligase 
NEBuilder HiFi DNA assembly Mix (Gibson Assembly) 
Taq DNA Polymerase 
Q5 High-Fidelity DNA Polymerase 
RppH 
Phusion High-Fidelity DNA Polymerase 
Protein Standard PAGE Ruler 
DNA Standard Gene Ruler, O'Gene Ruler Mix, 100 kb plus 
Novagen Thrombin Cleavage kit 
Promega TSAP Thermosensitive Alkaline Phosphatase 




Table 2.3 Recipes of homemade media and buffer used in this study 
Name Recipe 
23 % Bis:acrylamide Gel 1 x TBE, 7.5 M urea, 20 % acrylamide, 3 % bisacrylamide (0.1 % SPS, 0.1% TEMED) 
2x Transcription STOP buffer 1x TBE, 7 M urea, 20 mM EDTA, 100 µg/ml heparin, 0.02 % bromphenol blue, 0.02 % xylene cyanole, in formamide 
33 % Bis:acrylamide Gel 0.5 % TBE, 6 M urea, 30 % acrylamide, 3 % bisacrylamide (0.1% SPS, 0.1 %TEMED) 
ADC Supplement 50 g/L BSA, 20 g/L D-glucose, 8.5 g/L NaCl  
Bis:acrylamide dilution solution 1x TBE, 8 M urea 
Dialysis buffer (standard)** 50% glycerol v/v, 20 mM Tris HCl pH 7.4, 200 mM KCl, 1 mM DTT, 0.5 mM EDTA 
Grinding buffer 50 mM Tris HCl pH 7.9, 200 mM NaCl, 5% v/v glycerol, 
ICP-MS dilution buffer 0.7 mM KCl, 30% polyethylene glycol 
ICP-MS internal standard 2 % HNO3, 20 ppb Pt, 20 ppb In 
ICP-MS Standards 100 mg/L of all Zn, Mg, Mn, Cu, Co, Ni, Fe in internal standard 
Laemmli loading dye 100 mM Tris - HCl pH 6.8, 2% SDS. 20% glycerol, 4% β-mercaptoethanol 
LB agar 1% tryptone, 0.5% yeast extract, 1% NaCl, 2% agar 
23 
 
Luria – Bertani (LB) medium 1% tryptone, 0.5% yeast extract, 1% NaCl 
M. smegmatis RNAP Dialysis buffer 20 mM HEPES KOH pH 7.9, 50% glycerol, 0.5mM EDTA, 1mM DTT 
Middlebrook Top Agar (MBTA) 4.7 g 7H9, 7.0g/L BactoAgar (= 0.4% agar) 
MsRNAP transcription buffer 40 mM HEPES KOH pH 7.9, 50 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 5 % glycerol 
Ni-column buffer A 20 mM Tris HCl pH 7.9, 300 mM NaCl, 5% v/v glycerol, cOmplete EDTA protease cocktail inhibitor 
Ni-column buffer B 20 mM Tris HCl pH 7.9, 300 mM NaCl, 5% v/v glycerol, 200 mM imidazole, cOmplete EDTA protease cocktail inhibitor 
Ni-column charging buffer 0.2 M NiCl2 
P49 Dialysis buffer  30 % glycerol, 50 mM K-POH pH 7.5,  3 mM β-mercaptoethanol, 1 mM MnSO4 
P49 Lysis buffer 50 mM Tris-HCl pH 8, 150 mM NaCl, 3 mM β-mercaptoethanol, cOmplete EDTA protease cocktail inhibitor 
P49 Ni-column buffer A 20 mM Tris-HCl pH 8, 250 mM NaCl, 3.5 mM β-mercaptoethanol, 1% triton X-100 
P49 Ni-column buffer B 20 mM Tris-HCl pH 8, 250 mM NaCl, 3.5 mM β-mercaptoethanol, 1% triton X-100, 200 mM Imidazole 
P49 Priming buffer 50 mM HEPES KOH pH 7.5, 10 mM Mg-acetate, 50 mM K-glutamate, 2 mM DTT 
P49 Resource Q buffer A 50 mM Tris- HCl pH 7.5, 1 mM MnSO4, 1 mM MgCl2, 3 mM β-mercaptoethanol  
P49 Resource Q buffer B 50 mM Tris- HCl pH 7.5, 1 mM MnSO4, 1 mM MgCl2, 3 mM β-mercaptoethanol, 1 M NaCl 
Phage buffer  10 mM Tris-HCl pH 7.5, 10 mM MgSO4,  
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Pol I buffer 20 mM Tris0-HCl pH 8, 50 mM KCl, 10 mM MgCl2 
POLMRT transcription buffer 40 mM Tris-HCl pH 7.9, 10 mM MgCl2, 10 mM DTT 
Primase buffer 50 mM HEPES KOH pH 7.5, 20 mM Mg-acetate, 100 mM K-glutamate, 10 mM DTT 
Resource Q buffer B* 10 mM Tris HCl pH 7.9, 5% v/v glycerol, 0.1 mM DTT, 0.1 mM EDTA, 1 M NaCl 
Resource Q buffer A* 10 mM Tris HCl pH 7.9, 5% v/v glycerol, 0.1 mM DTT, 0.1 mM EDTA 
SDS-PAGE separating gel 12 % 12% acrylamide, 375 mM Tris-HCl pH 8.8, 0.1 % SDS, (0.1 % SPS, 0.01% TEMED) 
SDS-PAGE stacking gel 6 % 6 % acrylamide, 125 mM Tris-HCl pH 6.8, 0.1 % SDS, (0.1 5 SPS, 0.01 % TEMED) 
SDS-RunBuffer  1x TBE, 0.1 % SDS 
Simple Transcription Buffer 20 mM Tris-HCl, pH 7.9, 40 mM KCl (+10 mM MgCl2) 
Stripping buffer 2 M NaCl, 0.1 M EDTA 
TBE buffer 89 mM Tris, 89 mM Boric Acid, 2 mM EDTA pH 8.0 
TE buffer 10 mM Tris-HCl pH 8, 1 mM EDTA 
Terminator buffer 50 mM Tris-HCl pH 7.9, 20 mM KCl, 20 mM MgCl2 
*for ion exchange chromatography of NudC and Gp53 EDTA and DTT were omitted 




2.1.3 Strains, primer and templates 
Table 2.4 Strains of bacteria used in this study are listed, genotype and source are given as well. 
organism strain genotype plasmid source 
E. coli 
T7 Express 
fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 R(mcr-73::miniTn10--TetS)2 
[dcm]R(zgb-210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10 
 NEB 
DH5α 




F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, Δqor-
745::kan, hsdR514 
pCA24N-dnaB Dr Matthew Peake 
JW3038 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, ΔttdT755::kan, rph-1, Δ(rhaD-
rhaB)568, hsdR514 
pCA24N-dnaG ASKA strain collection 
M. 
smegmatis 
mc1255 wt  Prof. Graham Hatfull 
M. 
smegmatis 
mc1255 wt  Prof Dipankar Chatterji 
M. 
smegmatis 
mc1255 SM07 His-RpoC  Prof Dipankar Chatterji 
Mycobacteriophage D29  Prof. Graham Hatfull 
26 
 
2.1.4 Sequences (vectors, templates and primers) 
Table 2.5 Primer (and purpose) used in these studies. F= forward (direction of 
translation), R= reverse. 
Primer name (use) Sequence 
D29 gp53 F NdeI (RE cloning) 
GCCCATATGCCATGACAGGCGACATCAACAA
GCTC 




E. coli acnA F (PCR)  TATGATCAACACAAATATGAAATATTG 
E. coli acnA R (PCR)  GGAGCTATGTCGTCAACC 
E. coli dnaB pET insert F 
(Gibson Assembly) AGCCATATGGCAGGAAATAAACCCTTCAAC 
E. coli dnaB pET insert R 
(Gibson Assembly) GTGCTCGAGTTATTCGTCGTCGTACTGCG 
















E. coli dnaG DnaG pET insert 
R (Gibson Assembly) 
GGCAGCAGCCAACTCAGCTTCCTTTCGGGCTC
ACTTTTTCGCCAGCTCCTGGTTTAATGT 












E. coli dnaG K241A F (Quik 
Change) 
CAGACATTTTCCATGCAGGCCGCCAGCTTTAC 








E. coli dnaG pET vector F 
(Gibson Assembly) AGCCCGAAAGGAAGCTGAGTTGGCTGCTGCC 
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E. coli dnaG pET vector R 
(Gibson Assembly) AGCCCGAAAGGAAGCTGAGTTGGCTGCTGCC 




E. coli dnaG Y230A F (Quik 
Change) 
CGATACCCCCAAAGACCTGAACTCGCCGG 
E. coli dnaG Y230A R (Quik 
Change) 
CCGGCGAGTTCAGGTCTTTGGGGGTATCG 
E. coli nudC F NcoI no N-term 
tag (RE cloning) 
ATACCATGGATGGATCGTATAATTGAAAAAT
TAG 
E. coli nudC R NotI for C-term 
tag (RE cloning) GTGCGGCCGCTTTCTCATACTCTGCCCGAC 
E. coli rnai F (PCR) CAGCAGCCACTGGTAACAGG 
E. coli rnai R (PCR) GGTTTGTTTGCCGGATCAAGAG 
H. sapiens lsp F (PCR) 
 CATAACCTTATGTATCATACACATACGATTTA
G 
H. sapiens lsp R (PCR)  GCCGGATAAAACTTGTGCTTATTTTTC 
L5  P_left for gBlock F (PCR) GGGACTGTCCAGCGTGACCAGC 
L5 P_left for gBlock R (PCR) CAGCTTACCCGATAACCGGGTGGc 
L5 P_left genome F (PCR) TGCCGGGACTGTCCAGCGTG 
L5 P_left genome R (PCR) ATAACCGGGTGGCTGTCAAACCGGAGAA 
L5 P_left mod fusion F 
(mutagenesis) CAGTAGTGCATTCTTGTGTCAccgcgcgcggcggtt 
L5 P_left mod fusion R 
(mutagenesis) CCTCTCGGATCCGCCTACCGaaccgccgcgc 




M. smegmatis rbpA R stop 
XhoI (RE cloning) 
ATTCTCGAGTCAGCTTCCGGTTCCGCGCCGCT
TCC 
M. smegmatis rrsA F (PCR) CTGCATGCGGGCTGGCTGGTG 
M. smegmatis rrsA R (PCR) GCCGCTGCATTCTCTAGTGGC 
M. smegmatis sigA F (RE 
cloning) AATACATATGGCAGCGACAAAGGCAAG 




pCA24-N MCS F (PCR, 
Sequencing) GGCGTATCACGAGGCCCTTTCGTCTTCACC 
pCA24-N MCS R (PCR, 
Sequencing) TTGCATCACCTTCACCCTCTCCACTGACAG 
pET28a control MCS F (PCR, 
sequencing) TAATACGACTCACTATAGGG 
pET28a control MCS R (PCR, 
sequencing) CTAGTTATTGCTCAGCGG 
T7 t7a1 F (PCR) GCTCTAATACGACTCACTATAGG 
t7 t7a1 R (PCR) CACTGGCCGTCGTTTTACAACGTCG 
pET28a control MCS F (PCR, 
sequencing) TAATACGACTCACTATAGGG 




Table 2.6 Templates for transcription and primer synthesis used in these studies 
Template Sequence 
DnaG template Priming t -1A cagACACACACACACTAcaaagc 
DnaG template Priming t -1C cagACACACACACACTCcaaagc 
DnaG template Priming t -1T cagACACACACACACTTcaaagc 
DnaG template Priming t wt (-1G) cagACACACACACACTgcaaagc 
DnaG/PolI hairpin template TTTACGCTTCGTTGACACACACACTGCGCGTTTGGGAAAACTCTTTCCCAAAC 



































































2.2 Microbiological methods 
2.2.1 Bacterial growth and storage 
E. coli growth 
E. coli doubling time is 20 minutes at optimal conditions (Fossum, Crooke and Skarstad, 
2007). E. coli were grown at 37°C on solid LB agar or liquid LB medium. This is a complex 
medium that can be supplemented with antibiotic if required. Strains with plasmid pET28a 
were supplemented with 50 µg/ml kanamycin sulfate, strains with plasmid pCA24N were 
supplemented with 34 µg/ml chloramphenicol. Bcterial growth in liquid culture is observed 
via optical density at 600 nm (OD600). 
M. smegmatis growth 
M. smegmatis mc1255 wt and M. smegmatis mc1255 SM07 are resistant to carbenicillin. M. 
smegmatis grows both at 30°C and 37°C, preferably in the dark. Doubling time at optimum 
conditions is 3 h (Klann et al., 1998). Strains were grown as solid culture on 7H10 agar with 
0.5 % glycerol, supplemented with 10% Albumin-Dextrose-Chloride (ADC) supplement and 
50 µg/mL carbenicillin. For top agar (pouring of bacterial lawn), cells were mixed 
Middlebrook top agar (MBTA) (brought to 50°C) supplemented with 10% ADC and 50 
µg/mL carbenicillin. Typically, 300 µl stationary phase cells (which corresponds to ~107 
cells) are mixed with 3 mL Top agar. At 37°C a bacterial lawn is visible within one to two 
days, colonies can be picked from 37°C after two days, or at 30°C after 3 days. 
M. smegmatis liquid culture was inoculated from a single colony or low volume of smooth 
pre-culture (1:1000 liquid pre-culture into fresh medium). 7H9 broth was supplemented with 
0.25 % glycerol, 10% ADC and 50 µg/mL carbenicillin. Liquid cultures for maintenance 
contained 0.02-0.04 % tyloxapol to prevent clumping. Liquid cultures for phage infection 
contained 1-4 mM CaCl2 (D29 requires 2 mM, TM4 requires 4 mM, Adephagia requires 1 
mM). Optionally, 1 mg/ml D-xylose was added to liquid infection cultures to prevent 
clumping. For protein purification, M. smegmatis can be grown without ADC enrichment, to 
avoid contamination with bovine serum albumin. In that case, instead of 10% ADC 
supplement, 7H9 broth was supplemented with 1% glucose. Liquid cultures are incubated in 
the dark under constant shaking (~150 rotations per minute, rpm) M. smegmatis grows to 
stationary phase at 30°C within 3 days, to OD600 = 0.2 within 1 day.  
Stationary cultures of M. smegmatis were kept for several months to inoculate pre-cultures 
before each experiment. 
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E. coli / M. smegmatis storage 
Bacteria can be stored at -80% in 30% glycerol. For this, 700 µl stationary phase culture was 
mixed with 300 µl glycerol. Bacteria were left on the bench for 30 minutes before freezing. 
2.2.2 Mycobacteriophage growth, infection and storage 
Our mycobacteriophages were provided by Prof Graham Hatfull , Pittsburgh University, 
USA. All results shown later represent mycobacteriophage D29. 
Table 2.7 Mycobacteriophages provided by Prof Graham Hatfull. Phages, their cluster (phylogenetic 
relationship) and lifestyle are shown. Phages investigated here in host M. smegmatis can also infect M. 
tuberculosis. Presented results in chapter III concern D29. 
Phage Custer (subcluster) Infection of M. tuberculosis Lytic or temperate 
Adephagia Δ41Δ43 K (K1) yes lytic mutant of 
Adephagia 
D29 A (A2) yes lytic 
TM4 K (K2) yes lytic 
 
Mycobacteriophage plaque picking 
This protocol was designed as described in protocols from Actinobacteriophage database 
(Hatfull, Graham, Russell, Dan, Jacobs-Sera, Debbie, Pope, Welkin, Sivanathan, Viknesh, 
Tse, 2016). For propagation of a clonal phage culture, phages were picked from a single 
plaque. For this, a lawn of M. smegmatis as described above was mixed with 10 µL of diluted 
phage suspension before pouring. The MOI was kept around below 1 for plaque picking (e.g. 
107 cells were infected with 0.5*107 phages) thus the dilution depends on a previously 
identified titre, or several dilutions were plated if the titre was unknown. Dilutions were 
prepared in phage buffer, supplemented with 1-4 mM CaCl2.  
As soon as plaques were visible, top agar of the plaque was stabbed with a sterile pipette tip. 
The agar plug was suspended into 100 µL phage buffer and vortexed. A serial dilution was 
prepared to determine the titre. 
Phage titration 
This protocol was designed as described in protocols from Actinobacteriophage database 
(Hatfull, Graham, Russell, Dan, Jacobs-Sera, Debbie, Pope, Welkin, Sivanathan, Viknesh, 
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Tse, 2016). Phage solution of picked plaque can be titrated via spot test or plate method. 
These are described in more detail in chapter III. In short, a serial dilution from the starting 
material in phage buffer was performed (100 – 10-9). Samples (10 µl) of dilutions can were 
spotted on a bacterial lawn (spot test), or intermixed with top agar before pouring the bacterial 
lawn (plate method). As soon as plaques were visible, they were counted, phage titre was 
determined as plaque forming units (pfu)/ml with the equation presented in chapter III. 
Phage amplification 
This protocol was designed as described in protocols from Actinobacteriophage database 
(Hatfull, Graham, Russell, Dan, Jacobs-Sera, Debbie, Pope, Welkin, Sivanathan, Viknesh, 
Tse, 2016). To produce phage stock solutions of high titre, a single plaque sample was 
amplified. For this, information from full plate titration was used to create multiple plates 
with “lace pattern” (see figure 2.1). The lace pattern depends on plaque size, which is unique 
to the phage, thus it needs to be determined empirically. As a guideline, MOI 1-10 can lead to 
lace pattern, thus 107 cells could be infected with 107-108 phages. Typically 10 plates of lace 
pattern were incubated overnight with phage buffer at 4°C standing (3 ml of phage buffer 
were poured onto one petri dish). The phage buffer was then collected and centrifuged (10000 
× g, 15 min) to remove bacterial cells, and then passed through a 0.45 µm PVDF syringe 
filter. This phage stock was titrated again. 
 
Figure 2.1 D29 plaque lace pattern. Plaque edges blend into each other and little bacterial lawn is left between 
plaques. 
Infection of liquid culture 
The method was outlined according to methods described in (Hatfull, 2010a; Parish and 
Roberts, 2015) and private conversation with Deborah Jacobs-Sera. Liquid pre-culture of M. 
smegmatis was grown in presence of tyloxapol until stationary phase and then used to 
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inoculate another pre-infection culture. This culture cannot contain tyloxapol, but can contain 
xylose. A pre-infection culture was harvested at OD600 = 0.2, early log phase. Only smooth 
cultures were used. Cell pellets were resuspended in phage buffer supplemented with CaCl2. 
Phage was added (MOI 10) to the resuspended cells at small volume (synchronisation). The 
infection was incubated for 30 min at 37°C (adsorption). Addition of medium (restoring 
OD600 = 0.2) is considered the start of infection (t = 0), as growth is facilitated by addition of 
nutrients. 
Phage stocks 
Filtered phage suspensions in phage buffer are viable at 4°C for several months with some 
loss of titre. Phage suspensions were renewed (amplified from single plaque) and titrated 
before use when the stock was more than a month old. 
 
2.3 Molecular Cloning 
Polymerase chain reaction (PCR) 
PCR from purified DNA was performed using Q5 polymerase, PCR from cell lysates was 
performed using Phusion polymerase, and colony PCR was performed using Taq polymerase. 
Table 2. 7 shows general recipe and settings for each polymerase. 
After PCR amplification, a sample of the reaction was analysed by agarose gel 
electrophoresis. For this, a 0.75-1 % agarose gel (in 1x TBE) was poured with Nancy dye and 
samples were loaded on solidified gel in 1x TBE buffer. Electrophoresis was run at 160 mA. 
DNA fragments to be used in molecular cloning were purified either from a 1% agarose gel 
using GE gel elution kit, or directly from the PCR reaction using the PCR reaction clean-up 
protocol of the GE gel elution kit (if present as a single band). DNA concentration was 
measured on Nanodrop. 
Fragmentation of DNA with restriction endonucleases 
Restriction endonuclease recognition sites of pET28a multiple cloning site (MCS) were 
considered when designing primer (see table 2.5). Further, restriction endonucleases were 
chosen which are buffer compatible and heat sensitive. Both, vector (~1 pmol) and insert (1-2 
pmol) were incubated with the restriction endonucleases specified in primer names (table 2.5) 
at 37°C for at least 1 hour, with commercial restriction buffer specified by NEB. Then, 
thermosensitive alkaline phosphatase (TSAP) was added to the vector reaction according to 
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manufacturer specifications, and incubation was continued for at least 30 min at 37°C. Then, 
enzymes were heat inactivated at 74°C for 15 minutes. The reactions were then cooled on ice. 
Table 2.8 PCR recipes and PCR machine settings for Q5, Phusion and Taq polymerases 
recipe Q5 polymerase Phusion polymerase Taq polymerase 
DNA 
< 1 µg (0.1 µl purified 
DNA) 
< 250 ng (0.1 µl lysate or 1 
colony) 1 colony 
dNTPs (each) 200 µM 200 µM 200 µM 
Forward primer 0.5 µM 0.5 µM 0.2 µM 
Reverse primer 0.5 µM 0.5 µM 0.2 µM 
Provided buffer 1x  1x  1x  
Polymerase 0.02 U/ µl 0.02 U/ µl 0.025 U/ µl 
Final volume 50 µl 50 µl 20 µl 
Settings 
   
Denaturation 98°C / 30 sec 98°C / 30 sec 95°C / 30 sec 
DNA melting (loop) 98°C / 10 sec 98°C / 10 sec 95°C / 30 sec 
Annealing (loop) 50-72°C / 30 sec 45-72°C / 30 sec 45-68°C / 1 min 
Elongation (loop) 72°C / 20 sec per kb 72°C / 20 sec per kb 68°C / 1 min per kb 
Final elongation 72°C / 2 min 72°C / 5-10 min 72°C / 5 min 
Number of loops 35 35 30 
 
Ligation 
For ligation of vector and insert prepared by enzymatic restriction, vector and insert are mixed 
in a ratio of 1:3 (~0.02 pmol vector and ~0.06 pmol insert) and incubated with 1x T4 DNA 
ligase buffer and 1 µl T4 DNA ligase/ 20 µl reaction. Incubation was performed 10 min at 
room temperature or at 4°C overnight. Ligase was then heat inactivated at 65°C for 10 




Alternative to the molecular cloning protocol using restriction endonucleases, cloning can be 
performed with Gibson Assembly (NEB, 2015). Here, primers were designed which contain 
partly overlapping sequences of insert and vector, such that fragments of vector and insert 
generated by PCR partly overlap and therefore can be directly ligated and transformed. For 
this, PCR fragments were generated by Q5 polymerase, cleaned up by Gel elution, and mixed 
in a ratio vector to insert 1:2 (adding up to 0.2 pmol DNA). DNA was mixed with NEBuilder 
HiFi DNA Assembly Master Mix according to manufacturer specifications and incubated at 
50°C for one hour. Afterwards the assembly was cooled on ice and 2 µl were transformed into 
50 µl E. coli DH5α cells. 
QuikChange mutagenesis 
To introduce point mutations into a gene on a plasmid, primer were designed according to the 
Quik Change Site Directed Mutagenesis II manual from Agilent Technologies (Stratagene, 
2002). Primer-dimer were complementary to the site to be mutated on DNA sense and anti-
sense strand, with the exception of the point mutation. According to E. coli codon preference, 
an amino acid codon was changed by substituting one to two base pairs. Using these primers, 
the full plasmid containing the gene of interest was amplified with Pfu Ultra polymerase, 
according to the QuikChange user manual. After the PCR reaction, the assay was cooled 
briefly to 37°C before addition of DpnI restriction endonuclease for one hour at 37°C. This 
nuclease digests the parental template (without the mutation). The reaction was stored on ice 
until transformation into E. coli DH5α. 
Recombinant genetics (Twist) 
Cloning of the human primase catalytic subunit P49 was performed by Twist Bioscience 
(Genes - Gene Synthesis | Twist Bioscience). For this, the P49 cDNA sequence was 
downloaded (NCBI Reference Sequence: NM_000946.3), and codon optimised for expression 
in E. coli, using the codon optimisation tool of Twist Bioscience. The optimised P49 gene was 
virtually cloned into the vector pET28a with C-terminal His-tag. A schematic is presented in 




Figure 2.3 pET28a-p49 plasmid as constructed by Twist Bioscience. The gene of P49 is transcribed from the 
inducible T7 promoter and is fused to a C-terminal His-tag (c-his). The plasmid carries a kanamycin resistance 
cassette. All cloning for presented studies was performed using pET28a. 
Transformation into DH5α cells 
Plasmids were transformed into E. coli DH5α C2987I cells for amplification, according to the 
High Efficiency Transformation Protocol by NEB (NewEngland Biolabs, 2018) (with 
modifications). For this, a small amount of DNA (1-1000 pg) was added to 50 µl competent 
cells on ice and incubated for at least 30 minutes. The cells were heat shocked for 30 seconds 
at 42°C. After a short cooling period (5 minutes on ice), transformed cells were mixed with 
950 µL sterile LB medium (room temperature) and incubated shaking (750 rpm on 
Thermometer comfort 1.5 ml heatblock by Eppendorf) at 37°C. Then, 100 µl of a 
transformation was plated onto LB agar containing 50 µg/l kanamycin sulfate. Transformants 
were grown overnight at 37°C. As controls, linearised plasmid (negative control) and circular 
vector without the gene of interest (positive control) were transformed. 5-15 colonies were 
subjected to colony PCR to identify transformants that contained the construct. For this, 
pET28a MCS primer were used to amply the MCS and distinguish empty MCS from MCS 
that contains the gene of interest. Up to 5 positive clones were inoculated into 2 ml LB with 
antibiotic. Plasmids were purified using Qiagen plasmid prep kit (QIAgen, 2012), in 
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accordance to the user manual. Samples from plasmid purifications were sent for Sequencing 
at Eurofins Genomics.  
After sequencing of plasmids, constructs which contained the gene of interest without 
spontaneous mutations and in frame with the desired His-tag, one plasmid clone was 
transformed into E. coli T7 express cells. Transformation into T7 express C2566I cells 
(NewEngland Biolabs, 2015) was performed according to the above protocol for 
transformation into DH5α competent cells. The only modification was that heat shock was 
performed for 10 seconds and no controls were used. The gained transformants were used for 
overexpression and protein purification. 
 
2.4 Protein Purification  
RNAP Rif-pocket mutants (Q513L, D516V, D516Y, H526P, H526R, H526Y, I572F, and 
S531I) were kindly provided by Dr Yulia Yuzenkova, Newcastle University, UK. NudC as 
used in part of the experiments was purified by Dr Amber- Riaz-Bradley, Newcastle 
University, UK. EcRNAP core and σ70 were given by Dr Hamed Mosaei, Newcastle 
University, UK. Mitochondrial RNA polymerase POLMRT and transcription factors, TFAM, 
and TFB2M were kindly provided by Dr Andrey Revyakin, University of Leicester, UK. 
Purification of recombinant M. smegmatis RbpA, recombinant D29 Gp55, and DnaG mutants 
(K229A, Y230A, K241A, D309A)  
Proteins were overexpressed in E. coli T7 express cells from plasmid pET28a-rbpA or 
pET28a-dnaG (mutants). 1-2 l LB (with kanamycin, 50 µg/ml or chloramphenicol 34 µg/ml, 
respectively) were inoculated using 10-20 ml stationary phase pre-culture (also containing 
kanamycin/ chloramphenicol). At OD600 = 0.5 cells were transferred to a shaking incubator at 
room temperature and temperature was allowed to adjust until OD600 = 0.6. Addition of 1 mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) induces expression of T7 RNAP, which is 
then able to transcribe the gene of interest from the T7 promoter on pET28a. Cells were 
grown for 14-20 h and then harvested by centrifugation (7.5 000 × g, 15 minutes, Beckman 
JLA 8.1000 rotor). The pellet was stored at -80°C until lysis. Lysis was performed by 
sonication. E. coli cell pellets were topped with ~ 40 ml Grinding buffer supplemented with 
proteinase inhibitor cocktail. Cells were sonicated (Benson digital sonifier) on ice, at ~30-40 
% amplitude 2-3 times for 2 minutes with 2 second pulses and 2 second pulse breaks. The cell 
debris was removed by centrifugation (Beckman JA25.50 rotor, 10 000 × g, 15 minutes). The 
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lysate was filtered through 0.45 μM polyvinylidene difluoride (PVDF) syringe filter and 
adjusted to 10 mM imidazole. 
Ni-column buffers A and B containing 600 mM NaCl were mixed to give solutions of 10 mM 
imidazole, 25 mM imidazole and 100 mM imidazole and cooled in ice. A His-Trap Ni2+-NTA 
column with 5 ml column volume (CV) was equilibrated with cold 10 mM Ni-column buffer. 
Then, the filtrate was passed through the column. The flow-through was collected. The bound 
protein in the column was washed with 5 CV (25 ml) 25 mM Imidazole Ni-column buffer. 
The flow-through was collected. Then, bound protein was eluted by 3 CV 100 mM imidazole 
Ni-column buffer. The eluates were collected in aliquots of 1.5 ml. A final elution of 2 CV 
200 mM imidazole Ni-column buffer B was collected. 
Afterwards, the His-trap Ni2+-NTA column was washed with 5 CV water and then 2 CV 20% 
ethanol was passed through the column for storage at 4°C. Between purification of different 
proteins by His-trap Ni2+-NTA column, the reusable column was stripped and recharged. For 
this, the column was washed in 5 CV filtered water, and 4 CV stripping buffer. After another 
wash step with 5 CV water, the column was recharged with 3 CV Ni-column recharge buffer. 
Afterwards, column was washed in water again.  
Different fractions of the purification process (crude lysate, filtrate, flow-though, wash, 
elutions) were subjected to SDS-denaturing Polyacrylamide gel electrophoresis (SDS-PAGE) 
using Expedeon precast gels (4-20% gradient) using Expedion RunBlue SDS-PAGE running 
buffer. For this, samples were mixed (1:2) with Laemmli dye and boiled for 10 minutes to aid 
denaturation of proteins. Electrophoresis was performed at 140 mA, until the dye front left the 
gel. Gels were stained in Instant Blue commercial Comassie stain. 
On the stained gel the protein of interest was identified in reference to its relative size to the 
protein standard. The purification eluates which contained a visibly pure protein of interest 
were pooled and concentrated using Amicon Ultra centrifugation filter units. These 
concentration filters come in various sizes (olecular weight cut-off (MWCO) of 3kDa, 10 
kDa, 30 kDa or 100 kDa). The size of MWCO was made in reference to the protein of interest 
which was then concentrated at 4°C and 5500 × g. 
The concentrated protein was dialysed against 1l Dialysis buffer in Spectra/Pore 6 dialysis 
membrane pre-wetted RC tubing (MWCO 3.5 kDa) at 4°C overnight, and for another 2-3 




Purification of recombinant M. smegmatis SigA, recombinant D29 Gp53, DnaB, DnaG 
wildtype, and NudC,  
Purification of protein with this protocol was performed as the previous protocol with some 
modifications. 
Proteins were overexpressed from pET28a (kanamycin resistance, genes sigA, gp53, nudC) or 
pCN24A (chloramphenicol resistance, genes dnaG, dnaB). Gp53 was overexpressed at room 
temperature for 3 hours. SigA induction was commenced at a cell density of OD600 = 1.0. 
After Ni2+-affinity chromatography (buffers containing 600 mM NaCl), proteins were found 
to be visibly impure. Therefore, they were subjected to ion exchange chromatography. For 
this, eluates were pooled and diluted with Resource Q buffer A to yield a salt concentration of 
less than 100 mM NaCl. Buffers and proteins were kept on ice at all times. A 1 mL Resource 
Q anion exchange column was connected to the AKTA Explorer FPLC from GE Healthcare. 
The pumping system was equilibrated to Resource Q buffer A, before the protein was loaded 
via P960 sample pump at a flow rate of 2 ml/min. The flow-through was collected. The 
column was washed in 0% B buffer. The protein was eluted from the ion exchange column by 
gradual increment of buffer B (raising salt concentration from 0 to 70% B (700 mM NaCl) 
within 50 min at a flow rate of 1 ml/min. Elutions were collected guided by the UV 
Absorbance at 260 nm. At 70% B, the elution gradient was changed to an increment 70-100% 
B within 10 minutes. The column was washed in 100 % B for 10 column volumes, and then 
washed with water for at least 10 CV before storage was facilitated by washing in 5-10 CV 
20% ethanol. 
The protein was identified after SDS-PAGE on NuPAGE precast gels (4-12 % gradient) with 
commercial NuPAGE run buffer. Visibly pure protein eluates were pooled and concentrated 
and dialysed as described above. 
Purification of recombinant human P49 
Purification of P49 was performed at constant supplementation of MgCl2. E. coli T7 express 
cells with pET28a-p49 were grown in 2l LB with 50 µg/ml kanamycin sulfate and 1 mM 
MgCl2 to OD600 = 1.6 at 37°C. The culture was then transferred to a room temperature 
shaking incubator and overexpression was induced with 1 mM IPTG for 3 h. Lysates were 
sonicated in P49 lysis buffer. A first affinity purification with a 5 ml His-trap Ni2+-NTA 
column was performed with P49 Ni-column buffer. Pooled eluates were dialysed overnight 
against P49 resource Q buffer A, supplemented with 80 mM NaCl at 4°C. Protein was loaded 
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onto a 1 ml Resource Q column in AKTA Explorer FPLC equilibrated to P49 ion exchange 
buffer A, and eluted by increment of buffer B. After SDS-PAGE on NuPAGE gel, visibly 
pure eluates were pooled and dialysed against P49 dialysis buffer. After dialysis, different P49 
aliquots were stored at 4°, -20°C and -80°C. A first experiment was performed immediately 
after dialysis in case activity would be lost soon. Activity of the protein was equal for all 
storage conditions on the first days after purification. Only P49 stored at -80°C was used 
repeatedly the first day. 
Purification of M. smegmatis His-RNAP 
For isolation of His-tagged RNAP from M. smegmatis, 10 l M. smegmatis SM07 liquid 
culture (7H9 supplemented with 0.25 % glycerol, 1 % glucose, 0.04 % tyloxapol and 50 
µg/ml carbenicillin) were grown to OD600 = 0.8. Then, the culture was pelleted by 
centrifugation (10000 × g, 30 minutes, Beckman JLA 8.1000 rotor), and the pellet was frozen 
(-80°C). The pellets were topped with about 40 ml Grinding buffer with proteinase inhibitor. 
The Benson digital sonifier was set to an amplitude of 18-20 % with 15 sec pulses and 15 sec 
breaks for 5 minutes. The lysate was spun down (15 000 × g, 10 min, 4˚C) and filtered. Ni-
column purification was performed as described above, with Ni-column buffers containing 
300 mM NaCl. Afterwards, Resource Q ion exchange chromatography was performed as 
described before. Pooled fractions were concentrated to about 200 µl and dialysed against 
M.smegmatis dialysis buffer using Pur-A-Lyzer Mini 12000 dialysis tubes. 
Purification of mycobacteriophage-infected M. smegmatis 
For purification of RNAP from infected M. smegmatis (and as control non-infected or non-
His-tagged RpoC), purification was done at a smaller scale.  
To test the method, 200 ml M. smegmatis SM07 were grown to OD600 = 0.2. Cells were 
pelleted and frozen and then lysed by a) Zirconia BeadBeating or b) Sonication. 
a) Zirconia glass beads (0.1 mm diameter) were washed three times in Grinding buffer. 
Washed beads were transferred into the BeadBeater vial alongside the frozen pellet, to 
yield a volume ~ 70 ml. Using an ethanol-ice mixture, the BeadBeater was cooled 
while the cells were lysed with 20 sec pulses, interrupted by 1 min breaks five times. 
The lysate was recovered and centrifuged (15 000 × g , 15 min, 4˚C) and then filtered 
through a 0.45 µm low protein binding PVDF syringe filter.  




Filtered lysates were adjusted to 10 mM imidazole. 500 µl of Ni2+-NTA agarose beads 
(corresponding to one CV) were equilibrated to 10 mM imidazole Ni-column bufferand added 
to the lysate and incubated 20 min on ice. The supernatant was recovered. Beads were washed 
in 1 CV 25 mM imidazole Ni-column buffer three times and the washing supernatant was 
kept. Protein was eluted from beads by adding 200 µl 100 mM imidazole Ni-column buffer 
twice and 200 µl 200 mM imidazole Ni-column buffer once. RNAP-containing elutions were 
identified by SDS-PAGE and protein was concentrated and dialysed against M. smegmatis 
dialysis buffer using Pur-A-Lyzer Mini 12000 dialysis tubes. 
For infection, 300 mL M. smegmatis SM07 were grown in 7H9 broth supplemented with 0.25 
% glycerol, 1 % glucose, 1-4 mM CaCl2 and 50 µg/ml carbenicillin to OD600 = 0.2. Cells were 
infected with mycobacteriophage at MOI 10 (as explained in chapter III) and after adsorption, 
culture volume was restored with fresh medium. After predetermined time points (for D29 15 
minutes and 40 minutes after infection), cells were pelleted by filtration. For this, the culture 
was passed through a 0.22 µm Whatman filter using a vacuum pump (Laboport, KNF Lab). 
Retained cells were frozen on the filter membrane (-80°C). For lysis, cells were washed off 
the filter using 7 ml Grinding buffer and lysis was performed via sonication as described 
above. Ni-column buffers for purification of RNAP from infected cells had a salt 
concentration of 150 mM NaCl. Ni2+-NTA agarose bead purification of infected lysates and 
controls was performed as described above. However, after concentration of eluates (to ~ 50 
µl), proteins were loaded onto a self-made SDS-PAGE gel (12 %), excised from the gel and 
sent to the Proteomics facility (as described in chapter III). 
Thrombin cleavage for removal of His-tag 
His-tag was removed from Gp53 and RbpA by using the thrombin cleavage protocol by 
Novagen (Thrombin Cleavage Capture Kit, no date). Biotinylated thrombin enzyme cleaves a 
specific amino acid sequence that is positioned on the peptide between His-tag and gene 
product. 10 µg of His-tagged protein was digested by 10 µU of thrombin in presence of 10 
µM heparin. The final volume including provided thrombin cleavage buffer was 500 µl. After 
incubation overnight at 4°C while shaking, 50 µl streptavidin beads (provided in the 
Thrombin cleavage kit) were added to remove thrombin enzyme and the mixture was 
incubated shaking at 4°C for another 30 minutes. After centrifugation (500 × g, 5 minutes, 
room temperature), supernatant was recovered and adjusted to 10 mM imidazole. 50 µl Ni2+-
NTA agarose beads (equilibrated in Ni-column buffer, 10 mM imidazole) were added. The 
bead supernatant was recovered again after 5 minutes shaking incubation at room temperature 
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and centrifugation to pellet the beads. By this protocol, about 55 % of the added gene product 
were recovered without His-tag. 
 
2.5 NudC metal analysis 
Inductively coupled plasma mass spectrometry (ICP-MS) was performed by Dr Kevin 
Waldron, Newcastle University, UK. Metal stock solutions (Pt2+, In3+, Zn2+, Mg2+, Mn2+, 
Cu2+, Co2+, Ni2+, Fe2+, all at 1000 ppm = 1000 mg/l) were provided by Dr Kevin Waldron. 
First, an internal standard containing 2 % HNO3 and 20 ppb Pt
2+ and In3+ ions was mixed. A 
series of metal standards was prepared alongside different samples. Metal stocks at high 
concentration were diluted in internal standard to 100 ppm (or 100 mg/l). 100 ppm metal ions 
were mixed to create a standard series of 0 (only internal standard), 1, 5, 10, 50, 100, and 500 
µg/l of each metal in the mixture. Of “red” NudC (purification from overexpression in 
complex medium, purification in absence of EDTA and DTT) and “white” NudC (red sample 
was dialysed in dialysis buffer containing 10 mM EDTA until colour was not visible by eye) 
were adjusted to 100 µM protein concentration. 100 µl of this were mixed with 400 µl 
internal standard and then one volume (500 µl) of 70 % HNO3 and heated to 70°C for 10 
minutes. 100 µl of this were mixed with 1 ml standard series and volumes were adjusted to 5 
ml by adding internal standard. Thus, of seven samples per protein, one sample contains only 
internal standard and no other metals. Additionally, a control series without protein was 
prepared. 5 ml samples were mixed with one volume of 70 % HNO3. The final samples of 10 
ml were predicted to contain 1 µM NudC. 
 
2.6 In vitro RNA synthesis 
2.6.1 Synthesis of transcription templates 
For transcription assays we used linear, PCR-generated dsDNA fragments which contained a 
promoter sequence. 
Templates rnai (promoter of E. coli sRNA RNA1) and rrsA (promoter of M. smegmatis 16 s 
rRNA) were generated by PCR from heat-lysed E. coli or M. smegmatis. P_left wildtype 
template was generated using heat-lysed L5 particle supernatant. Templates t7a1 consensus, 
acnA, acnA mod, rnai mod and lsp were provided by Dr Yulia Yuzenkova and PCR 
amplified. P_left 14mer and rnai 18 mer templates were ordered as gBlocks from IDT and 
amplified by PCR.  
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PCR products were purified from a 1 % agarose gel using the gel elution kit from GE 
Healthcare. 
Templates for primaser synthesis were ordered as ssDNA oligos from IDT. 
2.6.2 In vitro transcription with E. coli RNA polymerase from E. coli or T7 phage 
promoters 
In vitro transcription experiments were performed as described in (Julius and Yuzenkova, 
2017). For initiation complex formation, 0.3 pmol RNAP core enzyme (wildtype or rif-pocket 
mutant) and 1 pmol σ70, σ70Δ3.2, or σS. The promoter template t7a1 consensus, rnai or acnA 
was provided at 2 pmol. The mixture was incubated in transcription buffer without MgCl2 at 
37°C for 10 minutes. DTT in the assay was carried over from protein storage buffer to a final 
concentration of  around 0.2 mM DTT. After addition of 500 µM of initiator (ATP, NAD+, 
NADH, NADP+, DP-CoA, FAD UTP, UDP-Glc, UDP-GlcNAc, or UDP-MurNAc-AA5), 
unless otherwise stated, also 50µM (12.5 Ci/mmol) of the +2 nucleotide to be incorporated, 
α(P32)-CTP (on rnai and acnA promoters) or α(P32)-UTP (for t7a1 promoter) were provided. 
For abortive initiation, reactions were started by adding 10 mM MgCl2 and stopped after 3 
minutes by adding 1 volume of transcription STOP buffer.  
For synthesis of 9mer products from rnai mod or acnA mod RNAP-promoter complexes, 20 
µM UTP and 20 µM α(P32)-CTP (20 Ci/mmol), or 25 µM ATP and 25 µM α(P32)-CTP (25 
Ci/mmol), respectively, were added. Rifampicin was given at 5 µg/ml or omitted. These 
reactions were started by addition of Mg2+ containing buffer and stopped after 10 minutes of 
incubation at 37°C. 
For transcription from rnai 18 template, first 1 mM NAD+ and 100 µM UTP, 10 µM and 25 
µM of α(P32)-CTP (12.5 Ci/mmol) were added to RNAP-promoter complexes in transcription 
buffer in a volume of 20 ul. The reaction was initiated by addition of 10 mM MgCl2, and then 
incubated at 37°C for 10 minutes unless otherwise stated. Then, 20 µl Ni2+-NTA beads were 
added to the reaction, bead supernatant was discarded and beads were washed three times in 
transcription buffer without MgCl2. Then, 10 µM of each CTP, GTP and UTP were added to 
produce 23mer RNA. The reaction was adjusted to 20 µl by addition of MgCl2-containing 
transcription buffer. RNA synthesis was stopped after another 2 minutes incubation at 37°C. 
2.6.3 NCIN-decapping with NudC 
For decapping of 9mer RNA produced by NCIN with EcRNAP on rnai mod, 1 pmol RNAP 
and 1 pmol σ70 were mixed with 1 mM ATP, NAD+, or FAD and 0.5 pmol rnai mod template. 
46 
 
The reaction was started by adding 25 µM α(P32)-CTP (12.5 Ci/mmol), and 100 µM UTP in 
transcription buffer with MgCl2. The final volume of this reaction was 10 µl. After 10 minutes 
at 37°C, 20 µl Ni2+-NTA agarose beads were added. Beads were incubated another 5 minutes. 
Then, the supernatant was retrieved and split into two assays. To one, 10 pmol NudC were 
added, to the other the equivalent volume of dialysis buffer was added. Decapping and control 
reactions were incubated at 37°C for 10 minutes before the reaction was stopped. 
Decapping of 18 mer and 23 mer RNA was performed after transcription from rnai 18 
template. Here, an RNAP-promoter complex was preassembled by mixing 5 pmol RNAP and 
10 pmol σ70 with 5 pmol DNA in a final volume of 10 µl. To 5’-biotinylated rnai 18 template 
20 µl streptavidin beads were added. After 5 minutes incubation at room temperature, the 
reaction volume was adjusted to 20 µl by removing bead supernatant. Onto 20 µl RNA-
promoter complex-loaded beads 10 µl reaction mixture containing transcription buffer with 
MgCl2, 1 mM NAD
+, 100 µM UTP and 50 µM α(P32)-CTP (25 Ci/mmol) were added. After 5 
minutes of incubation at 37°C, the beads were washed twice in transcription buffer (no 
MgCl2), containing 1 M NaCl, and three times in transcription buffer (no MgCl2). Then the 
original volume (30 µl) was restored and 20 µl of the mixture were removed and split into two 
samples. To the residual beads, 10 µl transcription buffer with MgCl2, containing 10 µM GTP 
and 10 µM CTP were added. The 23mer reaction was incubated for 5 minutes and washed as 
before, the original volume was restored (20 µl) and split in two. To 10 µl of 18mer or 23mer 
RNA, 10 pmol NudC or an equal volume of protein storage buffer were added. NudC reaction 
was initiated by adding 10 mM MgCl2 and incubated for 10 minutes at 37°C. Reactions were 
stopped by adding one volume of STOP buffer. 
2.6.4 NCIN-capping by POLMRT and decapping by NudC 
The experiment was performed as described in (Julius, Riaz-Bradley and Yuzenkova, 2018). 
50 nM POLMRT were mixed with equimolar concentration of transcription factors TFAM 
and TFB2M and lsp promoter DNA. 1 mM of adenosine-containing initiator were added (or 
as control no additional initiator). Then, the reaction was started by providing POLMRT 
transcription buffer (with MgCl2), 50 µM ATP, 300 µM GTP, and 10 µM α(P
32)-UTP (25 
Ci/mmol). The reaction was incubated for 30 min at 37°C. Then, 0.5 pmol NudC was added 
to half of the reactions, or an equal amount of protein storage buffer. Incubation was 




2.6.5 In vitro transcription with M. smegmatis RNA polymerase from M. smegmatis or L5 
phage promoters 
Transcription experiments were performed in 10 µl volumes using 0.5 pmol MsRNAP and 
optionally, 1.5 pmol σA, RbpA or Gp53, or any combination of these. DNA (rrsA, P_left or 
P_left mod) was provided at 2 pmol. Unless otherwise indicated, RNAP was mixed with other 
proteins first, then DNA was added and then the reaction was started by adding M. smegmatis 
transcription buffer containing MgCl2 and NTPs. Non-radioactive UTPs were added at 100 
µM, or 10 µM if the same NTP was added as radiolabelled. α(P32)-UTP (for rrsA) or α(P32)-
CTP (for P_left) were added at 25 µM (12.5 Ci/mmol). Only for order of addition experiment 
(figure 5.13), CpA initiating dinucleotide was added at 100 µM and other nucleotides at 50 
µM to yield a 15 nt transcript on template P_left mod. To stop a reaction, one volume of 
transcription stop buffer was added to the assays. For visualisation of the reaction at different 
time points, 3 µl STOP buffer were prepared and 3 µl were removed from the reaction which 
was incubating at 37°C and added onto STOP buffer. 
When EcRNAP was used on M. smegmatis promoters, 0.5 pmol EcRNAP core and 1.5 pmol 
σ70 were optionally mixed with 1.5 pmol Gp53 or Gp55. 
2.6.6 In vitro primer synthesis by DnaG 
For synthesis of primer RNA from templates “priming t” or “hairpin template”, 1 µM DnaG 
were mixed with 1 µM template DNA and 1 mM initiator, unless otherwise indicated. If 
DnaB was present (3 µM), DnaG and DNA were premixed and then added to DnaG premixed 
with initiator. Primer synthesis was initiated by addition of 10 µM α(P32)-GTP (5 Ci/mmol), 
100 µM UTP, and primase buffer containing Mg2+. The reaction was incubated at 30°C for 10 
minutes. The reaction was stopped by adding transcription stop buffer, or salt to a final 
concentration of 1 mM NaCl. 
Kinetics experiments were performed as described above, but α(P32)-UTP was used to label 
primer RNA, thus 10 µM UTP and 100 µM GTP were given. A large reaction was started and 
for each time point a small volume was added onto STOP buffer. 
2.6.7 NCIS versus ppGpp competition assay 
To test the inhibition of primer synthesis by ppGpp, we incubated several concentrations of 
ppGpp (0, 100 µM, 600 µM and 1 mM) with several concentrations of initiators ATP (10 µM, 
60 µM, and 100 µM), NADH and FAD (both 100 µM, 600 µM and 1 mM), giving 12 
samples per initiator. 1 µM DnaG was pre-mixed with 1 µM priming t. ppGpp/initiator mixes 
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were added. After that, reactions were started and radiolabelled as described above, incubated 
at 30°C for 10 minutes, and then stopped by addition of transcription STOP buffer. 
2.6.8 Primer decapping by NudC 
To test whether NudC can cleave 5’-NADH on primer annealed to DNA, DnaG was removed 
after primer synthesis. For this, the reaction was stopped by adding 1 mM NaCl. Then, Ni2+-
NTA agarose beads (in primase buffer containing 1 mM NaCl) were added and briefly 
incubated at room temperature. Bead supernatant was passed through a Micro-Bio Spin 6 gel 
filtration column equilibrated to transcription buffer with Mg2+. The filtrate was split into two 
reactions, one containing 30 pmol NudC, and a control without NudC. Reactions were 
incubated at 37°C for 10 minutes. 
2.6.9 Primer cleavage by RNase H, terminator, SVP, or RppH 
For cleavage of primer by other enzymes, shown in figure 4.12, DnaG was removed from the 
priming t template and the RNA-DNA hybrid was filtered as described above, but the Micro-
Bio Spin 6 gel filtration column was equilibrated in water. Reactions were mixed with 40 
pmol NudC, 1.25 U RppH, 2.5 U Pol I, or 15 pmol SVP with transcription buffer (including 
Mg2+). 1.25 U RNaseH was added with commercial RNase H buffer. The final reaction 
volumes were equal and contained 1x buffer, to the control only water was added. Reactions 
were incubated 10 minutes at 37°C before STOP buffer was added. 
2.6.10 Primer removal by Pol I 
For investigation of Pol I activity on NCIS-primer, primer were synthesised by DnaG on 
hairpin template, as described above, except for the concentration of ATP. While other 
initiators were provided at 1 mM, 100 µM ATP were given due to difference in KM to get a 
comparable amount of primer substrate for Pol I. DnaG was removed by addition of salt and 
Ni2+-NTA beads. The hybrid was filtered and eluted in water. A sample (4.2 µl) was retained 
and mixed with water (0.8 µl) as t = 0. 10 U of Pol I were premixed with 500 pmol of dNTPs 
and 3 µl 10x Pol I buffer to a volume of 5 µl. This was added to the reaction to a final volume 
of 30 µl. 5µl of this were removed to stop the reaction at different time points. 
2.6.11 Primer initiation by P49  
For primer initiation by P49, 2 µM P49 were mixed with 8 µM ssDNA template and 1 mM of 
initiators guanosine, GMP, GTP, dGTP, m7G, GpU, or ATP. 50µM α(P32)-UTP (25 
Ci/mmol), and 10 µM GTP in P49 priming buffer. This was incubated at 37°C for 10 minutes. 
The reaction was stopped by adding STOP buffer. 
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2.6.12 Denaturing bis:acrylamide gel electrophoresis 
Radiolabelled RNA products of transcription or primer synthesis were separated by size and 
charge by electrophoresis on homemade denaturing bis:acrylamide gels. Different gel 
densities were chosen depending on the size of the RNA. Di- and trinucleotide products were 
run on 33 % bis:acrylamide gels, 9 mer – 18 mer transcripts and primer were run on 23 % 
gels, and run-off transcripts were run on 15 % gels (made by dilution of 23 % gel mixture). 
After electrophoresis, the gels were incubated in a phosphoimaging screen cassette for 30 
minutes or up to 2 days. The phosphoimage was visualised by Typhoon imager by GE 












3 Chapter I: Bacterial and mitochondrial RNA Polymerases perform 
Non-canonical RNA capping 
3.2 Introduction 
With every new finding of molecular biology, many more questions arise. This is in no way 
different for the newly discovered non-canonical initiating nucleotide (NCIN) capping of 
bacterial and eukaryotic RNA. NCIN-capped RNA bears a nucleotide-containing small 
molecule, such as a cofactor or small metabolite, or a cell wall precursor, instead of a 5’-
canonical NTP. Due to the uniqueness of the classic eukaryotic 5’-RNA-cap, RNA capping 
was believed to have originated from an evolutionary time point after divergence of pro-and 
eukaryotes. In 2009 NCIN caps were first discovered on bacterial transcripts, and later shown 
to also be present on eukaryotic and viral RNA. The conservation of NCIN-capping in 
different kingdoms of life implies an important function. First findings allow to make 
assumptions about a physiological role of bacterial NCIN-caps in regulation of growth and 
virulence. There is so far no evidence for preserved function of NCIN-caps throughout 
evolution.  
A few years after the discovery of the existence of non-canonical caps we (and others) have 
elucidated the mechanism by which RNAP caps transcripts.  
3.2.1 Chronology of the Discovery 
The understanding of versatility and functionality of the RNA molecule in the cell has been 
extended considerably in the last decades (Chen et al., 2009; Repoila and Darfeuille, 2009; 
Waters and Storz, 2009). RNA seems to fulfil a much higher variety in functions than the 
molecule’s primary structure conveys. Thus, in 2009 the group around David Liu performed a 
screening of E. coli (Gram negative) and Streptomyces venezuelae (Gram positive) cellular 
RNA in an attempt to find previously unknown small molecule conjugates on RNA (Chen et 
al., 2009; Kowtoniuk et al., 2009). Their method was a combination of size exclusion 
chromatography, chemical and enzymatic processing of RNA and Mass Spectrometry and 
yielded besides many known RNA conjugates (such as amino acids on tRNA), and base 
modifications such as methylation, around 30 new small molecule conjugates for both 
organisms.  
Liu’s group focused on the determination of two of the unknown conjugates found in both 
species and identified dephospho-Coenzyme A (DP-CoA) and its succinyl- acetyl- and 
methylmalonyl-thioester derivatives, as well as nicotinamide adenine dinucleotide (NAD+). 
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NAD+-RNA was further determined to be present at high abundance in the bacterial cell, 
comparable in number to an individual tRNA. Using further analysis they were able to 
localise both conjugates to the 5’-end of RNA, thus the parallel to eukaryotic cap was drawn 
(Chen et al., 2009; Kowtoniuk et al., 2009; Cahová et al., 2015).  
First studies aimed at identifying which types of genes are frequently NADylated (NAD+-
modified). Cahová et al. found that in E. coli, most frequently sRNAs with functions for 
regulation of metabolism and stress response are NADylated. Further, 5’-mRNA fragments 
(size < 200 nt) of genes involved in metabolic pathways as well as stress response were 
enriched by their method NAD captureSeq (Cahová et al., 2015). With 13% of transcripts the 
highest NADylated RNA in E. coli was found to be RNA1, sRNA for replication control of 
plasmid ColE1. NAD captureSeq makes use of transfer reactions to enzymatically exchange 
the nicotinamide mononucleotide (NMN) moiety of NAD+ to a penynyl group from pentynol 
(transglycosylation) which can be chemically “clicked” to a biotin tag (copper-catalysed 
azide-alkyne cycloaddition) which was then captured on streptavidin beads. The captured 
RNA was reverse transcribed, PCR amplified, and the cDNA sequenced. The same method 
was tested on the yeast Saccharomyces cerevisiae, yielding the first proof of NADylated RNA 
in eukaryotic cells. mRNAs and mitochondrial RNAs were enriched, mainly of genes 
involved in translation and mitochondrial activity, such as cytochrome c oxidase subunit 2 
and F0 ATP synthase subunit c (Walters et al., 2017). Shortly after this, NAD captureSeq was 
applied on HEK293T (human kidney) cells revealing that mainly small nuclear (snRNA) and 
small nucleolar (snoRNA), as well as small Cajal body (scaRNA) RNAs are NADylated in 
mammals (Jiao et al., 2017). The finding that this RNA modification exists in both 
prokaryotes and eukaryotes spiked the interest in the discovery in hope to find unknown, 
ancestral mechanisms and pathways. This alternative capping was suggested to implement an 
unknown mechanism of epigenetic regulation (Kiledjian, 2018). In vitro experiments 
suggested that NCIN capping can also be expected on human mitochondrial, as well as viral 
RNA (Huang, 2003; Julius, Riaz-Bradley and Yuzenkova, 2018), which was recently verified 
in vivo (Bird, Basu, Kuster, Ramachandran, Grudzien-Nogalska, Towheed, et al., 2018; J. 
Wang et al., 2019). For this, new methods were developed. Bird et al. extended the Boronate 
affinity electrophoresis method developed by Nübel et al. in 2016 with hybridisation to 
radioactive probes (Nübel, Sorgenfrei and Jäschke, 2017; Bird, et al., 2018). Wang et al. 
invented CapQuant, a quantification method that relies on HPLC enrichment of non-canonical 
nucleotides and LC-MS/MS (J. Wang et al., 2019). They also used cap-analysis gene 
expression (CAGE) for identification of TSS, though this method relies on classical 
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eukaryotic caps. At last, NADylated RNA was also identified in the plant Arabidopsis (Y. 
Wang et al., 2019; Zhang et al., 2019), and Bacillus subtilis as well as Staphylococcus aureus 
(Frindert et al., 2018; Morales-Filloy et al., 2019), using NAD captureSeq and another new 
qualitative NAD+-RNA detection method, NAD tagSeq. Here, NAD+ is enzymatically 
replaced by a synthetic RNA tag, detected with a complementary DNA probe, and RNA is 
sequenced (Zhang et al., 2019).  
Besides discovery of capped RNAs, also potential dedicated cap removal (decapping) 
enzymes were identified. An E. coli protein of the family of NUDIX (nucleotide diphosphate 
bound to a moiety X) hydrolases, NudC, had previously been known as housekeeping enzyme 
for NAD(H) homeostasis (Frick and Bessman, 1995). NudC cleaves the disphophate bond in 
NAD(H), producing nicotinamide mononucleotide (NMN) and AMP. Its’ strong affinity to 
NADylated RNA was shown, which makes it a great tool to study NAD+-capping (Cahová et 
al., 2015; Höfer et al., 2016). Another NUDIX family protein was found to be involved in 
NAD+-cap removal and pyrophosphohydrolysis of triphosphorylated transcripts in B. subtilis, 
BsRppH (Frindert et al., 2018). Interestingly, the E. coli homologue RppH is a pure 
pyrophosphohydrolase (Foley et al., 2015), indicating a potential difference in NCIN-RNA 
degradation between Gram positive and Gram negative bacteria. NudC homologues were 
found in eukaryotic cells (Zhang et al., 2016). These might constitute one pathway of cap 
removal in eukaryotes, while another protein family, DXO, was also shown to decap both 
classical caps and NAD+-cap, albeit by a different mechanism (Jiao et al., 2017).  
The mechanism of NCIN-capping was soon identified using biochemical assays (Bird et al., 
2016; Julius and Yuzenkova, 2017). The presented research in this thesis is part of these 
studies and will be discussed further in this chapter. 




Table 3.1 Chronology of discoveries on NCIN-capping and decapping, including research papers but not reviews. 
publication date Authors Finding Methods 
May-09 Kowtoniuk et al. 
multiple small molecule conjugates on E. coli and S. venezuelae RNA, 
particularly CoA species 
alkaline/nucleophile chemical breakdown of RNA, 
LC/MS 
Dec-09 Chen et al. 
NAD+-linked RNA on subpopulations of small ( < 200 nt) transcripts 
cannot be installed by RNAP in vitro 
nuclease P1 digestion, LC/MS 
Mar-15 Cahová et al. 
E. coli NAD+-modification mainly on sRNAs and mRNA fragments, 
quantification of these, NAD-linked transcripts are resistant to RppH and 
RNase E cleavage, but susceptble to NudC 
NAD captureSeq, in vitro transcription, in vitro 
nuclease assays 
Jul-16 Bird et al. 
Non-canonical initiating nucleotides are substrates to E. coli and yeast 
RNAP, decapping by NudC with crystal structure, higher prevalence in 
stationary phase 
in vitro transcription, RNA isolation, ∆nudC mutant 
Sep-16 Höfer et al. 
crystal structure of E. coli NudC with NAD+ or NMN, NudC prefers 
NAD+-RNA over free NAD+, RNA binding is unspecific 
Crystallography, mutation studies, in vitro NAD+-
hydrolysis, next generation sequencing 
Aug-16 Zhang et al. 
Crystal structure of E. coli NudC with NAD+, NAD+ hydrolysis is metal 
ion-dependent, eukaryotic NudC-homologues decap RNA in vitro 
Crystallography, mutation studies, in vitro decapping 
Sep-16 
Nübel, Sorgenfrei and 
Jäschke 
Boronate-affinity electrophoresis as new method to analyse and isolated 
NAD+-RNA 
acryloylaminophenyl boronic acid- polyacrylamide 
gels to retain NADylated RNAs, gel elution 
Jan-17 Walter et al. NAD+-cap on  yeast nuclear and mitochondrial pre-mRNA 
NAD captureSeq (NAD+ on RNA is enzymatically 
replaced with biotin, streptavidin-captured RNAs are 
reversed transcribed, cDNA is sequenced) 
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Mar-17 Jiao et al. 
In mammals, predominantly NAD+-snRNA and NAD+-snoRNA, DXO 
proteins as new class of NCIN-removing enzymes, crystal structure of 
DXO with 3'-pNAD, NADylation interferes with translation 
NAD captureSeq, in vitro transcription, in vitro 
decapping, in vivo reporter-mRNA translation 
(lucifease) and fluorescence detection, DXO-KO 
May-17 Julius and Yuzenkova 
bacterial RNAP incorporates various cofactors of metabolism (NAD(H), 
NADP, DP-CoA, FAD) and cell wall precursors (UDP-Glc, UDP-GlcNAc) 
in vitro, NCIN-capping supports promoter escape, protein structural 
determinants of NCIN-capping (σ region 3.2, β Rif-region) 




mitochondrial RNAP incorporates metabolites in vitro in vitro transcription 
May-18 Vvedenskaya et al. 
CapZyme-Seq as new method for NAD+-RNA detection and quantitation, 
promoter structural determinants for NAD+-capping 
in vitro transcription of promoter library, decapping 
enzyme-and barcode DNA-adapter-based  
quantitation of transcript, reverse transcription, 
sequencing 
Jul-18 Bird et al. 
NAD(H)-capping by mitochondrial RNAP is more efficient than bacterial 
and yeast RNAP and reflect intracellular NAD(H) levels 
in vitro transcription, nuclease cleavage, boronate 
affinity electrophoresis, hybridisation to radioactive 
probes 
Aug-18 Frindert et al. 
Detection of NAD+-RNA in B. subtilis (Bs) are mainly mRNAs, BsRppH 
acts as decapping enzyme in vitro and in vivo, protein and promoter 
structural determinants 
nuclease digest, decapping, LC/MS, NAD captureSeq, 




NAD-capQ as new method to detect and quantitate NAD+-RNA, level of 
NAD+-RNA is proportional to cellular NAD+-level in human cells 
nuclease P1 digestion, colorimetric detection of 
NAD+, in vitro transcription and decapping, ∆nudC, 
∆rai1, ∆DXO1, DXO-KO 
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Jun-19 Wang et al. 
Identification of NAD+-capped mRNA of nuclear, mitochondrial, but not 
chloroplast genes of Arabidopsis 
NAD captureSeq 
Jun-19 Zhang et al. New method NAD tagSeq to identify genes that yield NADylated RNA 
NAD tagSeq (NAD+ is enzymatically replaced by 
synthethic RNA tag and enriched by complementary 
DNA probe, bound RNA sequenced 
Jul-19 Wang et al. 
in vivo evidence of FAD, UDP-Glc and UDP-GlcNAc caps on bacterial, 
yeast, mammalian and viral RNA 
CapQuant (nuclease P1, HPLC enrichment of cap 
nucleotides, LC-MS/MS for quantification), cap-
analysis gene expression (CAGE) for TSS 
identification (pull-down, reverse transcription, and 
bioinformatic analysis), RT-qPCR 
Sep-19 Morales-Filloy et al. NADylation of antitoxin RNAIII in S. aureus modulates virulence NAD captureSeq, RNA Seq 
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3.2.2 Mitochondrial transcription is dissimilar to bacterial and eukaryotic transcription 
After NAD+- and DP-CoA-capped bacterial transcripts were discovered, similar methods 
were used to detect NADylated RNA in yeast, revealing that yeast NADylated RNA were 
nuclear pre-mRNAs (unprocessed transcripts) and unprocessed mitochondrial transcripts. The 
yeast mitochondrial genome (mtDNA) is circular and encodes 30-40 genes, including 
ribosomal RNAs, 24 tRNAs, and genes for enzymes of oxidative phosphorylation (ATP 
synthase subunits, cytochrome c oxidase subunuits (COX), apocytochrome b, and in some 
yeast NADH-ubiquinone oxidoreductase subunits, ribosomal protein, and RNA subunit of 
mitochondrial RNase P). S. cerevisiae carries 50-200 mitochondrial chromosomes, depending 
on growth phase. mtDNA is about 85 kb large (Freel, Friedrich and Schacherer, 2015). Yeast 
mtDNA bears 28 promoters, all of which are +1A. Interestingly, mutation of +1 position was 
shown not to affect transcription. Therefore, authors hypothesised that “ATP sensing” is a 
means of transcription regulation by the availability of ATP in the mitochondrium. 
Furthermore, KM of POLMRT to initiating ATP varies on different promoters, making them 
more or less sensitive to regulation by ATP concentration (Deshpande and Patel, 2014). 
Transcripts of 21S rRNA gene and cox2, which were identified as highly NADylated in vivo 
(Walters et al., 2017), are reported to show lower sensitivity to regulation by ATP 
(Deshpande and Patel, 2014). 
The mammalian mitochondrial genome is circular, 16.6 kb, and encodes 13 proteins, 22 
tRNAs and 2 rRNAs. Uneven distribution of purines/pyrimidines causes one strand to be 
heavier (H strand) than the other (L strand). Transcription takes place starting at one promoter 
per strand, the heavy strand- or light strand promoter (hsp or lsp), yielding long polycistronic 
transcripts which require processing. Both promoters are located at a non-coding region 
together with origin of replication of H strand (Taanman, 1999). Both promoters are +1A 
(Morozov and Temiakov, 2016). Most genes are located on H-strand, starting with two rRNA 
genes, 14 tRNAs and 12 protein coding genes. The lsp-transcript starts with 8 tRNAs, and 
carries one protein gene. All mtDNA encoded proteins belong to the oxidatve 
phosphorylation pathway (Taanman, 1999). Replication also starts from transcripts on lsp 
(Chang and Clayton, 1985). 
Bacterial and eukaryotic cellular RNAPs are structurally similar multisubunit enzymes. 
Mitochondrial RNAP (POLMRT) however, is a single subunit enzyme with structural relation 
closer to bacteriophage transcriptases such as T7 RNAP. The C-terminal domain of the single 
subunit RNAPs forms a form a “right-hand” structure with thumb, palm and finger domains 
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wrapped around DNA. The catalytic centre is also located in this domain. Polymerisation 
requires two divalent cations. An O-helix of the finger domain is involved in promoter 
melting and remains at the downstream side of the transcription bubble. Promoter contact of 
POLMRT is via N-terminal domain and comprises an AT-rich recognition loop and an 
intercalating hairpin which is also involved in promoter melting. The specificity loop in the 
C-terminal domain stabilises the open complex and localises the template strand to the 
catalytic centre (Hillen, Temiakov and Cramer, 2018).  
Mitochondrial transcription initiation requires two essential transcription factors, 
mitochondrial transcription factor A (TFAM) and mitochondrial transcription factor B2 
(TFB2M). As shown in figure 3.1, transcription is initiated by TFAM binding promoter DNA 
-10 to -15 bp upstream of TSS. It induces a U-turn in the promoter and recruits POLMRT 
which binds on its N-terminus. POLMRT contacts DNA on a region at approximately -50 to -
60 relative to TSS. TFB2M binds POLMRT and induces structural isomerisation to open 
complex and promoter melting (D’Souza and Minczuk, 2018; Barchiesi and Vascotto, 2019).  
In mitochondrial transcription elongation, initiation factors are lost and mitochondrial 
transcription elongation factor (TEFM) binds POLMRT, which enhances transcription 
processivity and enables transcription of promoter distal genes. Especially transcription of 
RNAs high in secondary structure (such as tRNA) requires support by TEFM (Barchiesi and 
Vascotto, 2019). TEFM forms a “sliding clamp” structure around DNA and interacts with 
POLMRT via its C-terminus (D’Souza and Minczuk, 2018). 39S ribosomal protein L12 
(MRPL12) supports processivity of elongation (Barchiesi and Vascotto, 2019). 
In absence of TEFM transcription from lsp can be prematurely terminated at a site called 
conserved sequence block 2 (CSB2), a non-coding region. The transcript that results from 
this, premature termination can serve as primer for DNA replication (Chang and Clayton, 
1985; D’Souza and Minczuk, 2018). 
Mitochondrial transcription termination is not fully understood. Likely, mitochondrial 
termination factor 1 (MTERF1) binds mtDNA between hsp and tRNALeu, inducing unwinding 
of DNA and base flipping. The elongation complex clashes with this termination structure 
(D’Souza and Minczuk, 2018). Other studies, however, have shown that MTERF1 is 
expendable for mitochondrial transcription termination (Barchiesi and Vascotto, 2019). 
Another potential termination mechanism depends on folding of the RNA-DNA hybrid into a 
structure that halts the elongation complex. This folding occurs at a G-rich sequence, 
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neighboured by a short spacer and an AU-rich stretch (Wanrooij et al., 2012; Mukundan and 
Phan, 2013). 
Long polycistronic mitochondrial transcripts need to be processed. In the “tRNA punctuation 
model” of mtRNA processing, a first step of processing is cleavage of 5’- and 3’-ends of 
tRNAs by RNase P and Z, respectively (D’Souza and Minczuk, 2018). RNase P is 
predominantly described to be involved in tRNA maturation. It is a multiprotein complex that 
is encoded in the nucleus but acts on mitochondrial RNA. One subunit of RNase P, MRPP2, 
has an NAD+-binding site (Lopez Sanchez et al., 2011). 
 
Figure 3.1 From (Drakulic, Cuellar and Sousa, 2018). Mitochondrial transcription initiation.Transcription 
requies binding of TFAM to promoter DNA. POLMRT recognises the characteristic U-turn of the TFAM-
promoter complex. TFB2M binding to POLMRT causes promoter melting and transcription can commence. 
Additionally, several cellular Fas-activated serine/threonine kinases (FASTKs) might be 
involved in maturation of mitochondrial transcripts. Deletion of these kinases was shown to 
lead to accumulation of precursor mtRNAs, indicating a role in processing (D’Souza and 
Minczuk, 2018). After cleavage from the primary transcript, mRNAs are polyadenylated by 
polyadenylic acid RNA polymerase (mtPAP). Polyadenylation is assisted by an RNA 
chaperone, leucin-rich penticopeptide-rich domain containing protein (LRPPRC), which 
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interacts with stem-loop interacting RNA-binding protein (SLIRP) to enhance stability of 
both LRPPRC-mRNAs (D’Souza and Minczuk, 2018). In case of some mRNAs 
polyadenylation completes an otherwise absent stop codon. Besides that, the effect of 
polyadenylation in mammalian mitochondria is RNA-specific and cannot be generalised to 
lead to degradation, as in bacteria, or stability, as in the eukaryotic cytosol (D’Souza and 
Minczuk, 2018).  
3.3 Aims 
We hypothesise that the small-molecule conjugates found on 5’-RNA are utilised by bacterial 
RNAP to initiate transcription, and are thus incorporated at the 5’-end as a non-canonical 
initiating nucleotide. Our results should further shed light on several aspects of the capping 
mechanism, such as promoter and protein structural elements. We aim to verify that RNA-
capping with nucleotide-containing molecules is an ability of various DNA-dependent RNA 
Polymerases, specifically bacterial RNAP, Bacterial primase, and mitochondrial POLMRT. 
 
3.4 Results 
3.4.1 Bacterial RNA polymerase incorporates adenine containing cofactors for 
transcription on +1A promoters 
To test the hypothesis that the nucleotide-containing molecules at RNA 5’-end found by Liu 
have been attached via transcription initiation, we performed in vitro transcription assays. 
This method was inspired by early research on RNAP mechanism many years ago, where 
coenzymes NAD+, FAD, and DP-CoA were incorporated into RNA by T7 RNAP (Malygin 
and Shemyakin, 1979). These metabolites bear a free 3’-OH group from the ribose of 
adenosine, and α- and β-phosphates, but in place of γ-phosphate, another moiety X (such as 
nicotinamide or riboflavin) is attached. Here, we assess whether RNAP incorporates these 
non-canonical substrates in a template-dependent fashion. We hypothesised that the adenine-
containing metabolites could substitute for ATP on a +1 A promoter. This requires base 
pairing between non-template strand dT and incoming A (or ADP-part of metabolites). In a 
first experiment with metabolites and α(P32)-UTP on bacteriophage promoter t7a1 
dinucleotide abortive products were synthesised by EcRNAP with all tested nucleotide-
containing metabolites except NADP (see figure 3.2). The gel clearly shows the variation of 
migration of products on denaturing bis:acrylamide gel, caused by size and charge differences 
of the X moieties of initiator molecules. A further observation peaked our interest: Variations 
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in radioactive signal intensity indicates that the efficiency of dinucleotide formation differs, 
which means that RNAP has varying affinities to the substrates.  
We tested this hypothesis with kinetics experiments (figure 3.3). Michaelis-Menten constant 
KM was determined for substrates for ATP (90 ± 11 μM), NAD
+ (358 ± 67 μM), and NADH 
(380 ± 72 μM). Table 3.2 compares KM values with cellular concentration of these 
metabolites in E. coli cells growing in complex medium with glucose as carbon source, 
measured from log-phase cells (Bennett, Kimball and Gao, 2009). If KM of RNAP to a 
substrate is lower than the cellular concentration, this is an argument in favour of this process 
taking place in vivo. For both ATP and NAD+, cellular concentration is higher than KM. 
NADH is present at lower concentrations in vivo. However, the ratio of NAD+ to NADH is 
highly variable, dependent on many factors (such as oxygen levels) and underlies inherent 
measurement difficulty. Other studies challenge numbers presented by Bennet et al. and 
describe NAD+:NADH ratio is often equal (Sun et al., 2012). Total NAD(H) content was 
determined to range between a minimal 0.039 mM and maximal 8.49 mM in E. coli over 
various growth stages (Zhou et al., 2011).  
Since RNA1 was shown to be most frequently capped in vivo (Cahová et al., 2015), we tested 
NCIN-capping on the rnai promoter (figure 3.3). This promoter was then modified to allow 
for production of a transcript of specific size (rnai mod, figure 3.3 A). Interestingly, while 
NADP could not initiate transcription on t7a1 (figure 3.2 B), it was incorporated in both 
abortive as well as longer RNA products from rnai and rnai mod (figure 3.3 C). This led us to 
suspect that promoters might contain signals to regulate NCIN-capping.  
Table 3.2 Comparison of cellular concentration and KM of metabolites used as initiating substrates for 
transcription. Metabolite concentrations were tested by Bennet et al. in exponentially growing E. coli cells on 
complex medium, with glucose as carbon source (Bennett, Kimball and Gao, 2009). Michaelis-Menten constant 
was tested by in vitro transcription on rnai promoter giving excess initiator (0.5 mM) and α(P32)-CTP to E. coli 
RNAP. Transcription efficiency was determined via phosphor-imaging using ImageQuant. (Julius and 
Yuzenkova, 2017) 
substrate ATP NAD+ NADH 
Cellular concentration (mM) 9.6 2.6 0.08 





Figure 3.2 Promoter-dependent transcription initiation by EcRNAP using different 
adenine-containing metabolites. A sequence of t7a1 promoter with -35 and -10 
promoter elements (orange) and TSS (green). B Dinucleotide products of adenine-
containing initiator, given at high concentration (0.5 mM), and radiolabelled 
α(P32)-UTP as second nucleotide substrate. Results were ontained in collaboration 
with Dr Yulia Yuzenkova (Julius and Yuzenkova, 2017). 
 
 
Figure 3.3 Metabolite-capping on promoter rnai. A Sequences of promoters rnai 
and modified version rnai mod, which allows for transcription of precise 9-nt 
product when giving adenosine-containing initiator (+1A), α(P32)-CTP (+2C) and 
UTP. B Denaturing polyacrylamide gel of time-dependent synthesis of 
dinucleotide product initiated by ATP or NAD
+
. C Production of dinucleotide and 
9-nt products initiated by cofactors on rnai mod. Results were obtained in 
collaboration with Dr Yulia Yuzenkova (Julius and Yuzenkova, 2017).
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3.4.2 Uridine-containing cell wall precursors initiate transcription on +1U promoters 
Encouraged by the results for adenine-containing metabolites, we aimed to investigate 
whether another TSS would allow for capping with other nucleotide containing small 
molecules. Among the most abundant in growing bacterial cells is uridine diphosphate N-
acetyl glucosamine (UDP-GlcNAc), an intermediate of cell wall synthesis (9.2 mM (Bennett, 
Kimball and Gao, 2009)). Promoter acnA (of E. coli aconitate hydratase A gene) is +1U 
promoter (Cunningham, Gruer and Guest, 1997). We tested incorporation of UDP-GlcNAc, 
uridine diphosphate glucose (UDP-Glc) and uridine diphosphate N-acetyl-muramic acid-
pentapeptide (UDP-MurNAc-AA5). UDP-MurNAc-AA5 is a larger cell wall precursor which 
consists of five amino acids covalently bound UDP-MurNAc. Further, we included smaller 
uridine-analogues UDP and UMP (figure 3.4). Similarly to adenosine-containing coenzymes, 
uridine-containing cell wall precursors can be incorporated into RNA, both in abortive 
transcription as well as longer transcripts. The large UDP-MurNAc-AA5 was not able to 
initiate transcription on acnA (figure 3.4 B). Table 3.3 compares KM of cell wall precursors as 
substrates for RNAP with their cellular concentration, indicating that the reaction potentially 
takes place in vivo. 
Table 3.3 Comparison of cellular concentration and KM of UTP and cell wall precursors used as initiating 
substrates for transcription. Metabolite concentrations were tested by Bennet et al. in exponentially growing E. 
coli cells on complex medium, with glucose as carbon source (Bennett, Kimball and Gao, 2009). Michaelis-
Menten constant was tested in promoter-dependent in vitro transcription giving excess initiator (0.5 mM) and 
α(P32)-CTP to E. coli RNAP. Transcription efficiency was determined via phosphor-imaging using ImageQuant. 
(Julius and Yuzenkova, 2017) 
substrate UTP UDP-Glc UDP-GlcNAc 
Cellular concentration (mM) 8.3 2.5 9.2 





Figure 3.4 Transcription initiation by uridine-containing molecules on promoter acnA. A. sequence of wildtype 
acnA promoter and modified version, acnA mod, which allows for transcription of 12 nt products. For this 
uridine-containing initiator, radiolabelled α(P32)-CTP (+2C) and ATP are added. B. Resolution of dinucleotide 
products initiated by different uridine-containing molecules on denaturing bis:acrylamide gel (33%). C. 
Resolution of dinucleotide (left) and 12mer products (right), initiated by UTP or cell wall precrsors on a 23% 
bis:acrylamide gel. Results were ontained in collaboration with Dr Yulia Yuzenkova (Julius and Yuzenkova, 
2017). 
 
3.4.3 Promoter -1 position does not affect NADylation efficiency 
Cofactors such as NAD+ and FAD are essentially dinucleotides. We had to consider the 
possibility that the non-nucleotide moiety of the cofactor might undergo base pairing or other 
specific non-covalent interaction with promoter position -1. Therefore, we tested whether 
mutation of -1 on a given template would affect the efficiency of incorporation of cofactor 
NAD+. As can be observed in figure 3.5, mutation of position -1 on the promoter rnai mod 
from its wildtype -1A to -1C, -1 T, or -1 G affected incorporation of both, ATP and NAD+, 
similarly. This argues, that -1 template position affects transcription in general, but not 





Figure 3.5 Effect of template position -1 on incorporation of canonical substrate ATP vs non-canonical substrate 
NAD+. A. Promoter rnai mod was modified at -1 position relative to TSS. B. Analysis of enzyme kinetics for 
both initiating substrates on the different promoter variants shows that a pyrimidine (C or T) at -1 enhances 
incorporation of both substrates in comparison to wildtype -1A promoter. Exchange of -1A to -1G does not 
change KM of NAD+ significantly. Values are mean ± standard deviation of KM values of three independent 
experiments. (Julius and Yuzenkova, 2017) 
3.4.4 σ factor might the limit size of the NCIN-cap 
We have seen that some nucleotide-containing molecules are more efficient in transcription 
initiation than others. Interestingly, size and incorporation efficiency seem to have a 
proportional relationship, with bulkier molecules being less efficiently incorporated than 
smaller ones. σ subunit of RNAP binds at promoter sites close to TSS. It is known that σ70 
region 3.2 is involved in transcription initiation (Pupov et al., 2014). In RNAP crystal 
structure in complex with DNA and NAD+pC (Bird et al., 2016), σ70 region 3.2 is in close 
promoxity to the catalytic centre and to bound NAD+. This region is not contained in all σ 
factors and it is not conserved across the eubacteria (M. Paget, 2015). Therefore we tested 
which effect deletion of region 3.2 of σ70 will have on NCIN-capping in vitro. Figure 3.6 B 
and C shows that transcription efficiency by the mutant holoenzyme is slightly affected, 
however, incorporation efficiency of NCINs is unaltered as compared to wildtype 
holoenzyme. This finding was true for all tested NCINs, except for UDP-MurNAc-AA5. In 
figure 3.6 C we show that deletion of 3.2 facilitates incorporation of UDP-MurNAc-AA5 into 
the transcript. This might indicate that indeed, the 3.2 region sterically selects initiating 
substrates due to size or other unidentified biochemical interaction. 
Bacterial σ are typically classified as σ70-like or σ54-like (M. Paget, 2015; Zhang and Buck, 
2015). σS (or σ38), the stationary phase σ, belongs to the σ70-like factors. It contains a region 
3.2, and it has similar promoter requirements to σ70, but its’ association to RNAP leads to 
expression of stationary phase-associated genes (Colland et al., 2002). Interestingly,
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Figure 3.6. Role of σ in NCIN-capping A. Crystal structure adapted by from (Bird et 
al., 2016). σ70 region 3.2 (blue) protrudes into the catalytic centre of RNAP. Metal ions 
(orange) indicate catalytic centre and orientation of template DNA (grey), NAD+pC 
(pink) and β subunit Rif-pocket residues (light pink). B. Dinucleotide synthesis from 
cofactors and radiolabelled α(P32)-CTP by EcRNAP-σ70 vs mutant EcRNAP-σ70Δ3.2, or 
alternative EcRNAP-σS on promoter rnai C. Incorporation efficiency of NAD+ by 
EcRNAP-σ70 vs EcRNAP-σ70Δ3.2, or EcRNAP-σS, as compared to incorporation of 
ATP. Bars and error bars depict mean values ± standard deviation of three independent 
experiments. D. Ratio of incorporation of uridine-containing cell wall precursors into 
RNA by RNAP-σ70 vs RNAP-σ70Δ3.2. Bars and error bars are mean values ± standard 
deviation of three independent experiments. E. Dinucleotides produced from UTP or 
uridine-containing cell wall precursors and α(P32)-CTP in absence or presence of 
σ703.2. Here, incorporation of UDP-MurNAc-AA4 is increased in the mutant holoenzyme. F. P-values from experiments shown in C and D, comparing initiation efficiency of 
different substrates by EcRNAP-σ70Δ3.2 or EcRNAP-σS to RNAP-σ70. n.d.= not dtermined (Julius and Yuzenkova, 2017; Julius, Riaz-Bradley and Yuzenkova, 2018).
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NADylation was found to be increased in stationary phase as compared to log phase cells in 
E. coli (Bird et al., 2016). Therefore, we tested whether σS could be responsible for this 
observation. We initiated in vitro transcription with different cofactor caps using RNAP-σS 
holoenzyme, but we did not see a specific upregulation of NCIN-capping (figure 3.6 B and 
C). 
3.4.5 Rif-pocket residues might interact with NCIN-cap during initiation 
As shown in crystal structure (see figure 3.6 A) the rifampicin-binding pocket of RNAP (Rif-
pocket), a site within the RNA-exit channel of EcRNAP where the antibiotic rifampicin binds, 
is close to the catalytic centre of the holoenzyme. Therefore we tested, if a) rifampicin 
addition to the assay affects NCIN-capping and b) if rifampicin-resistant mutants (RNAPs 
which have point mutations in the Rif-pocket) have an altered capping spectrum as compared 
to the wildtype (wt) RNAP. The mechanism of action of rifampicin is to block the RNA exit 
channel and thus to inhibit not initiation, but extension of short RNA chains. In vitro, we can 
observe an increased production of canonical abortive products and inhibition of longer 
products, when subinhibitory concentrations of rifampicin are added to transcription assays. 
We used rnai mod template to see whether low concentration of rifampicin (5 µg/ml) would 
have the same effect on transcription initiation by NAD+. Figure 3.7 shows that, as expected, 
ATP-initiated 9mer transcripts are reduced, and the amount of abortive product is increased in 
presence of rifampicin. However, abortive products initiated by NAD+ were not increased by 
rifampicin addition. NAD+-initiated 9mer transcription was reduced in presence of rifampicin, 
thus the antibiotic acts still as transcription inhibitor. The fact that it does not enhance the 
release of NADylated abortive products indicates that NAD+-initiation counteracts early 
abortive release, and thus promotes RNAP promoter escape.  
We then tested rifampicin-resistant mutants of RNAP with single amino acid substitutions in 
the Rif-pocket (purified from the ASKA strain collection). Figure 3.8 shows that RNAP 
mutants produced relatively less NAD+-RNA as compared to wt RNAP, if relative 
incorporation efficiency of ATP to NAD+ is calculated. However, residues Q513 and D516 
seem to have the strongest detrimental effect on NAD+-capping. As can be seen in the crystal 





Figure 3.7 Initiation with NAD+ promotes promoter escape. Subinhibitory concentration of the antibiotic 
rifampicin leads to increased production of 2- and 3-mer abortive products when initiated with ATP, but not 
when transcription is initiated with NAD+. A. Bis:acrylamide gel electrophoresis of RNAP kinetics of 9-mer 
transcript from rnai mod initiated by ATP (left) or NAD+ (right). Addition of rifampicin (5 µg/ml, this is 10 
times lower than inhibitory concentration), leads to increased production of short abortive product pppApC, but 
not NAD+pC. B. Depiction of the same experiment as signal traces across 60 sec bands. Results were ontained in 
collaboration with Dr Yulia Yuzenkova (Julius and Yuzenkova, 2017). 
 
Figure 3.8 Rif-pocket residues are involved in NCIN-capping. A. Rif-resistant mutants of E. coli RNAP were 
tested for incorporation of NAD+ vs. ATP. Efficiency of incorporation of NAD+ by wildtype EcRNAP was 
normalised to 100%, all Rif-pocket mutants showed reduced NAD+-capping efficiency by at least 50%. Mutants 
of Q513 and D516 were found to be most detrimental to NAD+-incorporation, with around 90% loss of 
efficiency. P-values comparing relative transcription initiation efficiency with NAD+ to ATP of mutants against 
wildtype were P<0.001 (Tukey algorithm). Bars and error bars are mean values ± standard deviation of three 
independent experiments, Crystal structure of T. thermophilus RNAP in complex with DNA and NADpC. From 
(Bird et al., 2016; Julius and Yuzenkova, 2017).  
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3.4.6 NUDIX hydrolase NudC acts as decapping enzyme in vitro and can be used as a tool 
to verify NCIN-cap 
NudC has been established as NAD+-decapping enzyme in various studies (Cahová et al., 
2015; Bird et al., 2016; Höfer et al., 2016; Zhang et al., 2016). It cleaves nicotinamide 
mononucleotide (NMN) from NAD+ by hydrolysis of phosphodiester bond. The product is 
AMP or monophosphorylated 5’-RNA starting with adenosine. We tested if NudC would also 
also be applicable for decapping of other NCINs. This was also done in other studies with 
DP-CoA (Bird et al., 2016). Here we show that NudC treatment results in RNA products of 
faster migration on denaturing gels if RNA was produced from initiation with NAD+ or FAD 
(figure 3.9 A). However, FAD seems to make a poor substrate, as we observe incomplete 
decapping. It is possible to verify cap structure also using nucleases RppH and terminator 
(commercially available). Terminator is a 5’-3’-exonuclease which is specific to 5’-
monophosphorylated RNA. RppH cleaves pyrophosphate from triphosphorylated RNA 
substrates, creating a monophosphorylated end (Cahová et al., 2015).This is susceptible to 
terminator treatment. Likewise, NudC creates monophosphorylated RNA from a capped 
transcript. We tested if transcripts are susceptible to terminator-mediated degradation in 
presence of NudC, and if they are susceptible to RppH treatment (figure 3.9 B). Visibly, ATP-
initiated transcripts are not susceptible to NudC treatment, and capped transcripts are not 
susceptible to RppH treatment. Interestingly, the de-NADylated transcript was not susceptible 
to terminator (lane 9), while the de-FADylated transcript was (lane 14).   
Potentially, terminator cannot access RNA in (transient) complex with RNAP and NudC, and 
incomplete decapping might be due to presence of RNAP. It was shown previously (Zhilina et 
al., 2012), that 20mer transcripts are insusceptible to GreB-induced RNA cleavage, while 21-
24 nt transcripts are partially susceptible, and 25mer RNA is fully susceotible to cleavage. 
Authors proposed that RNA-20 is fully protected in the ternary elongation complex and 21-
24mer RNA is conditionally protected depending on the degree of promoter DNA scrunching.  
Therefore we assume that 9mer RNA as shown in figure 3.9 are only susceptible to decapping 
when released, and otherwise protected inside RNAP. We thus tested transcript length 
requirements of NudC to establish a method for capping and decapping without RNAP-
template complex disassembly. We designed a template rnai 18, which allows for transcripts 
of 18 nt length (figure 3.10 A) in an experimental setup that would assure to only show 




Figure 3.9 NudC decaps FAD-capped RNA at lower efficiency than NAD+-RNA. A. 
NudC used in this assay was purified by Dr Amber riaz-Bradley. Transcripts initiated 
by ATP, NAD+ or FAD were produced from rnai mod promoter. The initiation 
complex was washed and filtered to remove excess free NAD+ or FAD substrate, 
before adding NudC. B. RNA was produced from rnai mod, initiated with ATP, 
NAD+, or FAD. After 10 min, NudC. NudC and terminator, or RppH were added and 
incubation was prolonged for another 10 minutes (control is prolonged incubation 




Figure 3.10 Accessibility of RNAP-bound NAD+-RNA products to NudC. A. 
Promoter rnai 18 allows for control of transcript length by adding and washing off of 
NTP substrates during elongation. TEC is formed by transcription with NAD+, α(P32)-
CTP and UTP. TEC was bound to Ni2+-agarose beads and washed with transcription 
buffer 5 times before another set of nucleotides was added as indicated (GTP, UTP 
and CTP) to produce 23mer RNA. B. Bis:acrylamide gel for NudC walking 
experiment. To RNA products initiated with NAD+ 18mer and 23mer, in complex 
with RNAP and DNA, we added NudC. 18mer NAD+-RNA was partially susceptible 
to NudC, while 23 mer transcripts were fully susceptible.
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NudC cleavage, but 23 nt transcript is fully susceptible to decapping. This suggests that NudC 
and RNAP can come into close contact during decapping. 
3.4.7 NudC purification shows that NudC replaces Zn2+ with Fe2+ 
NudC can be overexpressed from a plasmid and purified via affinity chromatography and N-
terminal His-tag. We observed that when purified in buffers without EDTA, highly 
concentrated NudC (100-300 µM) appears red. This colour can be removed by long dialysis 
(>24 h) in EDTA, suggesting colouration is conferred by metal binding. Thus we have 
subjected a red purification sample as well as a colour-reduced sample (24 h dialysis in 10 
mM EDTA) to inductively coupled plasma mass spectrometry (ICP-MS), which was 
performed by Dr Kevin Waldron lab (Newcastle University, ICaMB). The analysis showed 
that approx. 1 μM of “red” NudC without EDTA contains 0.8 μM Zn2+ and 0.3 μM F2+e, 
while values for Mn2+, Co2+, Ni2+ and Cu2+ were 0.01, 0.0.015 and 0.031, respectively. 
Dialysis in EDTA reduced metal to 0.14 μM Fe2+ and 0.5 μM Zn2+ per μM NudC.  
If we assume that NudC concentration was not assessed accurately, we can conclude that one 
mol of NudC binds one mol Zn2+ if available, or replaces it with Fe2+, if Zn2+ is not available. 
0.8 μM Zn2+ and 0.3 μM Fe2+ would add up to 1.1 μM metal, indicating the assay contained 
more than the predicted 1 μM NudC (to which metal ions were bound). Alternatively, if the 
real NudC concentration was 0.8 µM, one mol of NudC coordinates one mol of Zn2+; or two 
mol of NudC coordinate one mol of Fe2+. As oxidised Fe2+ appears red, the observed colour 
might have been caused by Fe2+ binding in the protein. NudC is active in the cell as 
homodimer (Höfer et al., 2016). Our “red” NudC purification is active in vitro, but we cannot 
be certain that activity is only conferred by Zn2+-bound NudC. 
3.4.8 Mitochondrial RNA polymerase incorporates nucleotide-analogues as initiating 
nucleotides 
In the years 2016 and 2017 several studies have been published observing NAD+-capping in 
prokaroytes as well as eukaryotes (yeast and mammals). Notably, yeast mitochondrial 
transcripts were found to be NADylated (Walters et al., 2017). Both bacterial and eukaryotic 
nuclear RNAPs are multisubunit enzymes. Thus we wanted to test if mitochondrial RNAP, 
which is a single subunit enzyme, would perform NCIN-capping. We performed in vitro 
transcription experiments with human POLMRT. mtDNA genomes have only two promoters, 
light and heavy strand promoter (lsp, hsp). Lsp transcription start is A. Figure 3.11 shows 
POLMRT, assisted by essential transcription factors TFAM and TFB2M, utilises all tested 
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adenine-containing metabolites. We used NudC to verify presence of the cap and rule out 
initiation at unspecific start sites. Only FAD-RNA was not cleaved by NudC. Interestingly, 
mitochondrial transcription shows generally low abortive initiation, except for DP-CoA. 
 
Figure 3.11 NCIN-capping by POLMRT. A. lps is a +1A promoter. If CTP is omitted in the assay, a 18 nt RNA 
product is produced by POLMRT. B. POLMRT, in association to lps, TFAM and TPB2M, produced 18mer 
transcripts of varying length in dependence on size of initiating substrate. Metabolite concentration was very 
high (1 mM) to allow it to compete with ATP (10 µM) substrate. NudC was added to half of the assays to verify 
presence of cofactor cap (Julius, Riaz-Bradley and Yuzenkova, 2018). 
 
3.5 Discussion 
3.5.1 Metabolites and cell wall precursors on 5’-RNA were identified in vivo and shown to 
be incorporated by RNAP in vitro 
Hyptheses about the capping mechanism were controversial at first. Liu group proposed a 
post-transcriptional mechanism, comparable to classical, eukaryotic capping. However, such 
mechanism has not been proven to date. Other groups proposed transcription initiation as 
mechanism, inspired by a publication of Malygin and Shemyakin around 40 years ago, who 
synthesised dinucleotides from DP-CoA, NAD+ or FAD and labelled nucleotide (Malygin and 
Shemyakin, 1979). Since RNAP catalyses the bond between the 3’-OH of the first NTP and 
5’-α-phosphate of the second NTP, the 5’-side of the first substrate is not important for the 
reaction and another chemical group could theoretically substitute for triphosphate group of 
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the initiating nucleotide. Here we show that nucleotide-containing small molecules can 
initiate transcription on a promoter given the nucleotide moiety of initiator base pairs with the 
template at the transcription start site (TSS or +1) (figure 3.2 and figure 3.4). Adenosine- 
containing molecules can be used to cap transcripts on +1A promoters, and uridine-containing 
compounds were able to initiate transcription on +1U promoter. What makes this finding 
interesting is that these nucleotide-containing substrates are highly abundant functional 
molecules in the cell, which are known to interact with distinct pathways of metabolism or 
cell wall synthesis. Thus, their presence in RNA primary structure could potentially add a 
whole new layer to the function of those RNAs, or cofactors. 
In order to draw conclusions about the likelihood of NCIN-capping being performed by 
RNAP in vivo, we measured KM for production of short transcripts initiated by ATP, NAD
+, 
NADH, UTP, UDP-Glc and UDP-GlcNAc in vitro. RNAP utilises these substrates at varying 
efficiency, but at concentrations markedly lower than their cellular concentration during 
bacterial growth (tables 3.2 and 3.3), in all cases except NADH. NADH is incorporated at 
similar efficiency to NAD+, while its’ cellular concentration was determined to be lower 
(Bennett, Kimball and Gao, 2009). 
DP-CoA, FAD, UDP-Glc and UDP-GlcNAc caps have been found on bacterial or eukaryotic 
RNA in vivo (Chen et al., 2009; Kowtoniuk et al., 2009; J. Wang et al., 2019). A number of 
unidentified 5’-RNA conjugates was found but not further characterised, suggesting that other 
NCIN-caps exist (Chen et al., 2009; Kowtoniuk et al., 2009; J. Wang et al., 2019). These 
could be other highly abundant adenine- and uridine-containing molecules, as well as 
guanosine- or cytidine-containing molecules.  
It needs to be stressed that in vivo, for any encoded RNA only a small percentage of 
transcripts are found to be capped. The most frequently capped RNA in E. coli was RNA1 
with 13 % (Cahová et al., 2015). Hence, the regulatory event behind NCIN-capping might be 
availability of substrates in competition with canonical nucleotide. Nonetheless, further 
regulatory elements could be at work such as promoter sequences or transcription factors.  
3.5.2 Promoter-mediated regulation of NCIN-capping is controversial 
Besides substrate concentration, the template sequence around TSS might take part in capping 
regulation. The NAD+-cap contains besides adenosine another nucleoside-like structure, 
nicotinamide ribose. Therefore, van der Waals-interactions of this moiety to the -1 base of the 
template is conceivable. We thus tested the effect of mutation -1 rnai template position and 
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found that overall transcription is affected by identity of -1, but not capping in particular 
(figure 3.5). Possibly, the degree of interaction of NCIN with -1 could vary between 
promoters and between NCINs, or regulation could take place at another (not -1) site. From 
our data we cannot conclude a regulation of NCIN-capping by promoter -1 position. 
Other groups further characterised promoter structural elements which regulate capping and 
hypothesised that -1 base affects NADylation efficiency on rnai promoter and in B. subtilis 
transcription, contrary to our results (Bird et al., 2016; Frindert et al., 2018; Vvedenskaya et 
al., 2018). A crystal structure of T. thermophilus RPo in complex with two initiating NTPs 
revealed that +1 NTP undergoes stacking interaction with template -1 base which serves to 
stabilise initiation, if -1 template is a purine base (Basu et al., 2014). Basu et al. hypothesise 
that this stacking interaction explains prevalence of non-template -1 pyrimidine, +1 purine 
sequences on many natural promoters. Intuitively, initiating metabolites should interfere with 
such stacking interactions. Vvedenskaya et al. show that a promoter sequence of H-3R-2R-
1A+1S+2W+3W+4, where A is the TSS, increases likelihood of NAD
+ incorporation 40-fold as 
opposed to every single one of those positions (except +1) being exchanged by their 
individual anti-consensus giving the sequence G-3Y-2Y-1A+1W+2S+3S+4. The exchange of one 
individual position to the anti-consensus nucleotide results in 1.2 to 4.1 fold decreased 
cofactor incorporation, depending on the exact position (Vvedenskaya et al., 2018). Like most 
promoter elements this proposed consensus is characterised by a low G/C content. E. coli 
promoters are about 5% less GC-rich than the rest of the genome (Meysman et al., 2014). 
This structural feature facilitates more efficient DNA melting which might be a contributing 
factor for incorporation of bulky caps. Promoter curvature, as well as downstream template 
secondary structure can affect promoter binding, initiation efficiency and promoter escape 
(Kalate, Kulkarni and Nagaraja, 2002; Meysman et al., 2014), which could play in favour or 
against incorporation of specific caps.  
NADylation in B. subtilis was shown to underlie a certain degree of regulation by promoter -1 
position. In B. subtilis transcription, -1 base was mutated for promoter of veg gene (Frindert et 
al., 2018). Veg is a transcription factor that regulates genes for biofilm formation (Lei et al., 
2013). Mutation of veg promoter -1T to A, C, or G reduced overall transcription efficiency 
and resulted in lower proportions of NAD+-capped RNA in vitro, if both ATP and NAD+ 
were given at equimolar concentration. In vivo transcription from veg from plasmid DNA in a 
Δveg strain lead to NADylation of 3.6 % wt veg mRNA, or 2.1 % -1C veg mRNA (Frindert et 
al., 2018). Also NAD+-capping in S. aureus was found to be sensitive to changes in -1 
template position (Morales-Filloy et al., 2019). 
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All studies on promoter sequence- mediate capping regulation have focussed on NAD+ as 
initiator. Other NCINs, such as the phosphopantetheine of DP-CoA, do not bear a nucleotide-
like structure on their 5’-end. Thus van der Waals interaction of these moieties with -1 is 
unlikely. Future research might aim to identify signals to regulate incorporation of other 
metabolites. Possibly, different metabolites might interact with promoters in different ways. 
In E. coli and S. venezuelae cells, more NADylated RNA (>3000 per cell) as opposed to DP-
CoA-capped RNA (50-200 copies per cell) was found (Chen et al., 2009; Kowtoniuk et al., 
2009). 
Taking the presented results into account we conclude that -1 promoter position may take part 
in regulation of NCIN-capping on some promoters. However, due to the presented 
controversy, we do not view -1 position as major regulatory factor.  
3.5.3 Protein structural determinants of NCIN-capping were found in σ and β subunits of 
EcRNAP 
The structural study of Basu et al. showed that σ region 3.2 (σ3.2) does not interact with 
initiating NTP (Basu et al., 2014). However, involvement of σ3.2 in initiation and protrusion 
of “sigma finger” (a loop of σ3.2 ) was shown previously (Kulbachinskiy and Mustaev, 2006; 
M. S. Paget, 2015). The crystal structure of RNAP in complex with template DNA and 
NAD+pC “dinucleotide” revealed NAD+ to be in vicinity to β subunit Rif-pocket residues and 
σ3.2 (figure 3.8 B) (Bird et al., 2016; Julius and Yuzenkova, 2017). We suspected a role of E. 
coli σ703.2 as well as Rif-pocket residues as possible contributors to capping regulation.  
Deletion of σ703.2 did not inhibit in vitro transcription or capping. Initiation was not affected 
by ∆σ703.2 for most caps, only the very bulky compound UDP-MurNAc-AA5 was 
incorporated only in the mutant holoenzyme (figure 3.6 E). Likely, size of the capping 
molecule is limited sterically by the σ finger loop. This leads us to hypothesise that 
holoenzymes of alternative σ factors might alter the cap spectrum. Bird et al. found that 
stationary phase cells have higher amounts of NADylated RNA (Bird et al., 2016). We thus 
tested whether EcRNAP-σS holoenzyme allows for incorporation of NCINs. Our results do 
not indicate that σS enhances capping of RNA1 (figure 3.6 B and C). This experiment, 
however, was qualitative and not quantitative. Possibly, the observed increase NADylation in 
stationary phase of E. coli growth could be attributed to changes in RNA degradation, or 
involvement of other factors. The involvement of transcription factors in NCIN-capping 
specifically has not been investigated so far. 
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We further observed that rifampicin-resistant mutants of EcRNAP are deficient in NAD+-
capping in vitro. The amino acid substitutions of these mutants inhibit rifampicin binding 
either directly or via transmitting conformational changes across the structure (Campbell et 
al., 2001a). Mutation of residues 513 and 516, in closest vicinity to NAD+ in the crystal 
structure, had most detrimental effect on NAD+-capping (figure 3.8 A). Both positions are 
hydrophilic residues in wt EcRNAP and hydrophobic in mutants, so they might not 
accommodate NAD+ in the catalytic centre, such that transcription is not initiated. 
Alternatively, the mutations might alter the conformation of the enzyme close to the catalytic 
site such that accommodation of NMN is less favourable than in the wildtype. Typically, 
fitness of rifampicin-resistant E. coli is reduced (slow growth, increased heat-sensitivity, 
altered colony morphology) (Brandis et al., 2015). It is interesting to imagine a connection 
between faults in NCIN-capping and reduced fitness phenotypes of rifampicin-resistant E. 
coli.  
In vivo, fitness loss by mutations in the rif pocket can be eased by secondary mutations at 
another domain of RNAP (Brandis et al., 2012). Resistance can be maintained while fitness 
loss is compensated with mutations in RNAP subunits α, β, or β’. In vivo, also mutations in 
non-RNAP genes and intergenic regions were identified to be associated with fitness 
compensation in rifampicin-resistant mutants (Comas et al., 2012). According to Brandis et 
al., compensatory mutations located to RNAP subunit genes can act via restoring the 
environment of the wt Rif-pocket, affecting interactions between RNAP and RNA, affecting 
interactions between RNAP subunits, or affecting interactions between RNAP and NTPs 
(Brandis et al., 2012). It could be interesting in the future to study the effect of compensatory 
mutations on RNAP and NCIN-capping. If a strain was found that has NCIN-capping 
deficiency due to rif-pocket mutation in RNAP without fitness loss, this could allow to study 
NCIN-cap function in vivo. 
3.5.4 NCIN-capping stimulates promoter escape 
We further observed that capping seems to stabilise the transcript during initiation. NAD+-
RNA displayed a reduction in abortive product formation as opposed to ATP-initiated 
transcription in vitro (figure 3.7). Addition of low levels of rifampicin to a transcription 
reaction leads to inhibition of RNA elongation (Campbell et al., 2001a) and promotes release 
of abortive products. In the case of NAD+-initiation abortive synthesis is not enhanced. As 
NMN was not conclusively shown to base pair with the template, it is unclear whether the 
initiator “counts as” dinucleotide to RNAP. In that case, the first phosphodiester bond formed 
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would create an apparent trinucleotide. The ATP-initiated trinucleotide abortive product was 
less affected by presence of rifampicin as compared to ATP-dinucleotide, arguing that a 
trinucleotide competes better against rifampicin. 
As a functional consequence, enhanced promoter escape might make up for the lower 
efficiency in NAD+-initiation as compared to canonical RNA initiation. In other words, the 
number of NAD+-initiated full-length transcripts in a reality of NAD+-enhanced promoter 
escape, is statistically higher as opposed to an alternative reality in which NAD+-initiation 
was aborted at the same rate as regular initiation. However, there is no evidence to support 
this theory. 
3.5.5 Mitochondrial single-subunit RNAP readily incorporates adenosine-containing 
metabolites as 5’-caps 
NCIN-capping was shown for both bacterial and eukaryotic RNAPs (Cahová et al., 2015; 
Bird et al., 2016; Jiao et al., 2017; Julius and Yuzenkova, 2017; Walters et al., 2017). Both 
are multi-subunit RNA Polymerases. We then observed that also single-subunit H. sapiens 
mitochondrial RNAP caps RNA with NAD+, NADH, FAD and DP-CoA in vitro (figure 3.11). 
Our findings were supported by in vivo data (Walters et al., 2017; Bird  et al., 2018). While 
ATP was a favoured initiator (giving stronger signal on denaturing gel), all tested caps were 
incorporated (NAD+ around 25% as efficiently as ATP, other caps around 10-15%).  
We want to stress that the mammalian mitochondrial genome is transcribed from only two 
promoters, resulting in long polycistronic RNAs which require processing. Thus only the first 
RNA adjacent to promoter can be capped by POLMRT. As first genes behind promoters lsp 
and hsp are rRNA and tRNA, respectively, they will undergo 5’-processing. However, in vivo, 
10% of lsp-transcript were shown to carry NAD+ modification (Bird et al., 2018).  
In yeast, all NADylated mitochondrial RNAs identified by Walters et al. were not 5’-
processed (Walters et al., 2017). The yeast mitochondrial genome has 13 promoters, all of 
which are +1A thus could potentially lead to cofactor capping (Turk et al., 2013). Walters et 
al. found four frequently NADylated transcripts, of F0-ATP synthase subunit c (ATP9), 
cytochrome c oxidase subunit 2 (COX2) and rRNAs for 21S and 15S ribosomal RNA 
subunits. Mitochondrial capping was shown very high in yeast, with 50% of mRNA of COX2 
RNA being NAD+-modified and 10 % NADH-modified (Birdet al., 2018). Other cofactor-




3.5.6 NCIN-caps can be removed by NUDIX hydrolases 
The NUDIX hydrolases are pyrophosphatases that act on substrates of general structure 
NUcleoside DIphosphate linked to another moiety X (McLennan, 2006). The NUDIX box 
common to all NUDIX family members comprises the catalytic amino acids sequence 
Gx5Ex5[UA]xREx2EExGU where the central glutamate residues E174, E177 and E178 (E. 
coli NudC) interact with a divalent cation. NAD+ hydrolysis to NMN and AMP relies on 
presence of a Mg2+.(Zhang et al., 2016). 
A Zn-binding motif serves formation of a NudC homodimer and is essential for protein 
structure (Zhang et al., 2016). When we purified NudC from overexpression plasmid we 
observed a red colouration. Metal analysis via ICP-MS showed that our purification contains 
both Fe2+ and Zn2+. We therefore hypothesise that NudC overexpression in complex medium 
depleted free Zn2+ such that many NudC molecules replaced Zn2+ with Fe2+ ions at the Zn2+ 
binding site. Such phenomenon has been documented in literature. Replacement of Zn2+ with 
other metals can lead to structural or functional deficiencies of the Zn2+ binding protein 
(Deegan et al., 2011; Kluska, Adamczyk and Krężel, 2018). Our “red” NudC purification is 
active in in vitro capping. However, we cannot proclaim that (partially) Fe2+-bound NudC 
remains active. Possibly, a Zn2+-bound portion of the NudC population confers activity, 
contaminated by inactive Fe2+-bound NudC.  
As can be seen in figure 3.12, NudC homodimer binds one NAD+ molecule per monomer 
(Zhang et al., 2016). The C-terminal domain (CTD) binds NAD+ at the NMN part between 
three hydrophobic residues I132, W194 and M201. Nicotinamide ribose 3’-OH interacts with 
S199, while the amide of nicotinamide interacts with Q192 and A241. Adenine base interacts 
with another hydrophoc pocket at the dimer interface (Höfer et al., 2016). One residue each of 
the NudC dimer, F160 on NudC molecule A and Y124 on NudC molecule B. Further, 2’-OH 
of adenine interacts with E111 and Y124 of NudC molecule B. Thus binding of two NAD(H) 
requires NudC dimerization (Zhang et al., 2016).  
Mutation studies of the enzyme show that it interacts with the NAD+ on RNA and not with the 
RNA chain (Zhang et al., 2016), while another study describes it as ssRNA-specific, binding 
RNA non-sequence specific but rather via charge interaction, and favouring NADylated RNA 
over free NAD+ substrate (Höfer et al., 2016). We and others have seen that NudC performs 
also decapping of NADH and DpCoA (figures 3.9 and 3.11) (Bird et al., 2016; Julius and 
Yuzenkova, 2017; Julius, Riaz-Bradley and Yuzenkova, 2018), while it cleaves FAD 
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unreliably. Possibly, buffer conditions are responsible for inconclusive results on FAD-
decapping.  
It was shown that NudC deletion in E. coli increases NADylation of RNA1 from 13% to 26% 
in E. coli (Cahová et al., 2015). It would be interesting to investigate whether NudC deletion 
also affects levels of other metabolite caps. E. coli encodes 13 different NUDIX hydrolases 
(Xu et al., 2006), some of which might participate in metabolite decapping, potentially in a 
metabolite-specific, or a broadly specific fashion (Julius and Yuzenkova, 2017). One path of 
research our lab intends to focus on in the future is identification of other cap-specific NUDIX 
hydrolases in E. coli. 
 
Figure 3.12 Crystal structure of NudC in complex with NAD+ from (Höfer et al., 2016). A. NudC homodimer 
(green and blue ribbons) binds two NAD+ (red spheres), one molecule of NAD+ per molecule of NudC. B. 
Different structural regions of one NudC. N-terminal domain (NTD, dark blue), C-terminal domain (CTD, bright 
blue) binds NAD+, and Zn2+-binding motif (pink), in complex with one Zn2+ (grey sphere), which is important 
for protein folding. C. Surface of NudC in complex with NAD+. Blue areas are positively charged and were 
proposed to interact ith RNA unspecifically at the NAD+-RNA extension channel (indicated by arrow). D. 
NAD+-binding is conferred by NudC residues shown as stick models. The location of RNA-extension of NAD+ 
is indicated by the arrow. This view shows that residues from NudC molecule B (blue) and A (green) are 
involved in substrate binding. 
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Thus far, NudC has not been found in association to degradosome or other RNA-processing 
multienzyme complexes. The E. coli RNA degradation machinery degradosome is a complex 
based on scaffolding and endoribonuclease activity of RNase E, in interaction with 
exoribonuclease PNPase (Polynucleotide phoshohydrolase) which also performs 
polyadenylation, an RNA helicase and an enolase (Bandyra et al., 2013). RNase E shows 
strong preference for 5’-monophosphorylated RNA, despite its activity as endonuclease 
(Mohanty and Kushner, 2016). Thus the degradation pathway of many triphosphorylated 
RNAs involves a pyrophosphohydrolase step (Silva et al., 2011). In E. coli this is performed 
by RppH, another NUDIX hydrolase. NCIN-capped RNA degradation might rely on 
processing with NUDIX hydrolases to yield a monophosphorylated 5’-end (Jäschke et al., 
2016). Temporary or functional association of RNase E to polyadenylation enzyme poly(A) 
polymerase (PAP) and RNA chaperone Hfq was documented for RNA processing (Repoila 
and Darfeuille, 2009). If NudC-decapping was a prerequisite of NAD+-RNA degradation, a 
(temporary) association to an RNA processing or degradation complex would be expected. 
In B. subtilis, both 5’-triphosphate and 5’- NAD+ were found to be cleaved by BsRppH 
(Frindert et al., 2018). This means that both, NCIN-capped and triphosphorylated RNAs, 
likely undergo the same route of degradation. B. subtilis has no RNase E homolog, its main 
RNases are RNase Y and RNase J (Bandyra et al., 2013). Further, RNase J1 has important 
function in mRNA degradation. It has both 5’-exonuclease and endonuclease activity and 
binds to 5’-mRNA, and can then travel downstream to cleave internal regions (Yao, Sharp 
and Bechhofer, 2009). In analogy to findings in E. coli (Cahová et al., 2015), B. subtilis 
NAD+-RNA was protected against RNase J1 cleavage, and requied processing by BsRppH 
(Frindert et al., 2018). 
In eukaryotes, NCIN-capping promotes RNA decay (Jiao et al., 2017; Kiledjian, 2018). The 
classical eukaryotic m7G cap is removed by NUDIX hydrolases Dcp2, Nudt3 and Nudt16 in 
vivo and further by Nudt2, Nudt12, Nudt15, Nudt17 and Nudt19 at least in vitro (Kiledjian, 
2018). Besides NUDIX hydrolases, in eukaryotes also the DXO family is known to function 
as decapping enzymes with activity both on m7G-cap as well as NAD+-cap. However, 
cleavage by DXO removes the complete cap structure as opposed to removal of NMN by 
NudC (see figure 3.13) (Jiao et al., 2017; Kiledjian, 2018), thus the two enzyme classes yield 
different products which might have effect on both RNA and metabolite fate. Further, DXO is 
a 5’-3’ exonuclease and was suggested to hydrolyse the transcript following decapping (Jiao 




Figure 3.13 Schematic of NCIN-capping and decapping. A. RNAP caps RNA by initiating transcription with an 
adenosine diphosphate attached to a moiety X (XppA). Phosphodiester bond formation by nucleophilic attack of 
3’-OH of XppA on α-phosphate of pppN forms XppApN, pyrophosphate (PPi) is released. B. NCIN-decapping 
as performed by NudC-like or DXO-like enzymes. NudC hydrolyses the phosphodiester bond between X and 
nucleotide moiety, yielding monophosphorylated pX and 5’-pA-RNA. DXO hydrolyses the phosphodiester bond 
between the XppA cap and the penultimate nucleotide, restoring the XppA molecule and monophosphorylated 
5’-pN-RNA (Julius and Yuzenkova, 2019). 
Another contributing factor to RNA stability was recently discovered in eukaryotes. The first 
canonical nucleotide of the transcript, so the nucleotide adjacent to the m7G-cap, is usually 
methylated, giving for example a 2’-O-methyladenosine (Am). But additional methylation 
giving a N-6,2’-O-dimethyladenosine (m6Am) causes resistance of the cap to decapping 
NUDIX hydrolase Dcp2, thus conferring increased RNA stability as opposed to single 
methylated initiating nucleotides (Mauer et al., 2017; Kiledjian, 2018). This methylation is 
reversible and is considered an epitranscriptomic regulation process. 30% of mammalian 
cellular RNA carries the “extended mRNA cap” (Mauer et al., 2017). It is possible that also 
the NCIN-decapping process is amended by modifications on adjoining base or bases. The 
studies which identified 5’-metabolite caps also detected a variety of nucleotide modifications 
(Chen et al., 2009; Kowtoniuk et al., 2009). 
3.5.7 Metabolite-caps might be incorporated post-transcriptionally 
Some findings about NCIN-capping remain controversial. Some NAD+-capped RNAs have 
been found that might not arise from the 5’end of a transcript, such as scaRNAs found in 
eukaryotes which are generated by processing of RNA (Kiledjian, 2018). We should consider 
the possibility that alternative pathways exist to cap RNA post-transcriptionally (Chen et al., 
2009). In cellular NAD(H) de novo biosynthesis, a reverse reaction to NudC exists, performed 
by nicotinate mononucleotide (NaMN) adenylyltransferase NadD. In NAD+ synthesis, NadD 
catalyses the conversion of NaMN to nicotinate-adenine dinucleotide, which is then aminated 
to form NAD+ (Han and Eiteman, 2018). But NadD also performs an alternative reaction, the 
conversion of NMN to NAD+ (reverse to NudC) (Han and Eiteman, 2018) (see figure 3.14). 
Via such a pathway, NadD might theoretically be active in the process of RNA NADylation, 
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which we are going to investigate further. The NAD biosynthesis pathway is similar between 
eukaryotes and prokaryotes, but eukaryotic NadD does not differentiate between NaMN and 
NMN substrates, while bacterial NadD favours NaMN substrate (Wang et al., 2017). 
 
Figure 3.14 Theory of a post-transcriptionally active metabolite-capping enzyme. A. De novo synthesis of NAD+ 
in E. coli, from (Han and Eiteman, 2018). Enzyme gene names are given in blue, NAD+-precursors in black, 
arrows show direction of the performed reaction. NaMN adenyltransferase converts NaMN (nicotinate 
mononucleotide) to nicotinate adenine dinucleotide which is then aminated by NadE to form NAD+. Further, 
NadD converts NMN to NAD+, the reverse reaction to NudC. B. Schematic of NCIN-capping by an 
adenyltransferase such as NadD.  
In 2000, a study was published that attempted to produce DP-CoA, FAD and NAD+ via 
ribozymatic acitivity, as it might have happened in a time before protein enzymes (Huang, 
Bugg and Yarus, 2000). A phosphorylated cofactor precursor Xp (e.g. nicotinaminde 
monophosphate, Flavin monophosphate or 4’-phosphopantheteine) reacts with a 
triphosphorylated transcript that starts with ATP (pppApN(pN)n). Pyrophosphohydrolysis 
might provide the energy to create the XppApn(pN)n product, catalysed by a ribozyme. Such 
a ribozyme has not been found in nature, but might once have existed as part of the RNA 
world theory (White, 1976; Jeffares, Poole and Penny, 1998). 
3.5.8 NCIN-capping might have various physiological implications 
Alterations of the RNA primary structure must have downstream effects. If the NCIN-cap is 
not useful to the cell it might be removed to reconstitute functional RNA, or it might act as 
signal for destruction of a faulty copy. If the cap has a cellular function, this will be revealed 
in future research. The RNA 5’-end has special importance in both prokaryotes and 
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eukaryotes. The role of the classical 5’-cap in nuclear transport, translation initiation, and 
RNA stability is quite essential for mRNAs. However, classical cap-independent pathways of 
translation are known for eukaryotes (Mitchell and Parker, 2015) Also in bacteria, the 5’-end 
could affect translation, in the case of leaderless transcripts, or translation regulation via 
sRNAs. Further regulatory pathways rely on the 5’-end of RNA, such as riboswitches. Table 
3.4 sums up cellular functions of frequently NADylated RNAs that have been found to date. 
The following part of the discussion deals with the different possible physiological outcomes 
of NCIN-capping. The mentioned aspects are also discussed in (Julius and Yuzenkova, 2019). 
While writing this thesis a first publication describing a functional impact of NADylation of a 
bacterial RNA has shed a fleck of light on what we might expect to find more of in the future. 
S. aureus encoded RNAIII, sRNA involved in regulation of quorum sensing and virulence, 
was found to be highly NADylated (36.2% in wildtype cells) (Morales-Filloy et al., 2019). 
The NAD+-bearing population of RNAIII was varied in vivo, to determine the physiological 
impact of level of NAD+-capping. For this, Morales-Filloy et al. deleted the promoter of 
RNAIII and recovered mutants with two different plasmids that lead to production of 9.8 % or 
24.9 % of NADylated RNAIII. The strain that expressed more NAD+-RNAIII was less 
virulent via decreased expression of alpha-endotoxin Hla. Surprisingly, NADylation was not 
found to affect secondary/tertiary structure formation of RNAIII, thus the effect of NAD+-
RNAIII was not conferred by alterntive folding of this sRNA. Morales-Filloy et al. 
hypothesise further that the effect of RNAIII NADylation on S. aureus virulence represents a 
link between redox state and virulence of the bacterium. 
RNAIII is part of the agr quorum sensing system. High cell density is registered by the 
autoinducer peptide API, which binds the histidine kinase ArgC. AgrC activates AgrA by 
forming AgrA~P. In one pathway, ArgA~P activates modulins Psmα and Psmβ virulence 
factors which act by disrupting the mammalian cell membrane. On another path, AgrA~P acts 
as transcription activator on promoters P2 and P3. P2 regulates an operon that encodes Agr 
proteins AgrA, B, C, and D. The polycistronic transcripts of the agr genes is called RNAII. 
Transcription from P3 gives RNAIII, as well as another toxin, Hld. RNAIII itself has several 
functions. It negatively regulates expression of Rot, transcriptional repressor of a group of S. 
aureus toxins, and of several surface proteins e.g. coagulase. However, RNAIII also activates 
production of haemolytic exotoxins Hla and Hld, the first of which was focus of the study 




Table 3.4 Functional destinations of RNAs which have been identified as frequently NAD+-capped 
Organism Identified gene functions Publication 
E. coli 
sRNAs: plasmid replication, stress response 
mRNAs: enzymes of metabolism, enzymes of stress response 
Cahová et al. 2015 
S. cerevisiae 
mRNAs: cytoplasmic translation, protein transport/localisation to 
mitochondria, mitochondrial tansport, cellular macromolecule assemby, 
mitochondrial functions (F0 ATP synthase subunit c, cytochrome c 
oxidase subunit 2), mitochondrial rRNAs 
Walter et al. 2017 
HEK293T (H. 
sapiens) 
snRNAs, snoRNAs, scaRNAs, mRNAs (study did not focus on their 
cellular function) 
Jiao et al. 2017 
B. subtilis 
mRNAs: genes involved in phosphatase activity, nucleotidyltransferase 
activity, proteolysis, zinc binding, symporter activity, DNA binding and 
replication, oxidation/reduction, sporulation, transcription regulation, 
membrane integration, nucleotide binding 
Frindert et al. 2018 
Arabidopsis 
mRNAs of photosynthesis, protein synthesis, cytokinin response, stress 
response 
Wang et al. 2019 
S. aureus sRNA RNAIII: regulation of quorum sensing, virulence 
Morales-Filloy et al. 
2019 
 
sRNAs and RNA stability 
Bacterial NAD+-cap was associated to increased RNA stability via protection from RNase E 
and RppH (Bird et al., 2016; Jaschke et al., 2016), while eukaryotic NADylation of 
transcripts was described to promote degradation (Jiao et al., 2017). We think that although 
NCIN-capping in bacteria might protect the RNA from RppH and RNase E cleavage, this 
does not mean that stability is increased. In fact, among sRNAs which are highly NADylated 
in E. coli, no apparent correlation between capping and half-life can be observed (see table 
3.5). NAD+-RNA breakdown might lead over a different route of RNA breakdown. We think 
that findings that among highly NADylated mRNAs only 5’-fragments of <200 nt were found 
(Cahová et al., 2015), might be an argument in favour of degradation or endonuclelytic 
processing of NADylated mRNAs. 
RNA half-life can be very variable with 3-100 min in yeast and usually less than 10 min in 
bacteria (Silva et al., 2011), dependent on type of RNA and growth state (Deutscher, 2003). 
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Stationary phase RNA was shown to be more frequently NADylated (Bird et al., 2016). If this 
is evidence for a direct effect of 5’-NAD+ stability, or if other factors upregulate NCIN-
capping during stationary growth, is unknown. RNA half-life can have a strong downstream 
effect. A more stable mRNA will be translated more often before its degradation, and a more 
stable sRNA could regulate more genes. Table 3.5 sums up known half-lives, interaction 
partners and functions of sRNAs that were shown to be highly NADylated in E. coli. Half-life 
of the most frequently capped sRNAs seems to be quite diverse. Thus on first sight a 
relationship between sRNA capping and stability is not apparent. 
sRNAs are regulatory RNAs that bind to a target sequence. Few bind to proteins, e.g. 6S RNA 
sequesters growth phase RNAP-σ70 by binding σ70. This way, 6S RNA thus regulates stationary 
phase gene expression by suppressing σ70, but not σS (Waters and Storz, 2009). Most sRNAs 
interact with mRNAs. They may act as translational silencers, binding and occluding the 
ribosome-binding site (RBS) or other regions in the 5’-untranslated region (UTR) (Waters and 
Storz, 2009).  
Cis-acting sRNAs are encoded on the anti-sense strand of their target mRNA and have complete 
sequence homology, thus they are specific to their particular mRNA. Once produced, the sRNA 
can bind to the target but can also diffuse freely. This type of regulation is often found to control 
copy number of plasmids or transposons or in toxin/anti-toxin systems (Waters and Storz, 
2009). One example for the cis sRNA is RNA1, the most highly NADylated RNA in E. coli 
(Cahová et al., 2015). It regulates the replication of plasmid ColE1 by sequestering the ColE1 
primer (called RNA2) (Tamm and Polisky, 1985).  
Trans-acting sRNAs are generally transcribed from another location than their target mRNA. 
The sequence homology is limited and many trans sRNAs have several target RNAs. 
Therefore, RNA chaperone Hfq frequently mediates between sRNA and target mRNA. One 
example of a trans sRNA is GcvB, one of the sRNAs previously identified to be highly 
NADylated in vivo (table 3.5) (Cahová et al., 2015). It binds mRNA upstream of the 
translation start site. Formation of dsRNA then leads to degradation (Waters and Storz, 2009). 
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Table 3.5 sRNAs which were found to be highly NADylated in E.coli, including information on half-life, RNA and protein binding partners, and function (Julius and Yuzenkova, 
2019). 
*conflicting documentations, n.d. = not determined 
 
 
sRNA cis or 
trans 
target mRNA(s) protein binding half-life 
[min]  
function References 
RNA1 trans RNA2 Rop 1 ColE1 replication control (Tamm and Polisky, 1985; Bird et al., 2016) 
GadY trans/cis* GadX, GDS Hfq/Hfq-
independent* 
n.d. pH stress response (Opdyke et al., 2011; Cahová et al., 2015; Negrete and 
Shiloach, 2015; Bird et al., 2016)  
CopA trans CopT n.d. 3 r1 plasmid replication (Gerhard E, Wagner H, 1986; Cahová et al., 2015) 
GcvB trans CycA CsrA 2 peptide/aa transport, glycine 
transport 
(Pulvermacher, Stauffer and Stauffer, 2009; Stauffer and 
Stauffer, 2012; Cahová et al., 2015) 
ChiX trans ChiP Hfq 27 regulation of outer membrane 
channel 
(Mandin and Gottesman, 2009; Edwards et al., 2011; 
Cahová et al., 2015) 
McaS trans YdeH, YdcT Hfq, CsrA 20 biofilm regulation (Jørgensen et al., 2013; Cahová et al., 2015) 
GlmY trans GlmZ PAPI 1.4 peptidoglycan synthesis pathway (Reichenbach et al., 2008; Cahová et al., 2015) 
DsrA trans RpoS, Hns, 
MreB, RbsD 
Hfq 23 transcription, cell wall sythesis, 
ribose metabolism 
(Cayrol et al., 2009; Cahová et al., 2015; Wu et al., 2017)  
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More rarely, sRNA binding activates gene expression, by resolving secondary mRNA structure 
that inhibits ribosome binding (Repoila and Darfeuille, 2009; Waters and Storz, 2009). The S. 
aureus sRNA RNAIII mentioned earlier is an example of a trans sRNA which acts both as 
activator and inhibitor of translation. NADylation of RNAIII was found to modulate production 
of alpha-toxin (Morales-Filloy et al., 2019). Trans sRNAs are often regulated by a specific 
transcription factor in response to the environmental conditions (e.g. GcvB transcription factor 
GcvA is part of elevated glycine response), and they pass on this response by translation control 
of their various targets (Waters and Storz, 2009). If NCIN-capping was to affect the activity of 
sRNA this could have an accumulative downstream effect. 
Translation initiation 
The eukaryotic m7G-cap is an important structural feature of assembly of the translation 
initiation complex (Ramanathan, Robb and Chan, 2016). Experiments with luciferase reporter 
gene in cell culture have revealed that, in eukaryotes, presence of NAD+-cap inhibits translation 
initiation (Jiao et al., 2017). However, as m7G-capping is a post-transcriptional process, the 
m7G-cap could be attached to mRNA after NCIN-decapping by NUDIX hydrolases or DXO.  
The prokaryotic translation machinery does not rely on a 5’-cap. On mRNAs with ribosomal 
binding sites downstream of TSS, translation initiation relies on RNA sequence and secondary 
structure, and presence of initiation factors IF2 and IF3. On leaderless RNA, the AUG codon is 
necessary and sufficient recognition signal for ribosome binding. Leaderless translation is 
initiated by a complex of ribosome, IF2 and fMettRNA (Moll et al., 2002). NCIN-capping of 
leaderless RNA would disrupt the start codon (i.e. NAD+-UG instead of AUG) and could 
potentially fail ribosome binding and translation initiation. Alternatively, NCIN-capped 
translation initiation may rely on the presence of additional factors.  
The majority of NADylated RNAs in E. coli are sRNAs, thus non-translated. However, many 
bacteria contain high percentages of leaderless transcripts (e.g. one third of mycobacterial 
transcripts are leaderless (Shell et al., 2015). Hence, NCIN-capping of leaderless RNA likely 
occurs in vivo.  
Riboswitches and other regulatory 5’-elements 
Many regulatory elements are located in the 5’-UTR of bacterial RNA. This region can 
assimilate a secondary structure in response to environmental stimuli or can bind 
environmental signals and thus modulate translation (Waters and Storz, 2009). As an 
example, “RNA thermometers” exhibit temperature-sensitive secondary structure. 
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Riboswitches are cis-acting regulatory elements in the 5’-UTR that bind ligands. Often, they 
regulate expression of genes for regulation or utilisation of that ligand, as a type of feedback 
regulation (Waters and Storz, 2009). In riboswitch secondary structures the 5’-terminus can 
be included, or may remain single stranded (Montange and Batey, 2008). It would be 
interesting to see the effect of NADylation on riboswitch folding or ligand binding. However, 
folding of RNAIII in S. aureus was not found to be affected by NADylation (Morales-Filloy 
et al., 2019).  
RNA localisation and RNA-protein interactions 
Eukaryotic RNA localisation is often spatially confined by organelles such as nucleus or 
endoplasmic reticulum. In bacteria, RNA subcellular localisation is mainly undefined. For a 
long time it was thought that mRNA co-localises with the bacterial nucleoid, because 
transcription and translation would be coupled. However, more recent findings of fluorescence-
microscopy showed that indeed only 4% of translation processes are coupled and co-localised 
with transcription (Buskilay, Kannaiahy and Amster-Choder, 2014). As it seems, mRNA also 
localises to non-enclosed compartments or subcellular locations which are relevant for their 
cognate protein. Five patters of mRNA localisation have been indentified. i. Transcription site 
of chromosome, limited cytoplasmic diffusion ii. Cytoplasmic distribution, iii. Membrane 
localisation/ cell periphery, iv. Polar vs. septal (Buskilay, Kannaiahy and Amster-Choder, 
2014).  
The mechanism of mRNA localisation is however unknown. It has been proposed that due to 
bulkiness and RNA-protein interactions simple diffusion through the cytoplasm is unlikely the 
only mode of transport for RNAs (Buskilay, Kannaiahy and Amster-Choder, 2014).  
Many protein enzymes involved in metabolism interact with the adenine-containing cofactors 
like NAD+, NADH, FAD, DP-CoA. In addition to that, metabolism enzymes are known that 
“moonlight” as RNA-binding proteins (Castello, Hentze and Preiss, 2015). RNA interactome 
studies in yeast revealed 23 enzymes cross-linked to polyadenylated RNA. More than half of 
them also bind mono-or dinucleotides. Here, an interaction with NAD(H) or NADP(H) is 
commonly reported. One example is glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
of glycolysis. It converts glyceraldehyde-3-phosphate to D-glycerate-1,3-bisphosphate while 
generating NADH. Besides this, roles in transcription, DNA repair and interferon response 
have been documented for GAPDH. NAD+ and RNA seem to compete for the same 
dinucleotide-binding site. The presence of NAD+ or NADH interferes with GAPDH RNA 
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binding activity, as a means of regulating which function the enzyme assumes (Castello, 
Hentze and Preiss, 2015).  
Some bacterial proteins have been shown to be attracted by a specific membrane curvature 
(which differs at body and poles for non-spherical bacteria). Others recognise specific lipids, 
like cardiolipid, which populates pole membranes more densely in E. coli. In eukaryotes, RNA 
is believed to display cis-acting localising elements, or “zip-codes” in untranslated regions. 
Their mechanism of action is as of yet unresolved (Buskilay, Kannaiahy and Amster-Choder, 
2014). For prokaryotes it has been hypothesized that “zip-codes” are positioned in coding 
regions. (Buskilay, Kannaiahy and Amster-Choder, 2014). The case of RNA capped with cell 
wall precursors (Julius and Yuzenkova, 2017) is especially interesting. UDP-Glc and UDP-
GlcNAc are present at high concentrations in the cell and are turned over frequently during 
sugar metabolism and cell wall recycling (Konopka, 2012). It is possible that their incorporation 
into RNA “tags” the transcript towards the inner membrane. GlcNAc was besides being a 
precursor for murein, also associated to other cellular functions, such as signalling (Konopka, 
2012). In Streptomyces it is involved in signalling for sporulation (Konopka, 2012). UDP-Glc- 
and UDP-GlcNAc-RNAs have been found in vivo (J. Wang et al., 2019), though their cellular 
function is as of yet undefined. 
Effect of capping on cofactor pool and cellular redox potential 
NCIN-capping might reflect the metabolic state of the cell (Bird et al., 2018; Frindert et al., 
2018; Julius, Riaz-Bradley and Yuzenkova, 2018). NAD(H)-capping in mitochondria was 
shown to be responsive to NAD+/NADH levels and ratio (Bird et al., 2018; Grudzien-
Nogalska et al., 2018). 
The bacterial cytosol is packed with metabolites. Altogether about 300 mM of diverse small 
molecules that are involved in metabolism can be detected in growing E. coli (Bennett, 
Kimball and Gao, 2009). Proportionally the largest group of these are the amino acids, 
followed by nucleotides ATP (9.6 mM), and UTP (8.3 mM) (Bennett, Kimball and Gao, 
2009). Many metabolic molecules contain nucleoside moieties which would make them 
potential NCIN-caps. Adenine-containing cofactors of metabolism are present in high 
concentrations, such as NAD+ (2.6 mM), FAD (1.7 mM), Coenzyme A (1.4 mM) or NADP 
(1.2 mM). Much more highly concentrated are uridine-containing intermediates of sugar 
metabolism and cell wall synthesis, such as UDP-GlcNAc (9.2 mM), UDP-Glc (2.5 mM) or 
UDP-glucaronate (5.7 mM) (Bennett, Kimball and Gao, 2009). The intracellular 
concentrations of these molecules exceeds the previously measured KM of EcRNAP (Julius 
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and Yuzenkova, 2017) by far: KM of ATP utilisation is 0.09 mM, of adenine-cofactors NAD
+ 
and NADH 0.36 mM and 0.38 mM, respectively. RNAP KM to UTP is 0.12 mM in 
comparison to UDP-Glc (0.33 mM) and UDP-GlcNAc (0.3 mM).  
NCIN-capping was suggested to be a means of epigenetic regulation in eukaryotes (Kiledjian, 
2018), and it could also contribute to an analogous regulation in bacteria. Epigenetics relies on 
DNA modification and tertiary/quartenary structure affecting the transcriptome. In bacteria, 
DNA spatial organisation, though not as packed, is likely to affect RNA capping due to 
molecular crowding and concentration bias. In S. aureus it was recently suggested that 
pathogenicity might be modulated via the bacterium’s metabolic or redox state via NAD+-
capping (Morales-Filloy et al., 2019). 
Inversely, NCIN-capping might modulate the pool of free metabolites.This might be most 
impactful in mitochondria. Mitochondrial ATP-synthesis relies on availability of NAD(H) as 
redox factor. Therefore, regulation of RNA NADylation might be a crucial event in the response 
of mitochondria to nutrient or redox stress.  
 
3.6 Conclusion and Outlook 
NCIN-caps were verified to be a universal RNA modification or extension of primary 
structure. We (and others) have shown that NCIN-caps are incorporated into RNA by 
transcription initiation. Several protein and promoter structural features have been described 
to likely regulate NCIN-capping. Yet, the actual functional importance of this event remains 
to be determined. The finding that S. aureus alpha-toxin is regulated by the level of 
NADylated RNAIII is a first sign of functional significance (Morales-Filloy et al., 2019). 
Besides regulation of virulence factors, NCIN-capping might also direct interaction of the 
transcript with other molecules, balance free metabolite availability, or regulate gene 
expression via transcript stability, translation regulation, or RNA localisation. NUDIX and 
DXO enzymes direct NCIN-RNA degradation.  
Future research will show which NCIN-caps exist in nature, how the cap spectrum is 
regulated, whether NCIN-caps are specifically recognised by proteins or nucleic acids in vivo, 
if there are RNAP-independent pathways of non-canonical capping, and which physiological 
consequences arise from NCIN-capping and capping deficiency  
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4 Chapter II: Primase utilises cellular cofactors to initiate primer 
synthesis 
4.2 Introduction 
Primase is a specialised ssDNA-dependent RNA polymerase that initiates replication of the 
genome by producing RNA primer. Since DNA polymerases are inherently unable to initiate 
de novo DNA synthesis, they rely on primer as start points for replication. All bacteria and 
eukaryotes utilise RNA primer. Among viruses of eukaryotes other approaches to priming are 
known, such as use of tRNA or even protein primers (Kuchta and Stengel, 2010). Bacterial 
primase (as well as phage and plasmid primase) is a one subunit enzyme which associates 
temporarily to a multi-enzyme replisome, and interacts predominantly with helicase. Some 
bacteriophage primases instead have a helicase subunit (Kuchta and Stengel, 2010). 
Eukaryotic and archael primases have two subunits, the catalytic subunit P49 (also called P48 
or PriS) and a larger subunit P58 (or PriL) which is involved in template and NTP binding. 
P49-P58 complex associates to DNA Polymerase α (Pol α) to form the Pol α-primase or pol-
prim complex for RNA-DNA primer synthesis (Muzi-Falconi et al., 2003). In mitochondria, 
interestingly, RNA primer is generated by the transcriptase POLMRT as side product of 
transcription (Wanrooij et al., 2008). A second primase which generates deoxyribonucleotide 
primer is known in both eukaryotic nuclei and mitochondria, and is called PRIMPOL (García-
Gómez et al., 2013).  
The Primer is a short lived product (Balakrishnan and Bambara, 2013). Yet its’ synthesis and 
removal are the rate limiting steps of replication (Bailey, Wing and Steitz, 2006). After 
providing a 3’-OH to processive DNA polymerase for synthesis of leading strand or Okazaki 
fragments (DNA stretches between two primers on the lagging strand), primer is removed to 
facilitate production of a complete DNA strand. Bacteria remove primer by RNase H, a 
ribonucleic acid endonuclease with specificity for RNA-DNA hybrids, and/or by DNA 
polymerase I (Pol I) 5’-nuclease activity (Berkower, Leis and Hurwitz, 1973). Pol I fills up 
the gap between two Okazaki fragments with DNA, and DNA ligase seals the backbone 
nicks. Eukaryotic primer is removed by one or several flap-endocucleases after being 
displaced by DNA polymerase (Rossi and Bambara, 2006). 
We show that E. coli primase DnaG efficiently initiates primer synthesis using nucleotide-
containing metabolites such as NADH and FAD as non-canonical initiating substrates 
(NCIS). This is regulated by residues of DnaG basic ridge amino acids and does not respond 
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to alterations of primase recognition site -1 position on DNA. We found that stringent 
response alarmone ppGpp likely inhibits metabolite initiation. We hypothesise that non-
canonically initiated primer may affect replication via altered Okazaki fragment processing in 
bacteria, as Pol I is differentially affected by NCIS. Further, we show that human primase 
catalytic subunit P49 can initiate primer with methylated guanosine triphosphate (m7GTP). 
4.2.1 DnaG is an RNA polymerase that looks like a topoisomerase 
The chapter will use E. coli protein nomenclature, unless otherwise stated. Bacterial primases 
are widely conserved. The DnaG protein forms three distinct domains. The N-terminus bears 
a zinc-binding domain (ZBD). The Zn2+-finger found here confers binding to DNA 
(Akabayov et al., 2009; Lee et al., 2012; Ilic et al., 2018). The C-terminus is referred to as 
helicase binding domain (HBD) or helicase interaction domain (HID) (see figure 4.1 A) 
(Tougu, Peng and Marians, 1994; Kuchta and Stengel, 2010; Ilic et al., 2018). The largest 
domain in between both peptide termini is the RNA polymerase domain (RPD) containing a 
TOPRIM fold. The TOPRIM fold is common to many bacterial enzymes that are involved in 
DNA maintenance such as topoisomerases and recombinases (Rymer et al., 2012; Hou, 
Biswas and Tsodikov, 2018). Three divalent cations (Mg2+, Mn2+, or Fe2+) are coordinated by 
conserved residues in the TOPRIM domain for RNA synthesis and NTP binding. Potentially, 
DnaG oligomerisation (dimer up to hexamer) is important for enzyme activity, as found for 
T4 primase (Yang et al., 2005; Ilic et al., 2018) and allows for sharing of catalytic sites (Yang 
et al., 2005). The TOPRIM fold forms the walls of a central cleft in DnaG where most 
inhibitors as well as cofactors bind (Stamford et al., 1992; Aravind, Leipe and Koonin, 1998; 
Godson et al., 2000; Keck et al., 2000; Rymer et al., 2012). The N-terminal region of RPD 
domain also interacts with DNA (Hou, Biswas and Tsodikov, 2018).  
Possibly, DnaG travels dsDNA via interaction with RPD N-terminus until a replisome (multi-
protein replication complex) is encountered. It binds only one of the two strands but has 
similar affinity to dsDNA as to ssDNA (Hou, Biswas and Tsodikov, 2018). DnaG recognises 
a triplet of the consensus 5’-PyrPyrPur (two pyrimidines, one purine) on the non-template 
strand, thus primer synthesis can potentially be initiated frequently on many genomic 
locations. Its’ preferred recognition sequence is 5’-CTG (Yoda et al., 1988; Yoda and 
Okazaki, 1991).+1 position (first base pair) is the central pyrimidine of this sequence, thus the 
initiating nucleotide of the primer has to be a purine (A or G). Variation of -1 base affects 
initiation efficiency (G>T>C>A).  
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Figure 4.1 shows important structural information on DnaG and interaction with substrates 
and template. DnaG catalysis depends on two lysine residues and an EGxxD motif in the 
catalytic site for phosphodiester bond formation of the first dinucleotide (Lee and Richardson, 
2001; Rodina and Godson, 2006). A cluster of acidic residues that bind three divalent cations 
(Godson et al., 2000; Lee and Richardson, 2005; Hou, Biswas and Tsodikov, 2018), and 
positively charged residues of the “basic ridge” were found to make contact to the 
triphosphate moiety of substrates (Keck et al., 2000; Rodina and Godson, 2006). ZBD binds 
to ssDNA at the recognition site (Yoda and Okazaki, 1991; Swart and Griep, 1993; Hou, 
Biswas and Tsodikov, 2018).  
Two nucleotides are bound within DnaG to form the first phosphodiester bond. This is 
considered the rate-limiting step of primer synthsis, because the first dinucleotide is not 
stabilised in the catalytic centre by base pairing of a nascent RNA 3’-end with the template. 
Thus primer initiation widely depends on substrate concentration. DnaG catalysis functions 
using three metal ions. This is a main distinction between bacterial primase and other 
polymerases (including all known transcriptases), which all function by a two metal ion 
mechanism. The growing RNA chain is displaced as primase travels along the DNA template, 
while 3’-end of primer remains in the catalytic site between metal binding centre and basic 
ridge (Hou, Biswas and Tsodikov, 2018). Nucleophilic attack of 3’-OH of RNA to incoming 
NTP is catalysed by metal ion A (Hou, Biswas and Tsodikov, 2018). Metal ions B and C 
together with two arginine and one leucine residue were shown to coordinate the triphosphate 
of the NTP substrate (Rymer et al., 2012) (figure 4.1.1 D). Likely, metals A and B reside 
within the active site while metal C is introduced by incoming NTP which it serves to position 
correctly in the active site (Rymer et al., 2012). Metal B aids dissociation of pyrophosphate as 
the phosphodiester bond is made (Rymer et al., 2012). 
After primer synthesis, β clamp is loaded onto the RNA:DNA hybrid, and Pol III is recruited 
to extend the primer by DNA polymerisation onto the final 3’-OH (Lovett, 2007; Lewis, 
Jergic and Dixon, 2016). The primase-to-polymerase switch at the primer is coordinated by 
the clamp loading complex. Clamp loader protein χ binds SSB, breaking the connection of 
DnaG to SSB (Naue et al., 2013), reducing DnaG stability on DNA. Clamp loader can then 
displace DnaG and bind itself to load β clamp, which binds Pol III (Yuzhakov, Kelman and 
O’Donnell, 1999). β clamps have an additional role in recruiting DNA modifying and repair 
enzymes to the daughter strand (Lewis, Jergic and Dixon, 2016). 
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After Okazaki fragment synthesis, the primer needs to be removed to facilitate completeion of 
the DNA strand. This is done by RNase H endonucleoluyic cleavage of RNA part of RNA-
DNA hybrid, and/or Pol I 5’-3-nuclease activity (Xu, Grindley and Joyce, 2000; Sulej et al., 
2012), as described later. 
4.2.2 RNA primer synthesis by DnaG continually initiates DNA synthesis 
Bacterial replication is initiated at the origin of replication (chromosomal origin, oriC) by 
master initiator protein DnaA, an ATPase-containing enzyme that unwinds and melts oriC 
DNA, creating a replication fork (Jacob, Brenner and Cuzin, 1963; Skarstad and Boye, 1994). 
After generation of the first primers on oriC by DnaG, replication is performed by the 
bacterial replisome. The replisome is a multi-enzyme complex for DNA replication that 
moves along DNA to replicate both DNA strands simultaneously in one replication fork, the 
leading strand in a continuous, and the lagging strand in a discontinuous fashion (Yoshikawa, 
1970). DnaG synthesises about 2000-4000 primer per E. coli chromosome on the lagging 
strand (Kusakabe and Richardson, 1997). 
Members of the bacterial replisome are main DNA Polymerase III (Pol III), β2 sliding clamps, 
clamp loading complex, DNA helicase (DnaB), single strand binding proteins (SSB), and, 
transiently, primase DnaG and primer displacement polymerase Pol I (Wu et al. 1992) (see 
figure 4.2). The Pol III multisubunit enzyme consists of catalytic subunit α (dnaE), 3’-5’-
proofreading subunit ε (dnaA), and subunit θ (holE). Three Pol III cores are physically held in 
the replisome by interaction with τ proteins in clamp loader complex, and interact with β2 
(dnaN) sliding clamps on their respective template strands. The clamp loading complex can 
have different conformations of τ or  γ (dnaX) and δ (holA) and δ’(holB): τ3δδ’, γ3δδ’, γ2τδδ’, 
or τ2γδδ’ with τ being the full gene dnaX product, and γ being a C-terminally truncated 
version of DnaX created by translational frameshift or proteolysis (Lovett 2007, Johnson & 
O´Donnell 2003). The C-terminus of τ interacts with Pol III α as well as DnaB. DnaB is 
loaded onto ssDNA by helicase loader DnaC (not a stable member of the replisome) (Arias-
Palomo et al., 2013). DnaB hexamer sits on lagging strand and unwinds dsDNA at the edge of 
the replication fork. Replication is initiated as primase DnaG travels along DNA and finds an 
open replication fork (Hou, Biswas and Tsodikov, 2018). It is also attracted by a recognition 
sequence on ssDNA (Swart and Griep, 1993). Roughly three DnaG proteins associate with a 
DnaB hexamer (Arias-Palomo et al., 2013). DnaG is able to synthesise primer without DnaB 









Figure 4.1. DnaG primase from M. tuberculosis, S. aureus and E.coli structures 
and interaction with cofactors, substrates and template. From (Rymer et al., 
2012) (A-D, S. aureus DnaG numbering) and (Hou, Biswas and Tsodikov, 
2018) (E-F, M. tuberculosis DnaG numbering) and (Keck et al., 2000) (G). A. 
Domains of DnaG, N-terminal Zn-binding domain (ZBD), middle section is 
RNA polymerase domain (RPD), which has a N-terminal subdomain (N-SUB), 
a TOPRIM and a C-terminal helix-binding (HB) subdomain, and the C-
terminal helicase interaction domain (HID), which is also called helicase 
binding domain (HBD in text). B. Orientation of substrates CTP, UTP, ATP 
and GTP (left to right, stick models) in respect to three Mn2+ ions (grey 
spheres) as they would be seen in the catalytic centre. C. Close-up of RBD 
with metal ions (grey spheres) and NTP (all above NTPs superimposed, stick 
models). The subdomains of RPD are shown: N-SUB (purple), TOPRIM 
(bright blue) and HB (pink). Amino acid restudies of basic ridge are dark blue sticks, metal binding residues are red sticks. Indicated numbered residues are likely involved in 
NTP binding. D. close-up of catalytic centre residues interacting with three metal ions (spheres A, B and C) and CTP (orange/yellow). E. RBD of M. tuberculosis interacting 
with dsDNA (yellow) via HB (light blue). Also TOPRIM (off-white) and N-SUB domains (dark blue) are shown. F. Close-up of residues of HB (dark teal) interacting with 
DNA (yellow). G. Naming of subdomains within the RPD of E. coli DnaG. Note relative positions of metal binding centre and basic ridge.
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DnaG also interacts with SSB, a connection which is broken after primer is completed, 
resulting in dissociation of DnaG (Marceau et al., 2011; Naue et al., 2013). The clamp 
loading complex pentamer is held together by proteins ψ (holD) and χ (holC), which bind 
SSB during elongation stage (Marceau et al., 2011).  
Bacterial replication is initiated frequently on lagging strand, starting with primer synthesis. 
Likely, one Pol III core is responsible for continuous synthesis at leading strand and two are 
involved in lagging strand synthesis. According to the “trombone model” (Yoshikawa, 1970), 
the lagging strand successively loops out in the replication fork, and is bound by SSB for 
protection, to be replicated by Pol III into 5’-direction, while leading strand is replicated 
continuously. In a “polymerase switching” mechanisms, the lagging strand is synthesised by 
one Pol III and a “reserve” Pol III which is available to replace the active Pol III in cases of 
replication blocks. This was observed with EM in phage T7 replication (Hamdan et al., 2007). 
Alternatively, both Pol III are active on the lagging strand simultaneously, at start and end of 
successive Okazaki fragments. This was observed by EM for phage T4 replication (Yang et 
al., 2005).  
In bacteria, Okazaki fragment maturation and replication repair are directed over β sliding 
clamps which can connect to up to 3 different polymerases and factors simultaneously. 
Okazaki fragments are processed by Pol I and DNA ligase I (Lopez de Saro & O’Donnell 
2001). Pol I synthesises DNA starting at Okazaki 3’-ends, and cleaves primer via 5’-nuclease 
activity (Xu, Grindley and Joyce, 2000). Ligase seals the DNA backbone. Repair DNA 
polymerases II (Pol II) (polB), Pol IV (dinB) and Pol V (umuCD) are recruited to template 
breaks (Fuchs & Fuji 2007). Mismatch repair factor MutS repairs mismatches that have 
escaped proofreading during strand synthesis. As all these factors interact with the β clamp in 
the replication fork, it is referred to as “intrareplicative repair” mechanism (Lovett 2007).  
Termination of replication occurs at termination (ter) sites on the E. coli chromosome 
(Siddiqui, On and Diffley, 2013; Dewar and Walter, 2017). Two replication forks approach 
each other, causing positive supercoiling which is, to some extent, released by various 
topoisomerases (Hiasa and Marians, 1996; Levine, Hiasa and Marians, 1998; Postow et al., 
2001; Espeli et al., 2003). As replisomes enter ter, they are stalled. It is uncertain whether one 
is stalled as the other approaches (Dimude et al., 2016), or they encounter and collide (Duggin 
and Bell, 2009). It has been documented that replication forks can converge (Levine, Hiasa 
and Marians, 1998; Espeli et al., 2003), which can lead to re-replication, which is prevented 
by protein Tus (Hiasa and Marians, 1994; Markovitz, 2005; Rudolph et al., 2013). Replication 
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fork converging can also lead to 3’-flaps, which can be removed by Pol I (Markovitz, 2005). 
After disassembly of replisomes, a non-replicated stretch may remain between them which 
must be filled by an unknown mechanism that involves protein PriA (Hiasa and Marians, 
1994; Rudolph et al., 2013; Wendel, Courcelle and Courcelle, 2014).  
 
Figure 4.2 from (Kelch et al., 2012). The bacterial replisome and trombone model. Clamp loader heteropentamer 
connects helicase homohexamer and three cores of polymerase and sliding clamps. Helicase progressively opens 
the replication fork, sliding clamps follow on dsDNA daughter strands, holding polymerases in place for DNA 
synthesis. SSB are necessary for looping of the lagging strand. Potentially, two polymerases can be engaged on 
the lagging strand, in this case two ssDNA loops would be observed. Primase associates to helicase transiently to 
create primer. Further factors and repair polymerases, as well as Okazaki fragment processing enzymes interact 
with the replisome in the replication fork. 
4.2.3 Replication is regulated in stringent response via regulation of DnaG  
Regulation of replication via DnaG is one pathway of stringent response. The stringent 
response reacts to nutrient starvation signalled by uncharged tRNAs. Protein RelA recognises 
non-aminoacylated tRNA bound to the ribosome, and phosphorylates GTP to form ppGpp or 
pppGpp (Winther, Roghanian and Gerdes, 2018). Another pathway is formation of (p)ppGpp 
from GTP by SpoT in response to carbon, iron and fatty acid starvation (Traxler et al., 2008). 
Simultaneously, SpoT-mediated hydrolysis of (p)ppGpp is inhibited, which contributes to 
their accumulation in the cell. (P)ppGpp are called stress alarmones because they interact with 
various cellular targets to modulate rapid reduction of replication and biomass production 
(figure 4.3). (p)ppGpp were shown to bind DnaG at the catalytic centre, partially overlapping 
with bound NTP (see figure 4.3.B and C). While 5’-phosphates of (p)ppGpp are located like 
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those of GTP, 3’-phosphates change the orientation of base and ribose (Rymer et al., 2012). 
Rymer et al. assume that alarmones disturb binding of both 3’-end RNA and incoming NTP 
competitively. 
 
Figure 4.3 Stringent response and DnaG binding of alarmones. A. From (Magnusson, Farewell and Nyström, 
2005). Strigent response is elicited by SpoT or RelA phosphorylation of GTP to form (p)ppGpp, in response to 
starvation signals. Probably, ppGpp binds to an allosteric site in RNAP holoenzyme and affects transcription of 
many genes and downstream processes. B. From (Rymer et al., 2012). Besides targeting RNAP, (p)ppGpp also 
binds DnaG. Here, the alarmone binding site is almost identical to NTP binding site, thus (p)ppGpp competes 
with canonical substrates and inhibition depends on the relative concentrations of nucleotides and alarmones. C. 
From (Rymer et al., 2012). Overlap of binding of GTP (grey), ppGpp (pink) and pppGpp (yellow) at DnaG 
metal ions (purple) in the catalytic site. Phosphates (orange/red) are coordinated almost identically on the metal 
ions, yet presence of 3’-phosphates slightly shifts the molecules above metal A such that ribose and nucleobase 
occupy a different space as compared to GTP which has a free 3’-OH. 
4.2.4 Eukaryotic primer synthesis and removal differ from the prokaryotic system 
Despite sequence and structural differences between bacterial, archaeal and eukaryotic 
replisomes, the mechanism of replication is quite similar (Kelch et al., 2012). However, 
mechanisms of primer synthesis as well as structure of primase are quite dissimilar between 
bacteria and archaea/eukaryotes. Eukaryotic, archael and some viral primases are two subunit 
enzymes, generally consisting of a small catalytic and a large accessory subunit (Kuchta and 
Stengel, 2010).  
Archaeal and eukaryotic primases are structurally similar despite sequence variation. Their 
mechanism of primer synthesis is analoguous (Bell, 2019). Eukaryotic/archaeal primases have 
two (or three) subunits: catalytic subunit P49 (or P48 or PriS) and regulatory subunit P58 
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(also called PriL), accompanied by PriX in some archaea. In the following text I will refer to 
studies about archael subunits with using PriS, PriL and PriX, and eukaryotic primase will be 
referred to as P49P58 
The P49P58 heterodimer complexes with DNA polymerase α (Pol α) to form pol-prim, an 
association that generates the most prominent difference between replication priming in 
eukaryotes and prokaryotes, the RNA-DNA primer (Boudet et al., 2015). After 8-14 nt RNA 
primer is formed, primase is replaced by Pol α which attaches a 10-20 nt DNA extension to 
the RNA primer. Only then is DNA synthesis passed on to the processive DNA polymerases. 
While eukaryotic/aerchaeal primer are typically made of RNA, these primases readily 
incorporate dNTPs if abundantly available(Kuchta and Stengel, 2010; Ilic et al., 2016) and 
thus can form full DNA primer, albeit at lower efficiency and with reduced primer length (Liu 
et al., 2015). 
P49 contains a Zn2+-binding site which is important for protein structure, close to an active 
site which chelates cations via a cluster of conserved acidic amino acid residues (see figure 
4.4 A and B). Further, a group of conserved basic residues function in NTP and DNA binding 
(Augustin, Huber and Kaiser, 2001; Ito et al., 2003; Lipps et al., 2004; Lao-Sirieix et al., 
2005; Yang, Lee and Nowotny, 2006; Vaithiyalingam et al., 2014). In contrast to DnaG, P49 
exhibits a two-metal-ion mechanism of catalysis (Kilkenny et al., 2013). One divalent cation 
participates in NTP binding, and one in nucleotidyl transfer (Ito et al., 2003). Conserved basic 
residues of P49 contact the triphosphate moiety of a bound nucleotide, where D 306, D111 
hold Mg2+, D109 simultaneously contacts both Mg2+ and all three phosphates, and R162 and 
H166 interact with γ and β phosphates, respectively. Further ribose-contacting residues have 
been identified (Vaithiyalingam et al., 2014). 
The primase large subunit contains a C-terminal iron-sulfur cluster (FeS-cluster or [4Fe4S]). 
Some archeae have besides PriL another PriX which also contains FeS-cluster and is 
structurally similar to PriL FeS-cluster C-terminal subdomain (Lao-Sirieix et al., 2005; 
Klinge et al., 2007; Weiner et al., 2007; Pellegrini, 2012; Baranovskiy et al., 2015; 
Kazlauskas et al., 2018; Bell, 2019). P58 N-terminal half interacts with P49, while N-terminal 
P58 constitutes a pseudo-tandem repeat of the FeS-cluster subdomain. The catalytic subunit 
was found to predominantly execute primer elongation. Binding of the initiating nucleotide is 
facilitated at a conserved arginine in PriL/X or P58 (Kilkenny et al., 2013; Baranovskiy et al., 
2016; Yan et al., 2018). This binding site interacts with 5’-triphosphates of the initiator (Yan 
et al., 2018). In the crystal structure of free primase, PriS active centre and PriL initiator 
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binding regions are distal, but upon initiation of primer synthesis configurational changes of 
the primase heterodimer bring these sites closer together (Baranovskiy et al., 2015; O’Brien, 
Holt, et al., 2018) (figure 4.4 B and C). Likely, the FeS-cluster of P49P58 in complex with 
substrate NTPs bind to anionic DNA. Electrostatic interaction between FeS-cluster in this 
composition with NTPs and DNA cause a conformational change that enhances primase 
activity. Thus eukaryotic replication initiation has been proposed to be regulated by redox 
signalling via DNA charge and FeS cluster (O’Brien, Holt, et al., 2018). Figure 4.4 A-C show 
the orientation of primase subunits and domains in free conformation (B) and DNA/NTP-
bound conformation (C). 
Bacterial primer synthesis is initiated after DnaG first binds to DNA unspecifically and then 
finds its start site. In contrast to this, eukaryotic primer initiation begins with NTP binding, 
followed by template binding and first phosphodiester bond formation. Then, the catalytic 
centre is repositioned for the next cycle (Boudet et al., 2015). The precise DNA recognition 
site has not been defined, but most eukaryotic primer bear 5’-purines, and primase seems to 
prefer to initiate on pyrimidine-rich templates (Suzuki et al., 1993; O’Donnell, Langston and 
Stillman, 2013). The initiation site is likely determined by relative availability of NTPs rather 
than a specific recognition site (Sheaff and Kuchta, 1993; Kirk et al., 1997). P58 binds to 
DNA template and does not move as P49 proceeds to elongate the primer along the template. 
P49 counting of primer (~10 nt) is dictated by the maximum stretch between P58 template 
binding domain and P49 catalytic site (Xie, 2011) (see figure 4.4 D). The primer is then 
handed over to Pol α via a yet unknown mechanism (Boudet et al., 2015). 
At least two pathways are known for eukaryotic primer removal, the “short flap” and “long 
flap” pathways. In the short flap pathway, which is the main pathway, processive DNA 
polymerase δ displaces RNA/DNA primer forming a “flap” between two dsDNA Okazaki 
fragments. Pol δ-associated protein flap endonuclease FEN-1 binds the base of a flap of about 
10 nt, treads the free 5’-end through itself, and cleaves nucleic acid at the base of the flap 
endonucleolytically. This process is repeated a few times, eventually the RNA primer is 
removed and DNA ligase 1 seals the nick. Often, a part of an Okazaki fragment is removed 
which has been proposed to improve overall replication fidelity (Bambara, Murante and 
Henricksen, 1997; Lieber, 1997; Gloor, Balakrishnan and Bambara, 2010; Balakrishnan and 




Figure 4.4. Eukaryotic and archaeal primase from (Baranovskiy et al., 
2015) and (Sauguet et al., 2010) and (Baranovskiy et al., 2016). A. Protein 
domains of P49 (blue) with Zn2+-binding domain (orange lines) and P58 
N-terminal half (green) which interacts with P49 and C-terminal half 
(pink) which contains FeS-cluster (red lines). B Crystal structure of free 
heterodimer. P49 is blue, conversed residues of catalytic site (metal and 
NTP binding) shown in pink and bound Zn2+ is orange sphere. N-terminal 
domain of P58 (green), C-terminal domain (light pink) lie between P49 catalytic centre and FeS-cluster (yellow and blue spheres) and NTP- and DNA binding residues (pink). 
C. Orientation of PriS and PriL if bound to first two nucleotides and ssDNA. The nucleic acid binding sites, which are distal in free conformation, are now neighbouring. D. 
Primer synthesis starts as P49P58 dimer binds template DNA and two nucleotides. First, the second nucleotide is bound, then the initiating nucleotide (Boudet et al., 2015). 
P49 catalyses phosphodiesterbond formation and proceeds along the ssDNA template until the maximal distance to the stationary P58 forces termination of primer at ca. 10 nt.
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cleave short flaps repetitively, thus the flap becomes long enough for replication protein A 
(RPA) to bind. RPA is the eukaryotic pendent to SSB, it binds ssDNA loops during 
replication to prevent reannealing, but is additionally involved in recruitment of further 
replication factors. FEN-1 cannot bind to RPA-DNA, but Dna2 protein can bind the base of 
the flap, remove RPA, and thread the free flap through its arch similarly to FEN-1. While 
threading, it cleaves the flap every 5-6 nt. Yet, it cannot cleave the base of the flap. Here, 
FEN-1 or its replacement Exo1 performs the final cleavage at the flap base (Bae et al., 2001; 
Rossi and Bambara, 2006; Stewart et al., 2008; Kang, Lee and Seo, 2010; Budd et al., 2011). 
Further, an RNase H-mediated pathway of primer removal exists in eukaryotes. RNase H1 
removes primer of at least 4 nt length, RNase H2 removes primer of at least 2 nt length. Both 
cleave endonucleolytically between two ribonucleotides, but cannot cleave the RNA-DNA 
junction. This has to be conferred by another nuclease, such as FEN-1 (Turchi et al., 1994; 
Murante, Henricksen and Bambara, 1998; Cerritelli and Crouch, 2009). 
 
4.3 Aims 
Here, we wanted to test whether bacterial primase DnaG and human primase catalytic subunit 
P49 initiate RNA synthesis in vitro with nucleotide-containing metabolites, and if so, which 
DNA and protein structural determinants are involved in this process. We have previously 
seen that different RNA polymerases can initiate transcription with abundant cellular 
cofactors. These transcriptases include structurally unrelated multi-subunit and single-subunit 
enzymes. Additionally, POLMRT readily produces NCIN-capped transcripts which can 
function as primer in mitochondrial replication.  
Further, we intended to investigate the potential downstream effect of utilisation of metabolic 
cofactors in primer synthesis by DnaG on bacterial replication. Also, we wondered if nutrient 
availability in the cell, as signalled via stringent response alarmones (p)ppGpp, affects 








4.4.1 DnaG initiates primer synthesis with metabolic cofactors NAD(H), FAD and DP-
CoA at varying efficiency 
In order to test whether primer RNA can be synthesised by DnaG using adenine-containing 
cofactors, we designed an ssDNA template whith the DnaG recognition site 5’-CTG (figure 
4.5 A). Interestingly, we observed that DnaG initiates primer with NADH and FAD 
efficiently. KM for ATP, NADH and FAD were 47, 109 and 390 μM, respectively. 
Incorporation of NAD+ and DP-CoA was less efficient. Figure 4.5 B shows the different 
migration for primer initiated with cofactors. Figure 4.3.1 C further shows that metabolite 
initiation does not lead to the formation of abortive products. This finding is an analogy to 
NCIN-associated promoter escape in transcription (chapter I). 
4.4.2 DnaB improves specificity of primer initiation with canonical and non-canonical 
substrates 
In the cell, DnaG associates with helicase DnaB and SSB. It was known that DnaB strongly 
stimulates DnaG activity (Lu et al., 1996; Johnson, Bhattacharyya and Griep, 2000). We 
tested whether presence of DnaB would affect the efficiency of DnaG NCIS incorporation. 
We could observe two effects of DnaB: i) DnaB enhances DnaG activity, ii) DnaB does not 
alter the relative efficiency of incorporation of substrates (ATP>NADH>FAD). Furthermore, 
in presence of DnaB “overlong primer” are not produced. Overlong primer are side-products 
of in vitro primer synthesis likely caused by template-independent extension of primer by 
DnaG (Bhattacharyya and Griep, 2000). 
Primase was also reported to have a “counting” ability that ensures primer are usually 10-12 
nt in length. This can be observed in form of a secondary band (ATP-10 in figure 4.6). 
4.4.3 NudC can hydrolyse 5’-NADH on primer 
In the case of NCIN-capped transcripts, NudC is a useful tool for verification of the NAD(H)-
cap. Thus, we tested whether NudC would also cleave NADH-primer. Theoretically, the 
hybridisation of RNA primer to DNA might hinder NudC binding to its substrate. Here we 
show that if primase is washed off the hybrid (with 1M salt), NADH-primer is susceptible to 






Figure 4.5 DnaG utilises adenine-containing cofactors of metabolism to initiate primer synthesis on ssDNA. A. 
Template sequence including recognition site 5’-dCTG (purple). The resulting RNA primer starts with 5’ATP or 
ADP-containing cofactor. +1A and +2G are shown in purple. The assay contained radiolabelled α(P32)-GTP and 
UTP for elongation to yield an up to 13 nt long primer. B. Denaturing polyacrylamide gel electrophoresis (23%) 
allows for resolution of primer initiated by different cofactors. We can observe that full length primer (12 nt + 
initiator) is produced upon initiation with ATP (lane 1), NADH (lane 3) and FAD (lane 4) while NAD+ and DP-
CoA (lanes 2 and 5) make poor substrates for DnaG. Additional bands are result of either ultilisation of 
alternative start site (e.g. initiation at +2) or shorter than full length primer (e.g. NADH-11), which can be 
attributed to primer counting by DnaG. C. Migration of cofactor- or canonical primer and abortive products of 
primase reaction. Similar to RNAP, NCIS does not promote release of abortive products by DnaG. D. Kinetics 
for incorporation of ATP (green), NADH (blue), or FAD (orange) into 5’-primer by DnaG. Michaelis-Menten 
kinetics were calculated for an average from three imdependent experiments Dots and error bars are mean values 




Figure 4.6 DnaB stimulates DnaG activity. A. Addition of DnaB helicase (left hand side of gel) leads to much 
stronger signal of radiolabelled primer as compared to absence of DnaB (right hand side). Also, production of 
overlong primer is reduced in presence of DnaB. B. From (Monachino et al., 2018). DnaB helicase (blue) 
undergoes temporary interaction with DnaG (red) during primer synthesis. Many primer are generated on the 
lagging strand. 
 
Figure 4.7. NudC can be used to verify 5’-NADH-primer. A. Schematic of NudC reaction on NADH-primer. 
NudC cleaves the phosphodiester bond between nicotinamide mononucleotide (NMN) and adenine 
mononucleotide (AMP). We cannot say if primer remains fully or partially annealed to the DNA template. 
B.After primer synthesis with ATP or NADH initiator, DnaG was washed off the template by addition of 1 M 
NaCl, and Nickle-NTA agarose beads (via His-tag on DnaG). The reaction was filtered through MicroBio Spin 6 
column for buffer exchange, then 10 pmol NudC were added in 20 mM Tris-Hcl pH 8, 50 mM KCl and 10 mM 
MgCl2. In absence of DnaG, primer is sensitive to NudC cleavage.  
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4.4.4 Cofactor modified 5’-primer RNA does not interact with DnaG recognition sequence -
1 position on DNA template 
For bacterial transcription initiation with non-canonical substrates by RNAP Bird et al. found 
that -1 position of promoter can modulate NCIN-capping efficiency (Bird et al., 2016), 
although we could not confirm this (Julius and Yuzenkova, 2017). In the DnaG recognition 
site 5’-CTG, G functions as -1 position. As the non-adenosine moiety of cofactors could 
potentially interact with -1 base, we tested whether variation of this position (see figure 4.8 A) 
would affect cofactor incorporation efficiency. Reciprocally, if cofactors would lead to 
preference of alternative recognition sites, this might affect replication initiation frequency on 
the chromosome. We found that DnaG favoured recognition site does not change upon 
cofactor initiation (figure 4.8 B). In general, DnaG prefers -1 purines, with -1A being most 
efficient alternative to -1G. Therefore we conclude that X-moiety of cofactor does not interact 
with -1 template. 
 
 
Figure 4.8. -1 template base affects initiation efficiency with canonical and non-canonical substrates, but does 
not affect relative efficiency of cofactor incorporation as compared to ATP. A. We variated template -1 position 
from G to C, A, and T on the DNA template. B. If compared to initiation at -1G template, DnaG can synthesise 
primer on -1 variants at varying efficiency. -1A is preferred alternative, while -1C and -1T are equally 
unfavourable. All NCIS are incorporated at relatively similar rate when compared to ATP. Thus, an interaction 
of NCIS and -1 is not likely. ATP: olive green, NADH: blue, FAD: orange, DP-CoA: purple. Standard variation 





4.4.5 DnaG basic ridge residues are involved in binding of non-canonical initiating 
substrate 
To assess potential points of contact between NCIS and DnaG protein we mutated residues of 
“basic ridge” and catalytic site which had previously been documented to be involved in 
initiation (Rymer et al., 2012). Mutants K229A, K241A and Y230A (basic ridge mutants) 
(figure 4.9 A) were overall less efficient in primer synthesis than wildtype DnaG. 
Additionally, their relative efficiency of incorporation of NADH and FAD compared to ATP 
was reduced as compared to wildtype DnaG (figure 9 B). Mutant D309A (metal binding 
mutant) was not impaired in NCIS-primer formation (figure 4.9 B), albeit overall lower 
efficiency was observed. We hypothesise that basic ridge residues are involved in binding of 
substrate NTPs and potentially NMN and FMN moieties of initiating cofactors. 
 
Figure 4.9. DnaG residues of basic ridge are likely involved in NCIS binding. A. Adapted from crystal structure 
(Rymer et al., 2012; Hou, Biswas and Tsodikov, 2018). Wildtype DnaG residues that were mutated (pink) in 
spatial relation to catalytic metal ions (orange) and bound nucleotide (green). All residues were substituted to 
alanine in mutants. B. Relative incorporation efficiency of cofactors compared to ATP. wildtype DnaG (wt) 
incorporates NADH (blue) at about 25% efficiency as compared to ATP, and FAD (orange) only about 10%. 
Mutants K229A and Y230A were strongly inhibited in non-canonical initiation, K241A was also less efficient in 
relative incorporation. In contrast, D309A was able to incorporate both cofactors similarly to wt protein. Bars 
and error bars are mean values ± standard deviation of three independent experiments. C. P-values of the 
comparison of efficiency of incorporation of NADH or FAD by mutants to incorporation efficiency by wildtype 
DnaG (three independent experiments). P-values were generated using Tukey algorithm.  
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4.4.6 Stringent response alarmone ppGpp inhibits NCIS-primer synthesis 
Stringent response is a multifaceted mechanism that allows for selective reduction of 
metabolism and cell growth in response to amino acid starvation (Traxler et al., 2008; 
Winther, Roghanian and Gerdes, 2018). When ribosome-associated protein RelA senses non-
aminoacylated tRNA, it converts GTP to “alarmones” ppGpp or pppGpp. These alarmones 
are known to bind RNAP holoenzyme to downregulate production of ribosomes and many 
other gene products. (P)ppGpp was shown to inhibit E. coli primase in vitro (Maciąg et al., 
2010). Alarmone inhibition of replication in vivo is still subject of debate (Potrykus et al., 
2011; Maciąg-Dorszyńska, Szalewska-Pałasz and Węgrzyn, 2013). (P)ppGpp was shown to 
bind in the DnaG active site (Rymer et al., 2012), thus competition with canonical substrates 
was suggested as mechanism of inhibition. 
We tested whether ppGpp affects NCIS incorporation. PpGpp is always present in the cell at 
low level. Different studies report exponential phase levels of (p)ppGpp between few μM 
(Maciąg et al., 2010) and on average 40 µM (Varik et al., 2017). (P)ppGpp levels then rise to 
several hundred μM during stringent response (Maciąg et al., 2010; Varik et al., 2017) with a 
maximal accumulation up to 900 µM (Traxler et al., 2008).. Average stationary phase 
concentration of ppGpp is approximately 150 µM (Varik et al., 2017). Thus we tested 
whether metabolites compete with ppGpp to allow for primer initiation. We saw that NCIS 
incorporation is inhibited at distinctively lower ppGpp concentration than ATP (figure 4.10). 
We therefore propose that NCIS-primer formation is downregulated earlier during nutrient 
stress. An estimated stationary phase concentration of ppGpp around 150 µM would reduce 
incorporation of FAD by >70% and NADH by >40%. 
4.4.7 5’-cofactors differentially affect primer removal by DNA polymerase I 
Maturation of Okazaki fragments is required for formation of the lagging DNA strand. For 
this, primer needs to be removed and replaced by DNA, before DNA backbone nicks can be 
ligated. Pol I fulfils two functions, it degrades RNA primer by 5’-3’-exonuclease activity, and 
polymerises DNA in 5’-3’ direction to fill the gap between two Okazaki fragments (Xu et al., 
1997). A non-base paired 5’-end of NCIS might impair or promote Pol I exonucleolytic 
function. Here, we document that Pol I can remove NCIS-primer, but at varying efficiency. 






Figure 4.10 Inhibition of NCIN-primer synthesis by ppGpp. A-C. Measurement of primer synthesis at increasing 
concentrations of substrates ATP, NADH or FAD in presence of 100, 600, and 1000 µM ppGpp, or control 
(ppGpp ). D.Increasing concentrations of ppGpp compete with other substrates (all 1000 µM). Primer synthesis 
with the canonical substrate ATP (green), was reduced up to 60%. Inhibition of non-canonical initiation is 
inhibited at lower concentrations of ppGpp. PpGpp competes with both FAD (orange) and NADH (blue). Dots 





Figure 4.11 Primer removal by Pol I is affected by 5’-cofactors. A. Template and scheme of the reaction. We 
designed a hairpin template to present a free 3’-end upstream of the primase recognition site. After primer 
synthesis initiated by ATP, NADH or FAD (red X-A), DnaG was removed with 1M salt and Ni2+-NTA agarose 
beads, and the reaction was filtered through Micro-Bio Spin 6 gel filtration columns, then Pol I was added to the 
hybrid/template. Pol I binds the 3’-end of the hairpin and polymerises dNTPs. As it approaches the primer, the 
primer is displaced and broken up by 5’-nuclease activity. B. Denaturing polyacrylamide gel electrophoresis of a 
time course of Pol I reaction. The full length primer (ATP-12, NADH-12, or FAD-12) faded rapidly after 
addition of Pol I. Bands appear underneath the full primer which are breakdown products of Pol I 5’-3’-
exonuclease activity. C. Graph depicting the degradation of full length primer by Pol I over a time course of two 
minutes, in presence of 2.5 µM dNTPs. NADH-initiated primer is hydrolysed more rapidly than ATP-initiated 
primer. FAD-primer cleavage is strongly delayed. Dots and error bars are mean values ± standard deviation of 







4.4.8 5’-cofactors do not affect primer removal by RNase H 
Primer are short lived products which are degraded rapidly after they have fulfilled their 
purpose. In E. coli this is achieved by one of at least two different pathways, one of which is 
RNase H digestion. RNase H is an endoribonuclease with specificity for DNA-RNA hybrids 
(Nowotny et al., 2005). Our assays show that presence of 5’-NCIS on primer does not 
interfere with RNase H-mediated primer removal, although longer products seem to arise as 
RNase H does not cleave phosphate bond within the cofactor (see figure 4.12). Primer 
degradation by RNase H yields oligoribonucleotides of varying lengths, some of which are 
susceptible to NudC cleavage. We observed that RNase H cleavage made NCIS-primer oligos 
more susceptible to NudC, while FAD-12 and DP-CoA-12 are insensitive to NudC (figure 
4.12 B). It would be interesting to investgate in the future, whether any association between 
RNase H and decapping enzymes can be observed in vivo.  
 
Figure 4.12. Cleavage of primer by RNase H and decapping enzymes or other nucleases. A. ATP-12 and NADH-
12 primer were produced in a standard reaction. DnaG was washed off (lanes 1 and 9) and decapping enzymes or 
RNase H were added as indicated. ATP-12 is insensitive to NudC but RppH produces AMP-12 which runs 
slightly lower than ATP12. In contrast, NADH-12 is insensitive to RppH, but NudC creates AMP-12. B. As in 
A, NCIS-primer were produced by DnaG reaction and DnaG was removed. Addition of NudC alongside RNase 
H produced smaller oligos than RNase H alone. Snake Venom Phosphodiesterase (SVP) was added as control to 
ensure that DnaG was not bund to the hybrid. SVP cleaves all phosphodiester bonds, thus, removal of DnaG 
should result in mononucleotides. 
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4.4.9 The human primase catalytic subunit P49 can initiate primer synthesis with 
guanosine-analogues 
Bacterial and eukaryotic replication function overall by a similar mechanism and have the 
same result, yet primer synthesis is vastly different. Eukaryotic primase is a two-subunit 
enzyme, with catalytic subunit P49 and regulatory subunit P58. Here we tested whether P49 
would be able to initiate primer synthesis using cofactors. The exact recognition site on 
template DNA for P49 is unknown, though 5’-purines are most commonly found on 
eukaryotic primer. We thus designed a ssDNA template (figure 4.13 A) with E. coli DnaG 
recognition site 5’-CTG. However, P49 did not incorporate ATP. Only GpU and m7GTP 
were accepted by P49 as substrates for abortive initiation, albeit P49 did not elongate these 
abortive products (figure 4.13 B). As P58 subunit is involved in initiation and NTP binding, 
we are going to include it in future tests. 
 
Figure 4.13. Incorporation of guanosine-containing small molecules by eukaryotic primase catalytic subunit P49. 
A. ssDNA template was designed similarly to an E. coli primase template. If P49 was to initiate synthesis 
incorporating 5’-A, a 12-mer could be synthesises from added GTP and UTP. P49 could also initiate with 5’-G, 
then up to 11 nt could be polymerised in a template-dependent manner. B. First trials with adenosine-containing 
initiators were unsuccessful, thus we tested incorporation of guanosine-containing molecules. We found that 
GpU (dephosphorylated dinucleotide) was polymerised to α(P32)-UTP (lane 5), and also a methylated GTP was 
accepted as substrate by P49 (lane 4). Synthesis of longer products from these initiators was not observed. C. 
Structural formula of methylated GTP. 
Results presentd in this chapter were submitted to the journal Nucleic Acids Research for 
publication in collaboration with Dr Yulia Yuzenkova. The manuscript is currently in review 
and was therefore not cited here. The manuscript can be viewed in the bibliography at the end 




4.5.1 Bacterial primase DnaG readily initiates primer synthesis using nucleotide-
containing cofactors of metabolism 
Previously, it was documented that dsDNA-dependent RNA Polymerases of prokaryotes, 
eukaryotes, mitochondria, and viruses can initiate template-dependent transcription using 
cellular metabolites which contain a nucleotide moiety (Chen et al., 2009; Kowtoniuk et al., 
2009; Cahová et al., 2015; Bird et al., 2016; Jiao et al., 2017; Julius and Yuzenkova, 2017; 
Walters et al., 2017; Bird, Basu, Kuster, Ramachandran, Grudzien-Nogalska, Kiledjian, et al., 
2018; Julius, Riaz-Bradley and Yuzenkova, 2018; J. Wang et al., 2019). Here we show that 
also ssDNA-dependent RNA polymerase DnaG is able to initiate primer synthesis using 
adenine-containing metabolites.  
Bacterial primase DnaG preferentially initiates primer synthesis on triplet recognition site 5’-
d(C+2T+1G-1) (Kitani et al., 1985; Yoda and Okazaki, 1991). Thus, the 5’-end of primer 
constitutes an ATP, or here, an adenosine-containing metabolite. We observed that DnaG 
produces full length primer from initiation with NADH and FAD. Other NCISs, which were 
readily incorporated by EcRNAP in transcription, such as NAD+ and DP-CoA, proved to be 
poor substrates to DnaG (figure 4.5).  
In bacterial primer synthesis, the first phosphodiester bond formation is the rate limiting step 
of, as the two first nucleotides are not stabilised by an adjoining RNA chain base paired to the 
template (Ilic et al., 2018). Thus, an interaction of the nicotinamide or riboflavin of initiator 
with -1 template base could theoretically stabilise the initiation complex, as proposed for non-
canonical transcription initiation by EcRNAP (Bird et al., 2016; Vvedenskaya et al., 2018). 
Similarly to our findings on NCIN-capping of E. coli in vitro transcripts (Julius and 
Yuzenkova, 2017), NCIS did not seem to interact with -1 template position in primer 
synthesis by DnaG (figure 4.8). Unfavourable interaction with substrate binding sites in the 
active centre may account for the reduced initiation efficiency for NCIS as compared to 
canonical substrate. 
The catalytic centre of DnaG and the polymerisation mechanism are quite unique. While 
RNA transcriptases and DNA polymerases bind two dilavent metal ions, bacterial primases 
bind three metal ions. (Aravind, Leipe and Koonin, 1998; Keck et al., 2000; Kuchta and 
Stengel, 2010; Rymer et al., 2012). The catalytic centre of DnaG shows high similarity to 
topoisomerases (which bind one metal cation for catalysis) (Rymer et al., 2012). We tried to 
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determine how NCIS interact with DnaG conserved residues by mutation studies. We created 
mutants of the basic ridge, which were identified previously to be involved in substrate 
binding (Keck et al., 2000; Rodina and Godson, 2006; Rymer et al., 2012; Hou, Biswas and 
Tsodikov, 2018) or catalysis (Godson et al., 2000; Rodina and Godson, 2006; Rymer et al., 
2012; Hou, Biswas and Tsodikov, 2018). In nucleotide triphosphates, the triphosphate group 
is attached to the 5’C of the ribose. In cofactors, in place of the triphosphate,a disphosphate 
linker connects ribose to an inverted functional moiety, such as nicotinamide mononucleoside 
(NMN) or flavin mononucleoside (FMN). The crystal structure of DnaG soaked with ATP 
(figure 4.9), shows phosphate groups reach across metal B and C while basic ridge residues 
around position 230 protrude towards them (Rymer et al., 2012) (figure 4.1 and 4.9 A). 
Cofactorfunctional moieties are likely to affect the orientation of the substrate in the catalytic 
site (Hou, Biswas and Tsodikov, 2018). We substituted alanine for K229 and Y230 and 
observed that this substitution reduces DnaG ability to initiate with NADH and FAD 
drastically. Further, on the crystal structure it is visible that that K241 in wt interacts with 
upstream template and potentially primer. Sun et al. documented that K241 mutants can 
initiate but not elongate primer (Sun, Schoneich and Godson, 1999). Therefore, we tested the 
effect of substitution of this residue to alanine on NCIS-primer initiation and elongation. 
K241A displayed reduced formation of NCIS-primer, but the effect was not as strong as 
mutations of residues K229 and Y230 (figure 4.9 B). Several acidic residues are involved in 
metal coordination in wt DnaG. D309 interacts with metals A and B as well as phosphate of 
NTP substrates. Mutation of this residue reduced overall activity of the enzyme but had no 
effect on NCIS incorporation. We conclude that basic ridge residues, which have been shown 
to coordinate triphosphate moiety of substrates, also accommodate NMN and FMN. 
Thus far we have not been successful in verifying NCIS-primer synthesis in vivo. However, 
findings about NCIN-capping by transcriptases are encouraging. We believe that the in vitro 
ability of DnaG to incorporate NCIS efficiently in presence of DnaB, and high availability of 
these substrates in vivo (Bennett, Kimball and Gao, 2009), are in favour of our hypothesis.  
4.5.2 NCIS incorporation by DnaG might have downstream effects on replication 
The only function of primer is to provide a free 3’-OH for DNA polymerases to be able to 
start DNA synthesis. Synthesis of one primer requires about 0.2 sec (Kusakabe and 
Richardson, 1997; Frick, Kumar and Richardson, 1999) and per E. coli genome about 2000-
4000 Okazaki fragments are generated with a size of approx. 1-2 kb (Ogawa and Okazaki, 
1984; Swart and Griep, 1995; Lewis, Jergic and Dixon, 2016). Overall replication speed of E. 
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coli is around 1 kb/sec (Bailey, Wing and Steitz, 2006). As Pol III synthesises DNA at around 
750 nt/sec, Okazaki fragment maturation is another rate limiting step of replication (Kusakabe 
and Richardson, 1997; Frick, Kumar and Richardson, 1999). Arguably, replication speed can 
be strongly affected by failure to remove primer RNA. 
Okazaki fragment processing requires primer removal by E. coli Pol I (gene polA) and RNase 
H (gene rnhA) (Lewis, Jergic and Dixon, 2016). Deletion of either gene in E. coli is not lethal. 
RNase H seems to be dispensable for E. coli growth, whereas deletion of polA reduces 
bacterial growth (Konrad and Lehman, 1974). A double mutation (∆rnhA∆polA) is 
conditionally viable, also double mutants of ∆rnhA and thermo-sensitive Pol I have been 
produced in the lab (Konrad and Lehman, 1974; Ogawa and Okazaki, 1984; Kitani et al., 
1985; Kogoma, 1986). Pol I and RNase H cooperate in primer removal, and can also replace 
each other to some extent. In absence of both proteins, related enzymes, such as YpcP in B. 
subtilis, or other RNase H family genes (Fukushima et al., 2007) can replace Pol I at a fitness 
cost.  
Here, we tested whether Pol I activity would be affected by metabolites. Pol I was initially 
described as 5’-3’-exonuclease, yet reports are now conflicting (Xu et al., 1997). Pol I was not 
found to release mononucleotides (Kelly et al., 1969; Xu et al., 1997), which contrasts our 
presented results (figure 4.11). Pol I is also described as a structure-specific endonuclease that 
recognises ss/ds junctions or displaced 5’-“flaps”. Therefore the name was revised to 5’-
nuclease (Xu, Grindley and Joyce, 2000). Pol I is involved both in DNA repair (nick 
translation) and primer removal (Lundquist and Olivera, 1982; Lyamichev, Brow and 
Dahlberg, 1993; Xu et al., 1997). In primer removal, the polymerase domain of Pol I 
displaces the 5’-end of primer which “flaps out” and thus becomes sensitive to structure-
specific endonuclease activity (Lundquist and Olivera, 1982; Xu et al., 1997). In fact, 5’-
nuclease domain of Pol I was shown to have structural similarity to eukaryotic 5’-flap 
endonuclease FEN-1, which removes primer in eukaryotic replication (Harrington and Lieber, 
1994; Robins et al., 1994). We have shown that cofactor non-adenine moiety does not base 
pair with -1 base on DNA (figure 4.8), thus we saw a possibility that cofactor initiation might 
aid “flapping out” of primer, which might support 5’-structure-specific nuclease activity of 
Pol I. Indeed, NADH primer removal by Pol I was more efficient as compared to ATP-primer 
(figure 4.11). However, FAD-primer removal by Pol I was found to be delayed. We have to 
assume that Pol I interacts with 5’-FAD unfavourably. The 5’-nuclease domain of Pol I 
contains an arched structure of two helices. One helix is clad with positively charged residues, 
the other with hydrophobic residues. The nuclease active site is at the bottom of the arch 
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where two metal ions are bound (Ceska et al., 1996; Hosfield et al., 1998; Xu, Grindley and 
Joyce, 2000). Similarly to eukaryotic FEN-1, Pol I 5’-nuclease threads the free 5’-end through 
this arch (Balakrishnan and Bambara, 2016). As riboflavin is slightly hydrophobic, there 
might be an interaction with Pol I 5’-nuclease arch such as to resist contact with FAD-flap, or 
interact too tightly to FAD-flap. Both ways would hinder 3’-5’-progression of the enzyme 
along DNA. Pol I also confers repair of apurininc/apyrimidic sites on damaged DNA 
(deoxyribose-phosphates (dRp) which lost their base) by deplacing the dRp and the next one 
or two deoxuribonucleotides to excise small oligo“nucleotides” with 5’-dRp from the 
damaged strand (Price and Lindahl, 1991; Price, 1992).  
RNase H was shown to remove primer RNA, but is non-essential if Pol I is present (Konrad 
and Lehman, 1974; Fukushima et al., 2007; Lewis, Jergic and Dixon, 2016). Here, we tested 
if presence of 5’-NCIS on primer inhibits RNase H cleavage of primer. We observed that 
primer can be cleaved by RNase H, but resulting oligos might be longer than those of 
canonical primer (figure 4.12). Longer cleavage products were susceptible to NudC treatment, 
showing that RNase H likely does not cleave between NCIS and first canonical 5’-nucleotide. 
Sensitivity to NudC also shows that oligos dissociate from the template. These oligos have to 
be recycled by oligoribonuclease (Bandyra et al., 2013). We intend to test oligoribonuclease 
activity on NCIS-capped oligos in the future. 
Another potential downstream process of replication which has not been covered in this study 
is the primase-to-polymerase switch (or primer hand-over) on capped primer. In bacteria, the 
clamp loader complex loads β clamp dimer onto the RNA-DNA hybrid in a directional 
fashion for Pol III to bind and synthesise the Okazaki fragment (Kelch et al., 2012). In yeast, 
it was proposed that the clamp loader recognises the primer-template junction via altered 
flexibility of the template in hybrid state vs ssDNA state (Bowman, O’Donnell and Kuriyan, 
2004; Kelch et al., 2012). Further, clamp loader might recognise typical RNA-DNA hybrid 
helix symmetry which is close to A-form DNA, while B-form DNA was shown to be 
excluded by clamp loader inner spiral chamber (Fedoroff, Salazar and Reid, 1993; Simonetta 
et al., 2009; Kelch et al., 2011). No study to date gives reason to assume the primer 5’-end 
matters for clamp loader binding. Although clamp loading likely recognises 3’-end of the 
primer, it might be worthwhile to test the effect of 5’-NCIN on clamp loading. 
Bacterial primase DnaG is essential in the initiation of replication and its’ inhibition is 
bactericidal (Ilic et al., 2018). Study of primase inhibitors is thus of interest in development of 
new antibacterials. Interestingly, a list of DnaG inhibitors has been published (Ilic et al., 
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2018) which are classed as NTP-analogues and non-NTP analogues. Here we see, that 
nucleotide-containing molecules with free 3’-OH can be utilised by DnaG to initiate primer 
synthesis efficiently. Greater understanding of DnaG structure and function provided by this 
study help screening for inihibitors, but use of primase inhibitors might also help us to 
understand NCIS-primer synthesis better. We intend to test several known DnaG inhibitors in 
the future. 
4.5.3 Starvation response results in inhibition of NCIS-primer synthesis 
Alarmones ppGpp and pppGpp in bacteria are produced by proteins RelA and SpoT in 
response to amino acid, fatty acid, carbon and iron starvation (Traxler et al., 2008; Winther, 
Roghanian and Gerdes, 2018). While B. subtilis replication was shown to be directly inhibited 
by (p)ppGpp (Maciąg-Dorszyńska, Szalewska-Pałasz and Węgrzyn, 2013), it is unclear 
whether E. coli replication is inhibited (Maciąg et al., 2010; Potrykus et al., 2011). A direct 
interaction between E. coli DnaG and (p)ppGpp was shown in vitro (Maciąg et al., 2010; 
Rymer et al., 2012). Crystallisation studies of DnaG soaked in (p)ppGpp showed that the 
alarmone binding site is almost identical to nucleotide (GTP) binding site (Rymer et al., 
2012). As in (p)ppGpp, the 3’-OH is occupied by phosphate groups, chain extension is not 
possible. Thus competitive binding was proposed as mechanism of inhibition (Rymer et al., 
2012). Here we show, that ppGpp competes with cofactors for DnaG catalytic site, and 
inhibits primer synthesis in a concentration-dependent manner (figure 4.10). Due to the strong 
affinity of DnaG to ATP (KM=46 µM), primer synthesis is reduced by increasing 
concentration of ppGpp. Average stationary phase concentration of ppGpp around 150 µM 
(Varik et al., 2017) reduced ATP-primer synthesis by less than 20%, but NADH-primer 
synthesis by over 40% and FAD-primer by over 70%. Maximal ppGpp of 0.9 mM (Traxler et 
al., 2008) reduced ATP-primer synthesis by less than 60%, but both NADH- and FAD-primer 
over 90%. Thus, stationary growth E. coli do not seem to completly abolish primer synthesis, 
but incorporation of metabolites is inhibited. Higher ppGpp levels of stringent response 
inhibit NCIS-primer formation. This could be viewed as a mechanism to “save” valuable 
metabolites during starvation.  
4.5.4 Eukaryotic primase might initiate primer synthesis with non-canonical substrates 
NCIN-capping is performed by both multi- and single subunit RNAPs (bacterial RNAP, 
eukaryotic RNAP II, and mitochondrial POLMRT). We showed that also bacterial primase, 
which exhibits a different mechanism of RNA polymerisation, can initiate primer synthesis 
with abundant cellular metabolites. We thus wanted to investigate, whether eukaryotic 
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primase can similarly synthesise non-canonically initiated primer. Both enzymes are 
structurally and also mechanistically dissimilar, as described in the introduction. 
Here we describe an initial test of this hypothesis which focussed only on the catalytic subunit 
of the two subunit primase, P49. P49 was previously shown to be active without P58, albeit at 
very low efficiency (Schneider et al., 1998). P49 was purified from recombinant expression in 
E.coli in accordance to the protocol outlined by Schneider et al., who describe stability and 
activity of the purified subunit is highly dependent on availability of divalent cation (Mg2+) at 
every step of the purification. However, we have no positive control to compare the activity of 
our purified P49 to. 
Our results of in vitro primer synthesis showed that P49 accepts m7GTP and GpU as 
substrates to polymerise to α(P32)-UTP on an ssDNA template (figure 4.13). It is interesting 
that P49 accepted only a modified nucleotide and a dinucleotide as substrates, but not the 
canonical purine nucleotides. Theoretically, initiation requires assistance by large subunit P58 
which contains the nucleotide binding site. Binding of the first two NTPs as well as DNA 
template are also required to fold the heterodimer into active conformation (Sauguet et al., 
2010). Apparently, altered binding characteristics of these two non-canonical substrates was 
able to stabilise the P49 active site enough to allow for catalysis. These results are 
encouraging to study cofactor incorporation in presence of P58 in the future. In the following 
text I would like to discuss theoretical considerations about NCIS initiation by P49P58, and 
theoretical implications on eukaryotic replication. 
In archaea, PriX/L does not discriminate identity of initiating nucleobase or pentose and PriX 
affinity to ATP was found to be similar as to dATP. Thus, it was proposed that initiation of 
primer synthesis in archaea is regulated by substrate availability rather than template-
dependent selection of substrate. NTPs are about 100 times more abundant in the cell than 
dTNPs, in favour of an RNA primer (Liew et al., 2016; Yan et al., 2018). In fact, the 
nucleotide-binding residues of the large primase subunit were to date described to interact 
only with 5’-triphosphate groups and not ribose or base (Sauguet et al., 2010; Baranovskiy et 
al., 2015). Without experimental evidence, we cannot assume that these conserved residues 
would bind NCIS, or constitute a regulatory mechanism against NCIS incorporation. The here 
observed ability of P49 to initiate primer at low efficiency with NCIS might indicate a 
previously unrecognised role of P49 in substrate binding. Interestingly, we have shown that 
P49 is inhibited by canonical substrates such as ATP and GTP, in contrast to results of 
(Schneider et al., 1998). Possibly, the enzyme might bind canonical initiators, but lacks ability 
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to initiate polymerisation without P58. Studies on herpes primase showed that incorporation 
of dNTPs and NTP-ribose significantly shortened the final length of primer (Keller, 
Cavanaugh and Kuchta, 2008). Nucleotide analogues, such as 9-β-arabinofuranosyladenosine 
5’-triphosphate (ara-ATP) were proposed to be potential eukaryotic primase inhibitors 
(Kuchta and Willhelm, 1991; Boudet et al., 2015). 
Eukaryotic and archaeal primase both contain FeS-cluster in the large subunit. Eukaryotic, but 
not archael, primase contains some sequence similarity to base-excision repair DNA 
Polymerase β. FeS-cluster are present in most eukaryotic replicative polymerases and are 
sensitive to nucleic acid electrochemical potential. The FeS cluster can be oxidised and 
reduced when bound to DNA and (d)NTPs (Beinert, Holm and Münck, 1997; Klinge et al., 
2007; Weiner et al., 2007; Rouault, 2015; O’Brien et al., 2017). P58 C-terminal domain 
(P58C) switches from resting redox state [4Fe4S]+2 (loosely bound to DNA) to oxidised 
[4Fe4S]+3, leading to 500-fold stronger affinity to DNA. This redox switching is considered a 
regulatory event for primer synthesis (Gorodetsky, Boal and Barton, 2006; O’Brien et al., 
2017; Tse, Zwang and Barton, 2017; O’Brien, Salay, et al., 2018). It is possible, that presence 
of redox cofactors such as NAD(H) or FAD could affect this redox regulation. On the other 
hand, redox switching of primase P58C may regulate a distinction between NCIS of different 
redox states (e.g. NADH vs NAD+).  
Further, Sheaff and Kuchta hypothesised that binding of penultimate NTP takes place before 
binding of 5’-NTP (Sheaff and Kuchta, 1993). This might explain why initiation with 
dinucleotide GpU was more successful than other G-analogues. Sauguet et al. compared the 
DNA and NTP binding site of yeast P58 to photolyase/cryptochrome flavoproteins, due to 
structural homology. The DNA photolyase cryptochrome DASH (a DNA repair enzyme) 
binds FAD as cofactor and photon recipient in repair of UV-mediated crosslinking mutations 
(Sauguet et al., 2010). Both DNA and FAD binding sites of crypotochrome DASH and P58C 
have high similarity. Importantly, Sauguet et al. hypothesised the FAD binding site in DASH 
corresponds to dinucleotide binding site in P58 (Sauguet et al., 2010). The involved 
FAD/NTP binding residues are conserved. It is thus conceivable that P58 may allow for 
binding of dinucleotide cofactors such as FAD or NADH during primer synthesis. We intend 
to test this hypothesis in the future.  
Primer removal of prokaryotes and eukaryotes is not so different. Both involve a 5’-flap 
endonuclease, Pol I in bacteria, or FEN-1 in eukaryotes (Balakrishnan and Bambara, 2013). 
The arch structure in both enzymes is homologous(Robins et al., 1994), therefore the 
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inhibitory effect of 5’-FAD on Pol I-mediated primer removal might turn out to be analogous 
in FEN-1.  
 
4.6 Conclusion and outlook 
In the presented study we report that bacterial primase DnaG efficiently initiates primer 
synthesis with adenosine-containing metabolites on recognition site 5’-d(CTG) in vitro. DnaG 
incorporates NADH and FAD efficiently, while DP-CoA and NAD+ were poor substrates. No 
sequential determinants of ssDNA template could be identified, but we showed that basic 
ridge residues of DnaG may be involved in NCIS incorporation. 
We found that breakdown of primer by Pol I might be differentially affected. Interestingly, 
NADH-primer breakdown is more efficient than ATP-primer, while presence of 5’-FAD 
delays Pol I 5’-nuclease activity. 
Initial experiments on human primase catalytic subunit P49 show that eukaryotes might be 
able to form NCIS-primer. Here, it is crucial to perform more experiments including the 
second primase subunit P58. 
However and most paramount, verification of cofactor-primer in vivo still stands out. We are 
currently working on different approaches to investigate primer 5’-ends enzymatically, 
chemically and via liquid chromatography coupled with mass spectrometry (LC/MS). Various 
LC/MS methods are known for quantification of NCIN-caps on cellular RNA. Our prevalent 
difficulty is the enrichment of primer, which is a very short lived structure. We are attempting 
to enrich primer by growing double mutants of rnhA and polA.
121 
 
5. Chapter III: Screen for Bacteriophage Regulators of Mycobacterium 
smegmatis Transcription 
5.1 Introduction  
Owing to the fast spread of antibiotic resistance and the increasing complexity of antibiotic 
treatment of mycobacterial infection (including TB), new treatment options need to be 
explored. Phage therapy is the administration of live phages to the infected patient in order to 
kill the bacterial pathogen. It has been known as alternative to antibiotics for almost a century 
and was used to treat many infections from cholera (D’Herelle, 1929) to chronic antibiotic-
resistant otitis (Wright et al., 2009). Application was also found in food preservation, 
agriculture and leather/pelt-production (Coffey et al., 2011; Clark, 2015). Enzybiotics are a 
new group of protein enzymes of phage origin, which can lyse bacterial cells and have 
prospect of medical antibacterial application, as a bactericidal mechanism or to enhance 
susceptibility to other drugs (Nelson, Loomis and Fischetti, 2001; Dams and Briers, 2019). In 
response to intrinsic difficulties of anti-TB treatment, mycobacteriophages should be studied 
for their antimicrobial potential, both in phage therapy, and the newer field of enzybiotics. We 
think that also other bactericidal or bacteriostatic phage products, such as inhibitors of 
bacterial gene expression, could be used as therapeutic phage products. Further, investigating 
phage-host interactions provides us with a new pool of previously undiscovered inhibition 
mechanisms which are of interest in basic research of cellular processes. All information 
found in this introduction is also reviewed in (Puiu and Julius, 2019). 
5.1.1 Mycobacteriophages are diverse and resourceful 
Genomic studies have revealed that mycobacteriophages are among the most diverse class of 
bacteriophages so far characterised. Bacteriophages have evolved alongside their bacterial 
hosts, which consequently developed numerous defence mechanisms (Jacobs-Sera et al., 
2012). By developing spontaneous mutations, site-specific recombination and molecular 
mimicry (a form of autoimmune attack) phages can counteract bacterial defense (Cusick, 
Libbey and Fujinami, 2012). These processes have greatly influenced the genetic diversity of 
bacteriophages. Mycobacteriophage genomes present highly mosaic structures due to 
horizontal gene transfer and a wide evolutionary background (Hatfull, 2018). Approximately 
1795 mycobacteriophage genomes have been sequenced to date, and arranged into clusters 
according to shared nucleotide sequence similarities: A total of 29 clusters, which share little 
or no sequence similarity, and five singletons (phages with no close relatives). Some of the 
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clusters are so diverse that they have been grouped into subclusters. The genomes in a cluster 
share at least 50% sequence similarity and features such as regulatory systems or tRNA 
sequences (Hatfull, 2014b, 2018). The potential to find new regulatory mechanisms in the 
mycobacterium-phage interaction is high. 
Mycobacteriophages, as all bacteriophages, undergo two major types of life cycle: lytic and 
lysogenic (Young, Wang and Roof, 2000; Hatfull, 2014b) (see figure 5.1). Infection starts 
with adsorption of the phage to host cell receptor and injection of phage DNA into the 
cytoplasm. Lytic phages proceed to transcribe viral genes and replicate their genome. 
Subsequently, structural gene products (Gps) are organised into capsid (or ‘head’) and tail by 
assembly proteins. This is followed by association of viral daughter genomes and capsids, 
which leads to formation of virions. At the end of the lytic cycle, a phage-encoded holin 
forms pores in the bacterial cytoplasmic membrane, allowing phage endolysins to cleave the 
host cell wall, followed by the release of newly formed viral particles (Young, Wang and 
Roof, 2000). Temperate phages may opt for a lysogenic lifecycle, in which phage DNA 
integrates into the host chromosome where it remains as dormant prophage. In this case, 
phage integrase must insert the phage genome into the chromosome via homologous 
recombination (Jones and White, 1968). “Attachment” sites are present on the phage (attP) 
and bacterial genome (attB), usually located in tRNA genes (Hatfull, 2014a). After integration 
they form attL and attR sites, flanking the prophage (Peña et al., 1997; Lewis and Hatfull, 
2001). The majority of transcription of phage genes must be supressed by a phage repressor 
protein and phage DNA is replicated along the host chromosome. A lytic cycle can be 
triggered by different stress conditions causing DNA damage. In some cases, phages may 
undergo a pseudotemperate lifestyle in which phage DNA does not integrate into the host 
chromosome, but replicates in the form of a plasmid in the host cytoplasm (Pope et al., 2011).  
To date, no mycobacteriophages were found to encode an own RNAP (Hatfull, 2018). Thus, 
mycobacteriophage transcription must exploit host RNAP. In many mycobacteriophages 
promoters corresponding to mycobacterial main sigma factor σA can be identified (Nesbit et 
al., 1995; Hatfull, 2014a; Oldfield and Hatfull, 2014). However, other mycobacteriophage 
promoters are structured to be recognised by alternative host σ, or phage-encoded σ (Hatfull, 
2014a). These phages regulate their transcription using their own gene products. Genome 
length is variable (40-160 kb) and usually divided into regions of structural (typically 20-25 
kb, containing 20-40 genes) and non-structural genes (larger part of the genome). The non-
structural genes encompass many open reading frames that are not yet identified. In fact, 
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many novel genes have been found in mycobacteriophage genomes that are unrelated to any 
GeneBank entries (Hatfull, 2014a).  
5.1.2 Tuberculosis treatment requires research and innovation 
Tuberculosis (TB) is an infectious disease of the lung or more rarely, of extrapulmonary 
tissues. In humans it is caused by Mycobacterium tuberculosis (Mtb) (Smith, 2003). Active 
tuberculosis lesions are caused by the immune response and bacterial growth. Depending on 
the tissue, these lesions can lead to further complications, such as hypoxia, if the lung is 
affected (Smith, 2003). The active stage of the disease is typically preceded by a latent phase 
of varying time span. Mtb can remain dormant in the host for weeks, months, years or even 
decades. After phagocytosis into macrophages or tissue cells, the bacteria are able to resist the 
phagolysosome, and the immune system proceeds to contain the infection by forming 
granuloma around infection foci. The granuloma are densely layered rigid structures meant to 
shield the body from the pathogen. Mtb can sense if the immune system is in a weakened state 
and liquefy the granuloma via an unknown mechanism (Silva Miranda et al., 2012). The 
disease then progresses into the active stage. New cases of active pulmonary TB were 
documented in about 10 million people in 2017. 1.7 million died in 2016 (World Health 
Organization, 2018). Most of these cases are located within 30 high prevalence countries in 
the undeveloped world, due to lower standards of hygiene, poor economy and poor health 
care. Much lower prevalence in developed countries shows that high standard of living, 
including good nutrition and access to medical care, are the most important factors in the 
prevention of disease. However, outbreaks of TB, including drug resistant (DR) TB, are 
documented increasingly more often on the Northern hemisphere (Dye and Espinal, 2001; 
Udwadia and Vendoti, 2013; World Health Organization, 2018). People with autoimmune 
diseases, such as AIDS patients, are at higher risk of infection and development of acute 
disease, and fatality is higher in these subpopulations (Schutz et al., 2010).  
The treatment of TB as well as other diseases caused by mycobacteria (e.g. M. ulcerans 
ulcers, M. leprae lepsrosy) is particularly challenging due to the unique physiology and 
lifestyle of mycobacteria. Dormancy, intracellular infection and a thick cell wall with high 
lipid concentration render mycobacteria resistant to many treatments (Smith, 2003; Hoffmann 
et al., 2008). Mycobacteria are also able to form biofilms, although it has not been determined 






Figure 5.1 Phage lifestyles. Most phages are either lytic or lysogenic (temperate). This means that after infection, they either initiate phage gene expression and replication, 
followed by virion assembly, and finally lysis (lytic cycle). Or they integrate into the host genome, where they are maintained by host replication machinery until 
environmental signals lead to initiation of the lytic cycle (lysogeny). 
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Current treatment of drug susceptible (DS) TB constitutes a 6-month course of four drugs 
(rifampicin, isoniazid, ethambutol and pyrazinamide). The patient suffers side effects and 
damage to the natural microbiota (Smith, Wolff and Nguyen, 2013; Hofman et al., 2016; 
World Health Organization, 2018). Although using a combination of drugs and long treatment 
duration reduces the chances of resistance development, DR-TB is on the rise (Zumla et al., 
1999; Tiberi et al., 2018). TB is considered drug-resistant if sensitivity to at least one drug of 
the regimen is lost. Most commonly, rifampicin resistance develops due to chromosomal 
mutations in rif-binding pocket of RNAP (Koch, Mizrahi and Warner, 2014). If the strain is 
resistant to at least two drugs of the first line treatment, it is considered multidrug resistant 
(MDR). Roughly 4.5 % of new cases of active TB reported in 2015 were MDR (Pai et al., 
2016). Most commonly resistance to rif and isoniazid are reported (Hofman et al., 2016). In 
such cases, second-line and third-line treatments are applied which can include further drugs 
which are currently in clinical trials (e.g. bedaquiline, delanamid). MDR treatment has higher 
toxicity, cost and longer duration. Resistance to third-line or all drug treatments have been 
reported. These strains are referred to as extensively drug resistant (XDR) and pan resistant, 
respectively (Stoffels et al., 2013; Udwadia and Vendoti, 2013; Hofman et al., 2016).  
Survival of active DS-TB is estimated to 86% with first line-treatment. MDR-TB treatment is 
successful in 50% of cases (Blumberg et al., 2003; Winston and Mitruka, 2012). The WHO is 
motivated to support research on alternative anti-TB strategies (World Health Organization, 
2018). 
Currently, treatment alternatives are mainly used in cases where standardised treatment is not 
available (poor and rural areas), and often includes traditionally used medicinal herbs. Some 
of these herbal treatments have been documented as effective (Semenya and Maroyi, 2013; 
Nguta et al., 2015; Sharifi-Rad et al., 2017), and could be investigated in search of plant-
derived drugs. Immunotherapy can be used to support antibiotic treatment. Administration of 
cytokines and other antigens (such as hepatitis virus antigens) or interferons was shown to 
modulate the immune response to reduce tissue damage and promote pathogen clearance 
(Batdelger et al., 2008; Dawson et al., 2009; Arjanova et al., 2011; Butov et al., 2013; 
Hofman et al., 2016). TB vaccination is currently administered by regulation in the largest 
part of the world (Asia, Eurasia, Africa, South America) (Zwerling et al., 2011), but in North 
America and Western Europe it is mainly administered to health care workers and people with 
increased risk, e.g. certain indigenous Canadians or people in MDR endemic regions (Vaudry, 
2003). This vaccine contains an attenuated strain of M. bovis called Bacille Calmette-Guerin 
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(BCG). Unfortunately, it shows varying degrees of effectiveness, between 0-83%, in 
treatment of the disease, depending on age and genetic background of the patient, geographic 
location and climate, Mtb strain variations and other uncontrollable factors (Vaudry, 2003). A 
variety of vaccine boosters and new preventive vaccines are under study (Hofman et al., 
2016). 
5.1.3 Mycobacteriophage therapy could aid TB treatment 
All potential new drugs must overcome the challenges of tuberculosis infection: Anti-TB 
drugs must be able to cross the mycobacterial membrane, the mammalian cell membrane, 
penetrate several types of tissue, most importantly granuloma, and should not interfere with 
HIV therapy. Furthermore, short treatment duration and low toxicity are just as desirable as 
low adverse effect on the microflora and good bioavailability. Additionally, potential to be 
distributed to remote and poor areas would be beneficial. Phage therapy has advantages and 
disadvantages. Bacteriophages have low production cost and virtually no effect on bacteria 
which are not their natural host. No direct adverse interaction of phages with drugs have been 
documented. Phages can invade their host naturally by interacting with specific receptors on 
the cell envelope (Bertozzi Silva, Storms and Sauvageau, 2016), and dosage adjusts naturally 
with availability of live host cells, as phages multiply inside the host cell (Bessman et al., 
2001; Capparelli et al., 2007; Chhibber, Kaur and Kumari, 2008). However, phages do not 
cross mammalian cell membranes, let alone multiple tissue layers (Mankiewicz and Béland, 
1972; Bessman et al., 2001). They can be removed by the animal immune system and can 
create immune memory (Nieth et al., 2015; Singla et al., 2016; Krut and Bekeredjian-Ding, 
2018) which could make long-term or repeated treatment obsolete. They are usually stored in 
liquid suspension and may require refridgeration, which could be an obstacle for distribution 
in poor countries with hot climate. The problem of clearance of phage by the immune system 
may be overcome by using liposomes, as shown for Klebsiella pneumoniae intracellular 
infection (Singla et al., 2016). Further, some scientists argue that while phage will be attacked 
by the immune system, their ability to multiply within the bacterial host will maintain phage 
titre while aiding bacterial clearance by modulating the immune response. This is called 
“immunophage synergy” (Leung and Weitz, 2017; Roach et al., 2017). Likewise, phage-
antibiotic synergy (PAS) has been documented. Here, phage can potentiate drug delivery by 
making the bacterial cell wall and even biofilm more permeable. Pre-existing drug resistance 
can even be reversed by PAS (Ryan et al., 2012; Jo, Ding and Ahn, 2016; Kim et al., 2018; 
Tkhilaishvili et al., 2018). 
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Mycobacteriophages in particular have been applied successfully for TB treatment in vitro 
and in animal models. Bacterial titre was reduced in the animal model of Mtb lung, liver and 
spleen infection (Sula, Sulová and Stolcpartová, 1981) and M. ulcerans ulcer on feet (Trigo et 
al., 2013). Even granuloma formation was reduced (Sula, Sulová and Stolcpartová, 1981). 
Still, transport across the animal cell membrane is an obstacle. Broxmeyer et al. developed a 
delivery system of phage to Mtb across the macrophage membrane using M. smegmatis as a 
vehicle. Mycobacteriophage TM4 can infect both Mtb and M. smegmatis. TM4-infected M. 
smegmatis were phagocytosed by macrophages which already carried Mtb infection. This 
resulted in infection of Mtb by TM4 and reduction of titre of both bacteria within the 
macrophage (Broxmeyer et al., 2002). 
5.1.4 Enzybiotics are protein antibacterials of phage origin 
Phage therapy encounters many challenges which research needs to overcome. Additionally, 
acceptance of phage therapy in Western medicine is historically low. Although phage therapy 
has been in use since before first antibiotics were discovered (Sulakvelidze, Alavidze and 
Morris, 2001), its effectivity is not widely accepted. Further limitations (high pathogen-
specificity, limited tissue permeation, standard hygienic requirements of drug manufacturing) 
did not make phage therapy a promising research topic to many scientists and funders. 
However, phage Gps have high potential to provide us with new bactericidal and 
bacteriostatic mechanisms, which could potentially be implemented in new TB treatment 
regimen.  
Enzybiotics is a new field that is being researched since the early 2000s and focusses on lytic 
enzymes encoded by bacteriophages (Nelson, Loomis and Fischetti, 2001). At the end of the 
lytic lifecycle of infection, the host cell wall is lysed via a two-step process: Phage endolysin 
is expressed at low level and accumulates during phage growth. Phage holin is expressed only 
in late infection, and creates inner membrane channels through which endolysin escapes into 
the periplasmic space. It then lyses peptidoglycan, which allows for virus progeny to rupture 
the cell (Schmelcher, Donovan and Loessner, 2012). Phage endolysins, although the name 
correctly suggests they lyse cells from the inside, were successfully applied exogenously to 
lyse cells from the outside (Nelson, Loomis and Fischetti, 2001; Schmelcher, Donovan and 
Loessner, 2012). Phage endolysins were shown to be highly specific to their bacterial host 
(Nelson, Loomis and Fischetti, 2001; Bustamante et al., 2010). Pre-existing antibiotic 
resistance likely does not affect phage-derived drugs. What is more, PAS could potentially be 
exploited using enzybiotics, as they can make biofilm and the bacterial cell envelope more 
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permeable to drugs and thus potentiate antibiotic treatment (Hermoso, García and García, 
2007; Manoharadas, Witte and Bläsi, 2009; Domingo-Calap and Delgado-Martínez, 2018; 
São-José, 2018). Enzybiotics can be engineered to facilitate delivery of the drug to the 
(intracellular) bacterial pathogen. In an effort to overcome the animal cell barrier, Wang et al. 
engineered a fusion protein of phage endolysin to a murine transcription activator. This 
transcription factor can cross the murine cell membrane, fused to endolysin, to treat 
intracellular S. aureus infection (Wang et al., 2018). Also recombinant expression of phage 
endolysin was shown to be effective in prevention of S. aureus infection in transgenic cattle 
and mice (Cheng et al., 2005; Wall et al., 2005). 
All to date investigated mycobacteriophages encode at least the two lysins, peptidoglycan 
endolysin LysA, and lipolysin LysB (Gil et al., 2008; Mahapatra et al., 2013; Lai et al., 
2015). Mycobacteriophages Ms6 and BTCU-1 were shown to produce lytic enzymes which 
can lyse M. smegmatis bacterial culture as well as intracellularly (Gil et al., 2008; Catalão et 
al., 2011; Mahapatra et al., 2013; Lai et al., 2015; Catalão and Pimentel, 2018). A large 
screen of 200 synthetic proteins generated from a mycobacteriophage database helped to 
identify several anti-mycobacterial peptides. Among these was PK34, a protein that binds Mtb 
glycolipid, and was successfully applied to clear TB in the mouse model (Wei et al., 2013; 
Teng, Liu and Wei, 2015). It is worthwhile to look for further antibacterials from 
mycobacteriophages. 
We propose that, besides endolysins, other mycobacteriophage proteins might be useful in 
phage anti-TB treatment, and could fall under the umbrella of enzybiotics. 
Mycobacteriophages are diverse and relatively well characterised. Several studies 
investigating mycobacteriophage L5 have yielded a variety of potentially cytotoxic proteins, 
some of which were shown to downregulate M. smegmatis gene expression (Donnelly-Wu, 
Jacobs and Hatfull, 1993; Hatfult and Sarkis, 1993; Rybniker et al., 2008). Few antibacterial 
mycobacteriophage effectors of bacterial transcription have to date been investigated. One is 
TM4 encoded transcriptional regulator of mycobacterial cell division, TM4-WhiB (Rybniker 
et al., 2008). We aim to identify further inhibitors of mycobacterial gene expression with the 






5.1.5 Host transcription regulation is a common phage strategy 
Inhibition of host gene expression during viral infection is called host shut-off (McAllister 
and Barrett, 1977; Roucourt and Lavigne, 2009). If a phage does not encode its own RNAP, it 
might not completely shut off cellular transcription, but rather manipulate it. Many phages are 
able to downregulate host transcription to the benefit of their own gene expression, to 
monopolise resources (NTPs, enzymes, tRNAs, etc) and prepare host lysis (e.g. abolish repair 
mechanisms). Additionally, they employ mechanisms to redirect host RNAP to prioritise viral 
promoters.  
Thus far, no mycobacteriophage has been described which encodes an own RNAP (Hatfull, 
2014a). For this reason, it can be assumed that mycobacteriophages manipulate host RNAP to 
express phage genes. RNAP gene sequences are vastly conserved throughout the prokaryotes 
and altogether about 25% of sequences show evolutionary variability. Variable regions are 
mostly expendable and their deletion does not affect basic enzymatic activity. However, they 
provide targets for species-specific regulators as well as exogenous interaction partners, like 
phage encoded regulators (Nechaev et al., 2002; Nechaev and Severinov, 2003). As 
mycobacteria have been proposed to have gone through many host transitions in the past 
(Hatfull, 2008), RNAP conserved regions also make a good target requiring no adaption in a 
new host. Therefore, we think that transcriptional regulators can be found via exploring phage 
proteins that interact with mycobacterial RNAP. 
The process of transcription in bacteria was described in the general introduction. In short, it 
can be segregated into 6 main steps, all of which could be potential targets of interference by 
phage Gps. i) Holoenzyme formation and promoter recognition, ii) Promoter melting and 
isomerization from closed to open promoter complex, iii) Transcription initiation, iv) 
Promoter escape, v) Elongation, and finally vi) Transcription termination (Ma, Yang and 
Lewis, 2016). The RNAP core is made up of the protein subunits α, β, β’, and ω, completed 
by the σ factor to give the holoenzyme. The promoter DNA is an essential determinant of 
transcription as binding of σ is sequence and structure specific (Kalate, Kulkarni and 
Nagaraja, 2002). In mycobacteria, transcription factor RbpA was determined to be necessary 
for transcription initiation on many promoters (Tabib-Salazar et al., 2013; Perumal et al., 
2018). Mycobacterial promoters differ from E. coli promoters in many ways. While a 
conserved -10 element of the sequence TATAaT (small a is found in less than 50% of 
mycobacterial promoters) was identified in M. smegmatis, -35 region consensus remains 
undetermined (Newton-Foot and Gey Van Pittius, 2013). This is likely due to high G/C 
130 
 
content of mycobacteria, as well as the wide variety of σ factors (M. smegmatis has 26 σ) 
(Mulder et al., 1997; Newton-Foot and Gey Van Pittius, 2013). Instead, additional sequence 
motifs constitute binding sites for alternative σ and other, environmentally regulated, 
transcription factors (Newton-Foot and Gey Van Pittius, 2013). Strongest M. smegmatis 
promoters have an extended -10 element (TGn). RbpA binds σA and σB promoters and 
substitutes for missing -35 and extended -10 TGn motifs (Perumal et al., 2018). 
Mycobacterial RNAP can perform intrinsic termination in absence of RNA termination loops, 
meaning only via 7-9 nt U-tracts, in presence of elongation and termination factor NusG 
(Czyz et al., 2014). Also, Rho-dependent termination is described in mycobacteria 
(D’Heygère et al., 2015; Botella et al., 2017). 
Not much is known about mycobacteriophage transcription. Lysogenic mycobateriophage L5 
gene expression is susceptible to rifampicin treatment, which is anargument in favour of L5 
utilising bacterial RNAP. L5 gene expression results in shut-off of host gene expression 
(Hatfult and Sarkis, 1993; Hatfull, 2014a). However, for mycobacteriophage TM4 no host 
shut-off was observed (Ford, Stenstrom, et al., 1998). TM4 is pseudotemperate (Ford, 
Stenstrom, et al., 1998), meaning its genome is maintained in the host cell in plasmid form. If 
TM4 uses host RNAP without inhibition of host gene expression, the cell can remain healthy 
and provide factors until lysis is initiated. TM4, like many phages, regulates its own gene 
expression in chronological phases. Early phase genes are expressed upon activation of lytic 
cycle or 20-60 minutes post infection (p.i.), late phase after 60 minutes p.i. (Ford, Stenstrom, 
et al., 1998). Figure 5.2 shows transcription of a hypothetical mycobacteriophage that, like 
TM4, regulates its own gene expression in early and late phases. Late genes often code for 
structural and assembly proteins. Mycobacteriophage SWU1 ensures its own gene expression 
via an alternative route, by enhancing overall cellular gene expression. SWU1 regulates host 
transcription in a differential fashion. While some genes are downregulated (e.g. 
siderophores), genes of transcription (RNAP subunits), translation, RNA degradation and 
protein transport and secretion are upregulated (X. Fan et al., 2016). Yet another phage trick 
to ensure its own transcription is the use of particularly strong promoters, as shown for BP 
(Oldfield and Hatfull, 2014). Transcription termination is targeted by mycobacteriophage Ms6 
encoded anti-termination factor (Garcia, Pimentel and Moniz-Pereira, 2002). Anti-termination 
is employed by many phages to facilitate transcription of long polycistronic operons 
(Gottesman and Weisberg, 1995; Santangelo and Artsimovitch, 2011). The hypothetical 
mycobacteriohage of figure 5.2 uses anti-termination to transcribe long polycistronic RNAs. 
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Table 5.1 lists different mechanisms of transcription regulation by various phages as well as 
drugs. Phage regulators are proteinaceous while antibiotics are usually smaller organic 
compounds (with exception of Microcin J25, which is a peptide). It becomes apparent that 
phage regulators usually do not target the same epitope, or employ the same inhibition 
mechanism as drugs. 
 
Figure 5.2 from (Puiu and Julius, 2019). Gene expression by a hypothetical lytic mycobacteriophage. The 
mycobacteriophage genome is transcribed by mycobacterial RNAP (tbRNAP). Transcription of this phage is 
regulated into early (A) and late (B) stage of infection, yielding long polycistronic transcripts. Early genes often 
encode non-structural proteins such as regulators of phage and host gene expression, e.g. phage antiterminator. 
Antiterminator is a common regulatory mechanism employed by phages to ensure transcription of promoter-




Table 5.1 Inhibitors of bacterial transcription of phage origin (phage effector) vs antibiotics or chemicals that are used in clinic or research. For each stage of transcription, 
phage Gps and drugs are listed with name, function and reference. 
Target 
Phage effector Other inhibitory substances 




Initiation     
σ binding 
AsiA (T4, E. coli) 
Anti-σ / σ appropriation (Orsini et al., 1993; Pal 
et al., 2003; Lambert et al., 2004) 
Compound C5 
(developmental drug) 
Blocks β' σ binding site (Ma, Yang 
and Lewis, 2016)  
G1ORF67/ Gp67 (G1, S. 
aureus) 
Anti-σ (Dehbi et al., 2009)   
Gp39 (P23-45, T. 
thermophilus) 
σ-appropriation (Tagami et al., 2014; Ooi et al., 
2018) 
    
Promoter 
binding 
AsiA + MotA (T4, E. 
coli) 
Redirection of RNAP to phage promoter (Guild 
et al., 1988; Ouhammouch et al., 1995; Hinton et 
al., 1996) 
  
G1ORF67/ Gp67 (G1, S. 
aureus) 
Redirection of RNAP from UP-element host 
promoters to phage promoters (Dehbi et al., 





Gp2 (T7, E. coli) 
Destabilises RPo (Nechaev and Severinov, 1999; 
Klimuk et al., 2013) 
Fidamoxcin (antibiotic) 
Destabilises RPo via σ and RbpA 
(Fruth et al., 2014) 
Gp76 (P23-45, T. 
thermophilus) 
Redirection of RNAP from host -35/-10 to phage 
extended -10 promoters (Berdygulova et al., 
2011; Ooi et al., 2018) 
Myxopironin (antibiotic 
candidate) 






  Rifampicin (antibiotic) 
Blockage of RNA polymerisation >3 
nt (McClure and Cech, 1978; 




Interferes with phosphodiesterbond 




Binds active centre, prevents NTP 
binding (Zhang et al., 2014) 








Allosteric alteration of active site 
(Degen et al., 2014) 
  Streptolygidin 
Stabilises inactive intermediate of 
TEC (Temiakov et al., 2005) 
Pausing P7 (Xp10, X. oryzae) 
Stabilisation of TEC to inhibit pausing (Zenkin, 
Severinov and Yuzenkova, 2015) 
Microcin J25 (peptide 
antibiotic) 
Blocks secondary channel (Adelman 
et al., 2004) 
Termination     
Termination 
  
N-protein (λ, E. coli) 
Binding of elongation factors creates termination 
resistant TEC (Roberts, 1969; Yang et al., 2014) 
  
p7 (Xp10, X. oryzae) 
Binding of β' stabilises TEC (Yuzenkova et al., 
2003) 
    
Gp39 (P23-45, T- 
thermophiles) 
Stabilisation of TEC to transcribe through poly 
(U) termination signal (Berdygulova et al., 2012) 




We intend to identify new phage effectors of an essential cellular process, transcription. We 
attempt to screen for all potential phage Gps which regulate transcription via direct interaction 
with RNAP. Using a mutant strain with His-tagged chromosomal RpoC (β’-subunit) 
(provided by Prof Dipankar Chatterji, Indian Institute of Science, India) we aim to sequester 
phage proteins at different time points during infection. The mix of associated phage proteins 
can be identified by mass spectrometry, expressed recombinantly, and then investigated 
individually. 
5.3 Results and Discussion 
5.3.1 Workflow 
This method was developed using three different mycobacteriophages, D29, TM4 and 
Adephagia ∆41∆43 (lytic mutant of temperate phage Adephagia). Because we ended up 
finding a promising inhibitor of mycobacterial transcription from D29, figures presented here 
depict results from D29.  
 
Figure 5.3. Schematic of infection workflow. Five liquid cultures of M. smegmatis SM07 or wildtype (wt)  
mc1255 are simultaneously infected with mycobacteriophage. Infected cells are harvested at two different 
timepoints post infection (t1 and t2). Cells are lysed and the lysate is subjected to affinity chromatography that is 
specific to the RNAP of strain SM07 (His-RpoC). All proteins that are purified due to their interaction with His-
tagged –M. smegmatis RNAP are identified by mass spectrometry. Only those phage proteins which are 
contained in SM07-infected samples, and not wiltype control or not-infected control, are cloned and 
recombinantly expressed for further analysis. 
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In order to screen for phage Gps that interact with RNAP, we prepared several samples and 
controls, as outlined in figure 5.3. M. smegmatis SM07 (His-tagged RpoC) or as method 
control wildtype M. smegmatis mc1255 liquid cultures are infected with mycobacteriophages 
at two different time point post infection, t1 and t2. As negative control, no infection occurs. 
RNAP from cell lysates is purified, and proteins that can be pulled down via RpoC are 
identified via mass spectrometry. Then, identified phage proteins were cloned, recombinantly, 
expressed, and investigated. 
This protocol and additional procedures for optimisation are described in the following text. 
5.3.2 Optimisation of M. smegmatis growth conditions 
We intended to observe M. smegmatis growth in order to develop a protocol that can be 
applied in a standardised way. This method was outlined in reference to (Hatfull and Jacobs, 
2014; Parish and Roberts, 2015) and private conversation with Deborah Jacobs-Sera from the 
Hatfull Lab, Pittsburgh University, USA. 
First of all, uniform infection requires knowing the infectious dose, or multiplicity of 
infection (MOI). This number describes the ratio of phage to bacterium that is mixed. In 
mycobacteriophage protocols, traditionally, an MOI of 10-100 is used (10-100 phages per 
bacterial cell) (Hatfull, 2014a). In order to guarantee a known MOI we first determined the 
correlation of OD600 and cell count by dilution series and colony counting. For this, we 
sampled M. smegmatis cultures at several ODs, performed a serial dilution of the sample and 
plated the dilutions on solid medium. 
With knowledge of dilution and applied volumes we can calculate the concentration of colony 
forming units (cfu)/ml for each OD after counting colonies on agar plates. OD600 = 0.1 
corresponded to 2.5 *107 cfu/ml. OD600 = 0.2 corresponded to 5*10
7 cfu/mL.  
To ensure a smooth process we determined growth times at different temperatures. We 
determined that at 30°C M. smegmatis culture inoculated 1:1000 (e.g. 100 µl starter culture in 
100 ml medium) grows to OD600 = 0.2 within 24 h. M. smegmatis grows to OD600 = 1.0 within 
24 h at 37°C (see figure 5.4). Thus, cultures to be infected were inoculated 24 h prior 
infection and grown at 30 °C to achieve the desired OD. We further observed that incubation 
in light induces yellow pigmentation which has been known to be caused by utilisation of 
alternative σF (Provvedi et al., 2008). In order to standardise composition of RNAP 





Figure 5.4 Growth of M. smegmatis in liquid culture at different temperatures. Cells were incoculated 1:1000 and 
grown in 7H9 broth supplemented with 10% ADC supplement, 0.02% Tyloxapol and 50 µg/ml carbenicillin at 
30 °C (A) or 37 °C (B). At 30°C culture grows to OD600=0.2 within 24 h, and at 37°C to almost 1.0. 
A common problem encountered when growing M. smegmatis in liquid culture is clumping. 
Usually, clumping is prevented by addition of detergent, here tyloxapol (0.02-0.04%). 
Detergent cannot be applied during infection, as it interferes with phage adsorption. We thus 
tested D-xylose as alternative against cell-aggregation which was suggested to reduce 
clumping (Anton, Rougé and Daffé, 1996). We have previously observed that culture 
clumping translates to wide error between OD measurements. Thus Figure 5.5 shows 
measurement error between 4 cultures of M. smegmatis grown in 0.02 % tyloxapol or 1 mg/l 
D-Xylose over 24 h. We deduct that tyloxapol and xylose prevent clumping to a similar 
extend. Thus we added 1 mg/L xylose to cultures when tyloxapol had to be omitted. 
5.3.3 Phage titration methods 
These protocols were designed in reference to (Hatfull, 2010a) and information found on 
Actinobacteriophages Database website (Hatfull, Graham, Russell, Dan, Jacobs-Sera, Debbie, 
Pope, Welkin, Sivanathan, Viknesh, Tse, 2016).  
For infection with known MOI also the phage titre needs to be known. For titration of phage, 
a phage suspension is serially diluted and added to a sample of cells. After 30 min adsorption, 
the infected cells are mixed into liquid top agar (0.5 %) agar and poured onto solid medium. 
Bacterial lawn grows overnight and infected cells lyse, but phage diffusion through top agar is 
limited, thus plaques (foci of lysed cells) can be counted to calculate the plaque forming units 




Figure 5.5 Evaluation of tyloxapol or xylose to prevent M. smegmatis cell aggregation. Traditionally, detergents 
are added to liquid cultures of M. smegmatis to prevent cell aggregation. This is not possible in cultures which 
are grown to be infected by bacteriophage as detergent inhibits phage adhesion to the cell. Different sugars were 
indicated to prevent clumping of mycobacteria (Anton, Rougé and Daffé, 1996). By plotting the error in OD600 
between measurement of 4 cultures grown in parallel in  1 mg/L D-xylose (black dots and full line quadratic 
standard curve) and 0.02% tyloxapol (white dots and dotted quadratic standard curve) we can see that degree of 
clumping between both methods is similar. 
Spot test is similar to previously described titration, but here, the bacterial lawn is poured 
first, then phage dilutions are dropped onto the top agar. From the dilutions which show a 
countable number of plaques within the drop, the pfu/ml can be calculated.  
Figure 5.6 shows spot test and whole plate assays for phage titration. Both methods require 
serial dilutions of phage to be plated on a bacterial lawn. If single plaques can be counted, 





#𝑝𝑙𝑎𝑞𝑢𝑒𝑠 ∗ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 ∗ 𝑉𝑜𝑙𝑢𝑚𝑒 𝑓𝑎𝑐𝑡𝑜𝑟 (𝑒. 𝑔. 103𝑓𝑜𝑟 𝜇𝐿)
𝑉𝑜𝑙𝑢𝑚𝑒 (𝑒. 𝑔. 10 𝑓𝑜𝑟 10 𝜇𝐿)
 
 
5.3.4 Determination of an infection timeline 
Cells are synchronised prior infection. Synchronisation is achieved by inoculating the 
infection culture with a pre-culture in early stationary phase (growth at 37 °C for at least 24 h) 
and by pelleting cells prior infection (Hoppensteadt, 1989; Kirtania et al., 2016). The pelleted 
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cells are resuspended in phage buffer which provides ideal ionic strength for phages to adsorp 
to the cell. Adsorption is done in small volume in absence of carbon source and infection (t = 
0) is initiated by adding fresh growth medium. 
Alternative methods of synchronisation, such as use of vitamin C, have been described 
(Kirtania et al., 2016), but not tested by us. In order to determine time points of infection in 
which we can assume phage gene expression is in progress, we observed the correlation 
between cell lysis (measured by OD) and phage titre (measured by spot test).  
If measurements of OD and phage titre are plotted (figure 5.7) we can see that a steep fall of 
OD coincides with a steep rise in phage titre, as expected. In case of phage D29 this takes 
place about 110 min p.i. Therefore we chose to harvest infected cells 15 and 40 min p.i. for 
investigation of early and late Gps (t = 0 is after 30 min of adsorption). Infection dose was 
MOI 10 (ratio of cfu to pfu 1:10). MOI 100 was also tested (data not shown). As the resulting 
curve did not vary noticeably, we chose to proceed with MOI 10. 
 
 
Figure 5.6 Spot test and plate assay for titration. Phage concentration in a suspension is calculated by counting 
plaque forming units after serial dilution. A. Spot test. Bacterial lawn is poured onto an agar plate, then 10 μL 
drops of dilutions of phage suspension are dropped onto the freshly inoculated lawn. Bacteria grow in absence of 
phage, phage formes holes (plaques) in the lawn. Here, dilution 10-7 allows for counting of 4 plaques, with the 
above equation we determine a phage titre of 4*109 pfu/mL. B. Plate assay. Here, instead of dropping phage onto 
the lawn, the phage (10 μL of one dilution, here 10-6) is dispersed into cell suspension before the top agar is 
poured. The bacterial lawn is laced with plaques. Here, 210 plaques were counted, giving a titre of 2.1 *1010 





Figure 5.7 Correlation of M. smegmatis growth and D29 titre in infected cultures (MOI 10). A culture was 
infected at OD600=0.2 (left Y-axis). The OD of the culture (black dots) was documented when culture samples 
were collected over 3 h. The phage titre (grey triangles) in culture supernatant was assessed by spot test and is 
given in pfu/ml (right Y-axis, logarithmic scale). Sudden onset of lysis was observed and sudden rise in phage 
titre were observed at around 110 min p.i. 
5.3.5 Cell harvesting 
In order to obtain intact infected cells and assure accuracy of time points, we tested two 
different methods of pelleting cells, centrifugation and filtration. Cells can remain viable 
during pelleting, hence also viral growth continues. Centrifugation was done at 4°C, 400 ml 
flask rotor FA 500, 10 000 × g. Unfortunately, pelleting of M. smegmatis requires over 30 min 
at high volumes. Vacuum filtration using 0.22 μm pore size Whatmann membrane allows for 
“pelleting” within 2-10 min. The culture is filtered and cells are retained on the filter. Cells 
can be scraped off the filter and immediately frozen at -80 °C. 200 ml can be filtered very fast 
(2-3 min), the speed then decreases drastically (300 ml takes 7-10 min). We chose to filter 





5.3.6 Phage protein pull-down via His-tagged mycobacterial RNA Polymerase 
We tested various methods of cell lysis and salt concentrations for His-tag affinity 
chromatography. For lysis, BeadBeating was compared to sonification. Table 5.2 shows yield 
of purified RNAP from BeadBeating (1) and sonication (2). As comparable yield was 
achieved and sonication is faster and easier to use, we decided to continue using sonication. 
M. smegmatis were sonicated in 7 ml ice cold grinding buffer with 20 µg/ml proteinase 
inhibitor at 20% amplitude, 15 sec pulses on/off, for 5 min. Care was taken to keep the lysates 
ice cold. Further, total yield of purified protein (RNAP) of late stage infected cells (sample 3) 
was found to be much lower, indicating that cells may become permeable during infection and 
suffer loss of protein during pelleting.  
Table 5.2 Yield of purified His-tagged RNAP for different cell lysis methods. Protein was purified via affinity 
chromatography (Ni2+-NTA agarose binding to His-tag on RpoC). Starting material (200 mL early log phase 
cells) were lysed via BeadBeater (1) or sonication (2,3). Infected cells give lower yield, probably due to 








BeadBeater 200 0.156 
2 
not infected 
Sonication 200 0.18 
3 
infected 
Sonication 200 0.036 
 
For pull down of phage proteins that interact with RNAP, different samples and controls were 
purified as described above (figure 5.3). 
In contrast to use of His-Trap Ni-affinity chromatography as described in the methods section, 
here, Ni-affinity purification was performed using Ni2+-NTA agarose beads. The lysate in 
grinding buffer was centrifuged to remove cell debris (10 000 × g, 15 min, 4 °C), and filtered 
through 0.45 μM filter, 10 mM imidazole was added. 500 μL Ni2+-NTA agarose beads, 
previously equilibrated in 10 mM Imidazole Ni-column buffer, were applied to 7 ml cleared 
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lysate (= Load, see figure 5.3.5). Beads were incubated on ice with occasional shaking for 
about 15 min. Beads were allowed to settle by gravity and supernatant was removed (= flow 
through, FT). Beads were washed in 500 μL wash buffer 3 times (= wash, W). For elution, 
beads were washed in 200 μL elution buffer (100 mM imidazole) twice and then in 200 mM 
imidazole once (=eluates). After His-tag affinity purification via Ni2+-NTA agarose beads we 
subjected different samples to denaturing SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) to detect RNAP as well as potential phage Gps. Figure 5.8 shows eluates from phage 
D29 (t = 15) infection which compared to control (uninfected) RNAP shows an additional 
band of ~55 kDa size. Coincidentally, wash fractions of both infected and not-infected 
purifications contain a 55 kDa band as well. This gel is representative of other gels from 
different rounds of infection. In most cases, no additional bands could be detected with the 
naked eye. Either way, the eluates from RNAP purification were pooled, concentrated and 
sent for MS analysis. 
 
Figure 5.8 SDS-PAGE of RNAP pull-down from infected and uninfected cells. M. smegmatis strain SM07 (His-
tagged RpoC) was infected (+D29) or not infected (-D29) with mycobacteriophage D29. At t=15 min, cultures 
were filtered, frozen, and then lysed by sonication (Lysate, lane 2). The lysate was cleared from cell debris 
(Load, lane 3), and incubated with Ni2+-NTA agarose beads at 10 mM imidazole. The bead supernatant (FT, lane 
4) was removed and bead were washed (W, lane 5 and 9) in 25 mM imidazole. Beads were eluted twice by 100 
mM imidazole and once by 200 mM imidazole (lanes 6-8 and 10-12) . 10 μL samples of each step were loaded 
on this gel. Lanes 2-8 show samples from D29-infected cells, lanes 9-12 from not-infected cells (control). 
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5.3.7 Mass Spectrometry analysis of pull-down 
Protein yield of infected cells was often very low with about 10-50 pmoles per purification. 
Thus pooled eluates were concentrated to smallest possible volume and loaded on SDS-
PAGE. Electrophoresis was discontinued as soon as protein had completely entered the 
separating gel and was cut out. The gel slice was sent to Fingerprints Proteomics Facility at 
Dundee University for mass spectrometry. For each phage we analysed 5 samples: Infection 
of strain SM07, at two different times p.i. (15 and 40 min for D29), infection of wildtype 
strain at both time points, and strain SM07 without phage infection. From the results of 
infected pull-downs we subtracted all non-phage hits and Gps found in mock pull-down (see 
table 5.3). All found phage proteins were contained at 40 min p.i., only Gp68 was also found 
at 15 min p.i. No phage protein was found in negative control. 
 
Table 5.3 Mycobacteriophage Gps found in samples of infected RNAP purifications. MS was performed by 
Fingerprints Proteomics Facility at the University of Dundee. Five Gps encoded by phage D29 were found only 
in infected SM07, not in wildtype or negative control (no infection). Four of these are previously uncharacterised 
proteins. (Gp53, Gp55, Gp65, and Gp68). Protein size in amino acid (AA), and molecular weight (MW) are 
given as well as calculated isoelectric point (pI).  









Probable thymidylate synthase 
OS=Mycobacterium phage D29 GN=48 PE=3 
SV=1 - [THYX_BPMD2] 
no yes 26.5 5.17 
Gene 53 protein OS=Mycobacterium phage 
D29 GN=53 PE=4 SV=1 - [VG53_BPMD2] 
no yes 26.3 7.20 
Gene 55 protein OS=Mycobacterium phage 
D29 GN=55 PE=4 SV=1 - [VG55_BPMD2] 
no yes 17.3 5.41 
Gene 65 protein OS=Mycobacterium phage 
D29 GN=65 PE=4 SV=1 - [VG65_BPMD2] 
no yes 25.1 4.65 
Gene 68 protein OS=Mycobacterium phage 
D29 GN=68 PE=4 SV=1 - [VG68_BPMD2] 




5.3.8 Cloning of phage proteins 
In order to identify transcription inhibitors, we needed to test potential candidates 
individually. For this, the phage proteins identified in mass spectrometry which were not 
found in controls and had not been previously identified (D29 proteins Gp53, Gp55, Gp65 
and Gp68) were PCR amplified with custom primers from IDT and cloned into T7 expression 
system vector pET28a for recombinant expression in E. coli, as described in methods. Not all 
phage proteins could be purified via this route due to problems at cloning or overexpression. 
If a protein is cytotoxic in the overexpression system (E. coli), only mutants will be 
overexpressed (e.g. which developed a frameshift mutation in the gene). If too much protein is 
overexpressed, misfolding can occur and inclusion bodies can form. These need to be purified 
at denaturing conditions, and renaturation is not always possible. Gp65 was not 
overexpressed. The reason of this is uncertain. Of this D29 set, Gp53, Gp55 and Gp68 have 
been tested in in vitro transcription. As only Gp53 showed distinct inhibition of M. smegmatis 
RNAP, further graphs will focus on Gp53 results.  
5.3.9 Purification of phage proteins 
As phage proteins were previously uncharacterised, we ran a preliminary test for optimal 
overexpression conditions, considering different temperatures and durations of induction. 
Cells were grown in selective medium to OD600 = 0.5 at 37 °C. After temperature shift to 30 
°C or room temperature (ca 20-25°C), cells were induced with 1 mM IPTG. After 3 h of 
overexpression, samples were collected, lysed by heat and cell debris was removed by 
centrifugation. SDS-PAGE of lysates showed that Gp53 formed inclusion bodies if 
overexpressed at 30 °C, thus we decided to overexpress at room temperature for 3 h. A larger 
culture (2 L) was inoculated in complex medium with antibiotic kanamycin for pET28a 
overexpression vector. Colder temperatures lead to a slower protein production which can be 
beneficial to prevent formation of inclusion bodies. Overexpression was induced 20 min after 
transferring the culture to room temperature, at OD600 = 0.5, and harvested cells 3 h later, at 
OD600 = 0.95.  
Cells were lysed and Gp53 was purified via Ni2+-affinity chromatography as described in 
methods, in presence of 300 mM NaCl. After a first purification, bands that resemble RNAP 
subunits β, β’and σ70 were present as contaminants in Gp53 eluates. We cannot rule out that 
EcRNAP was co-purified with Gp53. Since relative concentration of Gp53 according to SDS-
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PAGE was much higher than protein contaminants, we proceeded to investigate this Gp53 
purification in initial tests (section 5.3.8). 
However, as initial results were promising, Gp53 was repurified at higher NaCl concentration 
(600 mM), and using ion exchange to eliminate contaminants (figure 5.9). 
Further, the N-terminal His-tag of Gp53 was removed by Thrombin cleavage. This was done 
in case Gp53 activity or structure depends on a N-terminal domain. A thrombin cleavage site 
is positioned on the protein between His-tag and start codon. Gp53 purification shown in lane 
7, figure 5.9 was subjected to thrombin cleavage. The protein is incubated with Thrombin 
enzyme overnight at 4 °C (according to Thrombin kit protocol). Thrombin was removed via 
affinity resin. Residual His-tagged Gp53 was removed by Ni2+-NTA agarose beads. 
 
Figure 5.9 Purification of His-Gp53. Lanes 2-4 can be disregarded as they show the purification of a different 
protein (NudC). His-Gp53 was purified by Ni2+-affinity chromatography and then loaded onto an ion exchange 
column (Resorce Q). Resource Q buffers without EDTA and DTT were used. Lanes 5-9 show different 
purifications pooled after ion exchange chromatography of Gp53 in 100 mM imidazole, and after dialysis in 
storage buffer containing DTT. Lane 5 contained Gp53 eluted as monomer from ion exchange, 6 - 8 were eluted 
as monomer and homodimer.  
5.3.10 His-tagged Gp53 supports transcription of long products 
To assess the effect of purified phage proteins on transcription, it is added to in vitro 
transcription assay. 1 pmole RNAP with 2 pmoles SigA was mixed with 3 pmoles of template 
DNA rrsA. This mocobacterial promoter precedes the gene of 16S rRNA (Dal Molin et al., 
2018). 3 pomoles Gp53 were added to half of the assays (ratio RNAP:Gp53 1:3). We also 
tested Gp53 effect in presence of M. smegmatis transcription factor RbpA (1:3 RNAP to 
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RbpA). Transcription assays further contained 100 μM of each NTP except UTP (10 μM) 
which was additionally provided as α(P32)-UTP for radioactive labelling. This allows for 
“run-off” products, where RNAP transcribes from promoter to the end of the linear DNA, or 
until a pause/termination signal is encountered. The M. smegmatis transcription buffer 
containing 10 mM MgCl was added last to start the reaction. After 10 min incubation at 37 
°C, reactions were stopped with transcription stop buffer and then loaded on 15% 
polyacrylamide gel.  
Gp53 increases transcription by more than two fold without transcription activator RbpA 
(figure 5.10). When RbpA was present, transcription was 5% stronger upon addition of Gp53. 
This does not mean that Gp53 replaces transcription activation by RbpA. It might act as 
transcriptional activator, or act as anti-terminator. Contamination by EcRNAP might temper 
with the results. Therefore, after this initial experiment, Gp53 was repurified. If Gp53 co-
purifies EcRNAP at medium salt concentrations (300 mM NaCl) this could be an indication 
that Gp53 interacts with bacterial RNAP directly, and the binding region might be an 
evolutionarily conserved region of RNAP. Alternatively, it might co-purify RNAP because of 
a strong interaction of both Gp53 and RNAP with promoter DNA. 
5.3.11 Gp53-mediated transcription inhibition relies on free N-terminal domain 
We removed the N-terminal His-tag from Gp53 using the Thrombin cleavage kit. We 
performed a run-off transcription assay on M. smegmatis promoter rrsA as described above 
and observed that Gp53 inhibits transcription by MsRNAP holoenzyme, with increased effect 
in presence of transcription activator RbpA (figure 5.11 B). Addition of His-Gp53 to 
MsRNAP holoenzyme reduced transcription by 17%. Addition of free Gp53 to holoenzyme 
resulted in loss of transcription efficiency by 70 %. Addition of RbpA alone to holoenzyme 
did not enhance transcription on rrsA, but addition of His-Gp53 to MsRNAP-σA-RbpA 
increased transcription by 30%. This is another indicator that the previous transcription 
enhancement by Gp53 (section 5.3.9) is due to an activator activity of Gp53. This activator 
activity might rely on misfolding due to the N-terminal His-tag. Possibly, Gp53 has several 
roles. Addition of non-tagged Gp53 to RNAP-σA-RbpA decreased transcription efficiency by 
87.7% as compared to RNAP-σA-RbpA alone and by 90% as compared to RNAP-σA-RbpA-
His-Gp53. This indicates that Gp53 N-terminal domain is likely involved in a) protein folding 
or complex formation or b) inhibitory activity (via RNAP/RbpA binding, DNA/RNA binding 
or enzymatic acitivty). Seemingly, involvement of RbpA increases inhibition by free Gp53. 
The effect might thus be promoter-dependent. RbpA was previously shown to confer 
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MsRNAP holoenzyme stability on promoters lacking -35 and extended -10 elements. rrsA has 
-35 and a regular -10 element (Perumal et al., 2018). 
We tested the effect of Gp53 on transcription from promoter P_left, a mycobacteriophage 
promoter (see figure 5.11 A and C). P_left is the early lytic promoter of lysogenic 
mycobacteriophage L5, a close relative of D29 (Brown et al., 1997). This promoter has both a 
-35 and an extended -10 element, thus in theory it does not require RbpA. We observed that 
Gp53 inhibits transcription from P_left by 58% as compared to transcription by MsRNAP 
holoenzyme, and by 88% in presence of RbpA. At this point we cannot make any detailed 
conclusions about the mechanism of inhibition. Interaction of Gp53 with RbpA seems likely. 
 
Figure 5.10 Transcription activation by first Gp53 purification. A. promoter region of the rrsA template. 
Promoter region -35 and -10 are marked in red and transcription start site is marked in freen. The full template 
allows for run-off products of up to 400 nt. The run-off products are likely due to a termination signal on the 





Figure 5.11 Gp53 inhibits transcription on two promoters. A. Promoters rrsA and P_left with σ-binding elements 
(red,orange) and TSS (green). B. Transcription of MsRNAP on rrsA in presence/absence of RbpA and Gp53. 
His-tagged and non-tagged versions of both RbpA and Gp53 were tested. Non-tagged Gp53 visibly inhibits 
transcription in absence of RbpA, but even more so in presence of RbpA. His-tagged Gp53 seems to act as weak 
transcriptional activator C. Transcription of MsRNAP on promoter P_left in presence/ absence of RbpA and 
non-tagged Gp53. Gp53 reduces transcription efficiency in absence but more so in presence of RbpA.  
 
5.3.12 Gp53 inhibits M. smegmatis RNAP, but not E. coli RNAP 
One of the advantages of enzybiotics is that the narrow host range of bacteriophages is 
generally reflected in their narrow specificity to orthologous proteins. We therefore tested, if 
Gp53 affects E. coli transcription in vitro. We designed a modified version of promoter P_left 
to facilitate single nucleotide resolution observations. The reactions were performed as 
described earlier with the modification that only ATP, CTP and GTP substrates were added). 
EcRNAP transcription was much more efficient on P_left than M. smegmatis RNAP 
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(MsRNAP). Addition of Gp53 inhibited production of short products by MsRNAP, less by 
EcRNAP (figure 5.12). This gel also shows another D29 protein, Gp55, which reduces 
transcription of EcRNAP, but not MsRNAP. Gp55 is N-terminally His-tagged. 
 
Figure 5.12 Transcription inhibition of Gp53 is species-specific. A. Promoter P_left mod is designed to allow for 
production of precise length RNA chains (14 mer). B. Transcription of 14mer RNA from P_left mod by 
EcRNAP-σ70 vs Ms-RNAP in presence or absence of additional factors. Addition of σA creates the functional 
MsRNAP holoenzyme. Transcriptional activator RbpA was added to half of Ms-RNAP samples. D29 protein 
Gp53 (not His-tagged) and Gp55 (His-tagged) were added to assays as indicated. Gp53 inhibits Ms-RNAP, but 
not Ec-RNAP. A 15 nt transcript was loaded as size control (C). 
 
5.3.13 Gp53 interacts with RNAP rather than DNA 
Non-His-tagged Gp53 was shown to inhibit MsRNAP, but less so EcRNAP. To discriminate 
whether Gp53 inhibition relies on promoter binding, we varied the order of addition of 
transcription assay components. Figure 5.13 shows that addition of Gp53 to E. coli 
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transcription first (before RNAP and DNA, lane 3) or last (after RNAP-promoter complex 
formation, lane 4) does not affect EcRNAP transcription efficiency. In contrast, addition of 
Gp53 to M. smegmatis in vitro transcription resulted in reduced efficiency of RNAP in any 
case (lanes 8-11), but inhibition was more prominent, when Gp53 was added to RNAP before 
DNA was added  (lanes 8 and 9). We conclude that Gp53 binding to RNAP holoenzyme (in 
presence and absence of RbpA) reduces transcription, and this binding might or might not 
hinder RNAP association to the promoter. We can further conclude that Gp53 does not inhibit 
transcription via blocking of the RNAP-binding site on the promoter. 
 
Figure 5.13. Gp53 inhibits transcription via protein-binding. Transcription components were added in different 
chronological orders to determine whether Gp53 inhibits transcription via unspecific binding of promoter DNA 
(P_left mod), or if inhibition relies on interaction with RNAP after RNAP-promoter complexation. E. coli (lanes 
1-3) or M .smegmatis (lanes 5-11) RNAP was added before or after DNA and Gp53. It becomes visible that 
Gp53 inhibits transcription if added before and after RNAP-promoter complex formation, but inhibition is most 
efficient when GP53 is added to RNAP before DNA. A 13mer transcript was loaded as size control (C). 
 
5.3.14 Further improvement of the protocol 
This protocol was shown to allow for isolation of phage proteins that inhibit transcription via 
interaction with RNAP. However, some improvements can still be made.  
In order to omit the step of His-tag removal by Thrombin cleavage, proteins can be cloned 
and purified with both C-terminal and N-terminal tags (two versions of each protein).  
In several mass spectrophotometric analyses, structural proteins were found. This could be an 
indicator that time points for harvesting cells were chosen too late, such that virion assembly 
had already commenced. At the point of virion assembly, the phage might have ceased its 
manipulation of host RNAP. However, structural genes can affect host transcription as well as 
shown for E. coli phage Gp Psu, a capsid protein which also acts as anti-terminator for Rho-
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dependent terminator (Linderoth and Calendar, 1991; Ghosh et al., 2018), thus they should 
not be prematurely excluded from further analysis.  
Further, purified Gps were not always active in in vitro transcription. This likely means that 
the protein is not involved in transcription regulation. However, this protocol does not take 
into consideration potential requirement for coenzymes such as metal ions. If a phage protein 
requires a ligand that is not abundant in the complex medium it might not be active or stable 
after purification. Although this limitation might cause us to overlook some interesting phage 
transcription regulators, it would be too much work to consider all potential coenzymes for 




We have developed a protocol that allows for screening for phage regulators of mycobacterial 
transcription via interaction with RNAP or accessory proteins. This method has thus far been 
applied for mycobacteriophage D29, TM4 and Adephagia mutant ∆41∆43. Only one species-
specific inhibitor was found. Gp53 from mycobacteriophage D29 is here shown to inhibit M. 
smegmatis transcription in vitro on two different promoters, rrsA and P_left. Both promoters 
have -35 and -10 elements and bind the housekeeping σA. Promoter rrsA is an rRNA 
promoter. These are often regulated independently of other promoters, by signalling of 
metabolic state and several feedback mechanisms (Jacob, 1995; Burgos et al., 2017). 
Promoter P_left is a mycobacteriophage L5 early lytic promoter which is regulated by the 
phage repressor (Brown et al., 1997). It is possibly an extended -10 promoter, as it contains a 
TG motif upstream of the -10 element. Phage D29 is a lytic phage in both M. smegmatis and 
M. tuberculosis. It is very closely related to temperate phage L5 (Hatfull, 2010b). Both are 
Cluster A2 mycobacteriophages. They differ by deletion of a 3.6 kb deletion which includes 
loss of repressor gene Gp71. However, phage attachment site as well as integrase gene are 
present on the D29 genome, and it is affected by superinfection immunity by L5. 
Superinfection immunity is conferred by repressor proteins which bind to certain sites on the 
phage genome and repress expression of genes involved in lytic lifecycle. The repressor of 
one phage can supress gene expression of a secondary infecting phage if repressor binding 
sites comply. Thus a bacterium that is infected with one phage can be immune to a second 
phage (Donnelly-Wu, Jacobs and Hatfull, 1993; Ford, Sarkis, et al., 1998). L5 operators have 
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been found to overlap with a variety of L5 promoters, including the early lytic promoter 
P_left which was used in this study (Ford, Sarkis, et al., 1998). P_left is also present on D29 
genome but has some nucleotide substitutions as compared to P_left from L5, mainly within 
the -10 element (Ford, Sarkis, et al., 1998). L5 also encodes a homologue of Gp53 (82% 
sequence identity to D29 Gp53). The function of this protein has not been identified. As Gp53 
inhibits transcription on both promoters we can speculate that its’ inhibition does not 
specifically target P_left and it is not a phage repressor. Instead, Gp53 might function as a 
general transcription regulator.  
Interestingly, we have further observed a likely interaction between Gp53 and host-encoded 
transcription activator RbpA. RbpA is essential in mycobacteria  (Forti et al., 2011; Hu et al., 
2012; Tabib-Salazar et al., 2013; Hubin et al., 2015; Berger et al., 2017). RbpA C-terminus 
binds to region 2 of the housekeeping sigma, but not alternative sigma (Tabib-Salazar et al., 
2013). RbpA-σA binds tightly to -10 promoter element and stabilises open complex formation 
(Elizabeth A Hubin et al., 2017) (see figure 5.14). In M. tuberculosis, 73% of promoters have 
a -10 element of consensus sequence TANNNT, 7 of which are preceded with an extended 
TGN. -35 elements are rare in the mycobacterial genome (Cortes et al., 2013). Thus, Gp53 
inhibition might be predominantly directed towards σA –promoters, via interaction with 
RbpA. This mode of transcription inhibition might allow the phage to shut off the majority of 
host transcription without completely inhibition host RNAP. This hypothesis requires further 
investigation. 
Further, we have observed that Gp53 activity likely relies on its N-terminus, as N-terminally 
His-tagged Gp53 does not inhibit transcription, but might acts as anti-terminator or 
transcription activator in vitro. The protein might have several functional roles. Gps which act 
on several stages of transcription have been identified in other phage-host systems as well, 
such as Gp39 of T. thermophilus phage P23-45, which acts both in σ-appropriation as well as 
anti-termination.  
 
5.5 Outlook/ Perspectives 
The outlined methodology has been shown to facilitate rapid identification of phage-encoded 
transcription inhibitors. The steps to be taken are i) Choice of appropriate time points for 
harvesting infected cells and controls (non-tagged RNAP and non-infected cells). ii) Cell lysis 
and purification of M. smegmatis RNAP via His-tag. iii) Mass spectrometric analysis of 
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proteins iv) Cloning and overexpression of phage proteins which are not contained in controls 
vi) Further in vitro analysis of individual proteins. We found an inhibitor of mycobacterial 
transcription, Gp53 from phage D29. Extensive in vitro analysis and characterisation was not 
within the scope of this thesis. Further experiments need to identify i) binding partner(s) of 
Gp53 (protein-protein interactions as well as protein-nucleic acid interactions) ii) the precise 
step of transcription it interferes with and iii) its’ precise mode of action. A further essential 
experiment would be effectivity on M. tuberculosis transcription.  
 
Figure 5.14 Structure of mycobacterial transcription factor RbpA in complex with RNAP-σA holoenzyme and 
DNA. From (Elizabeth A. Hubin et al., 2017). A. Structural domains of RbpA are N-terminal tail (NTT), core 
domain (CD), basic linker (BL) and the C-terminal sigma-interacting domain (SID). B. CD contacts β’ Zn2+-
binding domain (β’ZBD) and β’zipper, both belonging to conserved RNAP “clamp”. BL interacts with DNA and 
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ABSTRACT
Bacterial RNA polymerase is able to initiate tran-
scription with adenosine-containing cofactor NAD+,
which was proposed to result in a portion of cellu-
lar RNAs being ‘capped’ at the 5′ end with NAD+,
reminiscent of eukaryotic cap. Here we show that,
apart from NAD+, another adenosine-containing co-
factor FAD and highly abundant uridine-containing
cell wall precursors, UDP-Glucose and UDP-N-
acetylglucosamine are efficiently used to initiate
transcription in vitro. We show that the affinity to
NAD+ and UDP-containing factors during initiation
is much lower than their cellular concentrations, and
that initiation with them stimulates promoter escape.
Efficiency of initiation with NAD+, but not with UDP-
containing factors, is affected by amino acids of
the Rifampicin-binding pocket, suggesting altered
RNA capping in Rifampicin-resistant strains. How-
ever, relative affinity to NAD+ does not depend on
the −1 base of the template strand, as was sug-
gested earlier. We show that incorporation of ma-
ture cell wall precursor, UDP-MurNAc-pentapeptide,
is inhibited by region 3.2 of  subunit, possibly pre-
venting targeting of RNA to the membrane. Overall,
our in vitro results propose a wide repertoire of po-
tential bacterial RNA capping molecules, and provide
mechanistic insights into their incorporation.
INTRODUCTION
For few decades multi-subunit RNA polymerase (RNAP)
from Escherichia coli was known to be able to start RNA
synthesis with cellular nucleotide coenzymes, adenosine
derivatives NAD+ (nicotinamide adenine dinucleotide),
NADH (reduced form of NAD+) and FAD (flavin adenine
dinucleotide) (1). Authors of this work suggested that co-
factor moiety could function analogously to the eukary-
otic mRNA cap. Until very recently, the physiological sig-
nificance of this discovery remained obscure, and the ac-
cepted view was that non-processed bacterial RNAs carry
5′ triphosphate. In the last few years however, the data
started to accumulate that some cellular RNAs carry cap-
like structure––E. coli and Streptomyces venezuelae bear
NAD+ at the 5′ end (2). In 2015 those RNAs in E. coli were
captured via 5′ NAD+ moiety and identified by next gen-
eration sequencing (3). It transpired that those RNAs were
mainly regulatory sRNA and some mRNAs. Only relatively
small proportion of the whole population of the particular
RNA was NADylated in vivo. The most heavily NADylated
were RNAI and CopA, abundant short antisense RNAs
controlling pUC19 plasmid replication. Notably, for the
NADylated transcripts with known start site, the +1 posi-
tion coded for A, suggesting that it is RNAP incorporates
NAD+ at the 5′ end of RNA via mechanism shown earlier,
rather than some post-transcriptional mechanism being in-
volved (2). While our paper was in preparation, biochem-
ical and structural data using specific promoter assays has
been published that confirmed the promoter-dependent and
sequence-specific incorporation of NAD+, NADH and 3′-
dephosphocoenzyme A (dpCoA) (4). Correlation between
efficiencies of NAD+ incorporation in vitro and the extent
of NADylation in vivo on two different promoters suggested
that transcription might be the main, if not the only, cap-
ping mechanism. Crystal structures of initiation complex
containing dinucleotide RNA products (to avoid confusion,
here and after, we refer to the RNA length counting NAD+
and other dinucleotide co-factors as a single nucleotide)
initiated with adenosine triphosphate (ATP), NAD+ and
dpCoA were solved for Thermus thermophilus RNAP (4)
demonstrated that, apart from interactions common for all
three cofactors, contacts of NAD+ moiety additionally in-
clude side chains of  subunits residues D516 and H1237.
The authors also proposed that nicotinamide moiety of
NAD+ may rotate to interact with the −1 position of the
template, thus explaining different efficiencies of NAD+ in-
corporation on different promoters.
Eukaryotic mRNA turnover depends on the efficiency of
cap removal. Major catalytic role in decapping in eukary-
otes is played by NUDIX motif-containing protein Dcp2p.
In bacteria, NudC (NADH pyrophosphohydrolase), which
contains NUDIX motif was shown to de-cap RNAs from
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NAD+ (5). Notably, NudC has much higher affinity to-
wards NADylated RNA compared to NAD+ itself (5). Ex-
istence of decapping mechanism makes the analogy be-
tween prokaryotic and eukaryotic RNA processing even
stronger.
In eukaryotes mRNA capping plays vital role in RNA
degradation, splicing, translation initiation and nuclear ex-
port. Physiological significance of bacterial RNA capping is
not yet clear. The only role for capping that was put forward
and got some experimental backing, is the protection of the
transcript from degradation. The data on capped RNA sta-
bility are, however, conflicting. Bird et al. reported 3- to 4-
fold increase of in NADylated RNAI stability in NudC
cells (lacking de-capping activity) (4), in contrast to another
study, where deletion of NudC did not affect the overall sta-
bility of RNAI and GcvB, two RNAs, most heavily NADy-
lated in vivo (3). Moreover, some RNAs with high NAD+
cap content are inherently very stable, for example sroB with
half-life of more than 32 minutes (6). All these data suggest
possible additional roles for prokaryotic capping apart from
RNA stability.
To date only ADP analogues were identified as caps,
NAD+ and/or NADH. Cells use a number of nucleotide
cofactors and these might be just the first identified ones
among many substrates used by RNAP for RNA capping.
There are several poorly characterized NUDIX hydrolases
in E. coli, which can potentially serve to remove capping
molecules different from NAD+ (7), which have not been
found yet.
Here we provide further insights into the mechanism
of capping with adenine containing cofactors (NAD+,
NADH, NADP+, FAD) and its possible role in transcrip-
tion. We also show that the repertoire of potential cap-
ping molecules is wider, and includes uridine containing
precursors of cell wall synthesis (UDP-glucose and UDP-
N-acetylglucosamine). Our data also suggest the role of re-
gion 3.2 of initiation factor sigma in guarding transcription




ATP and UTP were from GE Healthcare; AMP, ADP,
NAD+, NADH, NADP+, FAD, UMP, UDP, UDG-
Glc and UDP-GlcNAc were from Sigma Aldrich; UDP-
MurNAc pentapeptide was a kind gift from Prof. Vollmer.
Proteins
Mutations in E. coli rpoB gene were constructed by site-
directed mutagenesis in polycistronic expression plasmid
pGEMABC, coding for RNAP core subunits ,  and ’
(8). Those subunits were overexpressed in E. coli T7 ex-
press strain (New England Biolabs) together with  sub-
units from expression plasmid pRSFD 2 rpoZ (8). Wild-
type and mutant RNAPs core enzymes were purified as de-
scribed in (9). RpoS gene encoding S was cloned into ex-
pression vector pET28, as previously were 70 and 703.2
(10). N-terminal Hisx6-tagged 70, 703.2, S were ex-
pressed from overexpression vector pET28 and purified as
described in (11).
In vitro transcription
A total of 0.3 pmols of wild-type or mutant RNAP core
with 1 pmols of 70 (wild-type or mutant) or S and 2 pmols
of promoter-containing linear DNA fragment were incu-
bated at 37◦C for 10 min in 10 l of transcription buffer
(20 mM Tris–HCl (pH 7.9), 40 mM KCl, 0.1mM ethylene-
diaminetetraacetic acid) at 37◦C, then nucleotides or nu-
cleotides analogues were added to the final concentration
of 500 M (unless otherwise indicated). Transcription was
initiated by the addition of 10 mM MgCl2, 50 M (32P)-
CTP, 12.5Ci/mmol (Hartmann Analytic) for RNAI and
acnA templates; for T7A1 template 50 M (32P)-UTP,
12.5 Ci/mmol of were used. Reactions were stopped af-
ter 3 min incubation at 37◦C (unless otherwise indicated)
by the addition of formamide-containing loading buffer.
For the kinetics of synthesis of 9 nt-long transcript from
RNAImod, 500 M ATP or NAD+ were incubated with
promoter complex and then 20 M UTP and 20 M (32P)-
CTP, 12.5 Ci/mmol were added in the absence or presence
of 5 g/ml of Rifampicin. Reactions were stopped after pe-
riods of time indicated on Figure 4A. Products were sepa-
rated on denaturing polyacrylamide gels (30% acrylamide,
3% bis-acrylamide, 6M urea, 0.5 Tris-borate EDTA buffer),
revealed by PhosphorImaging (GE Healthcare), and anal-
ysed using ImageQuant software (GE Healthcare). For 9-nt
long RNA synthesis in Figure 2D on RNAImod template
500 M of either ATP, NAD+, NADH, NADP or FAD
were incubated with promoter complex and then 25 M
UTP and 25 M (32P)-CTP, 12.5 Ci/mmol, were added
and reactions were incubated for 10 min. For similar ex-
periment on Figure 5C to synthetize 12-nt long RNA on
acnA template 500 M of either UTP, UDP-Glc or UDP-
GlcNAc were incubated with promoter complex and then
25 M ATP and 25 M (32P)-CTP, 12.5 Ci/mmol, were
added and reactions were incubated for 10 min. For appar-
ent Km determination on RNAImod and acnA templates
NTPs and analogues were used in concentrations ranging
from 10 M to 10 mM and constant 50 M CTP (second
NTP for both templates) concentration. Reactions were in-
cubated for periods of time chosen to get approximately
the same intensities of the product bands. The bands inten-
sities were quantified using ImageQuant software; to cal-
culate the initial reaction rate these numbers were divided
by reaction duration time. These data were fitted to hy-
perbolic equation using non-linear regression procedure in
SigmaPlot software.
RESULTS
Escherichia coli RNAP is able to initiate transcription using
adenosine diphosphate analogues
Abortive production of short oligonucleotides is the very
first stage of the synthesis of the RNA. These products
can be resolved in high density denaturing polyacrylamide
gel. We analysed the efficiency of incorporation of poten-
tial cap molecules into RNA in abortive synthesis by E.
coli RNAP 70 holoenzyme on a linear DNA containing
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Figure 1. ADP-related cellular cofactors are utilized by RNAP for initiation of transcription. (A) Structures of ATP, NAD+, NADP+, FAD, UDP, UDP-
Glc (GlcUDP), UDP-GlcNAc (GlcNAcUDP) and UDP-MurNAc pentapeptide (5AAMurNAcUDP). (B) Templates (partial sequence of non-template
strand around transcription start site) used for in vitro experiments containing T7A1, RNAI promoters and RNAI template with modified initially tran-
scribed sequence, RNAImod. +1 position for all templates is in bold, −1 position is framed, 9 nt initially transcribed sequence in RNAImod is underlined.
(C) Initial transcript synthesis on RNAImod template using RNAP holo 70, holo S and holo703.2 and 500M ATP, NAD+, NADH, NADP+ and
FAD as initiating substrates and (32P)-CTP as the next nucleotide. (D) Plot reflecting incorporation efficiencies for alternative substrates in percentage
from efficiency of ATP incorporation for RNAP holo 70, holo S and holo703.2 on RNAImod, the values are an average of the three independent
experiments, error bars represent plus and minus one standard deviation.
promoter RNAI (that was shown to be the most heavily
modified by NAD+ in E. coli). ATP or co-enzymes (each
at 500 M concentration) (structures on Figure 1A) were
extended by (32P)-CMP (at 50 M). Position +3 of the
RNAI promoter was mutated to T to make RNAImod tem-
plate (here and after we refer to the sequence of the non-
template strand) to preclude extension of RNA further than
position +2, which would obscure kinetics analysis (Figure
1B). As can be seen from Figure 1C, NAD+, NADH, FAD
can be efficiently incorporated into the 2-nt long transcript.
The results are consistent with the recently published work
(4) and the earlier study (1). Efficient incorporation of these
coenzymes into the transcript is not a particular property of
RNAI, as they were similarly efficiently extended by (32P)-
UMP on a strong promoter A1 from bacteriophage T7,
where transcription also starts with A (Figure 2A). NADP+
was incorporated very inefficiently into the transcript on
both templates, likely due to the 2′-phosphate group ster-
ical hindrance during phosphodiester bond formation. At
1 mM initiating NAD+ and ATP on RNAImod template,
the kinetics of formation of NAD+pC was comparable (∼2
times slower) to that of pppApC (Figure 2B). The Kms for
ATP, NAD+ and NADH in initiation on RNAImod tem-
plate were 90 ± 11 M, 358 ± 67 M and 380 ± 72 M,
respectively, which is much lower than their cellular concen-
trations (see ‘Discussion’ section).
In the presence of CTP and UTP, the short transcripts
initiated with NAD+, NADH and FAD on the RNAImod
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Figure 2. Biochemical characterization of the ADP analogues incorporation into a transcript. (A) Initial products synthetized using ATP and cofactors as
initiating substrates on T7A1 promoter template with RNAP holo70Escherichia coli and (32P)-UTP as next nucleotide. (B) Kinetics of initial product
synthesis on RNAImod template with RNAP holo70 with either ATP or NAD+ as initiating substrate. (C) Km for ATP and NAD+ as initiating substrates
measured on RNAImod templates with different identity of −1 template bases (sequences in Figure 1B); numbers that follow the ±sign are errors that are
standard deviations of the fitting. (D) Transcripts initiated with ATP, NAD+, NADH, NADP+ and FAD, are elongated to 9 nt transcript on RNAImod
template.
template were efficiently extended into 9-nt products (Fig-
ure 2D). The amounts of 9-nt products were comparable to
those initiated with ATP, suggesting that, similar to NAD+
capping, NADH and FAD capping may exist in the cell.
Note also that the efficiency of abortive products extension
(the ratio between 9-nt RNA and dinucleotides) in the case
of co-factors was higher than in the case of ATP, suggesting
that co-factors increase efficiency of promoter escape (see
below).
The −1 position of template does not influence the relative
efficiency of NAD+ versus ATP incorporation into the tran-
script
Nicotinamide moiety may, in theory, form base pair with
template DNA base at the position −1. This may change
specificity of NADylation at promoters with particular base
at −1 position. It was observed that A to C (non-template
strand) change in −1 position decreased the overall effi-
ciency of NADylated transcript synthesis (4). To test if the
base at position −1 affects the affinity to NAD+, we used
linear templates with RNAImod promoter variants with
changes in the −1 position (Figure 1B). We measured ap-
parent Km for NAD+ and ATP on these four promoters
variants in abortive synthesis as above (Figure 2C). We
found that Km for NAD+ incorporation in transcript was
lower for templates with C and T in −1 position compared
with values for −1 A or G. However, the same tendency was
observed for incorporation of ATP, suggesting that posi-
tion −1 of template does not specifically affect affinity to
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Figure 3. Aminoacids of Rifampicin-binding pocket of  subunit of RNAP influence incorporation of ADP analogues into a transcript. (A) Crystal
structure of the initiation complex with NAD+pC product with Thermus thermophilus RNAP, adapted from PDB ID: 5D4D (4). The amino acids of
Rif-pocket, whose changes were tested in vitro are in purple (Escherichia coli numbering), NAD+ is in yellow, DNA is in blue, −1 and +1 positions of the
templates are indicated. (B) Relative efficiency of incorporation of 500 M NAD+ versus ATP into dinucleotide product on RNAImod template by WT
and mutant RNAPs with aminoacid changes in  subunit indicated below the plot. The values are an average of the three independent experiments, error
bars represent plus and minus one standard deviation.
NAD+. This result is consistent with crystal structures of
the initiating complexes where initiating NAD+ makes the
same contacts with template DNA as initiating ATP (4).
Therefore it is likely that different steps of initiation, rather
than direct interaction with the template, may influence the
relative efficiency of initiation with NAD+ on templates
with different −1 position (4). Note that the measured Kms
for NAD+ on either of the templates are much lower than
the cellular concentrations (see ‘Discussion’ section).
Core RNAP determinants for NAD+ incorporation
We tested if there are any other structural determinants
for cofactors incorporation apart from −1 position of tem-
plate. 5′ NTP of the growing transcript passes through the
Rifampicin-binding pocket of the  subunit of RNAP. It
was shown that  -phosphate of the initiating ATP is in
proximity to the  subunit fragment between amino acids
516 and 540 (12), suggesting where the nicotinamide group
of NAD+ could be bound during initiation. We tested
several RNAPs with amino acid changes in Rifampicin-
binding pocket (Rif pocket) –– Q513L, F514A, D516V,
D516Y, H526Y, H526R, H526P, S531L, N568A, I572F on
RNAImod promoter with either NAD+ or ATP as an ini-
tiating substrate. The activities of the enzymes in abortive
synthesis varied significantly (either due to specific activi-
ties of the enzymes or distortion of the Rif pocket). Fig-
ure 3B shows relative efficiencies of NAD+ incorporation
(NAD+/ATP ratio) by the mutant enzymes in percentage
from that of the WT RNAP. Indeed, in agreement with
our hypothesis that part of NAD+ maybe bound in the Rif
pocket, the effect was dependent both on the position and
nature of the amino acid substitution. The strongest effect
on NAD+ utilization was produced by mutations of D516
of  (Figure 3B). This corroborates the crystal structure of
the initiating complex with NAD+ primed RNA product,
where the D516 side chain is in close proximity of the nicoti-
namide moiety of the NAD+ (4) (Figure 3A). Changes of
other aminoacids that are too far to interact with NAD+
directly, perhaps affect the overall shape of the Rif-pocket.
Initiation factor does not play a role in selectivity of ADP-
containing co-enzymes as substrates
A larger proportion of RNAI was found to be NADylated
in stationary growth phase compared to the exponential
phase (3). In stationary phase most transcripts are made by
RNAP holoenzyme containing S, while housekeeping 70
operates in exponential phase. We analysed if different ini-
tiation factors may dictate specificity towards capping co-
factors. To answer this question we tested initiation with
NAD+ on RNAI promoter with holo 70 and holo S (Fig-
ure 1C and D). The rates of abortive products formation
with ATP, NAD+, NADH, NADP+ and FAD were similar
for both RNAPs (Figure 1C and D). Km values for NAD+
were also close for both holoenzymes (358 ± 67 M for holo
70 and 352 ± 88 M for holo S) The results suggest that at
least the two initiation factors tested do not provide signif-
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icant specificity towards utilization of NAD+ as initiation
substrate.
Previous functional and structural analyses suggested
that region 3.2 of  subunit protrudes towards catalytic
site of the RNAP and may contact the 5′ end of short
transcripts (10,11,13,14). We tested initiation with NAD+,
NADH, NADP+ and FAD (500 M) on RNAI promoter
by holoenzymes containing either wild-type 70 or mutant
70 lacking region 3.2, 703.2 (Figure 1C and D). We did
not observe any significant differences in specificity, sug-
gesting that region 3.2 does not make contacts critical for
cofactors’ binding.
NADylation of transcript stimulates escape of the RNAP
from promoter
From our results it follows that NAD+ interacts differently
with RNAP as compared to ATP. These differences might
affect stability of the short abortive transcripts, and as a re-
sult, their extension during promoter escape. We therefore
tested kinetics of 9-nt RNA production initiated with ei-
ther ATP or NAD+ (500 M) on RNAImod template. A
relatively low concentration of CTP and UTP (20 M) al-
lowed us to monitor the accumulation of short RNAs rang-
ing from 2 to 9 nt in length. As can be seen from Figure
4A and B there were much less accumulation of the 2- and
3-nt long transcripts when transcription was initiated with
NAD+ as compared to ATP (compare the traces of 600 s
products in Figure 3B). Rifampicin is known to block es-
cape into elongation, with concomitant increase of abortive
synthesis (15). We hypothesized that, if NAD+ containing
initial transcripts are bound tighter by RNAP than ATP
containing ones, Rifampicin may have different effect on
their release. We used low concentration of Rifampicin (5
g/ml), which was not enough to block transcription com-
pletely. Addition of Rifampicin to reaction inhibited pro-
duction of 9-nt RNA initiated by either ATP or NAD+.
Also, as expected Rifampicin increased release of pppApC
dinucleotide. However, Rifampicin almost didn’t affect pro-
duction of NAD+ containing short RNAs, highlighting the
difference between promoter escape with ATP and NAD+
(compare the traces of 600 s products in Figure 3B). These
results suggest that NAD+ moiety at the 5′end indeed can
stabilize short transcripts in the RNAP active centre.
UDP derivatives can serve as initiating substrates for tran-
scription
Exponentially growing in rich medium E. coli cells con-
tain high concentrations of a number of nucleotide ana-
logues potentially capable of initiating transcription. One
of the most abundant small molecules in E. coli cell, second
only to ATP, is UDP-N-acetylglucosamine (UDP-GlcNAc)
(16), which participates in formation of peptidoglycan,
lipopolysaccharides and teichoic acid cell wall components.
We tested if UDP-GlcNAc, along with another precursors
of cell wall synthesis, Uridine 5′-diphosphoglucose (UDP-
Glc) (structures in Figure 1A) can initiate transcription.
We also tested a more complex compound, UDP-MurNAc
pentapeptide (Figure 1A), the last-step precursor before the
formation of Lipid I, a building block of the cell wall.
In this experiment we used linear templates containing
acnA promoter, on which transcription starts with UTP
(Figure 5A). We analyzed initiation from UDP-Glc, UDP-
GlcNAc, UDP-MurNAc pentapeptide (5AA-MurNAc),
along with UMP, UDP and UTP as controls (each at 500
M concentrations) (Figure 5A) by monitoring synthesis
of the dinucleotide transcript after addition of an (32P)-
CMP (at 50 M concentration). As can be seen from Fig-
ure 5A, E. coli RNAP can efficiently incorporate UDP-Glc
and UDP-GlcNAc (comparably to UTP; lanes 3–5). The
Km values on the acnA promoter for UDP-Glc and UDP-
GlcNAc were 300 ± 62 M and 333 ± 41 M, respec-
tively (compared to 120 ± 17 M for UTP). These Km val-
ues are well below intracellular concentrations of UDP-Glc
and UDP-GlcNAc in exponential growth phase (2.5 and
9.2 mM, respectively). We analysed if dinucleotides initiated
with UDP-Glc and UDP-GlcNAc can be extended to facili-
tate escape into elongation. We mutated acnA promoter (ac-
nAmod; Figure 5A) so that we could monitor extension to
12-nt RNA in the presence of the ATP and CTP. As can be
seen from Figure 5C, the transcripts initiated with UDP-Glc
and UDP-GlcNAc were elongated by RNAP to the 12 nt.
Note also, that the efficiency of promoter escape with UDP-
Glc and UDP-GlcNAc was higher than that with UTP.
These findings suggest that the cell wall precursors UDP-
Glc and UDP-GlcNAc may serve as an RNA caps in vivo.
Interestingly, UDP-MurNAc pentapeptide was not uti-
lized by RNAP at all. It is possible that RNAP possesses a
mechanism that prevents incorporation of UDP-MurNAc
pentapeptide into an RNA, which would be too costly for
cells and may lead to unwanted targeting of the modified
transcript towards the membranes. One of the possible ob-
stacles for the pentapeptide in the active site could be region
3.2 of 70. We therefore analysed incorporation of UMP,
UDP, UTP, UDP-Glc, UDP-Glc NAc and UDP-MurNAc
pentapeptide (500 M) by holoenzymes formed with wild-
type 70 or 703.2. As can be seen from Figure 5A, the
mutant RNAP indeed acquired partial ability to incorpo-
rate UDP-MurNAc pentapeptide, while usage of smaller
cell wall precursors was not affected (see also relative effi-
ciencies of dinucleotide formation in Figure 5B). This result
suggests that region 3.2 may participate in guarding against
incorporation of the cellular nucleotide analogues with long
side chains.
To test if Rif-pocket plays role in selectivity of UDP-
GlcNAc utilization in initiation, as it does for ADP-
containing co-factors, we tested the activities of Rifampicin
resistant mutant RNAPs that we used above. Mutant
RNAP with Q513I substitution was inactive on acnA even
with UTP, and was excluded from analysis. The rest of mu-
tations in Rif-pocket did not affect incorporation of UDP-
GlcNAc into the transcript strongly (Figure 5D), suggest-
ing that UDP-GlcNAc may not make specific contacts with
amino acids of the Rif-pocket.
DISCUSSION
Here we showed that RNAP is able to incorporate variety
of cellular cofactors at the 5′end of the transcript, suggest-
ing a possibility of a wide repertoire of RNA caps in bacte-
ria. In addition to NAD+ that had been shown to cap some
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Figure 4. NAD+ as initiating substrate improves escape of RNAP from promoter compared to ATP. (A) Kinetics of synthesis of 9 nt transcript on
RNAImod promoter template (Figure 1B) using either ATP or NAD+ at 1 mM, 20 M (32P)-CTP and 20 M UTP in the absence or presence of 5
g/ml of Rifampicin. (B) Signal traces taken across the 600 s bands.
of bacterial RNAs in vivo, another adenine containing co-
factor FAD can also be incorporated by RNAP in sequence-
dependent manner, and thus cap RNAs on +1A (T in the +1
position of the template strand) promoters. Furthermore,
we show that UDP-containing cell wall precursors may ef-
ficiently cap RNAs on +1U promoters.
The crystal structure of promoter complex with NADpC
dinucleotide transcript showed the interactions of nicoti-
namide moiety with the Rif-pocket of  subunit (4). Indeed,
all amino acid substitutions in the Rif-pocket we tested in
our experiments specifically decreased the ability of RNAP
to incorporate NAD+, thus confirming the structural ob-
servations. We observed that substitutions at position 516
are the most detrimental for NAD+ incorporation, consis-
tent with the contacts of nicotinamide moiety with D516
seen in the structure. Interestingly, Rifampicin resistant sub-
stitutions at positions 516, 526 and 531 that strongly inhib-
ited NAD+ incorporation, are those most frequent found
in clinic (17). The control of the RNA capping by the Rif-
pocket may be involved also after the cap binding in the ac-
tive centre, at the stage of RNA extension and promoter
escape. Indeed, we found that transcription started with
NAD+ produced far less of short abortive products than
transcription started with ATP on the same promoter.
The crystal structure of the promoter complex with the
NADpC revealed that nicotinamide moiety does not inter-
act with the template (4). The authors however observed
that a change in the −1 position of the template may change
the proportion of NADylated RNAs when both ATP and
NAD+ are used in the reaction. They suggested that nicoti-
namide moiety might change conformation to interact with
the template base in −1 position, which has not been cap-
tured in the crystals. Although we found that Km for NAD+
for promoters with −1C or −1T were lower compared to the
promoters with −1G or A, the same tendency was observed
for ATP, suggesting that the preference of NAD+ for −1
position is not explained by specific base-pairing of nicoti-
namide moiety with the −1 position of the template. We
therefore suggest that −1 position of the promoter affects
the properties of other steps(s) of initiation, thus affecting
the efficiency of RNA NADylation.
Region 3.2 of the  subunit is in close proximity to the
Rif-pocket (8) and may serve as another determinant for
an efficiency of incorporation of the cofactors. However,
we did not find any significant effect of the deletion of re-
gion 3.2 on incorporation of either NAD+, NADH, FAD
or NADP, as compared to ATP. We also observed no dif-
ference in efficiency of usage of these factors by RNAP
equipped with either housekeeping 70 versus stationary
phase S initiation factor. These results suggest that  sub-
units do not directly interact with the initiating co-enzymes.
We however cannot exclude that other alternative initia-
tion factors can contribute towards or against incorpora-
tion of non-canonical capping nucleotides analogues. Fur-
thermore,  region 3.2 may affect the relative efficiency
of capping by its interactions with the template DNA up-
stream of the start site, thus affecting escape into productive
elongation.
We further extended the potential bacterial RNA cap
repertoire to derivatives of UDP, the highly abundant pre-
cursors of cell wall components. Interestingly we found that
while  region 3.2 did not have effect on the incorporation
of UDG-Glc and UDP-GlcNAc, it did inhibit incorpora-
tion of a larger UDP-MurNAc pentapeptide. The protec-
tion of more complex cell wall precursor from incorpora-
tion into RNA may have biological significance. The more
complex precursors are more expensive for the cell than ini-
tial precursors UDG-Glc and UDP-GlcNAc. Furthermore,
modification of the 5′ end of RNA with UDP-MurNAc
pentapeptide may potentially lead to targeting of an RNA
to a membrane, thus affecting its expression.
K m values for NAD+ are in the range of 100–400 M on
various promoter variants, which is below published intra-
cellular concentration of 2.3 mM in exponential E. coli cells
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Figure 5. Analogues of UDP can serve as initiating substrates for RNAP in vitro. (A) Template with acnA promoter (partial sequence around transcription
start site) and acnAmod template, +1 position is in bold, 12 nt initially transcribed sequence in RNAImod is underlined. Dinucleotide synthesis on acnA
template using either RNAP holo 70 or holo 703.2, and 500 M UMP, UDP, UTP, UDP-Glc, UDP-GlcNAc and UDP-MurNAc pentapeptide as
initiating substrates and (32P)-CTP as the next nucleotide. (B) Plot below the gel represents the ratio of incorporation of indicated substrates by holo
703.2 versus holo 70, the values are an average of the two independent experiments, error bars represent plus and minus one standard deviation. (C)
Transcripts initiated with UTP, UDP-Glc, UDP-GlcNAc, are elongated to 12 nt transcript on acnAmod template. (D) Relative efficiency of incorporation
of 500 M UDP-GlcNAc in comparison to UTP into dinucleotide product on RNAImod template by WT and mutant RNAPs with aminoacid changes
in Rifampicin-binding pocket of  subunit indicated below the plot. The values are an average of the two independent experiments, error bars represent
plus and minus one standard deviation.
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grown with glucose (16). Km values for the UDP-GlcNAc
and UDP-Glc (both in the range of ∼300 M) on acnA
promoter are also far lower the cellular concentration of
these compounds (∼9 and 2.3 mM, respectively) (16), and
thus are even more favorable for RNA capping. In addition
to NudC, which was shown to uncap NAD-RNAs, there
are 13 poorly characterized NUDIX hydrolases in E. coli,
which can potentially remove capping molecules, hypothet-
ically including FAD and derivatives of UDP (7).
There might be an unexpected connection between cap-
ping (and thus potentially gene expression) and the effect of
various antibiotics. For example, inhibition of protein syn-
thesis by chloramphenicol or tetracycline, as well as inhi-
bition of cell wall biosynthesis by fosfomycin lead to sig-
nificant increase of the UDP-GlcNAc concentration (18),
potentially changing capping efficiency for transcripts pro-
duced from +1U promoters. All tested Rifampicin resis-
tant mutants of RNAP have impaired NAD+ capping ac-
tivity most likely due to an altered geometry of Rif-pocket.
Therefore the reduced fitness of Rifampicin resistant mu-
tants (19), in part, may be attributed to the altered NADy-
lation of RNA resulting in aberrant regulation of RNA sta-
bility and thus gene expression. Furthermore, subinhibitory
concentrations of Rifampicin may have different effects on
production of RNA initiated with NTP and a co-factor, as
can be seen from Figure 4A.
Overall our work provides mechanistic insight into the
process of prokaryotic capping of RNA by RNAP with the
variety of cellular cofactors in vitro.
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ABSTRACT
Recently, it was found that bacterial and eukaryotic transcripts are capped with cellular cofactors
installed by their respective RNA polymerases (RNAPs) during transcription initiation. We now show
that mitochondrial RNAP efficiently caps transcripts with ADP – containing cofactors. However, a








The discovery of non-canonical transcript
capping
Capping of RNA is no longer seen as an exclusive fea-
ture of eukaryotes, thanks to the recent discovery of
bacterial transcripts capped by NAD+ and 3 0-dephos-
phocoenzyme A (DP-CoA) [1,2]. NAD+ is the only
cap investigated in vivo in E. coli, and is found on a
number of small RNAs (sRNAs) and messenger RNAs
(mRNAs). In addition, a number of currently unchar-
acterised moieties were found attached to E.coli cellu-
lar RNA which could potentially also serve as 5’ RNA
caps [3]. The extent of NAD+ modification (NADyla-
tion) in the cell varies greatly for different RNA spe-
cies. The RNA species that are most heavily
NADylated in vivo [1] are listed on Figure 1A. Even
for these species, only a relatively small proportion of
the transcripts are capped with NAD+ (13% in the
case of most heavily NADylated species, namely
RNAI – the antisense RNA involved in the regulation
of pUC19 plasmid replication [1]). More recently
NAD+ capping was shown not to be unique for bacte-
ria, as NADylated RNAs were found in vivo in Saccha-
romyces cerevisiae and human cells [4,5].
The search for an enzyme that can potentially
NADylate RNA transcripts was relatively straightfor-
ward, as bacterial RNA polymerase (RNAP) was shown
previously to use NAD+ as an initiating nucleotide
(given its ADP moiety and free 3’ hydroxyl group) [6].
Studies by Bird et al., and Julius and Yuzenkova, using
promoter-specific assays, demonstrated that capping
can be performed by RNAP on promoters where tran-
scription starts with A [7,8]. These studies showed that
the Km for NAD
+ in transcription initiation was much
lower than the in vivo concentration of NAD+
(Figure 1B). Furthermore, Bird et al. observed a strong
correlation between the extent of NADylation of a cho-
sen transcript in vivo and the efficiency of NADylation
by RNAP in vitro [7]. Eukaryotic RNApol II was also
shown to be able to incorporate NAD+, suggesting that
the NADylated transcripts observed in vivo are also
capped by RNAP [7].
Other ADP-containing cofactors were shown to be
efficiently incorporated at the 5’ end of RNA by
RNAP, such as FAD and 3 0-dephosphocoenzyme A
(but not NADP and NADPH) [7,8]. The efficiency of
incorporation for these compounds and their concen-
tration in the cell are lower than those for NAD+, sug-
gesting that the possible abundance of these caps is
also lower [9].
Cell wall precursors are potentially another class
of prokaryotic capping molecules
Dinucleotides UDP-Glucose and UDP-GlcNAc, the
precursors of bacterial cell wall synthesis, are even more
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abundant than NAD+ in E. coli cells grown on rich
media (Figure 1B). We recently found that for pro-
moters coding for U at position +1, their RNA tran-
scripts can be efficiently capped in vitro by E. coli RNA
polymerase with UDP-GlcNAc and UDP-Glucose [8].
The relatively low Km for the incorporation of these sub-
strate at the 5’ end of the RNA transcripts by RNAP,
favours the probability of in vivo capping by UDP-
GlcNAc and UDP-Glucose, by analogy with NAD+
(Figure 1B). Although less than 10% of E. coli promoters
code for U at position +1, a link between gene expres-
sion and cell wall synthesis could be of potential signifi-
cance for coordinating biomass and cell wall synthesis.
The ability of RNAP to incorporate variety of known
nucleotide-containing molecules at the 5’ position of
transcript, as well as a number of identified but unchar-
acterised RNA modifying moieties [3], suggests the
existence of a wide repertoire of RNA caps in the cell.
At least two domains of bacterial RNAP
determine efficiency of NAD+ capping
We showed that initiation with NAD+ stabilises short
transcripts and favours promoter escape by E. coli
RNAP in vitro [8]. Whether this stabilisation comes
via additional base pairing of cap with the -1 position
of the promoter (since NAD+ has a nicotine mononu-
cleotide moiety, which may potentially interact with
DNA template at -1 position) remains somewhat con-
troversial. Bird et al. showed that the identity of the
base at position -1 (-1A vs -1C) affects the efficiency
of capping [7]. However, our data suggests that the
base at -1 affects initiation in general, without chang-
ing the preference for NAD+ [8]. Indeed, in the crystal
structure of the RNAP initiation complex with a short
NADylated transcript, the NMN moiety does not
make contacts with DNA but rather faces the protein
[7] (Figure 1C). Also, in agreement with the crystal
structure, we showed that amino acid changes in the
rifampicin-binding pocket of RNAP strongly affected
the efficiency of NAD+ incorporation, suggesting that
observed stabilisation of short capped RNAs is due to
interactions between the NAD+ cap and the RNAP
rifampicin-binding pocket [8] (Figure 1C). Therefore,
different configuration of rifampicin-binding pocket
may affect NADylation of RNA capping in different
bacteria. In contrast to NAD+, the incorporation of
UDP-containing cell wall precursors was not affected
Figure 1. A. A list of 6 heavily NAD+ modified RNA species found by Cahova et. al., [1] with half-lives reported in [22]. B. Cellular concen-
trations of nucleotides and analogs in E. coli cell reported by Bennett et. al., [9], and the Km for their usage as a substrates in transcription
initiation [8]. C. Regions of RNAP shown to influence capping efficiency. PDB 5D4D structure of Thermus thermophilus RNAP open com-
plex with NADpC was used, NAD is shown in cyan. Part of rifampicin-binding pocket corresponding to cluster I of Rif region of b subunit
is in magenta, region 3.2 of s subunit is in green, template DNA is grey, Mg2+ ions are in ruby.
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by the amino acid substitutions in the rifampicin-
binding pocket.
Cofactors bound at +1 position may potentially
interact with the 3.2 region of initiation factor s70,
which protrudes towards the RNAP active centre [10].
However, we found that a mutant version of s70 lack-
ing region 3.2 (s70D3.2) had no effect on incorporation
of NAD+, NADH, FAD, UDP-Glucose or UDP-
GlcNAc. In contrast, the mature cell wall precursor
UDP-MurNAc-pentapeptide, was incorporated by the
s 70D3.2 mutant of RNAP much more efficiently, sug-
gesting that region 3.2 of s70 may serve to prevent
incorporation of advanced cell wall precursors [8]
(Figure 1C). Region 3.2 is absent from many sigma
factors, suggesting that alternative sigma subunits may
allow capping with bulky substrates.
Decapping enzymes for non-canonical caps
The discovery of NudC (NUDIX nicotinamide pyro-
phosphohydrolase) as an enzyme that removes the
NAD+ cap from RNA made the parallel between clas-
sic eukaryotic and non-canonical capping processes
even more striking. E. coli NudC was initially
described as a housecleaning enzyme hydrolyzing the
pyrophosphate bond of NAD+/NADH to produce nic-
otinamide mononucleotide (NMN+/NMNH) and
AMP [11]. Recently, it was shown than NudC effi-
ciently removes the NAD+/NADH cap to produces
5 0-monophosphorylated RNA [1]. In eukaryotes, the
role of NudC in decapping could be played by NUDIX
hydrolases NPY1 in Saccharomyces cerevisiae and
Nudt19 in Oryza sativa, which both showed decapp-
ing activity in vitro [12]. The activity spectrum of the
bacterial NudC is relatively wide; it can remove several
ADP analogues from RNA in vitro, including DP-CoA
[7], consistent with its hydrolase activity towards a
broad range of dinucleotides [11].
Removal of cap by NudC was proposed to be the
first stage in the degradation of capped RNA to pro-
duce a monophosphorylated species, which are a pre-
ferred substrate for endonuclease RNaseE [13].
Curiously, however, NudC was not associated with
McaS (IsrA) sRNA [14], one of the most highly
NADylated sRNAs in E. coli (Figure 1A), while other
known components of the RNA degradation machin-
ery, such as RNaseE, RNA helicase RhlE and PNPase,
were present [14]. This may suggest that the involve-
ment NudC in RNA maturation might be more
complex. Differential decapping by NudC, and its
association with target RNAs, could be influenced by
the secondary structures of RNAs, as NudC is single-
strand dependent [13].
NudC is orthologous to the RppH NUDIX
hydrolase, which removes pyrophosphate from tri-
phosporylated RNA (leaving 5’ monophosphate)
[15]. A number of additional poorly characterised
NUDIX hydrolases in E. coli [16] suggests that
there might be more potential decapping enzymes
for different caps. Notably, neither NudC nor
RppH are essential for E. coli under normal growth
conditions, suggesting possible redundancy of the
decapping activities.
Human mitochondrial RNAP efficiently caps RNA
with NAD+ and other ADP-containing cofactors
Recently, mitochondrial transcripts capped with
NAD+ were detected in human cells [5]. Mitochondria
contain a major cellular pool of NAD+ (up to 70%),
where it is used for redox reactions and for signalling
[17]. We explored the possibility that mitochondrial
RNAP (mtRNAP) could cap RNA via a mechanism
that is similar to multi-subunit RNAPs. We found
that human mtRNAP (hmRNAP) efficiently initiates
transcription with NAD+, NADH, FAD and DP-CoA
on the light strand promoter (LSP; one of the only two
human mitochondrial promoters) in vitro (Figure 2).
The efficiency of initiation with NAD+ was approxi-
mately 25% compared to ATP, while the other cofac-
tors showed of between 10 to 15%. Our results suggest
that mtRNAP is likely to be responsible for adding a
NAD+ cap to mitochondrial transcripts. Capping in
human mitochondria might have consequences for
both translation and replication in these organelles.
The initially transcribed sequences from both mito-
chondrial promoters are precursors of tRNAs. It is
therefore possible that 5’ NADylation might affect
their maturation process. Additionally, RNA synthes-
ised from the LSP promoter serves as replication
primer [18], and its capping might influence initiation
of replication, primer removal and subsequent DNA
ligation.
Emerging physiological roles of non-canonical
capping
The first experimentally confirmed role for non-
canonical NAD+ cap in bacteria is an increased
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resistance to degradation, shown for RNAI in the
absence of NudC processing [7]. However, this
remains controversial, since in other studies [1] dele-
tion of NudC did not affect the overall stability of the
RNAI and GcvB populations, the two RNAs most
heavily NADylated in vivo. Moreover, overall stability
of NADylated sRNAs varies widely in wild type E.
coli, and there is no direct correlation between NADy-
lation and stability (Figure 1A). Notably, in contrast
to E. coli, NADylation in eukaryotes promotes mRNA
decay [5] via decapping by the DXO enzyme, which
might additionally supply its 5 0-3 0 degradation
activity.
The existence of subpopulations of capped RNA
may play a potential role in bistability, the creation of
phenotypic variability among clonal population that
bacteria use in processes such as dormancy, persis-
tence and sporulation [19]. Capping with dinucleotide
analogues might play role in number of regulatory
processes involving unstable regulatory RNAs. One
example of such process is the type I toxin-antitoxin
systems in bacteria, based on translational repression
of toxin mRNA by an antisense RNA. This idea is sup-
ported by high in vivo NADylation of QUAD (sib)
RNA (Figure 1A) – antitoxin sRNA preventing the
production of the small protein that depolarises the
cellular membrane [20].
The extent of capping could be responsive to the
changes in cellular metabolism. For example, in E.coli,
the proportion of NAD+ capped RNAI found in sta-
tionary phase compared to exponential phase was
two-fold higher [1]. Similarly, in yeast, more capped
RNA was found in cells grown on synthetic media
compared to those grown on the rich media [4]. Since
the NAD+/NADH balance plays key role in cellular
redox homeostasis, capping could connect transcrip-
tion directly to the cell’s redox state. Given the affinity
for NAD+ is roughly the same as for NADH
(Figure 1B), changes in their cellular concentrations
will be directly mirrored by the capping of RNA with
NAD+ or NADH. The functioning of such signalling
of course would depend on a mechanism recognising
NADylated from NADHylated RNAs. UDP-Glucose
and UDP-GlcNAc are the initial substrates for the
cascade of reactions leading to the synthesis of cell
wall components. It would be tempting to speculate
that expression of some cell wall synthesising
enzymes could be controlled directly by the pool of
Figure 2. Human mitochondrial RNAP (hmRNAP) incorporates ADP analogs in vitro. A partial sequence of the light strand promoter (LSP)
is shown, with the initially transcribed sequence underlined. For the assay, 50 nM TFAM, 50 nM hmRNAP, 50 nM TFB2M (purified as
described in [23]) were combined with 50 nM of linear DNA fragment containing LSP promoter (positions -70 to +50) in 10 ml of tran-
scription buffer (40 mM Tris pH 8.0, 10 mM MgCl2, 10 mM DTT), then ATP or ADP analogs were added to the final concentration of
1mM. Transcription was initiated by the addition of 10 mM MgCl2, 50 mM ATP, 300 mM GTP, 10mM [a
32P]-UTP, 25 Ci/mmol (Hartmann
Analytic). After 30 min incubation at 37C, 500 nM NudC was added to half of the reactions and incubated for additional 15 minutes at
37C. Transcripts modified with NAD+, NADH and DP-CoA (but not ATP or FAD) were susceptible to NudC (lanes 5,9,11) judging from
increased mobility of the products. Reactions were stopped by the addition of formamide-containing loading buffer. Products were sep-
arated on denaturing polyacrylamide gels (20% acrylamide, 3% bis-acrylamide, 6M urea, 1xTBE), revealed by PhosphorImaging (GE
Healthcare), and analysed using ImageQuant software (GE Healthcare).
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UDP-GlcNAc via capping of +1U transcripts. In gen-
eral, being rare, RNA modification with cell wall pre-
cursors might provide a better regulatory potential,
compared to ubiquitous capping with ADP analogs.
Capping might potentially influence translation ini-
tiation on a leaderless mRNA.
Another potential cellular role of capping could be
the targeting of a specific RNA species, via its cofactor
cap, to a protein with affinity for the cognate cofactor,
or to a specific subcellular location, e.g. to the vicinity
of the membrane in the case of UDP-GlcNAc capped
RNA.
Intriguingly, we showed that a number of rifampi-
cin resistant RNAPs, including the most widespread
clinical isolates, are deficient in capping [8]. This defi-
ciency may contribute to the overall fitness reduction,
characteristic for a rifampicin resistant strains [21].
To conclude, despite recent progress, the under-
standing of non-canonical RNA capping by RNAPs is
still patchy. More information is needed to put this
type of RNA 5’ modification into the category of
functional capping, rather than a side reaction of
RNAPs. Currently it is hard to envisage a “classic”
regulation by the stochastic process of capping. Never-
theless, this “unavoidable” side reaction has to be
either used to some advantage or, alternatively, fought
against. Both scenarios would have wide ranging cel-
lular consequences with multiple regulatory mecha-
nisms involved. It seems that RNAP has a limited
ability to control capping process, apart from alterna-
tive sigma factors exchange. It is more feasible to reg-
ulate amounts of capped RNA post-transcriptionally,
by the linked processes of decapping, alternative fold-
ing and RNA chaperons binding. Being a stochastic
process, capping might generate variability in a clonal
population, which can be exploited at a population
level to benefit the organism in adaptation to rapid
change in growth conditions. At present, an exact
roles of various non-canonical caps in bacteria, eukar-
yotes and mitochondria are still to be established, as
well as full repertoire of enzymes that process non-
canonically capped RNAs are to be characterised.
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Recently a new type of 50-RNA cap was discovered. In contrast to the specialized
eukaryotic m7G cap, the novel caps are abundant cellular cofactors like NAD+.
RNAs capped with cofactors are found in prokaryotes and eukaryotes. Unlike m7G
cap, installed by specialized enzymes, cofactors are attached by main enzyme of
transcription, RNA polymerase (RNAP). Cofactors act as noncanonical initiating
substrates, provided cofactor's nucleoside base-pairs with template DNA at the tran-
scription start site. Adenosine—containing NAD(H), flavin adenine dinucleotide
(FAD), and CoA modify transcripts on promoters starting with +1A. Similarly,
uridine-containing cell wall precursors, for example, uridine
diphosphate-N-acetylglucosamine were shown to cap RNA in vitro on +1U pro-
moters. Noncanonical capping is a universal feature of evolutionary unrelated
RNAPs—multisubunit bacterial and eukaryotic RNAPs, and single-subunit mito-
chondrial RNAP. Cellular concentrations of cofactors, for example, NAD(H) are
significantly higher than their Km in transcription. Yet, only a small proportion of a
given cellular RNA is noncanonically capped (if at all). This proportion is a net bal-
ance between capping, seemingly stochastic, and decapping, possibly determined by
RNA folding, protein binding and transcription rate. NUDIX hydrolases in bacteria
and eukaryotes, and DXO family proteins eukaryotes act as decapping enzymes for
noncanonical caps. The physiological role of noncanonical RNA capping is only
starting to emerge. It was demonstrated to affect RNA stability in vivo in bacteria
and eukaryotes and to stimulate RNAP promoter escape in vitro in Escherichia coli.
NAD+/NADH capping ratio may connect transcription to cellular redox state. Poten-
tially, noncanonical capping affects mRNA translation, RNA-protein binding and
RNA localization.
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1 | INTRODUCTION—DISCOVERY OF NONCANONICAL CAPPING
In the last decades knowledge of RNA functional roles was extended quite a bit from an information intermediate (mRNA),
ribosomal component (rRNA) and peptide formation (tRNA) to regulation (e.g., sRNA and miRNA), immunity and defense
(RNA interference), and signaling (e.g., toxin–antitoxin) (Chen, Kowtoniuk, Agarwal, Shen, & Liu, 2009; Liu et al., 2016;
Wagner, 2013). Overall, RNA seems to perform a much broader variety of functions than the molecule's sequence and struc-
ture conveys; some of these functions rely on RNA modifications. In search for novel RNA modifications, in 2009 the group
of David Liu found abound 30 unknown small molecule RNA conjugates in Escherichia coli (Gram negative) and Streptomy-
ces venezuelae (Gram positive) bacterial species (Chen et al., 2009; Kowtoniuk, Shen, Heemstra, Agarwal, & Liu, 2009).
Two molecules that were found in both bacteria were dephospho-coenzyme A (DP-CoA and its derivatives) and nicotinamide
adenine dinucleotide (NAD+). The latter turned out to be present at high abundance as RNA conjugate, comparable in number
to an individual tRNA (Chen et al., 2009; Kowtoniuk et al., 2009). Later NAD+ and DP-CoA were shown to be attached to
the 50-end of RNA, and a parallel between these modifications and classic eukaryotic m7G cap was drawn (Cahova, Winz,
Hofer, Nubel, & Jaschke, 2015).
In bacteria, NADylated (NAD-modified) RNA were mainly small regulatory (sRNAs) and 50-terminal fragments of
mRNAs coding for proteins involved in metabolic pathways, stress response control, and for poorly characterized proteins.
Notably, different RNAs displayed various degrees of NADylation, always much below 100%. The most frequently NADy-
lated RNA in E. coli was found to be RNAI, sRNA for replication control of ColE1 plasmids, with 13% of transcripts bearing
NAD+. More recently NAD+ capped RNAs were found in Bacillus subtilis, these were mainly mRNAs (including full length
transcripts; Frindert et al., 2018). Corresponding gene products were associated with various cellular pathways, including
DNA replication, membrane protein components, sporulation, and oxidation/reduction processes (Frindert et al., 2018).
Following prokaryotes, noncanonical capping of RNA with NAD(H) was also found in eukaryotes. In Saccharomyces cer-
evisiae NADylated RNAs were nuclear mRNAs of genes involved in translation, and mitochondrial RNAs (Walters et al.,
2017). In human cells (HEK293T, human kidney tissue) mainly small nuclear (snRNA), and small nucleolar (snoRNA) RNAs
were found to be NADylated (Jiao et al., 2017).
As it happens, the newly discovered noncanonical capping of bacterial and eukaryotic RNA challenged the old paradigm
and prompted many new questions. First of all, capping of RNA can be viewed no longer as a hallmark of eukaryotic organ-
isms. For a long time it was considered that RNA capping originated from an evolutionary time point after divergence of pro-
karyotes and eukaryotes. The finding that same noncanonical capping of RNA with cellular cofactors exists in both kingdoms
spiked the interest in the discovery in hope to find unknown, ancestral mechanisms and pathways. Conservation of this cap-
ping process might imply a functional significance beyond evolutionary ancestry, possibly as previously unrecognized univer-
sal mechanism of epigenetic gene expression regulation (Kiledjian, 2018).
The classic cap, methylated guanosine (m7G) caters to a sum of functions that are specific to eukaryotes, such as nuclear
exit, RNA splicing and assembly of the eukaryotic translation initiation complex (Topisirovic, Svitkin, Sonenberg, & Shatkin,
2011). Potential (common) functions of noncanonical caps in bacteria and eukaryotes are currently actively explored.
2 | THE MECHANISM OF NONCANONICAL CAPPING—INCORPORATION BY RNA
POLYMERASE IN TRANSCRIPTION INITIATION
First reports describing the noncanonical capping mechanism were conflicting, as Liu group proposed a posttranscriptional
mechanism, similar to classical, eukaryotic capping (Chen et al., 2009; Kowtoniuk et al., 2009). However, other groups pro-
posed transcription initiation (Bird et al., 2016; Julius & Yuzenkova, 2017) as main mechanism (scheme in Figure 1a).
The latter proposition was consistent with a publication about 40 years ago by Malygin and Shemyakin (1979), who used
E. coli RNA polymerase (RNAP) to promoter-independently synthesize short transcripts initiated with NAD(H) or flavin ade-
nine dinucleotide (FAD). Modern works (Bird et al., 2016; Julius & Yuzenkova, 2017) showed that E. coli RNAP initiates
transcription with NCINs (noncanonical initiating nucleotides, NAD+, DP-coA, and FAD) on a specific promoter with A at
+1 position, and where cofactor base-pairs with template with its adenine moiety.
Transcriptional mechanism of noncanonical capping is now established for E. coli RNAP, yeast RNAP II (both are multi-
subunit RNAPs) as well as T7 and human mitochondrial RNAP (evolutionary unrelated single-subunit enzymes) (Bird et al.,
2016; Huang, Bugg, & Yarus, 2000; Julius, Riaz-Bradley, & Yuzenkova, 2018). Given the universality of capping, it is not
unreasonable to suggest that all three types of eukaryotic RNAPs (including RNA PolI and PolIII) can incorporate NCINs; the
corresponding transcripts were never captured, presumably because they are processed and capped 50 fragments are quickly
degraded.
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Figure 2 contains a list of caps with corresponding capping and decapping mechanisms. NAD(H) capping is the most char-
acterized and most widespread, most probably due to a combination of its high availability in different types of cells and high
efficiency of incorporation into RNA (see Box 1). Km to NAD
+ and NADH in transcription initiation by E. coli RNAP (~0.36
and ~0.38 mM, correspondingly) (Julius & Yuzenkova, 2017), are much lower than intracellular concentration, explaining its
efficient incorporation into cellular RNA.
Another abundant metabolite in the cell is uridine-diphosphate N-acetylglucosamine (UDP-GlcNAc) (Bennett et al.,
2009). By analogy to adenine-containing molecules, UDP-GlcNAc as well as another abundant cell wall precursor and metab-
olite, UDP-glucose (UDP-Glc) were found to initiate transcription on +1U promoters (Julius & Yuzenkova, 2017). Km of their
incorporation by E. coli RNAP (~0.33 or ~0.3 mM, respectively) are well below their intracellular concentration in E. coli of
around 9 mM (Bennett et al., 2009) indicating that capping with cell wall precursors is likely to take place in the cell (Box 1).
3 | A CLOSER LOOK—PROMOTER DNA AND RNAP STRUCTURAL DOMAINS AS
DETERMINANTS OF CAPPING EFFICIENCY
Publication of a crystal structure of Thermus thermophilus RNAP in complex with template DNA and NADpC short transcript
(RNA product of extension of NAD+ with CTP) stimulated mechanistic characterization of capping process. Structure of the
complex revealed NAD+ positioned in vicinity of a template strand of DNA and β-subunit amino acid residues of rifampicin-
binding pocket (Rif-pocket; Bird et al., 2016) (Figure 3).
Since NAD+ is nucleotide, its NMN moiety can make contacts with −1 position of the template DNA (relative to tran-
scription start site [TSS]). Indeed, base in −1 position of the template was shown to affect efficiency of NAD+ incorporation,
even though it does not seem to contact NAD+ in the crystal (Bird et al., 2016). Presumably during initiation transient base-
pairing of template with nicotinamide adenine moiety may occur. The moderate effect of −1 base on the efficiency of NAD+
capping was also observed in B. subtilis (Frindert et al., 2018).
Recently, Vvedenskaya et al. (2018) described a promoter element around +1A, with consensus sequence
H−3R−2R−1A+1S+2W+3W+4, which affects capping with NAD
+ in context of particular E.coli promoter (ptac, hybrid between
placUV5 and ptrp promoter; de Boer, Comstock, & Vasser, 1983). Exchange of each one individual position to the anti-
consensus nucleotide (e.g., H to G) results in only 1.2- to 4.1-fold decrease in cofactor incorporation, yet the exchange of
whole element to anti-consensus sequence G−3Y−2Y−1A+1W+2S+3S+4 decreased likelihood of NAD
+ incorporation 40-fold.
The effect therefore does not seem to be additive, but rather cumulative, suggesting that it is the underlying DNA curvature or
duplex stability which affect NAD+ incorporation.
Another structural determinant of noncanonical capping in E. coli is the Rif-pocket of RNAP. Amino acid changes in Rif-
pocket of E. coli RNAP show reduced ability to perform NADylation, especially mutation of the residue 516, in close vicinity
to NAD+ on the crystal structure (Figure 3; Julius & Yuzenkova, 2017). Rifampicin-resistant mutants commonly display a
characteristic reduced fitness phenotype (slow growth, increased heat-sensitivity, altered colony morphology) (Brandis,
Pietsch, Alemayehu, & Hughes, 2015). Possibly, the reduced ability to cap RNA might contribute to this phenotype. The Rif-
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(b) Noncanonical cap removal
FIGURE 1 Schematic representation of noncanonical capping and decapping. (a) RNA polymerase (RNAP) creates a capped transcript by using the small
molecule as initiating substrate instead of canonical nucleoside triphosphate. This small molecule contains a nucleoside diphosphate (here adenosine
diphosphate), and another moiety X bound to β-phosphate. RNAP uses incoming nucleoside triphosphate substrates (pppN) to elongate RNA chain, and
moiety X is retained as noncanonical cap. (b) Cap removal in bacteria is performed by NUDIX hydrolase NudC, which hydrolyses the phosphate bond
between monophosphate-moiety and monophosphate-RNA. DXO decapping enzymes in eukaryotes removes the complete cap (XppA, containing nucleotide
moiety of the protein) from the residual RNA molecule. In both cases the product is 50-monophosphorylated RNA
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pocket is the site where the nascent transcript passes through the holoenzyme away from the active center of RNAP towards
RNA exit channel (Campbell et al., 2001). Presumably interactions of NAD+ with amino acid residues of Rif-pocket stabilize
capped transcript. This stabilization, along with additional template DNA contacts of NAD+, provides plausible explanation
for observed positive effect of capping on RNAP escape from RNAI promoter (Julius & Yuzenkova, 2017).
Addition of subinhibitory concentrations of rifampicin to a transcription reaction leads to reduction of RNA elongation
(Campbell et al., 2001) and thus promotes release of abortive products. NAD+ initiated transcripts are much less sensitive to
the same low concentrations of rifampicin on RNAI promoter, suggesting that capped transcript might somewhat compete
with the drug for binding in the pocket (Julius & Yuzenkova, 2017). In contrast to E. coli, analogous Rif-pocket mutations
RNAP in B. subtilis, did not affect capping with NAD+ in vitro or in vivo, suggesting different conformation of capped tran-
scripts and/or Rif-pocket of B. subtilis RNAP (Frindert et al., 2018).
Initiation factor σ70 region 3.2 (also called “sigma finger”) protrudes into the RNAP active center during initiation, and is
known to affect incorporation of initiating substrates (Kulbachinskiy & Mustaev, 2006). It can perhaps influence incorporation
of some NCINs. Indeed, its deletion was shown to enable the incorporation of the bulky uridine-containing cell wall precursor
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FIGURE 2 Comparison of classic and noncanonical capping of RNA
Note. From top to bottom: The classic eukaryotic m7G cap is attached co- or posttranscriptionally by a number of specialized enzymes. The process involves
dephosphorylation of 50-triphosphorylated RNA transcript, followed by transferase reaction to attach GTP to the 50-terminal diphosphate (along with
pyrophosphohyrolysis), and finally methylation of guanosine nucleotide. Here, the “inverted” nucleotide serves as the protective structure. Cap removal is
performed by NUDIX hydrolases (mainly Dcp2), or DXO proteins. ADP-containing cofactors, here NAD+, FAD, and DP-CoA, can be utilized by RNAP in
transcription initiation to form the 50-end of the transcript on promoters where synthesis starts with A (+1 promoters). The rest of the molecule (e.g., NMN of
NAD+) serves as the protective structure. Likewise, on +1U promoters UDP-containing cell wall precursors, such as UDP-Glc or UDP-GlcNAc, can
substitute for UTP in transcription initiation in vitro. The NCIN-caps are removed by NUDIX hydrolases in bacteria, and NUDIX hydrolases or DXO proteins
in eukaryotes. RNAP: RNA polymerase
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UDP-N-acetylmuramic acid pentapeptide (UDP-MurNAc-AA5), suggesting that σ finger acts as sterical hindrance for incor-
poration of large-molecule caps (Julius & Yuzenkova, 2017). Not all σ factors have a region 3.2; thus, alternative σ factors
might potentially alter capping activity of the holoenzymes and preference for particular NCINs. Yet, no difference was found
between incorporation of NAD+, NADH, FAD in vitro by E. coli holoenzymes with either housekeeping σ70 factor or station-
ary σS (Julius & Yuzenkova, 2017).
No additional transcription factor has yet been described to affect noncanonical capping. Possibly, on promoters sensitive
to concentration of initiating substrates, and responsive to ppGpp during formation of transcription–competent complex (Ross
et al., 2016; Rutherford et al., 2007), capping could be influenced by DksA protein.
Transcription factor binding, promoter curvature, choice of initiation σ factor, mutations in Rif-pocket, and other promoter
and RNAP-features might have a cumulative effect and contribute to variances in proportions of NADylated species for differ-
ent RNAs. Same factors, combined with differences in cellular concentration, are likely to contribute to the higher copy num-
ber of NADylated RNA (>3,000 per cell) as opposed to DP-CoA capped RNA (50–200 copies per cell) (Chen et al., 2009;
Kowtoniuk et al., 2009). Yet, currently the extent of noncanonical capping for any transcript cannot be predicted reliably, and
overall percentage of capped RNA is net balance between capping and decapping.
BOX 1
NAD+ concentrations in different cell types and cell compartments
NAD+ is likely among the most abundant noncanonical RNA capping molecules, due to its high availability in the cell.
In E. coli cells grown on glucose NAD+ concentration is 2.6 mM (Bennett et al., 2009). At least twice higher NAD+
concentrations were reported for Klebsiella aerogenes, Clostridium welchii, and Staphylococcus albus (Wimpenny &
Firth, 1972). In yeast values differ between 0.5 and 2.4 mM (Agrimi et al., 2011; Mei & Brenner, 2014). In mammalian
cells cytosolic NAD+ pool is 0.1–0.8 mM (Canto et al., 2015; Koch-Nolte et al., 2011; Stein & Imai, 2012). Mitochon-
drial NAD+ levels are generally high and in many types of cells they contain major share of NAD+ pool, for example,
70% in heart muscle cells and 50% in neural cells (Stein & Imai, 2012). The mammalian nuclear NAD+ concentration is
lower: 0.07–0.1 mM (Canto et al., 2015; Koch-Nolte et al., 2011).
In comparison, most NAD+-utilizing enzymes have a Km in the micromolar range (Bennett et al., 2009; Canto et al.,
2015). For example mammalian lysine deacylases SIRT4 and SIRT5 have 0.035 and 0.98 mM Km for NAD
+, corre-
spondingly (Canto et al., 2015). Km of RNAP for NAD
+ in transcription initiation is 0.36 mM, in the same range as for









FIGURE 3 Structural features of the capping complex. crystal structure of the initiation complex with NADpC (only nicotinamide adenine dinucleotide
[NAD+] is shown) product with Thermus thermophilus RNA polymerase (RNAP), adapted from PDB ID: 5D4D (Bird et al., 2016). The NAD+ (pink) is
positioned in vicinity to DNA template (gray) −1 position, RNAP catalytic site (indicated by Mg2+ ions), region 3.2 of σ (blue) and part of the rifampicin
(Rif )-binding pocket (lilac) of RNAP β subunit. The residues closest to NAD are βF514, βD516, and βT518
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4 | MECHANISMS FOR NONCANONICAL CAPS REMOVAL
Classic m7G cap is predominantly removed by NUDIX family hydrolase Dcp2. Mammalian genomes contain a high number
of NUDIX proteins, and many of them exhibit m7G decapping activity: Nudt3 and Nudt16 NUDIX hydrolases decap in vivo
and Nudt2, Nudt12, Nudt15, Nudt17, and Nudt19 at least in vitro (Kiledjian, 2018). The NUDIX hydrolases are pyrophospho-
hydrolases that act on substrates of general structure Nucleoside DIphosphate linked to another moiety X. The NUDIX box
common to all NUDIX family members comprises the catalytic amino acids sequence GX5EX7REUXEEXGU
(Abbondanzieri, Greenleaf, Shaevitz, Landick, & Block, 2005; McLennan, 2006) where the central glutamate residues interact
with a divalent cation. Many NUDIX hydrolases possess a zinc-binding motif, which can serve for protein dimerization.
The first enzyme found to remove noncanonical caps was E. coli NUDIX hydrolase NudC (Hofer et al., 2016; Jaschke,
Hofer, Nubel, & Frindert, 2016), acting on NADylated RNAs (Figure 1b). Previously, it was known as housecleaning enzyme
for NAD(H), recycling it to NMN and AMP. It forms a homodimer, and binds one NAD+ molecule per monomer as deter-
mined by Hofer et al. (2016) and Zhang et al. (2016). The current data on NudC present a conundrum. NudC was shown to
act preferentially on capped RNA rather than on NAD(H) substrate in vitro. Also, NudC strongly prefers single - stranded
RNA. Yet, mutation studies of NudC demonstrated that it interacts with the NAD+-moiety of RNA and not an RNA stretch
(Hofer et al., 2016; Zhang et al., 2016) in vitro. This is probably helpful to avoid specific interactions with RNA, but creates a
problem in vivo for recognition of capped RNA on a background of NAD(H) excess. Perhaps, by analogy with eukaryotic
decapping enzymes, additional adaptor proteins are needed for noncanonical decapping. Another possibility is that NudC acts
co-transcriptionally and some yet unknown factors might regulate its activity in connection to RNAP discontinuous movement
and RNA synthesis, folding and translation.
The possible number and diversity of NCIN caps is reflected by the finding of a high variety of potential decapping
enzymes. E. coli encodes 13 different NUDIX hydrolases, many insufficiently characterized. The conserved motif
SQPWPFPXS classifies most NUDIX hydrolases also as NADH hydrolases (Zhang et al., 2016), thus perhaps a functional
overlap exists between different E. coli NUDIX hydrolases, and this overlap could account for the moderate increase of
NADylation of RNAI found in ΔnudC strain compared to the wild type E. coli strain (26% vs. 13%) (Cahova et al., 2015).
Among E. coli NUDIX enzymes RppH is viewed as decapping enzyme of the sort, since it hydrolyses 50-triphosphate of RNA
producing quickly degradable 50-monophosphorylated RNA species (Vasilyev & Serganov, 2015).
While there is no NudC ortholog in B. subtilis, the RppH ortholog BsRppH was recently shown to have both pyrophos-
phate removal and NMN-removal activity in vitro (Frindert et al., 2018). Yet, deletion of BsRppH did not affect the level of
NADylated RNAs in vivo, suggesting that NADylated RNA is not an in vivo target of BsRppH. Therefore, it is unclear
whether the reported effect of BsRppH deletion on expression of about 600 different genes in B. subtilis was due to absence
of its pyrophosphate—or NMN—removal activity (Frindert et al., 2018).
Besides NUDIX hydrolases, in eukaryotes also the DXO family is known to function as decapping enzymes with activity
both on m7G cap as well as NAD+ cap (Figure 1b). However, DXO cleaves different phosphodiester bond, and removes the
complete cap structure as opposed to removal of nicotinamide mononucleotide (NMN) moiety of NAD+ by NudC (Jiao et al.,
2017) (see Figure 1). Dcp2, Nudt3, and Nudt16 cleave the triphosphate linkage between cap and RNA (Kiledjian, 2018). Thus
the mechanisms so far known for mammalian and bacterial NAD-decapping differ. A DXO-equivalent in prokaryotes has not
been found to date.
Mitochondrial decapping enzymes have not yet been reported, although at least six NUDIX hydrolases are targeted to this
organelle in mammals (Mildvan et al., 2005). One of them, Nudt13 has a strong affinity to NADH and NADPH, and might
act as de-capping enzyme for NADylated mitochondrial transcripts (Abdelraheim, Spiller, & McLennan, 2017).
5 | POTENTIAL FUNCTIONAL IMPLICATIONS OF NONCANONICAL CAPPING
5.1 | NCIN capping and RNA stability—up or down regulation?
The first experimentally confirmed global in vivo role for noncanonical NAD+ cap so far is its effect on RNA stability. This
effect is strikingly opposite for bacteria and eukaryotes—in E. coli NAD+ cap increases RNAI stability (in the absence of
NudC; Bird et al., 2016), in S. cerevisiae NADylation promotes mRNA decay via decapping and 50–30 degradation activity of
DXO enzyme (Jiao et al., 2017).
We expect, perhaps intuitively, these effects to be similar, and the cap to play a universal protective role. Probably differ-
ence between kingdoms might actually stem from different experimental conditions, that is, crucial absence of decapping
enzyme, NudC in case of bacteria, leading to specific stabilization of capped RNA. Notably, in work of Cahova et al. (2015)
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NudC deletion did not affect the overall stability of RNAI and GcvB populations, two RNAs most heavily NADylated
in vivo. In general, overall stability of NADylated sRNAs varies widely in wild type E. coli (see Table 1).
The nature and structure of the 50-end of RNA plays crucial role in RNA turnover in both bacteria and eukaryotes. Most
eukaryotic RNases are 50–30-exonucleases. Therefore, one of the first steps of eukaryotic mRNA degradation is decapping
(Kushner, 2004).
Although the main degradation enzyme in E. coli RNase E is an endonuclease, it has a preference for RNA substrates with
50-monophosphate ends. Therefore, capped RNA degradation might rely on processing with NUDIX hydrolases to yield a
monophosphorylated 50-end. Similarly, B. subtilis endo- and 50–30-exonuclease RNase J1 demonstrated a preference for 50-
monophosphorylated RNA (Yao, Sharp, & Bechhofer, 2009). NAD+ cap inhibits RNase J1-mediated degradation to a similar
extent as the 50-triphosphate (Frindert et al., 2018).
In E. coli, the main breakdown machinery for RNA forms a degradosome (Mohanty & Kushner, 2016; Silva et al., 2011).
This multiprotein complex comprises main endoribonuclease RNase E, exoribonuclease and polyadenylation enzyme PNPase,
RNA helicases, and enolase. However, neither of prokaryotic decapping enzymes—RppH nor NudC are associated with
degradosome. Perhaps, decapping enzyme(s) interact only transiently with degradosome. The finding that most bacterial
NADylated transcripts besides sRNAs are 50-fragments of mRNAs (Cahova et al., 2015) might imply that the found mRNA
TABLE 1 Examples of sRNAs highly NADylated in vivo, sorted by half-life






vivo (%) Function References
RNA1 cis RNA2 Rop 1 13 ColE1 replication control Cahova et al. (2015) and
Tamm and Polisky
(1985)
GlmY trans GlmZ PAPI 1.4 1.6 Peptidoglycan synthesis
pathway
Cahova et al. (2015),
Reichenbach
et al. (2008), and
Vvedenskaya
et al. (2018)
GcvB trans CycA CsrA 2 2 Peptide/aa transport,
glycine transport






CopA trans CopT n.d. 3 n.d., highly enriched
for NAD+
r1 plasmid replication Cahova et al. (2015) and
Gerhard, Wagner, and
Nordstrom (1986)





Cahova et al. (2015) and
Fozo (2012)
McaS trans YdeH, YdcT Hfq and CsrA 20 5.1 Biofilm regulation Cahova et al. (2015),
Jorgensen
et al. (2013), and
Vvedenskaya
et al. (2018)
DsrA trans RpoS, Hns,
MreB, RbsD





Cahova et al. (2015),
Cayrol et al. (2009)
and Wu et al. (2017)
ChiX trans ChiP Hfq 27 1.6 Regulation of outer
membrane channel
Cahova et al. (2015),





GadY trans/cisa GadX, GDS Hfq/Hfq-independenta n.d. 3.9 pH stress response Bird et al. (2016),
Cahova et al. (2015),
Negrete and Shiloach
(2015), Opdyke
et al. (2011), and
Vvedenskaya
et al. (2018)
Note. Stability of RNA does not seem to correlate with NADylation percentage (cells shading reflects the magnitude of these parameters). NADylated transcripts were
detected either by NAD-captureSeq (Cahova et al., 2015) or CapZyme-Seq (Vvedenskaya et al., 2018). Percentage of capping was calculated by Vvedenskaya
et al. (2018) (except for RNAI). Highly enriched RNA species were found by Cahova et al. (2015) (exact percentage of NADylation is not known). A further feature is
interaction with RNA chaperones, such as Hfq, or other protein partners. n.d.: not determined.
a Conflicting data.
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fragments are degradation intermediates, thus degradation would have started despite the presence of cap. This could indicate
that at least in some cases noncanonical cap in bacteria can promote degradation, just like in eukaryotes (Kiledjian, 2018).
Possibly, the cap leads to a yet undefined degradation pathway in bacteria. Alternatively, found fragments might belong to
RNA substrates which RNaseE processes via alternative, 50 independent “direct entry” mechanism (Bouvier & Carpou-
sis, 2011).
Capping might affect RNA stability indirectly via polyadenylation. While polyadenylation in eukaryotes serves as a stabi-
lizing structure, in prokaryotes the addition of the poly(A) tail initiates RNA degradation (Kushner, 2004). Likely, all bacterial
RNAs could be polyadenylated at some point (Sarkar, 1996). Due to main poly(A)-polymerase PAPI preference for monopho-
sphorylated substrates (Feng & Cohen, 2000), NCIN-capping might inhibit polyadenylation. Moreover, polyadenylation inhi-
bition might further decrease efficiency of degradation since poly(A)tail is required for RNA 30–50-degradation (Mohanty &
Kushner, 2016). Furthermore, the polyadenylation state of RNA affects its regulation by sRNAs. For example, RNA chaper-
one Hfq pairs trans-acting sRNAs with their target mRNAs, and has a preference for binding of poly(A) tail structures
(Mohanty & Kushner, 2016; Silva et al., 2011; Wagner, 2013). Therefore, repression of polyadenylation by NCIN-caps could
modulate effectivity of sRNA regulation. Overall, the net result on RNA stability of noncanonical capping and polyadenyla-
tion combination might vary for different RNA species.
It is possible that noncanonical decapping processes are influenced by modifications on adjoining base(s) of RNA, just like
the m7G cap. 30% of eukaryotic cellular RNA carries methyl group on the first nucleotide of the transcript adjacent to the cap,
and many transcripts are di- and tri-methylated. On methylated RNAs noncanonical cap might resists de-capping by NUDIX
hydrolase Dcp2, similarly to the classical cap (Kiledjian, 2018; Mauer et al., 2017).
5.2 | Potential effect of noncanonical capping on translation initiation
Significant number of NADylated mRNAs was identified in E. coli, B. subtilis, and S. cerevisiae (Cahova et al., 2015; Frindert
et al., 2018; Walters et al., 2017). The eukaryotic m7G cap is an important structural feature of assembly of the translation ini-
tiation complex (Ramanathan, Robb, & Chan, 2016). Notably m7G is replaceable by artificially generated alternative cap
structures (e.g., m7Gp3m
7G) some of which can inhibit or promote translation initiation (Grudzien et al., 2004). It was shown
that different GTP analogs attached during classic eukaryotic capping in vitro were more stable than uncapped RNA after
transfection into HEK293 cells. However, most of the unnatural caps were not recognized by the translation machinery (Issur,
Bougie, Despins, & Bisaillon, 2013). Apparently, in eukaryotic translation NAD+ cap does not function as classic m7G cap.
Experiments with luciferase reporter gene in cell culture have revealed that presence of NAD+-cap results in translation levels
similar to uncapped (50-triphosphorylated) RNA (Jiao et al., 2017).
How noncanonical capping affects translation of mRNAs in bacteria is yet unknown. Most probably it does not affect
translation initiation on mRNAs with ribosomal binding sites downstream of TSS. On the other hand, regulation via caps at
the 50-end of leaderless mRNA, in other words, with NAD+ UG starting codon instead AUG, is very possible. On leaderless
RNA, the AUG codon is the necessary and sufficient recognition signal for ribosome binding (in complex with IF2 and
fMettRNA) which can lead to successful translation initiation (Moll, Grill, Gualerzi, & Blasi, 2002). It remains to be deter-
mined whether capping stimulates or inhibits ribosome binding, or translation initiation on capped RNA relies on the presence
of additional factors. Translation regulation by noncanonical capping in bacteria is likely, since many bacteria encode high
numbers of leaderless transcripts, for example, one third of mycobacterial transcripts are leaderless (Shell et al., 2015). The
same is relevant for mitochondria, where mRNAs are generally leaderless (Jones, Wilkinson, Hung, Weeks, & Spre-
mulli, 2008).
5.3 | Capping and regulatory sRNAs functions of bacteria
sRNAs are the most frequently NADylated RNAs in E. coli (Cahova et al., 2015; Vvedenskaya et al., 2018). Table 1 sums up
known half-lives, interaction partners and functions of several sRNAs which were shown to be highly NADylated in E. coli.
Percentage of NADylated species, if known, is from Cahova et al. (2015) and Vvedenskaya et al. (2018). These RNAs do not
seem to share many common features in terms of their half-life, cis or trans mechanism of action (see below) or their ability to
bind RNA chaperones, such as Hfq.
Cis-acting sRNAs are encoded on the anti-sense strand of their target mRNA and have complete sequence homology, thus
they are specific to their particular mRNA. This type of regulation is often found to control copy number of plasmids or trans-
posons (Waters & Storz, 2009). One example for the cis-acting sRNA is RNAI, the most highly NADylated RNA in E. coli
(Cahova et al., 2015). RNAI regulates the replication of plasmid ColE1 by sequestering the ColE1 replication primer
(Tamm & Polisky, 1985).
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Many bacteria use regulatory toxin-antitoxin systems. They consist of a stable toxin protein, and an unstable antitoxin. In
Type I systems antitoxin is sRNA acting in antisense to repress translation of toxin mRNA (Berghoff & Wagner, 2017). Both
antitoxin sRNA and toxin mRNAs stability can be affected by noncanonical capping. Indeed, one of the highly NADylated
RNA examples in Table 1 is QUAD (sib) sRNA—antitoxin sRNA preventing expression of small protein depolarizing cellular
membrane (Fozo, 2012).
Trans-acting sRNAs are generally transcribed from another location than their target mRNA. The sequence homology is
limited and many trans sRNAs have several target RNAs. RNA chaperone Hfq frequently mediates between sRNA and target
mRNA. Trans sRNAs act as translational silencers, binding and occluding the RBS or other regions in the 50-UTR of the
mRNA (Waters & Storz, 2009). One example of a trans-acting sRNA is GcvB, shown to be highly NADylated in vivo
(Cahova et al., 2015). It binds mRNA upstream of the translation start site, resulting in degradation of dsRNA (Waters &
Storz, 2009). Trans sRNAs are often regulated by a specific transcription factor in response to the environmental conditions
(e.g., GcvB transcription factor GcvA is part of elevated glycine response), and they pass on this response by translation con-
trol of their various targets (Waters & Storz, 2009).
It was shown (Malecka, Strozecka, Sobanska, & Olejniczak, 2015) that interaction with RNA chaperone Hfq is influenced
by the 50-terminus of sRNA. Hfq can form a complex with PNPase, PAPI, and RNase E for the purpose of maturation or deg-
radation of polycistronic transcripts (Mohanty & Kushner, 2016). Interestingly, many examples of sRNAs that bind Hfq
strongly and thus have the tendency to displace more weakly bound sRNAs on Hfq, are also among the most frequently
NADylated sRNAs identified (Cahova et al., 2015), for example ChiX and DsrA. Notably, ChiX is a very stable RNA
(Table 1), its features that confer resistance to degradation are yet unknown; to date ChiX is the only known prokaryotic cata-
lytic sRNA (Mandin & Gottesman, 2009). Another frequently NADylated sRNA, McaS, binds to Hfq, as well as to global
RNA-binding protein CsrA (Malecka et al., 2015). Table 1 describes some further examples of NADylated sRNAs and their
function and interaction partners.
We can hypothesize that other regulatory functions of RNA could be modulated by NCIN-capping. For example, “RNA
thermometers” and riboswitches (cis-acting regulatory elements in the 50-UTR that bind ligands) assume a secondary structure
in response to environmental stimulus, can bind ligands and modulate translation (Waters & Storz, 2009). Riboswitches form
large complex secondary structures, the 50-terminus can be either included in this structure, or remains single stranded, con-
tributing to the “on” or “off” conformation of the switch (Montange & Batey, 2008). It would be interesting to see if/how non-
canonical capping might affect regulation. Perhaps, the formation of a dsRNA region could be affected by presence of the
cofactor moiety, possibly destabilizing/stabilizing one of the alternative conformations. Also, presence of a nonnucleotide
moiety in vicinity to the riboswitch ligand binding site could affect its binding (Montange & Batey, 2008).
5.4 | Noncanonical cap-dependent RNA localization
Another potential outcome of noncanonical capping could be RNA targeting via its cap to a specific protein with affinity for
the cognate cofactor or to a specific subcellular location. For a long time it was thought that mRNA co-localizes with the bac-
terial nucleoid, since translation is coupled with transcription (Vogel & Jensen, 1994). Yet more recently it was found that
indeed only 4% of translation complexes are coupled and co-localized with transcription (Buskila, Kannaiah, & Amster-Cho-
der, 2014). Moreover, a number of mRNAs in E. coli, independently from their translation, were found localized to intracellu-
lar sites of their encoded proteins (Nevo-Dinur, Nussbaum-Shochat, Ben-Yehuda, & Amster-Choder, 2011).
The mechanism of mRNA localization is unknown, and simple diffusion through the cytoplasm is unlikely the only mode
of transport for RNAs, which can be bulky (especially in complex with RNA-binding proteins). In eukaryotes, RNA is
believed to display cis-acting localizing elements, or “zip-codes” in untranslated regions. Their mechanism of action is unre-
solved (Buskilay et al., 2014). In light of mRNA colocalization with proteins, the case of RNA capped with cell wall precur-
sors (Julius & Yuzenkova, 2017) is potentially interesting. UDP-Glc and UDP-GlcNAc are present at high concentrations in
the cell and are turned over frequently (Konopka, 2012). It is possible that diffusion of these molecules throughout the cell
facilitates their incorporation into RNA, and their association to the cell wall and interaction with proteins in the cell periphery
might transport or “tag” the transcript towards the bacterial inner membrane.
5.5 | Protein–NCIN capped RNA interactions
Besides RNA-binding proteins like RNases, Hfq, and CsrA, many protein enzymes involved in metabolism interact with
RNA. Also, nucleoside containing molecules such as the adenine-containing cofactors (NAD+, NADH, FAD, DP-CoA, and
more) are often bound by enzymes of metabolism. In eukaryotes, growing number of metabolic enzymes are found to “moon-
light” as RNA-binding proteins (Castello, Hentze, & Preiss, 2015). It is tempting to speculate that at least some of these
protein-RNA interactions happen with assistance of a noncanonical cofactor cap.
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5.6 | Noncanonical capping and metabolism
Since NAD+ /NADH balance reflects cellular redox homeostasis, capping could connect transcription directly to redox state,
as affinity in transcription for NAD+ is roughly the same as for NADH (Julius & Yuzenkova, 2017).
In addition, the overall extent of capping depends on metabolic state of the cell. For example, in stationary phase E. coli,
two-fold higher proportion of NADylated RNAI was found (Bird et al., 2016). Likewise, in yeast grown on synthetic media
more RNA molecules are capped compared to the rich one (Chen et al., 2009).
Similarly, cell wall metabolism could potentially affect transcription on +1U promoters. UDP-Glc and UDP-GlcNAc are
precursors for peptidoglycan synthesis in bacteria. Their incorporation as NCIN-cap by bacterial RNAP was shown in vitro,
and might be responsive to the concentration of those molecules in vivo. Furthermore, pool of UDP-GlcNAc might control
expression of some cell-wall-making enzymes via capping of +1U transcripts. Inhibition of cell wall synthesis by antibiotics
would increase the precursor pool and probably provide feedback for cell wall making enzymes expression.
5.7 | Alternative model for noncanonical capping: Post-transcriptional
When the first noncanonical caps DP-CoA and NAD+ were identified in 2009 (Chen et al., 2009; Kowtoniuk et al., 2009), the
authors proposed a posttranscriptional mechanism for attachment of NAD+ and DP-CoA caps. Later transcription initiation
was identified as a major noncanonical capping mechanism. However, the possibility of an additional mechanism involving
enzymes other than RNAPs, should not be entirely dismissed. Jiao et al. (2017) proposed that at least in mammalian cells, an
alternative “NADing” mechanism occurs. Their hypothesis was fuelled by the finding that small nucleolar RNAs (snoRNAs)
and small Cajal body RNAs (scaRNAs) frequently carry an NAD+ modification. These RNAs are susceptible to DXO-
mediated “deNADing” and predominantly generated by processing of a transcript. However, at least snoRNAs are known to
be transcribed in various ways, and some are transcribed from an independent promoter, rather than generated via processing
(Dieci, Preti, & Montanini, 2009). Therefore, the RNAP might still be responsible for capping of these RNAs. Nevertheless,
we should keep in mind that the view that RNAP incorporation is the main if not the only capping mechanism is based on the
observation that an extent of in vivo capping correlates with in vitro efficiency of NAD+ incorporation by RNAP in just sev-
eral cases (Bird et al., 2016). Therefore, currently we do not have any basis to convincingly rule out a transcription-
independent capping mechanism.
Intriguingly, protein-independent mechanism for producing RNAs with cofactors attached to 50-end exists (Huang et al.,
2000). Ribozymes able to make NAD+, FAD, and CoA capped RNA, by attaching small molecule precursors to a 50-terminal
ATP were evolved in vitro. This ribozyme activity is consistent with the conservation of the nucleotide containing coenzymes
throughout all types of cells, since cofactors might be viewed as evolutionary remnants of “RNA world” (White, 1976). Hypo-
thetically, the ribozyme reactions might once have been the main pathway, and could also today still be working unrecognized
in in vivo synthesis of capped RNA.
6 | CONCLUSION: NONCANONICAL CAPPING—STOCHASTIC EVENT OR REGULATED
PROCESS?
The very universality of noncanonical capping—an ability of unrelated multi- and single-subunit RNAPs to incorporate
NCINs efficiently, poses a question whether this type of capping is just a stochastic process, side reaction of transcription
stemming from relaxed substrate specificity of RNAPs for initiating substrate. Kiledjian (2018) argues that RNAP infidelity of
incorporation could not account for the observation that different RNAs show different levels of NADylation. Yet, based on
currently available data it is hard to envisage mechanism for capping regulation at the stage of NCINs incorporation, espe-
cially given the considerable excess of substrates (see Box 1) in comparison to Km for them in transcription initiation, and
weak consensus for promoters (i.e., lack of specific features) for NAD+ incorporation, at least in E. coli (Veedenskaya et al.,
2018). Kiledjian (2018) proposes to vary cellular NAD+ concentrations to determine if NAD incorporation is a stochastic or a
specific event. The verification of functional roles of the caps in vivo is likely the only way to prove that NCIN-capping is a
regulatory event and not a simple side reaction of transcription.
Nevertheless, even if NCINs incorporation is entirely stochastic event, cells have to deal with it—use it or fight against it.
Universality of noncanonical capping is mirrored by widespread occurrence of NUDIX and DXO families of (potential)
decapping proteins in prokaryotes and eukaryotes. Members of DXO decapping family are involved in general 50-end RNA
quality control (Kiledjian, 2018). Likewise, NUDIX family proteins were described as housecleaning enzymes, displaying
broad substrate range (McLennan, 2013). Many of them show activity as antimutator enzymes (removal of mutagenic oxi-
dized radicals of nucleotides) leading to hypothesis that this activity might have been the original function of NUDIX hydro-
lases before cleavage of nucleotide analogs, cofactors, and other molecules evolved (McLennan, 2013).
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The efficiency of decapping could be predictably influenced by RNA secondary structure, binding of chaperons and other
factors. Therefore, decapping stage might be a true regulatory point and a process responsible for overall extent of RNA
modification.
Research into noncanonical capping in prokaryotes and eukaryotes is still in its infancy; future work will hopefully answer
the following questions:
• What is the full repertoire of noncanonical caps?
• How different is the spectrum of noncanonical capping in various prokaryotic and eukaryotic species (and their
organelles)?
• Are there any other polymerases initiating with NCINs?
• Are there any proteins specifically recognizing noncanonically capped RNA?
• Does posttranscriptional, RNAP independent mechanism for noncanonical capping exist?
• Finally, perhaps the most crucial question: what are the physiological roles of noncanonical capping?
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Tuberculosis (TB) is recognised as one of the most pressing global health threats among
infectious diseases. Bacteriophages are adapted for killing of their host, and they were
exploited in antibacterial therapy already before the discovery of antibiotics. Antibiotics
as broadly active drugs overshadowed phage therapy for a long time. However, owing to
the rapid spread of antibiotic resistance and the increasing complexity of treatment of
drug-resistant TB, mycobacteriophages are being studied for their antimicrobial potential.
Besides phage therapy, which is the administration of live phages to infected patients,
the development of drugs of phage origin is gaining interest. This path of medical
research might provide us with a new pool of previously undiscovered inhibition mechan-
isms and molecular interactions which are also of interest in basic research of cellular
processes, such as transcription. The current state of research on mycobacteriophage-
derived anti-TB treatment is reviewed in comparison with inhibitors from other phages, and
with focus on transcription as the host target process.
Introduction
Mycobacterium tuberculosis, the infective agent of tuberculosis (TB), is one of the deadliest human
pathogens, with 1.7 million related deaths reported in 2016. Tuberculosis infection in otherwise
healthy individuals can remain undetected for a long time. Thus, the disease is expected to be far
more common than documented. Twenty-three percent of the world population is estimated to be
carrier of latent TB [1], 10 million new cases of active TB were reported in 2017 globally [1]. Active
TB can affect all body tissues, though it most commonly manifests in the respiratory system. Death
results from extensive tissue damage which can be accompanied by hypoxia (pulmonary TB) or
seizures (TB meningitis) [2]. It is challenging to treat M. tuberculosis, as well as other infections
caused by Mycobacterium, such as Buruli ulcer (caused by Mycobacterium ulcerans), due to the
unique physiology of the organism. For a review on M. tuberculosis virulence, see [2]. Mycobacteria
have an unusually high lipid content cell wall which is impermeable to many drugs and hydrophilic
molecules [3]. Furthermore, it is an intracellular pathogen; therefore, the drug not only has to
penetrate the bacterial cell envelope but also the host cell (macrophages, dendritic cells or tissue cells,
e.g. alveolar cells). Above all, M. tuberculosis grows very slowly and after the initial infection can
remain dormant for months, and non-growing cells make a poor target for many drugs. Infection foci
can turn into granuloma that are formed by the immune system to contain the pathogen and are
exploited by the bacterium to remain dormant until the immune system is weakened. Then the
granuloma, which are otherwise able to contain the infection indefinitely, are liquefied and bacterial
growth resumes [2].
WHO has named research and innovation as the ‘third pillar’ of the End TB Strategy. Besides
increased efforts in improvement of and addition to the antibiotic repertoire of current treatment,
research on TB vaccines is intensified. However, the currently stated goal to reach complete eradica-
tion of TB by 2035 requires a research breakthrough both in TB diagnostics and treatment to which
mycobacteriophage research should be considered as a potential contribution.
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Current tuberculosis treatment and treatment alternatives:
more is more
The current first-line treatment of drug-sensitive TB (DS-TB) involves a 6-month course of rifampicin
(inhibition of bacterial RNAP), isoniazid (inhibition of fatty acid synthase with effect on cell wall), etham-
butol (inhibition of arabinosyl transferase with effect on cell wall) and pyrazinamide (inhibition of cell
wall synthesis via fatty acid synthase) [4]. The combination drug treatment was developed in 1960 and the
treatment duration was reduced from 18 to now 6 months [5]. Rifampicin revolutionised treatment as it
acts on dormant cells [6]. The drug cocktail reduces the risk of resistance development, which still can
arise especially if treatment is paused or prematurely aborted [7]. Drug-resistant (DR) infections are docu-
mented increasingly often [8]. One common cause of first-line drug resistance is resistance to rifampicin
via mutation of RNA polymerase (RNAP) at the rifampicin-binding pocket [6]. Strains resistant to at least
rifampicin and isoniazid are considered multidrug-resistant (MDR). Drugs which are currently used in
clinical trials, such as bedaquiline (inhibition of ATP synthase), delamanid (cell wall synthesis inhibitor)
or linezolid (blocks ribosome activity), classify as third-line treatment as they are used in anti-MDR-TB
treatment, but clinical trials are incomplete [5]. If the resistance profile also includes second- or third-line
medications, this is described as extensively drug-resistant (XDR) [5]. Pan-resistant strains have been
documented [9,10].
Treatment of drug-susceptible (DS)-TB is successful in 86% cases, MDR-TB is cleared in only 50% cases.
MDR/XDR-TB therapy can constitute up to 2 years [11,12]. Long-term antibacterial treatment has detrimental
effects on the natural microflora and thus promotes further health complications in addition to common
side effects of the drugs themselves. Side effects can result in abortion of treatment thus the infection is
prolonged, and resistance is more likely to emerge. Second- and third-line drugs prove to have higher toxicity
to the patient, and higher cost to the health care system [5]. Furthermore, the chances to transmit the disease
to others during prolonged treatment are higher. WHO thus sees an update in the treatment regimen as
desirable [1].
Alternatives to antibiotic treatment are commonly used in economically poor or rural areas where medicine
is not available. In provinces in South Africa, TB is often treated with medicinal herbs. The choice of an herb
(e.g. Artemisia afra, Carica papaya or Myrothamnus flabellifolius) is according to local traditions and beliefs
but their effectivity against TB is documented in the literature [5]. Such plant-based treatments could realistic-
ally constitute an addition to the antibiotic regimen, though in areas where prescription drugs are available
should not replace them. Research on plant-derived drugs could potentially be based on those traditionally
used herbs in the future.
Tuberculosis vaccine consisting of an attenuated strain of Mycobacterium bovis, the Bacille Calmette–Guerin
(BCG) vaccine, has been in use since 1921. It is not sufficiently effective to be a reliable preventive measure
[13], as it does not prevent primary or reactivated infection but helps cure acute and disseminated disease [5].
Its effectiveness varies across geographical location and ethnic group and also in dependence on the endemic
TB strain — and was documented to be between 0% and 83% [13]. Reasons for conflicting numbers in differ-
ent studies are likely molecular differences between BCG strain and TB strain, age and genetic background of
the patient, climate, vaccination dose, and other potentially unknown factors [13]. Vaccination of immunocom-
promised persons is not recommended as it can lead to complications [13]. Still, BCG vaccine is routinely
administered to newborns of Aboriginal Canadians and people at high risk to contract MDR-TB (e.g. health
care workers in dense MDR-TB areas) [13]. Variants of BCG vaccine boosters are currently being tested.
Those may contain fragmented M. tuberculosis as an antigen, e.g. RUTI, or recombinant fusion proteins,
e.g. AERAS-402 which is a replication-deficient adenovirus that expresses virus-M. tuberculosis fusion proteins.
Vaccines under study to replace the inefficient BCG vaccine are based on M. vaccinae or recombinant M. bovis
strain VMP2002 [5].
Another treatment method for TB is immunotherapy. Several immune therapies are in use or in a clinical
trial to be used as an adjunct to combination drug therapy to obtain a reduction in symptom severity and dur-
ation. Application of cytokines and immune modulators are being tested. For example, the subcutaneous appli-
cation of interferon-c1b results in reduced inflammation of the infected lung [14]. Interestingly, administration
of hepatitis C virus and hepatitis B virus antigens (called Immunitor-V5) has been shown to aid effectively in
TB clearance while M. vaccae antigen (also called V7) studies are conflicting [5,15–17]. For more information
on experimental TB drugs, see [5].
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Mycobacteriophages—potential and challenges of phage therapy against
tuberculosis
All TB treatment options will need to overcome the challenges the infection proposes (tissue/granuloma pene-
tration, host cell penetration, drug interaction with HIV therapy). Additionally, they have to be low in toxicity
and adverse effects on microflora, short in duration and will have to be made available in rural and poor areas.
Therapy with live mycobacteriophages may comply if the research can solve a few problems which shall be
described further in this chapter. The main advantages of phage therapy are low cost of production, sparing of
microflora, and autoregulation of phage levels in the patient. Negative interactions between phage and chemical
drugs have not been documented.
Genomic studies have revealed that mycobacteriophages are one of the most diverse groups of bacteriophages
so far characterised. Mycobacteriophage genomes present highly mosaic structures due to horizontal gene
transfer and history of host changes. Over 1720 mycobacteriophage genomes have been sequenced to date [18]
and arranged into clusters according to shared nucleotide sequence similarities. As Figure 1 illustrates, there are
a total of 29 clusters, which share little or no sequence similarity, and several singletons (phages with no close
relatives). The clustered genomes share features such as regulatory systems or transfer RNA sequences [19].
Unique variety in the mycobacteriophages makes them fascinating study objects since they offer insight into
mechanisms of phage evolution and diversity [20]. The potential to find new regulatory mechanisms of the
mycobacterium–phage interaction is therefore high.
Mycobacteriophages, like all bacteriophages, may execute one of two types of infection: lytic or lysogenic.
The lytic cycle is adopted by virulent phages and is initiated after adsorption of the phage to host cell recep-
tor and injection of phage DNA into the cytoplasm. Upon transcription of viral genes and replication of its
genome, phage structural proteins are produced and organised into capsids (or ‘heads’) and tails. With the
association of daughter genomes and capsid proteins, the virion is formed. At the end of the lytic cycle, the
host cell wall is enzymatically lysed. This leads to the release of newly formed viral particles which can under-
take the same infectious cycle [21]. Temperate phages, which may opt for a lysogenic life cycle, do so by
integrating into the host chromosome using integrases and attP and attB sites for homologous recombination.
They remain dormant by selectively expressing only the phage lytic repressor protein and phage DNA is
Figure 1. Phylogenetic tree displaying sequenced genomes of 471 mycobacteriophages as analysed by Hatfull [19].
The tree captures the diversity of mycobacteriophages, which also represent the largest class of phages with sequenced
genomes to infect a single bacterial strain, Mycobacterium smegmatis mc2155 [19]. The genomes have been classified into 29
clusters (clusters A, B, C, etc.) and further in subclusters (e.g. B1, B2) according to their shared sequence similarities.
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replicated alongside the host chromosome by host machinery. A lytic cycle can be triggered by different
stress conditions, predominantly those that lead to DNA damage response via RecA pathway [22,23]. The
repressor is deactivated and lytic and structural genes can be expressed in analogy to lytic phage gene
expression. Some phages have a pseudotemperate lifestyle in which their DNA does not integrate within
the host chromosome, but lytic growth is still repressed and the phage genome replicates in the form of a
plasmid [24].
Treatment of TB with live phages has been demonstrated by Sula et al. [25] in an animal model. They
reported decreased lesions in the lungs, liver and spleen and reduction in granuloma formation when testing
mycobacteriophage DS6A in M. tuberculosis-infected guinea pigs [26]. Another study documents successful
treatment of Buruli ulcer (M. ulcerans) on mouse feet using mycobacteriophage D29 subcutaneous injection
[27]. In theory, a live phage is its own delivery system. If phage is administered to the site of infection (skin,
airways, bloodstream, etc.), it is able to recognise its host, infect, kill and move on to the next host. By multi-
plying inside the host cells, phage concentration at the site of infection will automatically increase, and phage
titre will cease after eradication of bacterium. This has been shown to be performed by a variety of other
phages ([28] and references therein). For example, phage therapy was successful in a Klebsiella pneumoniae
lung infection [29] and against Staphylococcus aureus septicaemia and abscesses on organs in mice [30]. Both
K. pneumoniae and S. aureus can adopt an intracellular lifestyle within macrophages and phages successfully
cleared intracellular infection of macrophages in vitro [29,30]. Also, M. tuberculosis is an intracellular patho-
gen, and thus far delivery of mycobacteriophages on their own across the macrophage cell membrane has not
been achieved [31]. Broxmeyer et al. used non-pathogenic M. smegmatis cells to transport TM4 phage parti-
cles to M. tuberculosis in macrophages. TM4 is a lytic mycobacteriophage which is specific to both hosts, M.
tuberculosis and M. smegmatis [32]. The technique led to a substantial decrease in TB titre, suggesting that
TM4 successfully infected and killed M. tuberculosis. A further issue for mycobacteriophage delivery is granu-
loma formation [28]. Granuloma solid and layered structure is likely to interfere with phages reaching their
host [33]. This problem has not yet been tackled in mycobacteriophage therapy research.
Opponents of phage therapy state eradication of phage by the human immune system would abort treatment
and prevent consecutive treatments. Even though phages do not attack human cells, presence of foreign mater-
ial in the body will lead to immunoglobulin-directed phage inactivation, phagocytosis and immune memory
against the phage [34–36]. Special delivery systems that protect phage from antibodies need to be constructed
to overcome this problem. Chhibber and co-workers reported the use of liposomes to shield phage from anti-
body in anti-phage serum from mice [35]. In vitro, phage without liposome was inactivated within 3 h in blood
serum while liposomal protection was 100% efficient (no inactivation, no reduction in titre). Liposomes did
not interfere with phages’ ability to adsorb to bacterial cells. The same study also showed phage delivery into
macrophages was not hindered by liposomes to clear intracellular K. pneumoniae infection. Thus, this method
is potentially viable in TB therapy as well.
Other studies even observe a synergy between phage and immune system, coined ‘immunophage synergy’
[37,38]. In a mouse model of P. aeruginosa lung infection, the contrast between the phage elimination from the
tissue by the animal immune system, and the self-amplification of the phage at the site of infection, allowed for
phage population to remain stable, furthering pathogen lysis [38]. Also, phage–antibiotic synergy (PAS) has
been proposed and documented in several studies [39–42] with different pathogens. Phage characteristics such
as good biofilm penetration [42] and expression of lytic enzymes [39] potentiate the drug. Phage-induced
holins in the bacterial cell envelope support activity of cell wall destabilising antibiotics or reactive oxygen
species [39] to an extent that can reverse antibiotic resistance [40]. This way, also alternative treatments such as
honey were enhanced [43].
Antibacterial effectors of phage origin: enzybiotics as
potential drugs
Acceptance of phage therapy is low in Western medicine. Reasons for this are the necessity to determine the
infective agent prior start of therapy due to host specificity of the phage (which in the case of TB is not an
issue); interaction with (and possibly clearance by) the human immune system; necessity to eliminate sterilisa-
tion during drug manufacturing (virus elimination as part of regulated drug production); and limitations in
phage administration due to nature of phage or disease, as described above for TB in granuloma. However,
phages represent a rich source of potential new antibacterials, with new mechanisms of action which are not
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affected by pre-existing antibiotic resistance and could potentially be implemented in the treatment regimen of
MDR/XDR, as well as DS-TB [44–46].
The evolutionary arms race between phages and their hosts has previously been an exciting source for
molecular tools. Bacteriophages have evolved alongside their bacterial hosts, which consequently developed
numerous defence mechanisms such as the CRISPR/Cas system or restriction endonucleases [20,47]. Phages
have, in turn, adapted to host bacterial immunity by evolving mechanisms of defence from spontaneous
mutations [48]. Additionally, anti-CRISPR proteins can be found on phage genomes (which inhibit Cas
protein activity or cRNA transcription or maturation) [47]. Mycobacteriophage genomes are well characterised.
1720 genomes have been sequenced, with ORFs identified, yielding a large database of putative protein-coding
sequences. Among the non-structural genes, although, the proteins encoded are not well characterised, many
were shown to be cytotoxic in the mycobacterial host. A number of these also reduce host gene expression
[49–51], also called host shut-off, which is a typical feature of viral infection [49]. These toxic phage proteins
are good candidates for future antibacterials.
A few potential mycobacteriophage effectors are currently under investigation. It was proposed that phage
endolysins can be administered exogenously and that such antibacterial enzymes should be called enzybiotics
[52,53]. At the end of the lytic life cycle, a phage must lyse the bacterial cell wall in order for its progeny to be set
free into the medium. This is accomplished by a two-component system; a holin that creates holes in the inner
cell membrane and an endolysin that is enriched in the cytosol during phage growth and then leaks through the
pores. The endolysin is a peptidoglycan hydrolase; it digests the cell wall. Host specificity is one of the advantages
of phage gene products over antibiotics. Phages infect and kill via a cascade of molecular interactions which are
highly adapted to the host target structures, from cell surface receptors to epitopes on target host proteins. Also,
the phage peptidoglycan hydrolases show high specificity to a type of peptidoglycan of one genus or even serotype
[52–54]. Mycobacteriophage Ms6 genome encodes an endolysin LysA and a lipolytic enzyme LysB [55]. LysA
was previously described as an amidase which cleaves the bond between two essential amino acids that make up
the glycosidic bond, which is crucial in the peptidoglycan formation in bacteria [55]. LysB has a high affinity for
longer chain length substrates and brings additional lipolytic activity to hydrolyse the very complex mycobacterial
cell wall [56]. Resistricted access of peptidoglycanases to cell wall through the outer membrane has been proposed
to complicate administration of endolysins from the outside [57]. Though cell division might allow to overcome
the outer membrane, such that growing cells might indeed be susceptible to endolysins “from without” [58].
Some antibacterial activity was shown for M. smegmatis intracellular infection in macrophages. Both lysins of
mycobacteriophage BTCU-1, LysA and LysB, induced morphological changes to M. smegmatis cultures and
reduced titre of M. smegmatis intracellular infections [59]. Mycobacteriophage lysis proteins could also be of
benefit as supporting treatment to antibiotics, similar to the previously described synergy between phage and anti-
biotic. For example, mycobacteriophage Bxb1 is a lytic phage, which forms plaques with halos. Plaque centres are
composed of lysed cells. In the case of other phages, halos are often caused by an enzymatic component diffusing
through top agar and inducing changes to the bacterial cell wall, such as glucanases [60]. Such enzymes might be
studied for their potential to aid other therapies in the future.
Also in other phage–host systems, phage proteins are under investigation for antibacterial application. Wang
et al. [61] engineered a fusion protein to aid uptake of phage endolysin into mammalian cells. Staphylococcus
aureus phage JD endolysin JDlys was fused to a cell penetrating transcription activator CPPtat (to give
CPP-JDlys). CPP-JDlys was successfully used to treat murine intracellular skin infection with Methicillin-
resistant S. aureus (MRSA), a problematic nosocomial pathogen [61]. Such a protein-based delivery system for
phage effectors could be applicable for mycobacteriophage lysin or other cytotoxic mycobacteriophage proteins
as well. Mycobacteriophage enzybiotics could also be employed in infection prevention, as has been reported
for Streptococcus infections: Application of recombinant phage endolysin prevented bacterial infection in the
mouse model [62]. Enzybiotics can be taken even further in transgenic livestock: Wall showed prevention of
mastitis in transgenic cows expressing S. aureus phage endolysin [63].
Large-scale screening procedures may help to identify new anti-TB drugs. Wei et al. synthesised 200 peptides
based on mycobacteriophage gene databases and screened them for their activity on trehalose-6,60-dimycolate,
an M. tuberculosis glycolipid. They found one protein, PK34, which binds the glycolipid and cleared TB in the
mouse model, and reduced level of proinflammatory cytokines [64]. Further studies should be undertaken
which might focus on a specific mycobacterial target and use toxicity screening methods or pull-down assays to
efficiently find mycobacteriophage effectors. For a review on potential anti-TB peptides from various
sources, see [65].
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Host transcription as a target of bacteriophage regulators
One potential mycobacterial target is transcription, which is the first and most regulated step of gene expres-
sion. The main enzyme of transcription, RNAP makes a good target for inhibition because of its central role
in the cell and its conserved nature in the prokaryotic kingdom which allows for selective targeting. The
basal level of transcription is needed even in the dormant stage [66], therefore, non-growing cells can be
targeted with drugs against RNAP. The process of transcription can be segregated into several steps (see
Figure 2). These are (i) holoenzyme formation and promoter binding, (ii) melting of double-stranded DNA
around the transcription start site, and isomerization from RNAP-promoter closed complex (RPc) to
Figure 2. Schematic overview of transcription cycle in bacteria.
RNAP β and β0 subunit are depicted in pink, and the different domains of σ subunit (σ1, σ2, σ3, σ4) are depicted in blue. Upon
binding of the holoenzyme to the promoter (σ4 to the -35 region, and σ2 to the -10), DNA unwinds, leading to an open
complex. This is followed by transcription initiation (signalled as the +1 arrow) and release of short RNA abortive products.
Elongation stage is defined by the production of RNA chains ≥10 nucleotides long [62].
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RNAP-promoter open complex (RPo), (iii) initiation of RNA synthesis, (iv) promoter escape and elongation
and finally (v) transcription termination (not shown in the figure). The RNAP core is made up of several
subunits, α, β, β0, γ and ω (in Figure 2 only β, β0 are shown for simplicity), completed by the σ factor to
form the holoenzyme. Essential transcription factor RbpA is a common feature in Actinobacteria (such as
Mycobacterium) RNAP-promoter complexes. RbpA is a protein that binds the RNAP holoenzyme and has a
role in transcription initiation. It was hypothesised to play a role in promoter binding and open complex
formation on non-‘extended -10’-type promoters as well as σB promoters [67,68]. The elongation stage of
transcription takes place after dissociation of core enzyme from σ and promoter region in progressive fashion
along the template in open complex. Continuous RNA polymerisation can be interrupted by pausing and ter-
mination signals but can be resumed by the transcription elongation complex (TEC). Errors in transcription
(e.g. mismatches) can lead to backtracking of RNAP [69]. Transcription is terminated when RNAP reaches a
termination signal. Rho-dependent and Rho-independent termination function via two different mechanisms.
In Rho-independent termination, secondary structure formation in the RNA product (loops) destabilise TEC
and cause RNAP to pause and eventually dissociate from the template. In Mycobacteria this depends on
7–9 nt long U-rich sequences (U-tracts). Mycobacterial RNAP (in contrast with E. coli RNAP) terminates
efficiently at U-tracts even in the presence of elongation factors. Furthermore, the elongation factor NusG in
mycobacterial transcription can perform a second terminatory role [70]. Rho-dependent termination is
characterised by destabilisation of the TEC over termination factor Rho [71,72]. Similar to the E. coli
Rho-dependent pathway, mycobacterial Rho binds to sites on mRNA and uses ATPase and helicase activity
to move itself towards RNAP to initiate its release from the template. Transcription of ribosomal genes is
terminated in a different mechanism involving Nus proteins and other factors [72]. RNAP gene sequences
are vastly conserved throughout the prokaryotes and altogether ∼25% of sequences show evolutionary
variability. Variable regions are mostly expendable and their deletion does not affect basic enzymatic activity.
However, they provide targets for species-specific regulators as well as exogenous interaction partners, like
phage-encoded regulators [73].
Thus far, no phage RNAP has been found to be encoded by any known mycobacteriophage. In lysogenic
mycobacteriophage L5, it was shown that phage gene expression is susceptible to rifampicin, indicating that
the phage requires bacterial RNAP [50]. Thus, it is very likely that mycobacteriophages regulate host RNAP,
as many other known phages do [74]. It was also shown that L5 lytic gene expression results in host shut-off
[50]. However, for mycobacteriophage TM4, no host shut-off could be observed during lytic infection [75].
Figure 3 depicts how mycobacteriophage gene expression is regulated in the context of the phage life cycle.
Most of what is known about mycobacteriophage transcription regulation concern transcription patterns over
the course of an infection. In lytic infection, gene expression is often regulated to take place in phases [75].
For example, TM4 gene expression is regulated to take place in an early phase (20–60 min p.i [post infec-
tion]) and a late phase (60 min p.i. and later) [75], thus co-ordinated transcription regulation must take
place during TM4 infection as well. The late genes seem to be mainly associated with virus particle structure
and assembly [75]. TM4 also encodes a protein with high similarity to Streptomyces transcriptional regulator
WhiB, a transcription factor of sporulation [75]. M. tuberculosis also carries seven whiB-like genes
(whiB1-whiB7). Overexpression of TM4-whiB inhibits mycobacterial cell division via specific repression of
whiB2 (a component of cell division regulation) and is thus a putative candidate for anti-TB therapy research
[76]. Fan et al. [77] were the first to investigate the reciprocal effects of mycobacteriophage gene expression
(phage SWU1) and host gene expression (M. smegmatis). SWU1 infection shifted host gene expression
rather than causing a shut-off. While genes of RNA translation and degradation, protein export and other
secretion and glycerophospholipid metabolism were up-regulated, expression of siderophores and nitrotoluene
degradation genes were down-regulated. Markedly, SWU1 infection up-regulates translation of RNAP sub-
units genes rpoA, rpoB, rpoC and rpoZ as well as housekeeping σA and stress sigma factor σF [77].
Up-regulation of transcription machinery combined with strong promoters is a reasonable method of viruses
to ensure their own transcription without suppressing host maintenance. Mycobacteria have a variety of σ
factors (M. tuberculosis has 13, M. smegmatis 28) with σA being the housekeeping σ [78]. σA is also the
only −10/−35 type σ with sequence specificity in analogy to E. coli σ70. Mycobacteriophage BP, like many
other mycobacteriophages, potentially usurps transcription with a strong promoter that interacts with host
σA [78].
Another aspect of transcription known to be manipulated by phages is termination. Many phages have long
operons with many open reading frames (ORFs). To ensure transcription of long RNA, termination signals
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have to be ignored by RNAP [79,80]. Mycobacteriophage Ms6 was first shown to employ anti-termination by a
phage-encoded antiterminator factor [81]. A recent study [82] has demonstrated that a capsid protein (Psu) of
E. coli host bacteriophage P4 suppresses transcription terminator factor Rho by inhibiting its ATPase and trans-
locase activity, therefore, promoting anti-termination. Psu also inhibits Rho derived from other hosts, including
M. smegmatis, M. tuberculosis and M. bovis.
A
B
Figure 3. Illustration of phage transcription in the context of phage life cycle.
Upon adsorption onto the bacterial cell, the phage injects its genome into the host. Temperate phages integrate their genome
into the host chromosome to reside dormant (as a lysogen) and express a lytic repressor which can be suppressed to induce
the lytic life cycle. In case of lytic phages, phage gene expression follows genome injection [21,23]. (A) Host RNAP (tbRNAP,
yellow) recognises the strong phage promoter (here Pearly) to transcribe mainly non-structural genes used to regulate cellular
and phage processes such as for transcription factors, anti-terminators or nucleases for mRNA maturation. Anti-termination
systems (here in grey) may be used to ensure long phage operons are entirely transcribed. (B) Later in infection, transcription of
late genes is started (here from another promoter Plate) which usually encode structure and assembly proteins such as capsid
or tail subunits, proteases for capsid maturation or DNA packaging proteins. Finally, the enrichment of continually expressed
lysins lead to cell rupture and mature virions will be released [23].
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The state of research on bacteriophage effectors on transcription has also advanced in other phage–host
systems such as E. coli, Bacillus or Thermophilus phages. Examples of regulators of transcription from phage
origin along with known antibiotics targeting the same stage of transcription are given in Table 1. Remarkably,
phage effectors’ and antibiotics’ molecular targets often differ, supporting the hypothesis that phage enzybiotics
should remain active against DR pathogens.
Another necessary research focus should be drug delivery. The intracellular nature of M. tuberculosis means
that second barrier, the mammalian cell membrane, has to be crossed by the drug. In phage therapy, one strat-
egy to overcome the issue could be to feed phage-infected M. smegmatis to macrophages [32]. However, macro-
phages are specialised bacteria eaters. If tissue cells are infected, the eukaryotic membrane needs to be crossed
via regular phagocytosis/endocytosis. In enzybiotics, the development of fusion proteins that are able to
Table 1. Known inhibitors of RNAP or transcription processes from phage gene products or (developmental) drugs such as antibiotics
Published compound name/phage protein are given as referenced in literature, slash means compound or function was referred to in additional names.
Target
Phage effector Other inhibitory substances
Protein (phage, host) Function (reference) Inhibitor (classification) Function (reference)
Initiation
Sigma binding AsiA (T4, E. coli) Anti-σ/σ appropriation [80–82] Compound C5
(developmental drug)











Redirection of RNAP from








Redirection of RNAP from host




Blockage of switch region [91]
















Allosteric alteration of active site [96]
Streptolydigin Stabilises inactive intermediate of
TEC [97]




Blocks secondary channel [99]
Termination
Termination N-protein (λ, E. coli) Binding of elongation factors
creates termination-resistant TEC
[100,101]
p7 (Xp10, X. oryzae) Binding of β0 stabilises TEC [102]
Gp39 (P23-45, T.
thermophilus)
Stabilisation of TEC to transcribe
through poly (U) termination
signal [103]
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transgress mammalian membrane [61], is a good example of where future research might lead us. Finally, in
TB, drug delivery is further complicated by granuloma formation. A strategy to overcome this dense tissue has
not been found yet.
Conclusion
The study of mycobacteriophage effectors is currently in its infancy. As research of other phage–host systems
shows, however, the chances are good to find a mycobacteriophage protein that inhibits host transcription irre-
spective of antibiotic resistance. Bacteriophage effectors have been found which interact with RNAP, promoter
DNA, or other transcriptional regulators. Due to the unprecedented diversity of mycobacteriophages and
advanced state of documentation of mycobacteriophage genomes, focussed research for anti-TB drugs from
phage origin could be a potential solution to spreading antibiotic resistance of the pathogen. A major problem
of TB treatment is drug delivery, due to unique cell envelope and lifestyle of the pathogen. The field of enzybio-
tics works on protein-based drug design: Fusion proteins of a cell wall translocator and a phage effector protein
have been achieved in the context of MRSA skin infections and could be attempted for TB [104–109].
Perspectives
• Importance: TB is one of the leading causes of mortality among bacterial pathogens world-
wide, with an estimated 1.3 million deaths occurring every year. WHO has implemented a strat-
egy to eventually eliminate the TB pandemic until 2035. Progress of the strategy is monitored
annually and compared with intermediate goals set for 5-year periods. Even though the global
burden of the infection has been reduced, progress remains behind set intermediate goals,
and there is an increasing emergence of MDR and XDR-TB cases. For these, treatment is
much more expensive, has lower efficacy, longer duration and higher toxicity [8]. Intensive
research, as well as adapted guidelines to speed up the drug admission process, are neces-
sary to keep up with resistance spread. We view both phage therapy and enzybiotics as poten-
tial contributors to future TB treatment, which would be applicable to both drug-susceptible
and drug-resistant TB strains. Research should focus on exploiting phage effectors and derive
more intelligent antibacterials to (i) target the pathogen only, not the microflora and (ii) exploit
new mechanisms which circumvent evolved antibiotic resistance in MDR strains. These drugs
could potentially be added to or even replace the current TB treatment regimen and contribute
to WHO ‘End TB Strategy’.
• Summary: Studies of phage therapy against TB in animal models yielded promising results.
Also, mycobacteriophage endolysin has been shown to effectively reduce TB infection [59].
However, the search for new phage effectors can be intensified, focussing on different myco-
bacterial molecular targets. The important groundwork was laid by projects initiated by
Professor Hatfull: the sequencing of over 1720 mycobacteriophage genomes and their host
spectrum characterisation [18] makes successive work to identify specific inhibitors much
easier. Phages are intracellular pathogens to their bacterial hosts. In phage–host coevolution,
continual development of resistance by mutation of host structures was continually overcome
by new phage strategies. This race has been going on for thousands of years during which
more and more powerful, adapted and specialised targeting was developed by the phage.
Thus, it is not surprising that phages are highly specific to their host, and the molecular target
can often not be exchanged by the homolog from another bacterial species. Selectivity and
precision are clear advantages of phage gene products over antibiotics [44]. The study of
molecular interactions between phage and host proteins during phage infection reveals that
phages utilise various mechanism to target essential host processes, such as transcription. A
number of studies show different mechanisms used by phages to hijack host transcription
machinery for transcription of their own genes [76,81]. Remarkably, phage transcription inhib-
ition differs from transcription inhibition by known drugs, thus it is likely that drug resistance
does not affect the impact of the phage inhibitor. Thus cytotoxicity of phage gene products
could potentially be exploited in MDR- and XDR-TB therapy.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society10
Biochemical Society Transactions (2019)
https://doi.org/10.1042/BST20180506
• Future directions: Current research is focusing on DS- and DR-TB treatment from different
angles, such as improvement of existing substances like rifampicin [83]. Research in other
infectious bacterial diseases shows phage administration can stimulate the immune system
and work in synergy with antibiotics [38–42], potentially attributing to phage lysins which desta-
bilise the cell envelope to increase cytosolic drug concentration and activity of drugs which
attack the cell envelope [52–54]. Lysins as enzybiotics have been shown to be bactericidal and
support antibiotics. Also, mycobacteriophage endolysins are known [55,57]. Thus far, enzybio-
tics research is mainly focussed on phage endolysins. However, other phage gene products,
which interact with essential cellular structures or processes, could be used as biocins as well.
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Recently a new, non-canonical type of 5’-RNA capping with cellular metabolic 
cofactors was discovered in bacteria and eukaryotes. This type of capping is performed 
by RNA polymerases, the main enzymes of transcription, which initiate RNA synthesis 
with cofactors.  Here we show that primase, the enzyme of replication which primes 
synthesis of DNA by making short RNA primers, initiates synthesis of replication 
primers using the number of metabolic cofactors. Primase DnaG of E. coli starts synthesis 
of RNA with cofactors NAD+/NADH, FAD and DP-CoA in vitro. This activity does not 
affect primase specificity of initiation. ppGpp, the global starvation response regulator, 
strongly inhibits the non-canonical initiation by DnaG. Amino acid residues of a “basic 
ridge” define the binding determinant of cofactors to DnaG. Likewise, the human primase 
catalytic subunit P49 can use modified substrate m7GTP for synthesis initiation.  
For correct genome duplication, the RNA primer needs to be removed and 
Okazaki fragments ligated. We show that the efficiency of primer processing by DNA 
polymerase I is strongly affected by cofactors on the 5’-end of RNA. Overall our results 
suggest that cofactors at the 5’ position of the primer influence regulation of initiation 







A. Non-canonical capping of RNA by RNA polymerase. RNA polymerase uses cellular cofactor as 
initiating substrate for RNA synthesis, instead of NTP. Then RNA chain grows, while cofactor remains attached and 
serves as cap. B. Proposed mechanism of non-canonical initiation of RNA primer synthesis by DnaG primase during
replication. DnaG primase initiates synthesis of the primer for DNA replication using cellular cofactor. Primer stays annealed 
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This work was inspired by the recent discovery of the non-canonical RNA 
capping phenomenon. Many RNA species in bacteria and eukaryotes bear metabolic 
adenine-containing cofactors at their 5’-end; NAD+ (nicotinamide adenine dinucleotide) 
and DP-CoA (dephospho- coenzyme A) and FAD (flavin adenine dinucleotide), as well 
as cell wall precursors UDP-GlcNAc (uridine 5’-diphospho-N-acetylglucosamine) and 
UDP-Glc (uridine 5’-diphosphate glucose) (1, 2). Unlike the classic cap m7G, non-
canonical caps are installed by the main enzyme of transcription, RNA polymerase 
(RNAP)(3). It happens during initiation of transcription in a template-dependent manner 
– ADP-containing cofactors are incorporated at promoters with +1A start sites, i.e. 
promoters dictating ATP as the initiating substrate (3, 4), UDP-containing cell wall 
precursors - on +1U promoters (3).  
  By analogy with the classic cap, there are decapping enzymes for non-canonical 
caps, in E. coli it is NudC (NADH pyrophosphohydrolase of the NUDIX family). NudC 
processes NADylated RNAs into a monophosphorylated species that are quickly 
degraded in the cell (5).  
Overall it appears that unrelated multi-subunit eukaryotic and bacterial RNAPs as 
well as the single-subunit RNAPs of mitochondria and viruses can utilize non-canonical 
initiating substrates (NCISs) and perform RNA capping (6). Another DNA-dependent 
enzyme initiating de novo synthesis of RNA is primase (DnaG in bacteria) which makes 
primers for replication and present in all organisms. It is not structurally related to either 
single subunit e.g. mitochondrial RNAP or multi subunit bacteria or eukaryotic RNAPs. 
In E. coli, DnaG recognises a consensus GTC motif and makes a 10-12 nucleotides long 
RNA primer. Primase acts in concert with other replication proteins. Primase requires 
DnaB helicase to start synthesis on double-stranded DNA (7). Primase is then displaced 
and the primer is elongated by the DNA polymerase III to produce the RNA/DNA 
polynucleotide of a leading strand or an Okazaki fragment of a lagging strand (8). RNA 
primers need to be removed via the combined actions of DNA polymerase I (PolI) and/or 
RNaseH before the Okazaki fragments and leading strand are ligated to complete genome 
replication. Thus, synthesis of an RNA primer by primase is believed to be a rate limiting 
step of replication (9), tightly coupled to other steps of the replication process. Primase  
plays a key role during assembly of the replisome (10), regulation of replication 
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elongation and Okazaki fragments length (11, 12) in both bacterial and eukaryotic 
systems. In bacteria, DnaG primase plays a part in a global concerted response to 
starvation via starvation alarmone ppGpp which inhibits primer synthesis in nutrient 
limited conditions (13).  
 Here we show that E. coli primase DnaG starts synthesis of a replication primer 
using a number of ADP-containing cofactors in vitro, including NAD+/ NADH, FAD and 
DP-coA. This reaction requires amino acid residues of the DnaG “basic ridge” region, 
and is inhibited by global starvation alarmone ppGpp. We also show that cofactors on the 
5’-end of RNA specifically and differentially affect processing of this RNA by DNA 
polI. Our data suggest that 5’-cofactors influence initiation efficiency and the rate of 




E. coli DnaG primase initiates RNA primer synthesis using NAD+, NADH, FAD and 
DP-coA. 
DnaG primase functions as a low-processive RNA polymerase able to start de novo RNA 
synthesis on a DNA. We wanted to test if primase can initiate synthesis using ADP- 
containing metabolic cofactors, (structures on Fig. 1A), by analogy with other 
polymerases.  
We used a general priming system, i.e. minimal system in the absence of single-
strand DNA-binding protein. This set-up requires only DnaG for RNA primer synthesis 
on the short single-stranded DNA template containing GTC recognition motif (scheme on 
Fig. 1B)(7). 
 We found that DnaG makes a 13nt long RNA product in a subset of NTPs using 
either ATP, NAD+, NADH, FAD and DP-coA (Fig. 1B). To avoid confusion and for 
simplicity, we will refer to the length of RNA with conventional substrates even though 
cofactors are dinucleotides. Notably, DnaG incorporates NAD+  much less efficiently 
than NADH, in contrast to other RNAPs, which do not discriminate between NAD+ and 
NADH (4).  We found that affinity to the non-canonical initiation substrates is 
comparable with their physiological concentrations. Michaelis constants we measured for 
ATP, NADH and FAD as initiating substrates, were 46.6, 109 and 390 µM, 
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correspondingly. In actively growing in rich media E. coli cells, concentrations of ATP, 
NADH and FAD are 9.6 mM, 100-1000 µM and 200 µM, correspondingly (14, 15).  
NADH capped primers were not susceptible to decapping by NudC, unless 
primase was washed away with high salt buffer, like in the experiment shown on Figure 
1C. This result is in agreement with the view that full length primer stays bound to the 
DNA template and in complex with primase (12), in our case even if the primer contains 
extra moiety on its 5’-end. 
 
 
Figure 1. Primase DnaG initiates replication primer synthesis with NAD+,  
NADH, FAD and DP-coA. A. Structures of cofactors molecules (NAD+, NADH, FAD 
and DP-coA) in comparison to ATP, the preferred initiating substrate of primase. B. 
Replication primer synthesis on single-stranded DNA template, scheme above, with ATP, 
NAD+, NADH, FAD, and DP-coA as initiation substrates. C. RNA primer with 5’-
NADH is susceptible for cleavage by NudC nuclease after DnaG was removed from the 
complex with high salt wash. Note that absence of ATP from the reaction results in an 
increased amount of non-specific product, which is not susceptible to NudC in lanes 5, 6. 
We assume that this band results from initiation with GTP present in the reaction. 
 
Interestingly, after primase was removed, 5’-NADH of  “naked” RNA primer 
annealed to DNA was susceptible to NudC, in contrast to the published result with 5’-
NADH of RNA annealed to RNA (5). Therefore, NudC may have a limited window of 
opportunity to remove the cap from the primer during active replication and participate in 
processing of replication intermediates. 
 
Cofactors substrates do not affect DnaG specificity of initiation 
replication 























NudC -   + -    +-   +



















dinucleotide     
ATP
Adenosine 
5′-triphosphate    
A 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/741967doi: bioRxiv preprint 
	 6	
 Cofactors are dinucleotides, and therefore can make additional contacts with DNA  
template at -1 position relative to the start site (scheme on Fig. 2). These contacts may 
affect initiation specificity by DnaG which recognises GTC motif on a template strand. 
The central T codes for A and G is a template -1 base. To test if cofactors incorporation 
depends on the nature of -1 base, we tested synthesis of RNA13 on templates with -1 
changed to three other bases. This experiment we 
performed with initiation substrates concentrations 
roughly in the region of their corresponding Kms (50 
µM for ATP and 500 µM for cofactors). We found 
that primase preferred purines in this position, and 
the least preferred base is C (Fig. 2). Initiation with 
cofactors did not change these preferences, 
suggesting that cofactors do not make specific 
contacts with -1 base of the template. This result also 
implies that cofactors as substrates do not change 
specificity of DnaG initiation and do not lead to 
spurious initiation.  
 
Figure 2.  Cofactors do not make specific contacts with -1 DNA template base. 
Synthesis efficiency of RNA13 started with ATP or NADH, FAD or DP-CoA on DNA 
templates with C, A or T at position -1 was compared to consensus -1G template. 
Relative efficiency of synthesis is shown in percentage from -1G template, error bars 
reflect standard deviations from three independent experiments. 
 
Initiation of RNA synthesis with cofactors requires basic ridge amino acid residues 
of DnaG 
 Since cofactors do not make strong contacts with DNA, they most probably contact 
DnaG protein itself. A number of amino acid residues, including several in a “basic 
ridge”, were implicated in initiation nucleotide binding based on sequence conservation 
amongst primases and structural information for the Staphylococcus aureus primase (13). 
We tested synthesis of a primer by DnaG with amino acid substitutions, K229A, Y230A 
K241A (basic ridge) and D309A (participating in metal chelation), which were all 
previously shown to influence initiating substrate incorporation (13, 16), in the presence 
of DnaB. We found that “basic ridge” substitutions K229A, Y230A, and to some extent 
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D309A. We assumed that NMN and FMN moieties of the corresponding cofactors might 
make contacts with these amino acid residues either during binding of the initiating 




Figure 3. DnaG basic ridge residues affect initiation with NADH and FAD. A. 
Structure of the S. aureus DnaG-ATP complex in the vicinity of a catalytic site PDB 
4EDG. ATP (in two conformations) is in teal, amino acid residues, which we tested for 
efficiency of cofactor initiation are in magenta. B. Relative efficiency of NADH and FAD 
utilisation as initiation substrates in comparison to that of ATP, for WT DnaG and 
mutants with amino acid residues substitutions to alanines at positions 229, 230, 241 and 
309. Error bars reflect standard deviations from three independent experiments. 
 
ppGpp strongly inhibits non-canonical initiation by DnaG. 
 Under nutrient deficient conditions, replication is inhibited via the action of global 
stringent response regulator, alarmone ppGpp, on DnaG.  PpGpp binds DnaG at the 
active site (13), presumably overlapping with the binding site where caps bind during the 
initiation of primer synthesis. To test if ppGpp competes with capping cofactors NADH 
and FAD during initiation we measured the maximal rate of RNA product formation in 
the presence of increasing concentrations of ppGpp (control reactions were done with 
ATP as initiator). From the plot of residual activities vs ppGpp concentration, it appears 
that ppGpp competes with cofactors more efficiently than with ATP (Fig. 4). This 
tendency correlates with Michaelis constants for the initiation substrates which increase 
in a sequence ATP-NADH-FAD. Therefore, in the absence of structural information on 
DnaG complexes with cofactors, we can only suggest that binding site is shared by 
ppGpp and cofactors. During the stringent response, ppGpp concentration might raise 
above 150 µM in E. coli (17) which is roughly, judging from plot, above or close to 
ppGpp inhibition constants for synthesis reaction of FAD-RNA and NADH-RNA. This 
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result might additionally mean that in vivo replication initiation with cofactors would be 
inhibited earlier during transition into 











Figure 4. Initiation with cofactors is more susceptible to inhibition by ppGpp than 
initiation with ATP. Residual DnaG activities are plotted against an increasing 
concentrations of ppGpp, in percentages from amounts in the absence of ppGpp. Error 
bars reflect standard deviations obtained from three independent experiments. 
 
Cofactor 5’-caps differentially affect primer processing by PolI. 
To complete replication, the leading strand and Okazaki fragments of a lagging 
strand need to be processed and ligated. The processing involves RNA primer 
degradation coupled to extension of previous Okazaki fragment by PolI, which possesses 
5’-exonuclease and 3’- DNA polymerase activities. We examined if the presence of 
cofactor on the 5’-end of a RNA primer affects its removal by PolI. This experiment was 
done using a DNA-RNA construct mimicking part of replication intermediate (Fig. 5, 
top). The construct consisted of hairpin-containing DNA template with RNA primer 
(RNA12) produced by DnaG annealed to the single stranded DNA part. DnaG primase 
was subsequently removed by washing with high salt containing buffer. The DNA-RNA 
construct was immobilised on streptavidin beads via biotin on DNA, which ensured that 
the processing observed happens on an RNA annealed to a DNA (See Methods section 
for more details). Addition of PolI and dNTPs led to a stepwise degradation of RNA, as 
seen from kinetics of RNA12 degradation on a gel image and the plot below it on Fig. 5. 
PolI activity was stimulated by the 5’- end NADH; from Fig. 5 it can be seen that full 
length NADH-RNA12 disappeared in 30 seconds. In contrast, presence of 5’-FAD on the 
RNA12 greatly reduced the rate of degradation, and FAD-RNA12 was still visible after 4 
minutes. ATP-RNA12 was degraded with somewhat intermediate rate. Our data suggest 
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Figure 5. Cofactors at the 5’- end of a primer differentially affect its processing by 
PolI - NADH speeds it up, FAD inhibits. Scheme of the hairpin DNA substrate with 
annealed RNA made by DnaG is shown above the gel. On the gel products of time 
dependent degradation of the ATP-RNA12, NADH-RNA12 FAD-RNA12 made with 
either ATP, NADH or FAD as initiating substrates is shown. Below the gel image, the 
same degradation kinetics are presented on a plot. Plot shows amount of the initial full-
length of primer as a function of incubation time with PolI and dNTPs. Error bars reflect 
standard deviations obtained from three independent experiments. 
 
Eukaryotic primase catalytic subunit P49 uses modified initiating substrate 
 In addition to prokaryotic system, we wanted to test if the human primase catalytic 
subunit P49 utilises ADP containing cofactors. We analysed the formation of the first 
dinucleotide product by this enzyme on the single stranded DNA template (sequence on 
Fig. 6). We were unable to make this enzyme to start synthesis with ATP at a specific 
start site, and initiation with GTP was very inefficient on this template (lane 2). Yet, P49 
efficiently produced a dinucleotide using m7GTP as initiating and UTP as the substrate 
for the second position (lane 4). This ready incorporation of a modified substrate hints at 
P49 general low fidelity and propensity to non-canonical initiation. Therefore, our result 
suggests that P49 might utilise a variety of non-canonical substrates with possible 
consequences for initiation kinetics and elongation to full length primer (18).  
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Figure 6. Human primase catalytic 
subunit P49 efficiently utilises m7GTP as 
initiating substrate. Scheme of the single-
stranded DNA template is above the gel 
image. On the gel products of first step of 
synthesis with different initiating 
substrates and UTP as extending 




Here we showed that DnaG primase initiates synthesis of a replication primer 
with ADP-containing cellular cofactors. This ability is reminiscent of that of RNA 
polymerases of transcription, yet there are notable differences. We found that DnaG uses 
NAD+ very inefficiently compared to NADH, in striking contrast to bacterial and 
mitochondrial transcriptases which do not distinguish between the two (4, 6). This feature 
of DnaG might connect priming of replication to the redox state of the cell. We also 
showed that the template base at -1 position does not play role in non-canonical substrate 
utilisation by DnaG, unlike transcriptases, which at least in some instances are sensitive 
to the -1 base (3). This result suggests that the incorporation of cofactors does not lead to 
spurious initiation or increased noise in the system.  
For the first time here we show that global starvation response regulator, ppGpp 
affects non-canonical initiation of RNA synthesis. It remains to be seen if incorporation 
of non-canonical substrates by bacterial RNAP is influenced by ppGpp.  
RNA pieces of Okazaki fragments are destined to be removed. Yet despite the 
transient nature of these RNAs, a balance between kinetics of removal and extension 
defines the mean size and length distribution of Okazaki fragments and ultimately 
replication kinetics (9). We showed that the rate of processing of replication primer by 
PolI is affected specifically by 5’-cofactors. NADH greatly stimulates, and FAD and DP-
CoA inhibit the processing. We also found that decapping nuclease NudC can remove 5’-
cofactors from RNA even if RNA is annealed to DNA. Therefore, hypothetically, NudC 
may assist removal of primers aberrantly left unprocessed in the cell.  
The propensity of the human primase catalytic subunit to incorporate efficiently a 
modified substrate, an analogue of the classic cap m7GTP, suggests the probability of 
non-canonical initiating of replication in eukaryotes. 
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The evidence on physiological roles and the regulatory mechanisms of cofactors 
as non-canonical initiating substrates in transcription are emerging. It was demonstrated 
that capping influences the stability of RNA (2), and capping stimulates RNAP escape 
from the promoter (3). We show that replication may also be affected by cofactor 
incorporation. Currently, more potential nucleotide analogues, including dinucleotide 
polyphosphates incorporated into 5’ position of cellular RNAs are being discovered in 
both kingdoms (2). The role of these emerging substrates potentially extends to 
replication regulation. 
Our results strongly suggest that cofactor initiation of replication happens in vivo, 
and future research would confirm this. At present we were unable to detect presence of 
cofactors on RNA primers in vivo, most probably due to the transient nature of a 
replication primer, relatively low number of primers per cell, and the sensitivity 
limitation of the methods we used. Nevertheless, we keep trying. 
 
Materials and Methods 
Strains and Plasmids 
DnaG wt was overexpresed grom pCA24N-dnaG plasmid (KAYO collection), 
DnaB wt from pCA24N-dnaB (strain JW4012) ASKA collection. DnaG was transferred 
to plasmid pET28a via Gibson Assembly. DnaG mutants K229A, Y230A, F238A, 
K241A and D309A were generated by Quick change mutagenesis from pET28a-dnaG wt 
basis.  
Media and selection 
E. coli were always grown in Luria bertani (LB) medium (broth or agar). In 
presence of pET28a Kanamycin (50 mg/L) was given to select for plasmid, pCA24N was 
selected with Chloramphenicol (34 mg/L). 
Cloning of WT and mutant DnaG  
Gibson Assembly and QuickChange protocolls were used according to 
manufacturer’s specifications and transformed into E. coli DH5α cells. After sequencing, 
the plasmid was retransformed into E. coli T7 overexpression strain. 
Protein purification 
DnaG wt and mutants were grown in 1 L LB with Kanamycin to an OD600= 0.5 
at 37° C before induction with IPTG (1 mM) and continued growth at room temperature 
overnight. Cells were pelleted and stored at -80° C until lysis using sonication in 
Grinding Buffer (20 mM Tris-HCl pH 7.9, 200 mM NaCl, 5% Glycerol) and Ni-column 
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purification (His-trap) in Purification Buffers A (20 mM Tris-HCl pH8, 600 mM NaCl, 
5% g;ycerol) and B (same as A plus 200 mM imidazole). Protein was bound to column at 
10 mM Imidazole, washed at 25 mM, and eluted at 200 mM imidazole). The reasonably 
clean protein was dialysed against Storage buffer (20 mM Tris-HCl pH 8, 50 % 
glyceerol, 200 mM KCl, 0.5 mM EDTA, 1mM DTT). DnaB was overexpressed from 
pCN24A in presence of Chloramphenicol, but likewise induced with 1 mM IPTG 
administered at OD600= 0.8 and grown over night. The rest was done as with DnaG. 
NudC protein was purified similarly except in the absence of EDTA and DTT. 
In vitro primer synthesis 
Primers were synthesises by DnaG (+/- DnaB) on one of above mentioned 
templates in presence of 100 uM UTP and 10 uM GTP as well as approx 0.04 MBq 
αP32-GTP per uL in primase buffer (50 mM HEPES pH 7.0, 20 mM Mg-Acetate, 100 
mM K-Glutamate, 10 mM DTT) at 30° C for 10 minutes, unless otherwise indicated in 
results. The reaction was stopped either in Stop buffer (1x TBE, 7 M Urea, 20 mM 
EDTA, 100 ug/ml heparin, 0.02% Bromphenol blue, 0.02 % Xylene cyanole, 85% 
Formamide) or by addition of 1 M NaCl (final concentration). Buffer exchange or 
removal of excess NTPs and abortive products were performed by gel filtration (BioRad 
Micro-Spin 6), if necessary. 
Pol I primer degradation 
Primer was generated on the hairpin template 
(TTTACGCTTCGTTGACACACACACTGCGCGTTTGGGAAAACTCTTTCCCAAA
C) by DnaG (1 µM) and DnaB (3 µM) premixed at RT with initiator (100 µM ATP or 1 
mM other initiator (NAD, NADH, FAD, dpCoA)), 10 µM (α-32P) GTP (0.1 mCi/mmol), 
100 µM UTP, in primase buffer (50 mM HEPES pH 7.5, 20 mM Mg-Acetate, 100 mM 
K-Glutamate, 10 mM DTT) at 30 °C for 10 min. Reaction was stopped by adding a final 
concentration of 1 M NaCl. Protein was removed from reaction by adding Ni-NTA 
agarose beads in primase buffer and 1 M NaCl. After incubation at RT for 5 min, bead 
supernatant was transferred to gel filtration column (Micro-Bio Spin 6, BioRad). Filtrate 
was added onto DNA Polymerase 1 (PolI) (E. coli source, Fisher Scientific), 0.25U/uL 
reaction, alongside 10 uM dNTPs, and PolI buffer (20 mM Tris-HCl pH 8, 50 mM KCl, 
10 mM MgCl2). Incubation at 37°C was stopped after 5, 10, 20, 30, 45, 60, 120 and 180 
seconds with Stop buffer. 
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